hepat
lobul
anatom
unit
liver
anatom
model
liver
lobul
organ
irregular
polygon
demarc
connect
tissu
compos
plate
hepatocyt
radiat
outward
central
vein
portal
triad
figur
hepat
acinu
function
unit
liver
function
model
hepatocyt
instead
orient
around
affer
vascular
system
portal
vein
hepat
arteri
anastomos
sinusoid
figur
central
vein
peripheri
acinu
instead
central
locat
anatom
model
acinu
divid
three
contigu
zone
correspond
distanc
arteri
blood
suppli
hepatocyt
closest
proxim
arteriol
zone
receiv
greatest
oxygen
content
also
first
line
affect
toxin
transport
gut
portal
vein
zone
hepatocyt
resid
peripheri
acinu
near
central
vein
zone
hepatocyt
interspers
zone
zone
hepatocyt
anatom
model
perhap
easier
understand
function
model
serv
better
foundat
understand
liver
patholog
either
model
portal
venou
arteri
blood
flow
centripet
toward
central
vein
wherea
bile
flow
centrifug
away
central
vein
hepatocyt
extract
nutrient
oxygen
portal
arteri
perfus
respect
produc
bile
acid
bile
constitu
transport
hepatocyt
bile
canaliculi
ductul
duct
basic
element
biliari
tract
hepat
canaliculi
bile
ductul
intralobular
duct
interlobular
duct
hepat
duct
cystic
duct
gallbladd
common
bile
duct
pancreaticobiliari
sphincter
oddi
mani
variat
central
theme
import
pancreaticobiliari
sphincter
common
physiolog
anatom
channel
duoden
papilla
cat
b
mani
anatom
variat
felin
gallbladd
singl
gallbladd
bilater
gallbladd
bodi
duplic
fundic
duplic
complet
duplic
septat
yshape
gallbladd
hepatocyt
account
liver
cell
mass
see
tabl
contribut
wide
rang
metabol
activ
includ
carbohydr
protein
lipid
nucleic
acid
porphyrin
metal
vitamin
glutathion
hormon
xenobiot
metabol
coagul
factor
synthesi
biliari
secret
immun
surveil
hepatocyt
eosinophil
cytoplasm
reflect
numer
mitochondria
basophil
stippl
caus
larg
amount
rough
endoplasm
reticulum
free
ribosom
hepatocyt
nuclei
round
dispers
chromatin
promin
nucleoli
anisokaryosi
common
often
reflect
variou
degre
polyploidi
normal
featur
hepatocyt
averag
life
span
hepatocyt
month
reflect
abil
regener
hepatocyt
organ
plate
separ
vascular
channel
sinusoid
arrang
support
reticulin
collagen
type
iii
network
sinusoid
discontinu
fenestr
endotheli
cell
line
endotheli
cell
basement
membran
separ
hepatocyt
space
diss
drain
lymph
portal
lymphat
hepatocyt
support
number
cell
type
account
liver
cell
mass
basic
element
biliari
tract
hepat
canaliculi
bile
ductul
intralobular
duct
interlobular
duct
hepat
duct
cystic
duct
gallbladd
common
bile
duct
pancreaticobiliari
sphincter
oddi
mani
variat
central
theme
import
pancreaticobiliari
sphincter
common
physiolog
anatom
channel
duoden
papilla
cat
b
mani
anatom
variat
felin
gallbladd
singl
gallbladd
bilater
gallbladd
bodi
duplic
fundic
duplic
complet
duplic
septat
yshape
gallbladd
hepatocyt
account
liver
cell
mass
see
tabl
contribut
wide
rang
metabol
activ
includ
carbohydr
protein
lipid
nucleic
acid
porphyrin
metal
vitamin
glutathion
hormon
xenobiot
metabol
coagul
factor
synthesi
biliari
secret
immun
surveil
hepatocyt
eosinophil
cytoplasm
reflect
numer
mitochondria
basophil
stippl
caus
larg
amount
rough
endoplasm
reticulum
free
ribosom
hepatocyt
nuclei
round
dispers
chromatin
promin
nucleoli
anisokaryosi
common
often
reflect
variou
degre
polyploidi
normal
featur
hepatocyt
averag
life
span
hepatocyt
month
reflect
abil
regener
hepatocyt
organ
plate
separ
vascular
channel
sinusoid
arrang
support
reticulin
collagen
type
iii
network
sinusoid
discontinu
fenestr
endotheli
cell
line
endotheli
cell
basement
membran
separ
hepatocyt
space
diss
drain
lymph
portal
lymphat
hepatocyt
support
number
cell
type
account
liver
cell
mass
repres
liver
cell
mass
cholangiocyt
also
known
biliari
epitheli
cell
secret
water
bicarbon
cation
bile
physiolog
state
may
also
particip
immun
respons
antigenpres
cell
diseas
state
biliari
tract
converg
system
canal
begin
canaliculi
follow
bile
duct
end
common
bile
duct
bile
secret
depend
function
membran
transport
system
hepatocyt
cholangiocyt
structur
function
integr
biliari
tract
hepatocyt
constitut
abund
liver
cell
popul
gener
socal
primari
bile
canaliculi
biliari
canaliculi
blind
tubular
structur
high
surfacetovolum
ratio
mean
osmot
gradient
favor
format
bile
flow
cholangiocyt
constitut
liver
cell
modifi
canalicular
bile
secretori
reabsorpt
process
bile
pass
bile
duct
respons
approxim
bile
volum
contrast
hepatocyt
secret
constant
poorli
control
cholangiocyt
secret
broadli
regul
immunoglobulin
famili
without
liver
clear
complement
systemco
pathogen
diseas
state
kupffer
cell
contribut
patholog
ethanol
toxic
principl
product
inflammatori
mediat
activ
tolllik
receptor
elabor
tumor
necrosi
factor
kupffer
cell
activ
respons
earli
ethanolinduc
liver
injuri
common
chronic
alcohol
ethanol
activ
tolllik
receptor
receptor
kupffer
cell
intern
endotoxin
lipopolysaccharid
intern
activ
transcript
product
superoxid
prooxid
enter
stellat
cell
liver
lead
collagen
synthesi
fibrosi
fibrosi
eventu
caus
cirrhosi
loss
function
liver
see
role
stellat
cell
discuss
stellat
cell
section
follow
hepat
stellat
cell
hsc
also
refer
vitamin
astor
cell
lipocyt
interstiti
cell
fatstor
cell
ito
cell
exist
space
parenchym
cell
liver
sinusoid
endotheli
cell
hepat
lobul
store
vitamin
whole
bodi
retinyl
palmit
lipid
droplet
cytoplasm
physiolog
condit
cell
play
pivot
role
regul
vitamin
homeostasi
patholog
condit
hepat
fibrosi
liver
cirrhosi
hsc
lose
vitamin
synthes
larg
amount
ecm
compon
includ
collagen
proteoglycan
glycosaminoglycan
adhes
glycoprotein
morpholog
cell
also
chang
starshap
stellat
cell
fibroblast
myofibroblast
hsc
consid
target
therapi
hepat
fibrosi
liver
cirrhosi
activ
hsc
key
event
liver
fibrosi
caus
diminish
adipogen
transcript
wnt
signal
inhibit
antiadipogen
activ
hsc
liver
fibrogenesi
wnt
antagon
inhibit
hsc
activ
liver
fibrosi
also
known
natur
killer
nk
cell
larg
granular
lymphocyt
pit
cell
repres
liver
cell
mass
serv
part
immun
surveil
mechan
hepat
sinusoid
pit
also
known
browiczkupff
cell
stellat
macrophag
cell
repres
liver
cell
mass
special
macrophag
local
sinusoid
part
mononuclear
phagocyt
system
kupffer
cell
begin
develop
bone
marrow
genesi
promonocyt
monoblast
monocyt
peripher
blood
monocyt
complet
differenti
kupffer
cell
within
liver
health
kupffer
cell
involv
metabol
erythrocyt
hemoglobin
perfus
liver
senesc
red
blood
cell
phagocyt
kupffer
cell
hemoglobin
molecul
metabol
compon
part
globin
chain
amino
acid
reutil
ironcontain
portion
heme
remov
transport
store
heme
oxid
bilirubin
conjug
glucuron
acid
within
hepatocyt
secret
bile
kupffer
cell
also
express
complement
receptor
progenitor
cell
multilineag
potenti
similar
characterist
stem
cell
late
progenitor
cell
differenti
produc
progeni
singl
lineag
although
divid
rapidli
capabl
shortterm
tissu
reconstitut
selfrenew
earli
studi
hepatocyt
turnov
liver
regener
show
parenchym
cell
hepatocyt
primari
cell
involv
tissu
renew
howev
new
studi
liver
regener
hepatocarcinogenesi
liver
transplant
variou
cell
line
show
varieti
cell
type
particip
maintain
hepatocyt
number
mass
recent
studi
indic
presenc
intrahepat
extrahepat
stemprogenitor
cell
popul
serv
maintain
normal
organ
regener
damag
parenchyma
respons
varieti
insult
intrahepat
compart
like
deriv
primarili
biliari
tract
particularli
proxim
branch
canal
here
smallest
ductul
extrahepat
compart
least
part
deriv
divers
popul
cell
bone
marrow
embryon
stem
cell
consid
part
extrahepat
compart
precis
role
individu
cell
remain
determin
clear
aggreg
confer
vast
regen
capac
liver
liver
involv
mani
aspect
intermediari
metabol
liver
center
carbohydr
metabol
role
maintain
normoglycemia
glucos
primari
energi
sourc
mammalian
cell
metabol
tightli
regul
guarante
suffici
suppli
avail
glucosedepend
organ
particularli
brain
glucos
made
avail
two
sourc
absorpt
dietari
glucos
intestin
releas
glucos
organ
liver
kidney
earli
fast
major
endogen
glucos
gener
glycogenolysi
glycogen
liver
convert
regul
debranch
enzym
hepat
glycogen
phosphorylas
phosphorylas
kinas
prolong
fast
endogen
glucos
gener
gluconeogenesi
certain
substrat
amino
acid
lactat
glycerol
process
gener
must
dephosphoryl
order
transport
glucos
cell
earli
fast
glycogen
glycogenolysi
glucos
normoglycemia
prolong
fast
amino
acid
gluconeogenesi
glucos
normoglycemia
enzym
respons
dephosphoryl
alter
quantiti
locat
activ
seen
type
glycogen
storag
diseas
effect
result
lack
endogen
glucos
product
sever
hypoglycemia
develop
period
fast
liver
import
site
protein
metabol
amino
acid
protein
absorb
intestin
produc
bodi
deliv
liver
liver
deamin
amino
acid
cell
belong
group
sinusoid
cell
togeth
kupffer
endotheli
fatstor
stellat
cell
pit
cell
use
fasl
fa
ligand
fasl
perforingranzym
pathway
kill
target
cell
fasl
effector
cell
bind
fa
present
target
cell
membran
result
oligomer
fa
activ
caspas
perforin
granzym
granzym
b
potent
resid
granul
cytotox
lymphocyt
releas
exocytosi
intracellular
deliveri
granzym
b
result
initi
caspas
cascad
proteolyt
activ
caspas
either
directli
mitochondrialdepend
pathway
caspas
play
central
role
execut
apoptosi
lymphocyt
recruit
circul
tissu
depend
abil
lymphocyt
recogn
bind
molecul
endotheli
cell
surfac
promot
transendotheli
migrat
multistep
model
leukocyt
adhes
vascular
endothelium
describ
broadli
applic
although
detail
signal
involv
differ
tissu
gener
accept
model
tether
roll
receptor
express
endotheli
cell
captur
freeflow
leukocyt
receptor
may
either
selectin
member
immunoglobulin
superfamili
captur
leukocyt
receiv
activ
messag
present
endotheli
cell
form
chemokin
activ
specif
gproteincoupl
receptor
leukocyt
surfac
occup
receptor
trigger
cascad
intracellular
signal
result
present
highaffin
integrin
receptor
leukocyt
surfac
bind
immunoglobulin
famili
counterreceptor
endothelium
promot
leukocyt
arrest
vessel
wall
presenc
appropri
migratori
signal
leukocyt
migrat
across
endothelium
tissu
follow
hierarchi
chemotact
signal
toward
focu
inflamm
repres
liver
cell
mass
smooth
muscl
cell
locat
primarili
hepat
arteri
portal
vein
tributari
serv
primarili
regul
hepat
microcircul
hepat
fibrosi
common
outcom
hepat
injuri
dog
activ
fibroblast
develop
myofibroblast
characterist
play
essenti
role
hepat
fibrogenesi
compris
three
subpopul
portal
septal
myofibroblast
b
interfac
myofibroblast
c
perisinusoid
locat
hsc
difficult
arriv
univers
applic
definit
stem
cell
defin
properti
stem
cell
exhibit
stem
cell
tissu
organ
other
spite
gener
accept
consensu
defin
stem
cell
undifferenti
cell
capac
selfrenew
product
progeni
least
two
lineag
longterm
tissu
repopul
transplant
serial
transplant
addit
stem
cell
exist
mitot
quiescent
form
clonal
regener
differ
cell
type
constitut
tissu
exist
undergo
asymmetr
cell
divis
product
one
differenti
progenitor
daughter
anoth
daughter
still
stem
cell
offspr
stem
cell
refer
progenitor
cell
also
name
transit
amplifi
cell
therefor
serial
transplant
classifi
earli
late
earli
progenitor
stem
either
remov
circul
liver
undergo
transform
lipoprotein
lipas
andor
hepat
lipas
form
intermediatedens
lipoprotein
ldl
ldl
rel
deplet
triglycerid
enrich
cholesteryl
ester
phospholipid
circul
blood
bind
specif
ldl
receptor
wide
distribut
throughout
tissu
order
deliv
cholesterol
hdl
produc
liver
play
import
role
donor
acceptor
apo
c
apo
e
variou
lipid
lipoprotein
circul
revers
transport
hdl
play
import
role
revers
transport
cholesterol
periphey
liver
lecithin
cholesterol
acyl
transferas
esterifi
hdl
cholesterol
cholesteryl
ester
move
core
hdl
molecul
allow
free
cholesterol
absorb
particl
continu
absorpt
free
cholesterol
subsequ
esterif
lecithin
cholesterol
acyl
transferas
lead
format
larger
cholesteryl
esterrich
molecul
continu
acquir
cholesteryl
ester
result
format
molecul
cholesteryl
ester
transfer
tissu
liver
dispos
reus
ldl
vldl
molecul
human
transfer
cholesterol
peripher
tissu
function
may
account
lower
incid
atherosclerot
disord
dog
compar
human
nucleic
acid
pyrimidin
biosynthesi
one
classic
role
liver
nucleic
acid
metabol
recent
microrna
impugn
normal
develop
regener
liver
well
hepat
patholog
microrna
small
noncod
rna
regul
messeng
rna
protein
express
target
gene
result
alter
messeng
rna
stabil
translat
inhibit
microrna
influenc
least
onethird
human
transcript
known
regul
variou
import
cellular
growth
differenti
factor
microrna
recent
emerg
key
regulatori
molecul
chronic
liver
diseas
porphyrin
porphyrin
intermedi
heme
biosynthet
pathway
porphyrin
found
hemoglobin
myoglobin
cytochrom
catalas
peroxidas
enzym
liver
biliari
tract
serv
excretori
rout
porphyrin
liver
store
iron
toxic
excess
amount
hemochromatosi
amount
iron
bodi
larg
determin
regul
absorpt
upper
small
intestin
iron
store
intracellularli
ferritin
number
tissu
liver
larg
storag
capac
capac
liver
exceed
iron
accumul
hemosiderin
liver
incorpor
copper
specif
copper
protein
cytochrom
c
oxidas
mitochondri
monoamin
oxidas
ceruloplasmin
mobil
copper
hepatocyt
take
place
least
two
mechan
ceruloplasmin
bile
secret
cholestat
liver
diseas
associ
secondari
copper
retent
may
induc
hepatocyt
injuri
vitamin
liver
importantli
involv
vitamin
metabol
liver
produc
bile
absorpt
fatsolubl
vitamin
e
k
liver
import
site
vitamin
storag
convert
carbohydr
lipid
deamin
produc
acid
metabol
energi
use
synthesi
monosaccharid
fatti
acid
liver
synthes
amino
acid
intermedi
carbohydr
lipid
metabol
amin
transamin
exampl
amino
acid
transamin
includ
alanin
pyruv
glutam
aspart
oxaloacet
glutam
liver
synthes
mani
protein
includ
albumin
fibrinogen
globulin
globulin
prothrombin
clot
factor
v
vii
viii
ix
x
produc
liver
well
ceruloplasmin
ferritin
mani
serum
enzym
lipid
metabol
transport
organ
three
basic
transport
system
exogen
transport
associ
metabol
exogen
dietari
lipid
b
endogen
transport
associ
metabol
endogen
produc
lipid
c
revers
transport
associ
transport
lipid
peripheri
eg
skelet
muscl
adipos
connect
tissu
liver
exogen
transport
triglycerid
major
dietari
lipid
along
cholesterol
phospholipid
fatsolubl
vitamin
digest
dietari
lipid
begin
proxim
gi
tract
action
lingual
gastric
lipas
complet
small
intestin
action
pancreat
lipas
cholesterol
ester
hydrolas
phospholipas
lipid
digest
absorpt
complic
carbohydr
protein
digest
absorpt
lipid
solubl
characterist
involv
emulsif
lipid
bile
salt
hydrolysi
pancreat
lipas
colipas
solubil
fatti
acid
monoglycerid
mix
micel
absorpt
reesterif
chylomicron
format
transport
intestin
lymphat
portal
capillari
chylomicron
contain
shortand
longchain
triglycerid
newli
incorpor
apoprotein
preferenti
absorb
intestin
lymphat
transport
cisterna
chyli
thorac
duct
system
circul
acquir
apolipoprotein
c
e
circul
highdens
lipoprotein
hdl
apolipoprotein
apo
cii
activ
lipoprotein
lipas
capillari
bed
adipos
skelet
muscl
store
hydrolyz
free
fatti
acid
glycerol
cholesterolrich
remain
particl
refer
chylomicron
remnant
return
apo
cii
molecul
hdl
recogn
specif
hepat
apo
e
apo
receptor
rapidli
remov
circul
endocytosi
cholesterol
found
chylomicron
remnant
use
verylowdens
lipoprotein
vldl
lipoprotein
synthesi
bile
acid
format
cholesteryl
storag
endogen
transport
chylomicron
apoprotein
respons
transport
dietari
lipid
vldl
intermediatedens
lipoprotein
lowdens
lipoprotein
ldl
hdl
instead
involv
metabol
endogen
produc
lipid
triglycerid
cholesterol
produc
liver
combin
phospholipid
apo
apo
form
vldl
secret
liver
vldl
acquir
apo
c
apo
e
hdl
vldl
apo
cii
activ
lipoprotein
lipas
locat
capillari
bed
triglycerid
hydrolysi
take
place
product
free
fatti
acid
glycerol
vldl
molecul
remain
hydrolysi
vldl
triglycerid
intestin
bacteria
produc
secondari
bile
acid
deoxychol
acid
lithochol
acid
prior
secret
bile
acid
conjug
taurin
andor
glycin
form
tauroand
glycoconjug
bile
salt
see
figur
c
conjug
lower
pk
well
physiolog
rang
biliari
intestin
ph
conjug
bile
acid
becom
ioniz
anion
refer
bile
salt
rather
undissoci
bile
acid
ioniz
form
less
like
absorb
small
intestin
maintain
higher
intralumin
concentr
appropri
emulsif
digest
absorpt
lipid
dog
cat
conjug
primarili
taurin
dog
convert
glycin
conjug
taurin
defici
cat
cat
oblig
taurin
conjug
essenti
dietari
taurin
requir
bile
salt
amphipath
molecul
polar
nonpolar
domain
impart
two
import
function
bile
salt
initi
deterg
effect
fat
particl
food
permit
breakup
fat
globul
smaller
size
initi
emulsif
phase
bile
salt
facilit
intralumin
lipid
hydrolyt
digest
bile
salt
assist
absorpt
fatti
acid
monoglycerid
cholesterol
lipid
format
mix
micel
micel
serv
transfer
digest
lipid
across
unstir
layer
mucosa
follow
emulsif
micellar
fat
secret
bile
salt
transport
along
gi
tract
ileum
absorb
ileal
enterocyt
portal
blood
flow
via
na
bile
salt
cotransport
liver
play
import
role
maintain
hemostasi
liver
produc
procoagul
anticoagul
fibrinolyt
protein
also
remov
normal
abnorm
clot
factor
circul
hepatocyt
synthes
clot
factor
includ
clot
factor
fibrinogen
ii
prothrombin
v
vii
ix
x
xi
xiii
site
biosynthesi
factor
viii
remain
controversi
probabl
liver
play
import
role
factor
liver
also
respons
activ
vitamin
kdepend
factor
ii
vii
ix
x
protein
c
addit
product
activ
coagul
factor
liver
also
essenti
clearanc
activ
coagul
water
bilirubin
vitamin
store
stellat
cell
hepatocyt
approxim
total
bodi
vitamin
store
liver
repres
suppli
liver
continu
releas
vitamin
maintain
normal
blood
concentr
despit
reduct
content
liver
plasma
vitamin
concentr
reduc
malnutrit
liver
diseas
intestin
malabsorpt
sign
defici
appear
abnorm
becom
sever
fatsolubl
vitamin
e
k
requir
normal
bile
secret
absorpt
vitamin
k
particularli
essenti
synthesi
prothrombincomplex
clot
factor
watersolubl
vitamin
except
vitamin
b
cobalamin
readili
absorb
small
intestin
vitamin
use
primarili
coenzym
metabol
process
vitamin
phosphoryl
occur
primarili
hepatocyt
requir
produc
coenzym
thiamin
phosphoryl
thiamin
pyrophosph
exampl
primarili
liver
kidney
nicotin
acid
precursor
pyridin
nucleotid
synthesi
initi
step
convers
nicotinamid
synthesi
liver
pyridoxin
phosphoryl
activ
form
liver
transform
pantothen
acid
coenzym
folic
acid
convert
activ
form
liver
larg
amount
watersolubl
vitamin
except
vitamin
c
store
liver
glutathion
synthes
mammalian
cell
liver
particularli
activ
rel
high
level
glutathion
glutathion
perform
varieti
physiolog
metabol
function
includ
thiol
transfer
reaction
protect
cell
membran
protein
thioldisulfid
reaction
involv
protein
synthesi
protein
degrad
catalysi
reduct
capac
detoxif
hydrogen
peroxid
organ
peroxid
free
radic
foreign
compound
metabol
variou
endogen
compound
seen
dog
chronic
hepat
plu
cirrhosi
may
result
reduc
synthesi
rather
increas
consumpt
coagul
factor
numer
foreign
compound
includ
drug
hydrophob
would
remain
bodi
indefinit
hepat
biotransform
cytochrom
cyp
compris
superfamili
enzym
catalyz
oxid
varieti
xenobiot
chemic
drug
toxic
chemic
carcinogen
well
endobiot
chemic
includ
steroid
fatti
acid
prostaglandin
vitamin
cytochrom
enzym
famili
one
three
mediat
phase
idepend
metabol
clinic
use
drug
particip
metabol
huge
number
xenobiot
chemic
known
activ
gene
pseudogen
human
genom
activ
gene
dog
phylogenet
closest
human
although
mani
similar
dog
human
also
mani
import
differ
dog
present
product
product
clot
factor
inhibitor
antithrombin
antitrypsin
well
fibrinolyt
protein
like
plasminogen
liver
diseas
factor
inhibitor
synthesi
clearanc
activ
factor
coagul
factor
fibrinolyt
system
may
impair
extent
coagul
abnorm
depend
upon
degre
disturb
liver
function
patient
hepat
failur
may
present
entir
spectrum
factor
defici
may
even
develop
dissemin
intravascular
coagul
studi
dog
histolog
confirm
liver
diseas
one
coagul
abnorm
found
dog
liver
diseas
activ
partial
thromboplastin
time
significantli
prolong
dog
chronic
hepat
without
cirrhosi
mean
platelet
number
antithrombin
factor
ix
activ
significantli
lower
dog
chronic
hepat
cirrhosi
compar
dog
hepatopathi
ddimer
significantli
increas
group
three
dog
differ
histolog
diagnos
satisfi
criteria
dissemin
intravascular
coagul
hemostat
abnorm
primarili
ammonia
adenosin
triphosph
adenosin
triphosph
adp
adenosin
diphosph
p
inorgan
phosphat
amp
adenosin
monophosph
mineralocorticoid
aldosteron
glucocorticoid
cortisol
corticosteron
sex
steroid
androgen
estrogen
progesteron
metabol
liver
chang
concentr
total
free
cortisol
bind
capac
corticosteroidbind
globulin
report
canin
liver
diseas
consequ
hypercortisolemia
dog
liver
diseas
hepatoencephalopathi
clinic
biochem
characterist
pdh
includ
polyuria
high
basal
cortisol
level
chronic
hypercortisol
associ
impair
osmoregul
releas
vasopressin
inadequ
urinari
concentr
multipl
physiolog
function
liver
requir
immun
respons
local
regul
pathogen
microorgan
must
effici
elimin
larg
number
antigen
deriv
interest
challeng
assess
drugdrug
interact
enzym
complet
character
diet
age
induc
signific
chang
gene
express
dog
often
treat
offlabel
number
human
drug
littl
idea
risk
drugdrug
interact
drug
metabol
take
two
gener
form
phase
metabol
modif
reaction
phase
ii
metabol
conjug
reaction
phase
metabol
typic
subject
drug
oxid
hydrolysi
involv
cytochrom
cyp
enzym
facilit
reaction
includ
n
sdealkyl
aromat
aliphat
nhydroxyl
noxid
sulfoxid
deamin
dehalogen
phase
ii
metabol
conjug
drug
hydrophil
substanc
glucuron
acid
sulfat
glycin
glutathion
phase
metabol
usual
preced
phase
ii
metabol
alway
case
liver
import
site
drug
toxic
oxid
stress
proxim
relationship
gi
tract
seventyf
percent
hepat
blood
flow
come
directli
gi
tract
spleen
via
main
portal
vein
portal
blood
flow
transport
nutrient
bacteria
bacteri
antigen
drug
xenobiot
agent
absorb
gut
liver
concentr
form
drugmetabol
enzym
detoxifi
mani
xenobiot
might
activ
toxic
other
hepat
parenchym
nonparenchym
cell
may
contribut
pathogenesi
hepat
toxic
toxic
drug
consid
five
context
ontarget
toxic
hypersensit
immunolog
reaction
offtarget
pharmacolog
bioactiv
reactiv
intermedi
idiosyncrat
drug
reaction
ammonia
ammonia
import
byproduct
amino
acid
metabol
organ
easili
quickli
remov
ammonia
usual
convert
substanc
like
urea
uric
acid
much
less
toxic
insuffici
urea
cycl
occur
gi
tract
must
toler
liver
favor
induct
toler
rather
induct
immun
although
hepatocyt
constitut
major
cell
popul
liver
direct
interact
hepatocyt
leukocyt
blood
unlik
sinusoid
endotheli
cell
line
hepat
sinusoid
separ
hepatocyt
leukocyt
sinusoid
lumen
kupffer
cell
resid
macrophag
popul
liver
directli
interact
passeng
leukocyt
liver
clearanc
antigen
blood
occur
mainli
sinusoid
endotheli
cell
effici
receptormedi
endocytosi
liver
sinusoid
endotheli
cell
constitut
express
molecul
necessari
antigen
present
major
histocompat
complex
mhc
class
ii
function
antigenpres
cell
cell
thu
cell
probabl
contribut
hepat
immun
surveil
activ
effector
cell
antigenspecif
tcell
activ
influenc
local
microenviron
microenviron
character
physiolog
presenc
bacteri
constitu
endotoxin
local
releas
immunosuppress
mediat
prostaglandin
e
transform
growth
regener
liver
regener
partial
hepatectomi
complex
wellorchestr
phenomenon
appear
carri
particip
matur
liver
cell
type
process
associ
signal
cascad
involv
growth
factor
cytokin
matrix
remodel
sever
feedback
stimul
inhibit
growth
relat
signal
liver
manag
restor
lost
mass
adjust
size
organ
time
provid
full
support
bodi
homeostasi
entir
regen
process
situat
hepatocyt
biliari
cell
block
regener
cell
type
function
facult
stem
cell
gene
express
regener
liver
multistep
process
least
two
critic
step
transit
quiescent
hepatocyt
cell
cycl
prime
progress
beyond
restrict
point
g
phase
cell
cycl
hepatocyt
must
first
prime
fulli
respond
growth
factor
mani
differ
gene
particip
earli
respons
hepatectomi
tumor
necrosi
factor
tnf
interleukin
il
appear
major
cytokin
involv
prime
hepatocyt
prolif
effect
tnf
hepatocyt
influenc
reactiv
oxygen
speci
nitric
oxid
glutathion
content
multipl
transcript
factor
eg
nuclear
factor
kappa
b
play
major
role
initi
earli
liver
regener
progress
cell
cycl
beyond
initi
phase
requir
growth
factor
primarili
hepatocyt
growth
factor
transform
growth
subsequ
express
cellcycl
gene
establish
stage
replic
becom
growth
factorindepend
autonom
point
hepatocyt
irrevers
commit
replic
cell
cycl
replic
machineri
take
prolifer
hepatocyt
advanc
periport
pericentr
are
lobul
wave
mitos
hepatocyt
surround
central
vein
last
one
undergo
cell
replic
prolifer
biliari
epitheli
cell
occur
littl
later
hepatocyt
prolifer
endotheli
cell
start
day
end
around
day
partial
hepatectomi
kinet
prolifer
stellat
cell
incomplet
understood
regen
capac
residu
hepatocyt
may
restor
liver
mass
function
much
hepatectomi
take
place
day
anim
speci
small
wave
apoptosi
hepatocyt
occur
end
regener
liver
second
largest
organ
bodi
perform
estim
essenti
biochem
function
divers
function
includ
drug
metabol
remov
exogen
endogen
toxin
eg
ammonia
food
antigen
synthesi
vital
substanc
albumin
blood
clot
factor
protein
fat
carbohydr
metabol
vitamin
storag
activ
glycogen
triglycerid
miner
eg
copper
iron
storag
activ
convers
secret
deactiv
excret
variou
hormon
bile
salt
synthesi
conjug
excret
bilirubin
bile
among
other
symptom
defin
abnorm
note
owner
clinic
sign
defin
abnorm
found
physic
examin
diagnost
result
reflect
impair
function
hepat
repres
approxim
clinic
popul
companion
anim
teach
hospit
utrecht
univers
box
summar
common
liver
diseas
possibl
etiolog
dog
cat
properli
taken
histori
pivot
defin
clinic
relev
problem
need
resolv
structur
interview
process
understand
basic
commun
import
success
factor
retriev
crucial
inform
fortun
knowledg
commun
medic
profess
focu
veterinari
curriculum
increas
consider
last
year
basic
principl
kept
mind
understand
symptom
dog
cat
diseas
affect
hepat
parenchyma
portal
vasculatur
biliari
system
first
function
liver
tremend
approxim
reserv
capac
remark
potenti
regener
symptom
occur
progress
diseas
exhaust
hepat
reserv
diseas
often
remain
subclin
lengthi
period
time
symptom
may
rel
mild
nonspecif
liver
reserv
prevent
overt
abnorm
symptom
lethargi
vomit
mild
polyuria
polydipsia
pupd
may
alert
clinician
liver
disord
could
develop
seriou
symptom
may
indic
loss
hepat
reserv
onset
symptom
may
acut
may
end
result
diseas
present
mani
week
month
specif
physic
abnorm
occur
liver
diseas
import
rememb
liver
diseas
may
present
symptom
ill
unexplain
nonspecif
sensit
specif
laboratori
test
may
easili
detect
liver
diseas
second
liver
diseas
caus
similar
sign
symptom
tabl
one
achol
fece
occur
nearli
exclus
dog
common
bile
duct
obstruct
owner
b
document
human
may
occur
dog
cat
like
present
chronic
rather
acut
liver
diseas
clinic
sign
list
tabl
candid
primari
hepatopathi
case
diagnost
studi
perform
confirm
exclud
liver
diseas
figur
breed
sex
age
drug
may
predispos
dog
cat
hepatopathi
presenc
numer
risk
factor
stimulu
extend
diagnost
workup
diseas
investig
absenc
suspicion
caus
hypersensit
sulfonamid
destruct
cholangiol
common
druginduc
liver
diseas
recent
histori
therapi
sulfonamid
potenti
hepatotox
drug
combin
icteru
make
condit
like
prompt
immedi
discontinu
medic
breed
associ
may
occur
diseas
part
determin
genet
factor
breeder
may
chanc
increas
incid
hepat
diseas
famili
select
dog
breed
may
repres
less
close
popul
countri
breed
predisposit
may
vari
among
countri
therefor
section
mention
gener
applic
predisposit
local
breed
associ
may
pertin
chronic
hepat
cirrhosi
rule
differ
stage
one
diseas
occur
frequent
certain
breed
hepat
may
develop
age
typic
year
age
lobular
dissect
hepat
tend
occur
young
age
ie
often
year
age
breed
associ
hepat
doberman
pinscher
bedlington
terrier
west
highland
white
terrier
american
english
cocker
spaniel
labrador
retriev
mani
breed
recent
copper
excret
studi
shown
hepat
caus
copper
retent
vice
versa
doberman
pinscher
caus
copper
retent
remain
unclear
mani
test
candid
gene
includ
murr
affect
gene
bedlington
terrier
exclud
monogenet
caus
copperassoci
subclin
hepat
may
note
lightgray
appear
stool
combin
icteru
virtual
diagnost
extrahepat
cholestasi
differ
combin
clinic
sign
symptom
may
occur
liver
diseas
statist
one
diseas
may
associ
typic
pattern
sign
symptom
dog
cat
howev
overlap
pattern
great
useless
tri
identifi
exact
diseas
base
clinic
sign
symptom
alon
tabl
clinic
sign
symptom
associ
liver
diseas
cat
similar
dog
except
pupd
clinic
overt
cat
certain
liver
diseas
caus
neurobehavior
sign
associ
hepat
encephalopathi
sign
may
wax
wane
frequenc
sever
medic
given
may
appear
effect
natur
fluctuat
sign
therefor
sign
hepat
origin
may
easili
miss
seizur
alon
never
caus
hepat
encephalopathi
occur
occur
combin
sign
seen
syndrom
furthermor
medic
treat
liver
diseas
test
doubleblind
placebocontrol
studi
make
decis
best
therapeut
regimen
difficult
usual
possibl
differenti
hepat
diseas
diseas
organ
base
symptom
clinic
sign
sign
associ
hepat
diseas
nonspecif
similar
sign
may
occur
diseas
mani
organ
system
notabl
gi
neurolog
renal
hematolog
system
see
tabl
gi
tractrel
symptom
nausea
express
vomit
acut
case
reduc
irregular
appetit
occasion
vomit
weight
loss
time
common
liver
biliari
diseas
dog
cat
biliari
diseas
alway
promin
symptom
diarrhea
howev
major
symptom
liver
diseas
case
diarrhea
lead
symptom
liver
rare
caus
organ
except
rare
case
complet
common
bile
duct
obstruct
rare
sign
includ
tabl
ulcer
form
dermatosi
socal
superfici
necrolyt
dermat
hepatoderm
hepatocutan
syndrom
syndrom
occur
rare
dog
liver
cirrhosi
nodular
hyperplasia
whose
pathogenesi
poorli
understood
symptom
common
symptom
lethargi
inappet
vomit
diarrhea
weight
loss
pupd
neurobehavior
symptom
frequent
associ
diseas
organ
therefor
histori
often
disclos
symptom
may
suggest
hepat
diseas
may
also
caus
disord
two
main
reason
account
nonspecif
liverrel
symptom
first
liver
central
organ
mani
metabol
detoxifi
pathway
consequ
fail
liver
function
may
caus
dysfunct
organ
one
exampl
hepat
encephalopathi
metabol
dysfunct
liver
caus
neurotransmitt
dysfunct
brain
result
neurobehavior
sign
second
toxic
factor
result
diseas
organ
system
especi
gi
tract
often
secondarili
affect
liver
exampl
includ
hepat
lipidosi
diabet
mellitu
steroidinduc
hepatopathi
cush
syndrom
reactiv
hepat
gi
diseas
centrolobular
liver
necrosi
acut
sever
anemia
therefor
sign
symptom
liver
diseas
may
hidden
within
sign
organ
dysfunct
vice
versa
clinic
physic
examin
find
may
compat
hepat
diseas
laboratori
test
detect
hepat
diseas
also
abnorm
primari
secondari
hepatopathi
often
necessari
make
histolog
diagnosi
liver
disord
resolv
dilemma
lack
specif
physic
examin
find
may
prevent
recognit
primari
liver
diseas
dog
ill
caus
pathet
innerv
therefor
dilat
eg
extrahepat
cholestasi
cholecyst
cholelithiasi
suspect
vomit
dog
cat
vomit
also
common
upper
gi
diseas
mani
gi
diseas
transloc
bacteria
endotoxin
may
caus
secondari
nonspecif
reactiv
hepat
occur
frequent
dog
rare
cat
reactiv
hepat
character
intrahepat
canalicular
cholestasi
liver
cell
necrosi
exud
inflammatori
reaction
clinic
sign
symptom
diagnost
result
associ
primari
liver
diseas
reactiv
hepat
similar
therefor
diagnost
workup
import
reveal
primari
caus
small
boweltyp
diarrhea
occur
frequent
hepat
diseas
see
tabl
two
primari
mechan
may
account
clinic
sign
first
cholestat
diseas
intrahepat
extrahepat
caus
common
bile
duct
obstruct
disrupt
normal
enterohepat
cycl
bile
acid
therefor
less
bile
reach
duodenum
decreas
resorpt
dietari
fat
may
caus
hyperosmot
intestin
content
diarrhea
howev
studi
rat
show
cholestasi
must
sever
steatorrhea
result
disrupt
enterohepat
bile
acid
cycl
occur
anoth
mechan
diarrhea
liver
diseas
increas
resist
portal
blood
flow
result
portal
hypertens
congest
splanchnic
organ
intestin
vasculatur
congest
reduc
intestin
water
resorpt
increas
intestin
volum
content
predomin
mechan
underli
diarrhea
diseas
chronic
hepat
lobular
dissect
hepat
portal
vein
thrombosi
portal
vein
hypoplasia
altern
primari
caus
diarrhea
intestin
diseas
liver
may
affect
secondarili
case
hepat
macrophag
system
remov
increas
absorpt
endo
toxin
bacteria
affect
intestin
wall
increas
exposur
howev
lead
secondari
nonspecif
reactiv
hepat
endotoxin
also
effect
inhibit
bile
format
flow
lead
cholestasi
therefor
common
find
increas
plasma
liver
enzym
activ
bile
acid
level
case
reactiv
hepat
clinic
icteru
may
even
appar
caus
diarrhea
determin
diagnost
method
includ
histolog
evalu
liver
biopsi
specimen
reactiv
hepat
resolv
rapidli
primari
diseas
treat
success
author
experi
rare
find
diarrhea
singl
lead
symptom
case
liver
diseas
present
usual
one
less
promin
symptom
spectrum
promin
symptom
apathi
pupd
vomit
one
may
therefor
elect
follow
liver
laboratori
valu
treatment
intestin
diseas
perform
liver
biopsi
liver
paramet
fail
improv
within
week
hepat
encephalopathi
complex
neurobehavior
sign
result
portosystem
shunt
blood
combin
reduct
function
liver
mass
may
occur
anim
cpss
apscapsc
portal
hypertens
diseas
associ
latter
form
chronic
hepat
cirrhosi
portal
vein
hypoplasia
lobular
dissect
hepat
portal
vein
thrombosi
cat
depend
essenti
amino
acid
eg
arginin
may
develop
hepat
encephalopathi
without
portosystem
shunt
especi
sever
form
hepat
lipidosi
doberman
pinscher
hepat
doberman
pinscher
sex
link
confin
femal
aggress
respons
medic
penicillamin
may
termin
micronodular
cirrhosi
form
cirrhosi
predominantli
seen
copper
toxicosi
differ
form
chronic
hepat
patient
typic
develop
macronodular
cirrhosi
larg
hyperplast
nodul
hepat
overrepres
femal
doberman
pinscher
factor
studi
finland
show
approxim
doberman
pinscher
may
affect
inherit
copper
toxicosi
also
well
describ
entiti
bedlington
terrier
worldwid
sex
may
affect
clinic
sign
usual
develop
year
age
result
gradual
accumul
copper
caus
defect
murr
gene
lead
sever
decreas
excret
copper
hepatocyt
affect
breed
west
highland
white
terrier
particularli
unit
state
skye
terrier
dalmatian
anatolian
shepherd
dog
labrador
retriev
siames
cat
may
also
predispos
copperassoci
hepatopathi
although
essenti
life
copper
usual
ingest
excess
must
elimin
liver
prevent
toxic
central
role
liver
copper
homeostasi
make
vulner
elimin
process
fail
furthermor
increas
copper
level
add
oxid
stress
import
compon
chronic
inflammatori
cholestat
diseas
dog
spaniel
seem
form
chronic
hepat
unrel
copper
toxicosi
develop
macronodular
cirrhosi
left
untreat
sex
predisposit
exist
seem
worldwid
overrepresent
hepat
breed
congenit
portosystem
shunt
cpss
seen
sex
variou
breed
intrahepat
shunt
predomin
larg
breed
wherea
extrahepat
shunt
predomin
small
toy
breed
although
cpss
like
inherit
fashion
affect
breed
proven
irish
wolfhound
cairn
terrier
worldwid
predisposit
occur
irish
wolfhound
australian
cattl
dog
labrador
retriev
dachshund
yorkshir
terrier
cairn
terrier
maltes
terrier
miniatur
schnauzer
unit
state
increas
preval
shunt
also
report
occur
german
shepherd
dog
doberman
pinscher
golden
retriev
cpss
occur
often
mixedbre
cat
howev
persian
himalayan
cat
frequent
overrepres
clinic
sign
usual
seen
young
dog
cat
year
old
congenit
shunt
pathogenesi
common
symptom
primari
liver
diseas
vomit
one
common
symptom
note
dog
cat
liver
diseas
vomit
may
caus
direct
stimul
vomit
center
via
chemoreceptor
trigger
zone
fourth
ventricl
endo
toxin
clear
liver
typic
occur
toxin
gi
system
bypass
liver
access
bodi
system
vomit
common
condit
share
portosystem
shunt
liver
dysfunct
eg
congenit
shunt
acquir
shunt
hepat
fibrosi
cirrhosi
portal
vein
hypoplasia
thrombosi
hepat
diseas
caus
abnorm
liver
shape
may
reposit
upper
gi
tract
induc
nausea
vomit
vagal
stimul
caus
includ
hepat
tumor
especi
liver
cell
hepatocellular
carcinoma
unilater
collaps
contralater
hypertrophi
may
occur
thrombosi
main
branch
portal
vein
gallbladd
larger
bile
duct
rich
symform
ammonium
urat
affect
dog
usual
clinic
sign
relat
shunt
liver
dysfunct
hepat
encephalopathi
pupd
vomit
categori
enzym
uricas
form
allantoin
inact
inborn
error
affect
function
ammonium
urat
urolithiasi
occur
commonli
dalmatian
may
occur
breed
affect
dog
sign
relat
urolithiasi
eg
pollakiuria
stranguria
dysuria
owner
may
note
achol
fece
provid
direct
clue
underli
diagnosi
steatorrh
fece
contain
normal
bile
pigment
seen
bile
flow
intestin
tract
complet
disrupt
usual
consequ
extrahepat
obstruct
common
bile
duct
destruct
cholangiol
intrahepat
process
sever
enough
serious
disrupt
bile
flow
latter
diseas
caus
hypersensit
reaction
sulfonamidecontain
drug
smaller
bile
ductul
becom
necrot
liver
lobuli
may
disconnect
biliari
tract
affect
dog
histori
recent
medic
sulfonamid
achol
fece
contain
excess
fat
resorpt
impair
lack
normal
blackbrown
fecal
pigment
occur
precursor
bilirubin
reach
duodenum
therefor
fece
affect
anim
graywhit
soft
anim
condit
often
icter
presenc
icteru
reduc
likelihood
exocrin
pancreat
insuffici
diagnosi
abdomin
distent
may
occur
dog
cat
liver
diseas
sever
reason
first
ascit
frequent
find
associ
liver
diseas
dog
result
portal
hypertens
less
common
cat
abdomin
distent
may
also
result
organ
enlarg
case
liver
diseas
may
includ
liver
spleen
presenc
portal
hypertens
contrast
dog
cat
often
hepatomegali
liver
diseas
nonspecif
symptom
apathi
reduc
appetit
anorexia
weight
loss
may
occur
dog
cat
liver
diseas
retard
growth
common
young
anim
problem
reflect
central
role
liver
mani
metabol
detoxifi
function
addit
nausea
inappet
vomit
diarrhea
result
catabol
state
turn
may
aggrav
hepat
encephalopathi
sign
earli
hepat
encephalopathi
includ
depress
nonspecif
problem
anemia
anoth
common
find
liver
diseas
see
caus
gener
malais
dog
liver
cell
carcinoma
often
hypoglycem
may
primari
problem
underli
apathi
weak
product
insulinlik
growth
factor
tumor
may
respons
histor
find
physic
examin
find
rare
provid
enough
inform
pinpoint
liver
definit
caus
present
problem
possibl
find
includ
icteru
hepatomegali
splenomegali
ascit
pale
mucou
membran
petechia
skin
mucou
membran
occur
infrequ
possibl
find
icteru
hepatomegali
less
specif
liver
diseas
abnorm
physic
examin
occur
frequent
diseas
organ
system
hepat
encephalopathi
caus
derang
neurotransmitt
system
caus
defect
metabol
process
liver
inadequ
metabol
ammonia
aromat
amino
acid
liver
may
reduc
excitatori
glutamaterg
monoaminerg
neurotransmitt
system
tone
respect
addit
increas
tone
inhibitori
acid
gaba
system
neurotransmitt
derang
make
anesthesia
riski
anim
liver
diseas
liver
inactiv
mani
anesthet
unforeseen
delay
recoveri
anesthesia
may
suggest
underli
liver
diseas
caus
nonspecif
clinic
sign
occur
especi
dog
cat
portosystem
shunt
either
congenit
acquir
addit
reduc
hepat
clearanc
anesthet
exert
action
via
variou
neurotransmitt
system
brain
may
alreadi
function
abnorm
consequ
hepat
encephalopathi
especi
true
drug
act
via
gababenzodiazepin
pathway
pathway
alreadi
overstimul
may
provok
exagger
prolong
anesthet
effect
pupd
one
frequent
sign
case
dog
liver
diseas
less
common
cat
pupd
common
diseas
associ
congenit
acquir
portosystem
shunt
therefor
hepat
encephalopathi
affect
dog
abnorm
neurotransmitt
disturb
lead
increas
secret
adrenocorticotrop
hormon
acth
anterior
intermedi
pituitari
lobe
chronic
elev
acth
stimul
increas
level
free
cortisol
increas
level
free
cortisol
turn
affect
posterior
lobe
pituitari
creat
increas
threshold
releas
arginin
vasopressin
thu
higher
plasma
osmol
requir
stimul
antidiuresi
arginin
vasopressin
reach
threshold
affect
dog
becom
thirsti
start
drink
pupd
present
case
hepat
encephalopathi
also
frequent
liver
diseas
may
caus
certain
bile
acid
often
increas
plasma
anim
liver
diseas
bile
acid
may
inhibit
activ
steroid
dehydrogenas
enzym
protect
aldosteron
receptor
occup
cortisol
convert
cortisol
cortison
bind
receptor
present
plasma
tenfold
excess
compar
aldosteron
cortisol
occupi
stimul
aldosteron
receptor
therebi
induc
pseudohyperaldosteron
pu
reduc
hepat
format
urea
anoth
possibl
undocu
mechan
may
play
role
pathogenesi
pu
pd
urea
defici
state
kidney
suffici
urea
avail
build
osmot
gradient
medulla
apart
mechan
pd
also
occur
liver
diseas
associ
hepat
encephalopathi
eg
extrahepat
cholestasi
liver
tumor
mechan
unclear
howev
nausea
impuls
drink
compens
water
loss
vomit
diarrhea
may
play
role
dysuria
may
occur
result
insuffici
liver
function
nonmetabol
uric
acid
excret
kidney
precipit
form
urolith
calculi
seen
dog
rare
cat
two
main
categori
liver
dysfunct
caus
ammonium
urat
urolithiasi
frequent
caus
congenit
portosystem
shunt
wherebi
liver
underdevelop
fail
metabol
uric
acid
allantoin
urin
uric
acid
floccul
easili
presenc
high
ammonia
concentr
result
congest
heart
diseas
case
recogn
easili
physic
examin
circulatori
system
measur
central
venou
pressur
diagnost
except
liver
congest
caus
thrombu
caudal
vena
cava
proxim
liver
assess
method
liver
overtli
enlarg
congest
ascit
usual
present
ascit
fluid
typic
slightli
hemorrhag
appear
congest
fluid
dog
enlarg
liver
sign
congest
diseas
often
liver
cancer
may
primari
metastat
form
malign
lymphoma
tumor
liver
diffus
enlarg
primari
hepatocellular
carcinoma
adenoma
may
caus
enlarg
affect
lobe
bile
duct
carcinoma
dissemin
easili
biliari
system
usual
caus
pronounc
icteru
hepatomegali
cat
hepat
diseas
develop
pronounc
enlarg
liver
cat
liver
enlarg
occur
cholang
hepat
lipidosi
amyloidosi
hepat
tumor
primarili
malign
lymphoma
congest
diseas
liver
involv
felin
infecti
periton
may
enlarg
cat
cpss
small
liver
splenomegali
ascit
associ
liver
diseas
nonspecif
find
occur
especi
hepat
diseas
caus
portal
hypertens
find
frequent
dog
rare
cat
posit
undul
test
distinct
ascit
slight
ascit
found
ultrasonographi
rather
physic
examin
liver
may
enlarg
central
caus
venou
congest
canin
liver
diseas
associ
portal
hypertens
includ
chronic
hepat
cirrhosi
portal
vein
hypoplasia
lobular
dissect
hepat
portal
hypertens
sometim
seen
cirrhosi
advanc
cholangiohepat
cat
diseas
hepat
encephalopathi
also
common
portal
vein
thrombosi
prehepat
caus
portal
hypertens
usual
caus
ascit
although
rule
liver
small
case
unilater
obstruct
main
branch
portal
vein
may
caus
hypertrophi
rest
liver
may
palpabl
diseas
hepat
parenchyma
hepat
vasculatur
biliari
tract
rel
common
dog
cat
symptom
sign
accompani
liver
diseas
quit
nonspecif
liver
may
secondarili
involv
diseas
organ
liver
diseas
easili
go
undetect
therefor
take
thorough
histori
perform
physic
examin
critic
perform
addit
biochem
test
highest
possibl
diagnost
accuraci
whenev
liver
diseas
includ
differenti
diagnosi
liver
diseas
rule
base
examin
addit
test
necessari
defin
type
liver
diseas
notabl
ultrasonographi
cranial
abdomin
quadrant
examin
liver
biopsi
specimen
algorithm
figur
summar
approach
diagnosi
usual
depend
histopatholog
examin
liver
tissu
especi
parenchym
liver
diseas
mani
biliari
tract
diseas
tumor
liver
biliari
tract
although
biopsi
method
beyond
scope
chapter
excel
sourc
exist
one
note
caution
blood
coagul
test
vital
collect
liver
biopsi
specimen
histopatholog
anim
exampl
one
abnorm
coagul
test
factor
involv
may
includ
vitamin
k
defici
reduc
ascit
hepatoand
splenomegali
may
note
owner
abdomin
enlarg
biochemistri
analys
integr
part
diagnost
process
liver
diseas
analys
decis
factor
diagnosi
liver
diseas
serv
rule
liver
diseas
differenti
diagnosi
icteru
frequent
encount
specif
abnorm
note
physic
examin
dog
cat
liver
diseas
howev
approxim
dog
hepatobiliari
diseas
cat
icter
icteru
result
bilirubin
accumul
blood
extravascular
space
result
increas
product
reduc
clearanc
impair
conjug
liver
andor
impair
bile
flow
case
combin
factor
involv
cholestasi
predomin
therefor
conjug
bilirubin
fraction
present
greatest
quantiti
hemolysi
alon
result
icteru
normal
liver
function
hemolysi
sever
howev
may
result
degre
portal
hypoxia
centrolobular
zone
liver
lobul
becom
necrot
case
icteru
result
combin
increas
product
reduc
liver
function
cholestasi
hemolysi
primari
caus
icteru
must
sever
mucou
membran
extrem
pale
primari
liver
diseas
may
caus
icteru
commonli
accompani
hemolysi
wherea
erythrocyt
lifetim
reduc
day
dog
sever
primari
hemolyt
diseas
day
normal
day
hepatobiliari
diseas
increas
product
bilirubin
liver
dysfunct
cholestasi
result
combin
conjug
unconjug
hyperbilirubinemia
dog
cat
primari
hepat
hemolyt
diseas
icteru
caus
hemolyt
diseas
character
pale
mucou
membran
wherea
mucou
membran
anim
primari
liver
diseas
normal
slightli
pale
combin
evalu
icteru
color
mucou
membran
immedi
reveal
natur
underli
process
previous
discuss
hepatobiliari
diseas
accompani
increas
degrad
red
blood
cell
mechan
behind
hemolysi
liver
diseas
complet
clear
hypersplen
reduc
portal
blood
flow
due
portal
hypertens
may
drastic
prolong
transit
time
erythrocyt
spleen
greater
chanc
trap
slightli
abnorm
increas
fragil
red
cell
membran
may
result
high
bile
acid
level
liver
diseas
wherea
reduc
clearanc
enter
endotoxin
bacteria
liver
may
also
induc
immunemedi
hemolysi
apart
hemolysi
nonregen
anemia
also
may
occur
part
syndrom
anemia
chronic
diseas
express
catabol
slight
defici
iron
b
vitamin
although
common
liver
diseas
anemia
contrast
icteru
nonspecif
like
icteru
hepat
enlarg
distinct
sign
abnorm
liver
dog
liver
diseas
caus
hepatomegali
except
includ
tumor
liver
liver
congest
secondari
liver
involv
metabol
diseas
exampl
latter
condit
glycogen
accumul
liver
cush
diseas
fatti
liver
diabet
mellitu
rare
case
amyloidosi
liver
chronic
liver
diseas
dog
tend
reduc
liver
size
acut
diseas
caus
littl
chang
size
liver
enlarg
hormon
drug
lead
increas
serum
activ
patient
without
primari
hepat
diseas
addit
serum
hepat
enzym
activ
increas
consequ
secondari
hepatopathi
magnitud
hepat
enzym
activ
increas
may
aid
assess
sever
extent
hepat
injuri
consid
prognost
liver
larg
capac
regener
even
case
sever
hepat
injuri
dramat
rais
hepat
enzym
activ
full
recoveri
possibl
especi
true
injuri
acut
convers
case
chronic
endstag
liver
diseas
cirrhosi
serum
hepat
enzym
activ
may
markedli
increas
may
even
within
refer
interv
result
replac
hepatocyt
fibrou
tissu
consequ
serial
evalu
serum
hepat
enzym
activ
use
assess
prognosi
measur
singl
point
time
consist
decreas
previous
increas
activ
consid
favor
sign
acut
liver
injuri
wherea
decreas
hepat
enzym
activ
patient
chronic
liver
diseas
clinic
deterior
suggest
loss
hepatocyt
fibrosi
import
note
serum
hepat
enzym
activ
provid
assess
liver
function
alt
enzym
found
primarili
cytosol
hepatocyt
alt
releas
serum
hepatocyt
membran
permeabl
increas
hepatocellular
necrosi
alt
consid
liverspecif
enzym
alt
also
produc
cardiac
muscl
skelet
muscl
kidney
apart
hepat
form
muscl
isoenzym
clinic
signific
although
uncommon
sever
muscl
injuri
result
increas
serum
alt
activ
hepat
microsom
induct
respons
drug
also
produc
small
increas
alt
activ
controversi
exist
regard
serum
halflif
alt
dog
mean
serum
halflif
alt
report
minut
one
studi
hour
anoth
serum
halflif
alt
gener
believ
shorter
cat
dog
mean
serum
halflif
minut
report
experi
involv
three
healthi
cat
shorter
halflif
cat
mean
increas
serum
alt
activ
consid
clinic
import
speci
alt
metabol
liver
serum
halflif
may
longer
patient
liver
diseas
increas
cell
membran
permeabl
absenc
hepatocyt
destruct
caus
rapid
increas
serum
alt
activ
alt
activ
consid
highli
sensit
marker
hepatocyt
injuri
also
mean
increas
alt
activ
impli
sever
irrevers
hepatocellular
injuri
highest
increas
alt
activ
seen
acut
hepat
inflamm
necrosi
capac
liver
regener
indic
irrevers
damag
consequ
singl
measur
alt
activ
provid
accur
prognosi
howev
degre
alt
activ
increas
believ
correl
number
hepatocyt
injur
cholestasi
also
result
increas
serum
alt
activ
hepatocellular
damag
caus
accumul
bile
acid
certain
drug
lead
increas
serum
alt
activ
usual
minor
exampl
phenobarbit
use
therapeut
dose
frequent
lead
small
increas
serum
alt
activ
absenc
hepat
insuffici
increas
thought
occur
result
subclin
hepat
injuri
rather
induct
hepat
microsom
enzym
toxic
dose
product
clot
factor
degre
dissemin
intravascular
coagul
dic
sever
protein
defici
note
take
fineneedl
aspir
biopsi
consid
safe
even
abnorm
coagul
present
howev
diagnost
valu
limit
liver
architectur
lost
diagnosi
circulatori
hepat
diseas
depend
inform
obtain
laboratori
result
ultrasonographi
reliabl
diagnost
test
date
histopatholog
recent
paper
found
fast
ammonia
concentr
superior
fast
bile
acid
diagnos
portosystem
shunt
dog
ammonia
easili
measur
practic
dri
chemic
method
provid
reliabl
result
anoth
recent
public
show
ultrasonographi
reliabl
diagnost
method
noninvas
character
underli
hepat
diseas
dog
hyperammonemia
diagnost
evalu
hepatobiliari
system
sever
aim
determin
hepatobiliari
diseas
present
b
assess
liver
function
c
determin
liver
diseas
primari
secondari
definit
diagnos
hepatobiliari
diseas
e
monitor
respons
treatment
despit
appar
clariti
aim
hepatobiliari
diseas
present
diagnost
challeng
number
reason
first
clinic
sign
nonspecif
hepatobiliari
diseas
consider
evalu
patient
sign
system
diseas
dog
cat
hepatobiliari
diseas
may
clinic
sign
furthermor
liver
central
role
metabol
detoxif
endogen
toxin
xenobiot
agent
number
extrahepat
diseas
secondarili
affect
liver
import
distinguish
secondari
hepatopathi
diseas
origin
liver
primari
hepatopathi
addit
serum
marker
hepatocellular
damag
cholestasi
hepat
function
abnorm
absenc
hepatobiliari
diseas
final
liver
larg
reserv
capac
mean
detect
loss
liver
function
often
occur
late
cours
diseas
thu
assess
patient
suspect
hepatobiliari
diseas
import
consid
clinic
present
result
laboratori
test
diagnost
imag
find
result
cytolog
andor
histopatholog
evalu
togeth
hepat
enzym
divid
marker
hepatocellular
damag
marker
cholestasi
serum
alanin
aminotransferas
alt
aspart
transaminas
ast
activ
two
commonli
measur
marker
hepatocellular
leakag
serum
alkalin
phosphatas
alp
ggt
activ
two
commonli
measur
marker
cholestasi
although
increas
serum
hepat
enzym
activ
consid
sensit
specif
primari
liver
diseas
produc
extrahepat
tissu
rel
import
extrahepat
isoenzym
vari
extrahepat
releas
lead
increas
serum
activ
also
product
hepat
enzym
induc
certain
alp
balp
kidney
alp
kalp
transcrib
tissu
nonspecif
alp
gene
gene
encod
intestin
alp
ialp
probabl
glucocorticoidinduc
alp
galp
dog
serum
halfliv
placent
alp
kalp
ialp
less
minut
cat
serum
halflif
ialp
less
minut
halfliv
placent
alp
kalp
also
assum
short
cat
similar
structur
ialp
lalp
balp
dog
cat
galp
believ
contribut
significantli
serum
alp
activ
serum
halflif
lalp
approxim
hour
dog
hour
cat
lalp
bound
membran
hepatocyt
glycosylphosphatidylinositol
linkag
cleavag
link
glycosylphosphatidylinositolphospholipas
allow
enzym
releas
bloodstream
bile
acid
detergentlik
properti
accumul
bile
acid
cholestasi
facilit
process
cholestasi
also
result
induct
synthesi
lalp
galp
dog
consequ
serum
alp
activ
often
sever
increas
patient
cholestat
disord
dog
alp
consid
sensit
marker
cholestasi
sensit
short
halflif
lalp
cat
mean
increas
alp
cholestasi
high
dog
consequ
alp
lesssensit
marker
cholestasi
cat
dog
report
sensit
howev
shorter
halflif
cat
absenc
galp
mean
increas
alp
activ
consid
clinic
import
speci
increas
serum
alp
activ
differenti
intrahepat
extrahepat
cholestasi
wide
varieti
liver
diseas
caus
intrahepat
cholestasi
gener
caus
hepatocyt
swell
caus
obstruct
small
bile
canaliculi
increas
alp
follow
hepat
insult
delay
compar
rise
marker
hepatocellular
leakag
reason
take
time
enzym
synthes
releas
system
circul
alp
often
remain
increas
time
resolut
liver
injuri
balp
releas
bloodstream
result
activ
osteoblast
therefor
condit
result
increas
bone
format
lead
increas
serum
alp
activ
anim
skelet
immatur
mild
increas
serum
alp
activ
commonli
observ
anim
increas
osteoblast
activ
hyperparathyroid
neoplasia
involv
bone
osteomyel
may
mild
moder
increas
alp
activ
caus
increas
balp
activ
unlik
confus
primari
liver
diseas
increas
smaller
would
expect
cholestasi
bone
diseas
often
clinic
appar
final
increas
serum
activ
balp
report
famili
asymptomat
huski
dog
cat
galp
tissuenonspecif
alp
may
induc
corticosteroid
galp
believ
isoform
ialp
prolong
serum
halflif
produc
liver
posttransl
glycosyl
galp
believ
respons
prolong
halflif
induct
galp
may
caus
increas
total
serum
alp
activ
administr
exogen
corticosteroid
synthesi
isoenzym
also
induc
administr
anticonvuls
drug
phenobarbit
similarli
hypercortisolemia
frequent
caus
increas
serum
alp
activ
induct
galp
howev
dog
excess
serum
concentr
endogen
exogen
corticosteroid
hepatocyt
swell
caus
glycogen
accumul
vacuolar
hepatopathi
may
lead
intrahepat
cholestasi
anoth
potenti
contributor
increas
serum
alp
phenobarbit
caus
dramat
increas
serum
alt
activ
hepat
insuffici
prednison
glucocorticoid
caus
induct
alt
steroid
hepatopathi
consequ
small
increas
serum
alt
activ
serum
alt
activ
also
increas
secondari
hepatopathi
howev
persist
increas
serum
alt
activ
even
appar
normal
liver
function
indic
diagnost
test
serial
evalu
serum
alt
activ
help
prognost
must
done
consid
patient
clinic
sign
laboratori
valu
gener
declin
serum
alt
activ
acut
liver
injuri
consid
good
sign
ast
anoth
aminotransferas
enzym
use
marker
hepatocellular
leakag
ast
found
skelet
muscl
brain
liver
kidney
cardiac
muscl
lesser
extent
within
tissu
extrahepat
isoenzym
ast
rel
import
alt
muscl
diseas
caus
increas
serum
ast
activ
ast
consid
less
liver
specif
alt
howev
look
serum
ast
activ
conjunct
activ
hepat
enzym
muscl
enzym
usual
possibl
differenti
increas
caus
muscl
damag
increas
caus
hepat
damag
controversi
regard
serum
halflif
ast
dog
one
studi
report
halflif
mean
minut
anoth
studi
report
mean
hour
one
studi
report
mean
halflif
minut
cat
unlik
alt
consider
proport
ast
approxim
found
within
hepatocyt
mitochondria
rather
cytosol
cytosol
fraction
ast
releas
serum
hepatocyt
cell
membran
permeabl
increas
case
hepatocellular
necrosi
contrast
mitochondri
fraction
releas
hepatocellular
necrosi
releas
ast
hepatocyt
serum
parallel
releas
alt
therefor
like
serum
alt
activ
serum
ast
activ
consid
sensit
marker
hepatocyt
injuri
suggest
increas
ast
activ
may
sensit
increas
alt
activ
detect
hepatocellular
injuri
cat
corticosteroid
phenobarbit
may
caus
mild
increas
serum
ast
activ
consider
overlap
inform
provid
measur
serum
alt
ast
activ
measur
serum
ast
activ
may
redund
alp
enzym
bound
membran
hepatocyt
compris
bile
canaliculi
sinusoid
membran
consid
sensit
marker
cholestasi
especi
dog
liver
specif
cholestasi
canalicular
cell
necrosi
increas
hepat
synthesi
may
lead
releas
enzym
circul
synthesi
enzym
induc
certain
drug
notabl
corticosteroid
possibl
increas
serum
alp
activ
could
caus
extrahepat
diseas
could
induc
glucocorticoid
dog
make
interpret
find
challeng
dog
wide
varieti
tissu
exhibit
alp
activ
includ
intestin
mucosa
kidney
cortex
bone
marrow
pancrea
testicl
brain
lung
kidney
medulla
lymph
node
liver
skin
spleen
skelet
muscl
cardiac
muscl
disagr
literatur
regard
rel
contribut
alp
activ
tissu
cat
two
gene
encod
alp
dog
differ
form
alp
aris
gene
call
isoform
differ
among
isoform
aris
differ
posttransl
process
liver
alp
lalp
bone
globulin
produc
liver
exclus
liver
produc
wherea
lymphoid
cell
produc
immunoglobulin
hepat
insuffici
rare
lead
decreas
serum
globulin
concentr
convers
inflammatori
liver
diseas
may
associ
hyperglobulinemia
nonimmunoglobulin
fraction
produc
liver
includ
sever
acutephas
protein
creactiv
protein
haptoglobin
serum
amyloid
hepat
synthesi
protein
increas
system
inflamm
possibl
lead
rise
total
serum
globulin
concentr
addit
immunoglobulin
product
may
increas
infecti
neoplast
autoimmun
diseas
coagul
factor
except
factor
viii
anticoagul
factor
antithrombin
protein
c
fibrinolyt
protein
plasminogen
synthes
liver
liver
also
site
activ
vitamin
kdepend
clot
factor
ii
vii
ix
x
protein
c
furthermor
bile
acid
need
emulsifi
fat
aid
absorpt
vitamin
k
intestin
vitamin
k
malabsorpt
may
develop
secondari
cholestasi
consequ
hepatobiliari
diseas
affect
hemostasi
one
way
canin
felin
liver
diseas
coagul
paramet
abnorm
report
specif
clot
factor
activ
prothrombin
time
aptt
protein
induc
absenc
vitamin
k
fibrin
degrad
product
fibrinogen
proteinc
activ
abnorm
hemostasi
specif
liver
diseas
may
support
presenc
patient
liver
diseas
may
develop
dic
difficult
distinguish
coagulopathi
reduc
hepat
synthesi
clot
factor
alon
although
spontan
bleed
seldom
occur
patient
liver
diseas
assess
coagul
statu
patient
import
especi
invas
procedur
liver
biopsi
consid
recent
studi
investig
diagnost
valu
serum
protein
c
marker
hepatobiliari
diseas
portosystem
shunt
dog
serum
proteinc
measur
report
aid
differenti
portal
vein
hypoplasia
without
portal
hypertens
formerli
call
microvascular
dysplasia
portosystem
shunt
pss
dog
portal
vein
hypoplasia
without
portal
hypertens
significantli
higher
serum
proteinc
concentr
portosystem
shunt
urea
produc
ammonia
liver
releas
system
circul
subsequ
excret
kidney
serum
urea
nitrogen
concentr
may
close
lower
limit
refer
interv
patient
hepat
insuffici
pss
urea
cycl
enzym
defici
howev
serum
urea
nitrogen
concentr
may
also
decreas
medullari
solut
washout
caus
diuresi
malnutrit
proteinrestrict
diet
normal
find
neonat
patient
liver
diseas
high
fast
serum
urea
nitrogen
concentr
rel
serum
creatinin
concentr
suggest
gi
hemorrhag
ammonia
nh
produc
small
intestin
enterocyt
catabol
glutamin
colon
consequ
bacteri
deamin
ammonia
highli
diffus
ga
pass
readili
bowel
wall
bloodstream
blood
ph
ammonia
exist
form
ammonium
ion
nh
ammonium
transport
blood
intestin
hepat
portal
circul
liver
extract
ammonia
portal
circul
highli
effici
endogen
ammonia
produc
breakdown
activ
diagnos
primari
liver
diseas
dog
increas
serum
alp
activ
induct
galp
endogen
exogen
steroid
rule
recent
group
scottish
terrier
found
increas
serum
alp
activ
identifi
underli
caus
technic
possibl
select
measur
activ
galp
use
techniqu
levamisol
inhibit
measur
galp
activ
initi
investig
way
differenti
increas
alp
caus
corticosteroid
caus
cholestasi
unfortun
measur
galp
clinic
use
galp
activ
may
increas
varieti
condit
includ
hepat
diseas
diabet
mellitu
hypothyroid
pancreat
ggt
glycoprotein
enzym
bound
membran
hepatocyt
form
bile
canaliculi
bile
duct
also
periport
hepatocyt
comparison
alp
distribut
includ
distal
area
biliari
tract
measur
serum
ggt
activ
use
distinguish
intrahepat
extrahepat
cholestasi
ggt
also
produc
number
extrahepat
tissu
ggt
activ
serum
thought
result
hepat
isoenzym
colostrum
also
contain
ggt
respons
mild
increas
serum
ggt
activ
seen
suckl
anim
chang
serum
ggt
activ
gener
parallel
serum
alp
activ
activ
often
increas
patient
cholestasi
ggt
also
induc
glucocorticoid
activ
may
increas
patient
hyperadrenocortic
expos
exogen
steroid
dog
increas
serum
ggt
activ
consid
specif
less
sensit
alp
activ
presenc
liver
diseas
cat
measur
serum
ggt
activ
sensit
less
specif
detect
liver
diseas
alp
cat
hepat
lipidosi
may
except
often
normal
serum
ggt
activ
increas
serum
alp
activ
liver
play
central
role
protein
metabol
respons
synthesi
plasma
protein
deamin
amino
acid
convers
ammonia
urea
amino
acid
synthesi
interconvers
amino
acid
consequ
patient
hepat
diseas
function
may
compromis
albumin
import
plasma
protein
produc
exclus
liver
rate
albumin
synthesi
must
equal
rate
albumin
loss
maintain
serum
albumin
concentr
mild
decreas
serum
albumin
concentr
occur
varieti
condit
howev
differenti
diagnos
sever
hypoalbuminemia
gdl
limit
hepat
insuffici
sever
exud
skin
diseas
proteinlos
enteropathi
proteinlos
nephropathi
possibl
determin
caus
sever
hypoalbuminemia
combin
clinic
find
measur
serum
globulin
concentr
urinalysi
includ
protein
creatinin
ratio
test
gi
protein
loss
test
liver
function
albumin
contribut
significantli
colloid
oncot
pressur
sever
hypoalbuminemia
lead
ascit
pleural
effus
andor
subcutan
edema
liver
larg
reserv
capac
synthesi
albumin
albumin
serum
halflif
approxim
day
dog
consequ
hypoalbuminemia
rel
insensit
marker
hepat
insuffici
like
seen
patient
advanc
chronic
liver
diseas
portosystem
shunt
psss
hepatobiliari
diseas
dog
cat
patient
sever
hepat
insuffici
pss
serum
cholesterol
concentr
may
decreas
consequ
impair
hepat
synthesi
hypocholesterolemia
might
also
occur
result
inadequ
dietari
intak
maldigest
malabsorpt
hypoadrenocortic
serum
cholesterol
concentr
patient
hepatobiliari
diseas
may
within
refer
interv
patient
cholestat
diseas
becom
hypercholesterolem
fast
hypercholesterolemia
also
may
observ
patient
variou
endocrinopathi
obes
proteinlos
nephropathi
pancreat
primari
hyperlipidemia
serum
triglycerid
concentr
may
increas
normal
patient
liver
diseas
howev
increas
fast
serum
triglycerid
concentr
sensit
specif
marker
hepatobiliari
diseas
dog
cat
mild
increas
serum
triglycerid
concentr
may
develop
patient
cholestasi
evid
hypertriglyceridemia
associ
gallbladd
mucocel
format
hypertriglyceridemia
associ
increas
serum
hepat
enzym
activ
miniatur
schnauzer
increas
fast
serum
triglycerid
concentr
also
observ
patient
endocrinopathi
obes
pancreat
primari
hyperlipidemia
liver
play
central
role
carbohydr
metabol
respons
glycogen
storag
convers
galactos
fructos
glucos
gluconeogenesi
synthesi
mani
compound
carbohydr
blood
glucos
measur
sensit
specif
marker
liver
diseas
liver
larg
reserv
capac
glucos
product
consequ
hepat
insuffici
must
sever
hypoglycemia
occur
hypoglycemia
occur
proport
patient
congenit
pss
hepat
neoplasia
also
lead
hypoglycemia
thought
caus
releas
insulinlik
substanc
varieti
extrahepat
condit
also
lead
hypoglycemia
bilirubin
yellow
pigment
produc
breakdown
hemecontain
compound
measur
serum
bilirubin
concentr
use
assess
liver
function
hyperbilirubinemia
result
hepatobiliari
extrahepat
diseas
icteru
yellowish
pigment
caus
retent
bilirubin
soft
tissu
laboratori
assess
sensit
way
detect
increas
serum
bilirubin
concentr
hyperbilirubinemia
classifi
prehepat
hepat
posthepat
origin
bilirubin
may
artifactu
increas
vitro
hemolysi
administr
synthet
hemoglobin
polym
assess
hyperbilirubinem
patient
critic
local
underli
caus
bilirubin
major
product
degrad
hemecontain
compound
cell
mononuclear
phagocyt
system
bilirubin
releas
mononuclear
phagocyt
system
transport
plasma
bilirubin
revers
bound
albumin
water
insolubl
unconjug
bilirubin
absorb
hepatocyt
cell
membran
bound
glucuron
acid
conjug
conjug
bilirubin
water
solubl
activ
excret
hepatocyt
bile
canaliculi
eventu
excret
intestin
intestin
bilirubin
convert
urobilinogen
bacteria
urobilinogen
reabsorb
intestin
immedi
reexcret
liver
nitrogen
substanc
bodi
especi
glutamin
liver
ammonium
convert
urea
enzym
urea
cycl
use
convers
glutam
glutamin
urea
enter
circul
excret
kidney
ammonium
remov
liver
enter
system
circul
liver
larg
reserv
capac
convers
ammonia
urea
plasma
ammonia
measur
rel
insensit
marker
hepat
insuffici
howev
measur
blood
ammonia
concentr
sensit
test
congenit
psss
apsc
shunt
also
known
acquir
psss
portosystem
shunt
occur
ammonia
absorb
intestin
bypass
liver
reach
system
circul
directli
sensit
plasma
ammonia
measur
detect
pss
report
dog
cat
measur
postprandi
venou
ammonia
sensit
measur
fast
ammonia
sensit
respect
detect
congenit
pss
howev
sensit
detect
dog
hepatocellular
diseas
gener
hyperammonemia
consid
specif
hepat
insuffici
pss
howev
although
uncommon
ureacycl
enzym
defici
may
also
caus
increas
blood
ammonia
concentr
enzym
defici
hereditari
result
absenc
particular
enzym
secondari
cobalamin
arginin
defici
arginin
defici
especi
relev
cat
hepat
lipidosi
ammonia
one
substanc
caus
hepat
encephalopathi
therefor
blood
ammonia
measur
use
marker
howev
substanc
also
caus
plasma
ammonia
concentr
patient
may
within
refer
interv
ammonium
ion
labil
plasma
sampl
handl
critic
measur
plasma
ammonia
concentr
sampl
collect
place
immedi
ice
plasma
separ
red
blood
cell
soon
possibl
plasma
must
kept
cool
analyz
within
minut
collect
handl
requir
meant
ammonia
measur
mainli
confin
practic
immedi
access
commerci
laboratori
measur
plasma
ammonia
avail
inhous
dri
chemistri
analyz
vettest
idexx
laboratori
westbrook
although
method
consid
reliabl
agre
refer
method
serum
ammonia
concentr
greater
recent
studi
found
point
care
blood
ammonia
analyz
pocketchem
ba
menarini
diagnost
florenc
itali
may
suitabl
measur
blood
ammonia
concentr
dog
cat
ammonia
toler
test
att
investig
attempt
increas
sensit
ammonia
measur
detect
hepat
insuffici
pss
howev
oral
administr
ammonium
salt
caus
vomit
potenti
worsen
sign
ammonium
chlorid
sulfat
also
given
rectal
less
like
produc
advers
method
sensit
detect
pss
dog
liver
play
central
role
lipid
metabol
respons
oxid
fatti
acid
synthesi
cholesterol
synthesi
lipoprotein
synthesi
fatti
acid
protein
carbohydr
serum
cholesterol
concentr
may
increas
normal
decreas
patient
liver
diseas
increas
decreas
fast
serum
cholesterol
concentr
sensit
specif
fast
postprandi
suggest
hepat
dysfunct
pss
cholestasi
specif
particular
liver
diseas
bile
acid
exclus
synthes
liver
cholesterol
nearli
bile
acid
produc
hepatocyt
conjug
amino
acid
dog
cat
conjug
primarili
taurin
dog
may
also
convert
conjug
glycin
contrast
even
taurin
deplet
cat
conjug
bile
acid
almost
exclus
taurin
conjug
bile
acid
produc
liver
call
primari
bile
acid
secret
bile
store
gallbladd
cholecystokinin
releas
endocrin
cell
small
intestin
hormon
stimul
gallbladd
contract
flow
bile
duodenum
gallbladd
contract
bile
acid
releas
intestin
spontan
gallbladd
contract
also
occur
interdigest
phase
bile
acid
act
ionic
deterg
aid
emulsif
dietari
lipid
subsequ
intestin
absorpt
micel
bile
acid
recycl
process
known
enterohepat
circul
figur
primari
bile
acid
lipid
insolubl
thu
absorb
intestin
bind
specif
high
affin
ileal
mucos
receptor
ileal
reabsorpt
effici
reabsorb
bile
acid
enter
portal
circul
upon
reach
liver
effici
extract
plasma
subsequ
reexcret
total
bile
acid
pool
recircul
sever
time
day
consequ
rate
hepat
bile
acid
synthesi
fast
serum
bile
acid
concentr
dog
cat
normal
hepat
function
low
increas
releas
store
bile
acid
postprandi
period
small
increas
total
sba
concentr
occur
anim
normal
hepat
function
primari
conjug
bile
acid
undergo
bacteri
deconjug
intestin
lumen
result
unconjug
bile
acid
call
secondari
bile
acid
readili
absorb
colon
passiv
diffus
firstpass
extract
reexcret
secondari
bile
acid
less
effici
primari
bile
acid
consequ
secondari
unconjug
bile
acid
often
present
postprandi
serum
sampl
hepatobiliari
diseas
caus
increas
sba
concentr
interf
hepatocellular
function
caus
decreas
bile
flow
cholestasi
alter
hepatoport
blood
flow
main
clinic
use
sba
measur
assess
hepat
function
patient
suspect
hepat
diseas
serum
expos
air
urobilinogen
remain
intestin
alter
oxid
brown
pigment
sterocobilin
prehepat
hyperbilirubinemia
caus
increas
product
bilirubin
result
hemolysi
liver
larg
reserv
capac
bilirubin
excret
hemolysi
caus
hyperbilirubinemia
hepat
bilirubin
clearanc
must
decreas
occur
hemolyt
anemia
result
hepatocyt
dysfunct
hypoxia
hepat
hypoxia
occur
serum
hepat
enzym
activ
often
increas
prehepat
hyperbilirubinemia
mainli
distinguish
caus
hyperbilirubinemia
presenc
sever
anemia
support
evid
includ
presenc
regen
erythroid
respons
characterist
chang
red
blood
cell
morpholog
possibl
detect
red
blood
cell
bound
antibodi
hepat
hyperbilirubinemia
caus
decreas
rate
hepatocyt
bilirubin
uptak
conjug
excret
result
intrahepat
cholestasi
usual
hepatocyt
dysfunct
intrahepat
cholestasi
occur
concurr
hepat
enzym
activ
hepatocellular
leakag
marker
cholestat
marker
often
increas
although
also
increas
prehepat
posthepat
hyperbilirubinemia
hepat
reserv
capac
hepat
diseas
must
sever
order
caus
hyperbilirubinemia
rang
primari
secondari
hepatopathi
caus
hepat
hyperbilirubinemia
hepat
hyperbilirubinemia
usual
distinguish
prehepat
hyperbilirubinemia
assess
patient
hematocrit
posthepat
hyperbilirubinemia
abdomin
ultrasound
marker
hepat
insuffici
present
provid
addit
support
presenc
hepat
hyperbilirubinemia
posthepat
hyperbilirubinemia
result
extrahepat
bile
duct
obstruct
often
caus
pancreat
inflamm
much
less
commonli
neoplasia
main
diagnost
tool
document
extrahepat
bile
duct
obstruct
abdomin
ultrasound
typic
extrahepat
bile
duct
obstruct
lead
dramat
increas
serum
cholestat
enzym
activ
compar
hepatocellular
leakag
enzym
activ
hypercholesterolemia
bile
duct
complet
obstruct
achol
palecolor
fece
may
note
ruptur
biliari
tract
frequent
lead
hyperbilirubinemia
bilirubin
accumul
abdomen
possibl
measur
concentr
serum
conjug
bilirubin
howev
test
consid
clinic
use
distinguish
prehepat
hepat
posthepat
hyperbilirubinemia
thu
rare
perform
bilirubin
coval
nonrevers
bind
albumin
biliprotein
clear
liver
thu
persist
plasma
biliprotein
serum
halflif
compar
albumin
clinic
import
mean
hyperbilirubinemia
icteru
may
persist
sever
week
resolut
caus
bile
acid
bile
salt
deioniz
form
cholesterol
liver
major
constitu
bile
serum
bile
acid
sba
measur
use
test
liver
function
dog
cat
sba
either
measur
fast
sampl
withhold
food
hour
collect
pair
fast
postprandi
sampl
test
simpl
perform
safe
enzymat
measur
concentr
total
bile
acid
serum
becom
wide
avail
replac
techniqu
radioimmunoassay
collect
sampl
serum
store
room
temperatur
make
possibl
send
outsid
laboratori
evalu
lipemia
hemolysi
blood
sampl
avoid
interfer
assay
increas
sba
concentr
recent
studi
support
use
clabel
galactos
breath
test
assess
liver
function
dog
metabol
endogen
substanc
investig
find
possibl
marker
hepat
cellular
metabol
dog
hepat
diseas
hepat
neoplasia
significantli
higher
serum
lphenylalanin
concentr
healthi
dog
nonhepat
diseas
investig
need
determin
util
test
assess
liver
function
veterinari
patient
urin
specif
graviti
decreas
patient
hepat
insuffici
pss
caus
inabl
fulli
concentr
urin
result
pu
primari
pd
bilirubin
commonli
measur
semiquantit
canin
felin
urin
use
urin
dipstick
bilirubinuria
dipstick
normal
find
dog
especi
male
bilirubinuria
dog
without
hemolyt
hepatobiliari
diseas
occur
consequ
loss
unconjug
bilirubin
bound
albumin
proteinur
patient
renal
filtrat
small
amount
conjug
bilirubin
leak
liver
addit
renal
tubular
cell
male
dog
enzym
need
produc
conjug
bilirubin
cat
higher
renal
threshold
bilirubin
dog
bilirubinuria
alway
consid
abnorm
cat
bilirubinuria
cat
excess
bilirubinuria
dog
impli
hemolyt
hepatobiliari
diseas
dog
rel
low
renal
threshold
bilirubin
bilirubinuria
often
detect
bilirubinemia
jaundic
ammonium
biurat
crystal
detect
urin
sediment
light
microscopi
uric
acid
product
purin
catabol
convert
allanto
acid
hepat
urat
oxidas
case
sever
hepat
insuffici
pss
serum
uric
acid
concentr
may
higher
renal
threshold
combin
hyperammonemia
may
lead
ammonium
biurat
precipit
urin
urat
urolithiasi
seem
common
patient
pss
type
hepat
dysfunct
dog
pss
found
urat
crystalluria
howev
note
urat
crystalluria
specif
hepatobiliari
diseas
erythrocyt
seri
may
affect
hepatobiliari
diseas
result
erythrocyt
dysmorphia
anemia
abnorm
suggest
specif
hepatobiliari
diseas
patient
hepatobiliari
diseas
anem
result
blood
loss
case
sign
regen
respons
normal
present
within
day
hemorrhag
acut
sever
hemorrhag
may
occur
patient
hepatobiliari
diseas
follow
invas
procedur
liver
biopsi
consequ
hemorrhag
hepat
neoplasm
hepat
ruptur
lesssever
anemia
may
occur
result
gi
bleed
chronic
gi
blood
loss
may
eventu
lead
irondefici
anemia
character
microcyt
hypochrom
erythrocyt
variabl
regen
respons
addit
hepatobiliari
diseas
may
lead
anemia
chronic
diseas
typic
nonregen
normocyt
normochrom
erythrocyt
red
blood
cell
morpholog
chang
sometim
observ
dog
hepatobiliari
diseas
poikilocytosi
character
presenc
acanthocyt
target
cell
may
seen
patient
chronic
hepat
diseas
thought
result
alter
phospholipid
metabol
patient
pss
microcyt
red
blood
cell
common
dog
bilirubin
concentr
within
refer
interv
measur
postprandi
sba
concentr
seem
advantag
fast
sba
concentr
vice
versa
sensit
increas
collect
pair
preprandi
twohour
postprandi
sampl
numer
studi
show
sba
measur
use
test
diagnos
hepatobiliari
diseas
includ
pss
dog
cat
recent
studi
found
sensit
fast
sba
measur
diagnos
pss
use
cutoff
valu
dog
cat
report
specif
dog
cat
howev
sensit
sba
measur
detect
hepat
insuffici
lower
detect
pss
measur
sba
concentr
sever
limit
first
test
allow
differenti
variou
type
hepatobiliari
diseas
also
measur
serum
bile
acid
patient
proven
cholestasi
clinic
benefit
addit
limit
util
measur
sba
concentr
patient
hyperbilirubinemia
although
potenti
sba
measur
could
use
distinguish
prehepat
hepat
posthepat
caus
hyperbilirubinemia
prehepat
caus
hyperbilirubinemia
bile
acid
concentr
within
refer
interv
howev
case
prehepat
hyperbilirubinemia
easili
distinguish
presenc
sever
anemia
also
note
magnitud
increas
sba
concentr
correl
prognosi
diseas
sever
import
note
fast
sba
concentr
may
higher
upper
limit
refer
interv
higher
postprandi
valu
spontan
contract
gallbladd
fast
state
delay
gastric
empti
could
result
increas
fast
sba
concentr
absenc
hepatobiliari
diseas
increas
fast
postprandi
serum
bile
acid
concentr
result
increas
bacteri
deconjug
primari
bile
acid
secondari
bile
acid
falseneg
result
may
occur
enterohepat
circul
bile
acid
occur
lack
gallbladd
contract
could
problem
patient
anorect
eat
enough
food
consum
diet
insuffici
protein
fat
vomit
test
meal
delay
gastric
empti
ceruletid
inject
cholecystokinin
analogu
use
stimul
gallbladd
contract
use
sba
measur
diagnos
hepatobiliari
diseas
test
circumv
mani
factor
influenc
postprandi
sba
concentr
urin
bile
acid
measur
describ
dog
cat
diagnost
perform
similar
sba
measur
speci
test
offer
advantag
sba
measur
excret
exogen
tracer
anion
cholephil
dye
bromsulphalein
indocyanin
green
use
histor
assess
hepat
function
veterinari
patient
howev
test
consid
unreli
replac
measur
sba
concentr
metabol
exogen
substanc
use
assess
liver
function
varieti
substanc
investig
marker
hepat
metabol
human
medicin
assess
metabol
aminopyrin
investig
dog
lesser
extent
cat
clabel
aminopyrin
demethyl
blood
test
involv
intraven
administr
clabel
aminopyrin
subject
aminopyrin
metabol
liver
result
product
co
measur
blood
fraction
mass
spectroscopi
investig
util
test
assess
liver
function
need
dog
liver
diseas
dog
extrahepat
diseas
higher
dog
cirrhot
liver
diseas
dog
noncirrhot
liver
diseas
blood
ha
concentr
may
prove
use
marker
hepat
fibrosi
dog
studi
necessari
evalu
clinic
util
histopatholog
analysi
liver
biopsi
identif
shunt
blood
vessel
often
requir
definit
diagnos
hepat
diseas
howev
pattern
laboratori
test
abnorm
particularli
interpret
conjunct
patient
clinic
present
result
diagnost
imag
increas
decreas
clinician
index
suspicion
specif
liver
diseas
tabl
import
note
consider
overlap
pattern
differ
diseas
avoid
misinterpret
misdiagnosi
evalu
patient
liver
diseas
essenti
consid
limit
laboratori
test
discuss
diagnost
imag
import
part
investig
hepatobiliari
diseas
dog
cat
diagnost
imag
may
help
determin
whether
hepatobiliari
diseas
present
identifi
caus
secondari
hepatopathi
aid
diagnosi
specif
hepatobiliari
diseas
provid
prognost
inform
howev
except
diagnosi
pss
imag
seldom
yield
definit
diagnosi
radiographi
abdomin
ultrasound
frequent
use
imag
modal
assess
hepatobiliari
system
dog
cat
altern
imag
techniqu
use
frequent
abdomin
radiograph
allow
assess
hepat
size
shape
opac
locat
patient
radiographi
may
also
allow
identif
extrahepat
abnorm
affect
liver
howev
radiograph
provid
limit
inform
hepat
parenchyma
import
note
patient
hepatobiliari
diseas
often
normal
abdomin
radiograph
radiographi
allow
subject
assess
liver
size
cranial
displac
gastric
axi
may
observ
later
abdomin
radiograph
microhepatia
present
howev
subtl
microhepatia
unlik
appreci
radiograph
psss
hepat
cirrhosi
common
condit
caus
microhepatia
mild
bilater
renomegali
may
also
cat
microcytosi
also
occasion
occur
patient
hepatocellular
diseas
alter
iron
metabol
thought
lead
delay
red
blood
cell
precursor
gain
suffici
amount
hemoglobin
releas
circul
delay
lead
precursor
undergo
extra
cell
divis
bone
marrow
result
microcytosi
microangiopathi
occur
result
hepat
neoplasia
dic
may
lead
format
schistocyt
leukocyt
seri
may
affect
hepatobiliari
diseas
varieti
way
result
abnorm
inconsist
specif
hepatobiliari
diseas
leukocytosi
leukopenia
sometim
inflammatori
leukogram
may
present
infecti
less
commonli
inflammatori
neoplast
process
affect
hepatobiliari
system
leukocytosi
found
present
dog
chronic
hepat
thrombocyt
seri
occasion
affect
hepatobiliari
diseas
chang
inconsist
nonspecif
mild
moder
thrombocytopenia
may
occur
patient
sever
liver
diseas
may
result
decreas
product
thrombopoietin
liver
dissemin
intravascular
coagulopathi
associ
liver
diseas
also
may
lead
thrombocytopenia
addit
infecti
diseas
affect
liver
leptospirosi
may
result
thrombocytopenia
genet
test
copper
hepatotoxicosi
develop
bedlington
terrier
affect
bedlington
terrier
autosom
recess
defect
gene
dog
homozyg
affect
genotyp
develop
copper
hepatopathi
result
impair
biliari
excret
copper
initi
microsatellit
marker
linkag
disequilibrium
mutat
discov
use
identifi
affect
dog
select
dog
homozyg
unaffect
dog
breed
subsequ
mutat
gene
delet
exon
identifi
caus
condit
major
bedlington
terrier
genet
test
diseas
becom
commerci
avail
vetgen
ann
arbor
mi
test
run
alongsid
link
marker
small
proport
bedlington
terrier
delet
nevertheless
affect
diseas
dog
like
rare
second
mutat
gene
linkag
marker
may
track
hyaluron
acid
major
constitu
ecm
hyaluron
acid
ha
concentr
blood
use
marker
hepat
fibrosi
human
recent
studi
investig
use
ha
concentr
marker
hepat
diseas
dog
studi
found
blood
ha
concentr
significantli
higher
size
liver
subject
assess
abdomin
ultrasonographi
find
small
liver
cranial
displac
stomach
suggest
microhepatia
hepatomegali
anoth
subject
find
gener
focal
find
round
liver
lobe
margin
suggest
hepatomegali
hepat
parenchym
chang
classifi
diffus
multifoc
focal
wide
varieti
diseas
process
caus
diffus
chang
hepat
parenchyma
chang
isoecho
hypoecho
hyperecho
mix
echogen
case
architectur
liver
alter
case
chang
occur
exampl
diseas
echogen
hepat
parenchyma
diffus
chang
chang
architectur
occur
includ
cholang
neoplasia
hepat
lipidosi
vacuolar
hepatopathi
toxic
hepatopathi
earli
micronodular
hyperplasia
variou
degre
fibrosi
hyperechogen
liver
compar
falciform
fat
poor
visual
intrahepat
blood
vessel
increas
attenu
ultrasound
beam
use
criteria
sonograph
diagnosi
felin
hepat
lipidosi
diseas
hepat
architectur
alter
easier
detect
sonograph
includ
neoplasia
micronodular
hyperplasia
chronic
hepat
fibrosi
cystic
structur
abscess
hematoma
granuloma
exampl
focal
parenchym
liver
diseas
lesion
usual
easili
detect
sonograph
sonographi
seldom
allow
definit
diagnosi
hepat
parenchym
diseas
made
one
studi
overal
accuraci
ultrasound
discrimin
among
differ
categori
diffus
liver
diseas
dog
cat
hepat
lipidosi
cat
could
diagnos
slightli
accur
diffus
hepat
diseas
cytolog
histolog
evalu
hepat
tissu
sampl
usual
need
make
definit
diagnosi
hepat
neoplasia
whether
primari
metastat
diffus
multifoc
focal
distribut
round
cell
tumor
like
tumor
type
diffus
infiltr
liver
tumor
caus
hypoecho
hyperecho
mixedecho
chang
appreci
radiograph
patient
pss
urat
urolith
radioluc
might
visibl
plain
abdomin
radiograph
hepatomegali
gener
focal
gener
hepatomegali
caus
number
condit
includ
neoplasia
vacuolar
hepatopathi
congest
amyloidosi
focal
hepatomegali
caus
neoplasia
abscess
granuloma
liver
lobe
torsion
radiograph
sign
associ
hepatomegali
round
hepat
border
caudal
displac
gastric
axi
extens
hepat
silhouett
beyond
costal
arch
radiographi
allow
appreci
mild
hepatomegali
addit
normal
hepat
silhouett
extend
beyond
costal
arch
brachycephal
breed
chondrodystroph
breed
neonat
anim
geriatr
anim
liver
normal
appreci
area
homogen
softtissu
opac
radiograph
radioluc
area
within
liver
indic
accumul
ga
within
hepat
parenchyma
biliari
tract
portal
vasculatur
ga
parenchyma
liver
associ
hepat
abscess
ga
around
gallbladd
report
dog
emphysemat
cholecyst
although
uncommon
dog
cat
cholelith
choledocholith
contain
enough
calcium
may
appreci
miner
opac
within
hepat
silhouett
miner
gallbladd
wall
associ
biliari
adenocarcinoma
dog
parenchym
miner
associ
granuloma
abscess
hematoma
neoplasia
hepat
necrosi
angiographi
allow
visual
hepatoport
vasculatur
includ
abnorm
vessel
often
provid
definit
diagnosi
pss
indic
patient
suspect
pss
shunt
adequ
evalu
abdomin
ultrasound
anatom
character
congenit
pss
import
plan
attenu
angiograph
procedur
often
allow
sever
techniqu
mesenter
portographi
oper
mesenter
portographi
commonli
perform
immedi
prior
surgic
attenu
congenit
pss
involv
catheter
mesenter
vein
inject
contrast
agent
oper
contrast
portographi
allow
evalu
portal
vasculatur
shunt
attenu
techniqu
disadvantag
rel
invas
cranial
mesenter
portographi
accomplish
less
invas
use
ultrasound
guidanc
percutan
catheter
splenic
vein
howev
technic
demand
may
possibl
smaller
patient
transven
retrograd
portographi
describ
involv
catheter
jugular
vein
techniqu
allow
select
catheter
shunt
vessel
measur
portal
pressur
figur
transven
retrograd
portographi
appli
percutan
transjugular
coil
embol
intrahepat
shunt
percutan
splenoportographi
involv
percutan
inject
contrast
media
spleen
techniqu
simpl
perform
risk
complic
splenic
infarct
hemorrhag
abdomin
ultrasonographi
commonli
use
imag
modal
evalu
small
anim
patient
suspect
hepatobiliari
diseas
ultrasonographi
allow
assess
hepat
parenchyma
biliari
tract
evid
extrahepat
diseas
caus
secondari
hepatopathi
may
also
detect
addit
ultrasound
guidanc
often
use
collect
sampl
cytolog
histolog
evalu
liver
gallbladd
mucocel
also
lead
biliari
obstruct
might
also
appreci
sonograph
sensit
ultrasound
detect
gallbladd
wall
ruptur
dog
gallbladd
mucocel
report
abdomin
ultrasound
use
assess
liver
vascular
diseas
congenit
pss
classifi
intrahepat
extrahepat
although
angiograph
techniqu
consid
gold
standard
detect
character
pss
abdomin
ultrasound
use
increasingli
purpos
sonograph
assess
portal
vasculatur
timeconsum
highli
oper
depend
high
index
suspicion
pss
perform
studi
secondari
find
consist
pss
includ
mild
bilater
renomegali
urolithiasi
urat
crystalluria
microhepatia
ascit
hepat
parenchym
chang
consist
congenit
pss
extrahepat
shunt
typic
occur
smallbre
dog
aris
splenic
vein
right
gastric
vein
intrahepat
shunt
typic
occur
larger
breed
dog
aris
right
left
portal
branch
intrahepat
pss
usual
easier
detect
sonograph
extrahepat
pss
dog
cat
typic
singl
extrahepat
shunt
wider
degre
anatom
variat
dog
ultrasonographi
report
sensit
specif
detect
pss
dog
portal
hypertens
develop
result
chronic
hepat
fibrosi
hepat
arterioport
fistula
portal
vein
thrombosi
primari
portal
vein
hypoplasia
extralumin
compress
portal
vein
ligat
congenit
pss
find
hepatofug
reduc
veloc
hepatopet
blood
flow
use
doppler
ultrasound
consist
portal
hypertens
howev
patient
portal
hypertens
chang
ascit
frequent
alway
develop
secondari
portal
hypertens
readili
detect
abdomin
ultrasound
examin
acquir
portosystem
collater
also
known
acquir
pss
may
develop
sustain
prehepat
hepat
portal
hypertens
present
sonographi
may
allow
detect
portal
hypertens
apscapsc
although
apsc
vessel
difficult
identifi
congenit
pss
posthepat
portal
hypertens
result
develop
may
affect
echogen
liver
neoplasia
also
lead
appear
nodul
within
hepat
parenchyma
malign
liver
nodul
variabl
appear
size
difficult
distinguish
nonmalign
condit
cyst
hematoma
benign
hyperplast
nodul
granuloma
abscess
find
one
target
lesion
liver
spleen
posit
predict
valu
detect
malign
thu
consid
specif
find
cytolog
histolog
evalu
tissu
sampl
need
differenti
malign
benign
liver
nodul
tumor
hepatoma
hepatocellular
carcinoma
also
focal
infiltr
liver
contrastenhanc
harmon
ultrasound
allow
assess
tissu
perfus
pattern
gasfil
microbubbl
administ
intraven
patient
microbubbl
rel
echogen
reach
tissu
interest
produc
potent
harmon
signal
surround
tissu
techniqu
allow
enhanc
differenti
tissu
vari
perfus
pattern
one
studi
sensit
contrast
enhanc
ultrasound
differenti
benign
malign
liver
nodul
dog
report
specif
report
sonographi
also
valuabl
tool
evalu
biliari
system
biliari
diseas
classifi
obstruct
nonobstruct
term
cholang
refer
group
nonobstruct
biliari
diseas
common
cat
dog
typic
ultrasound
find
cat
includ
hypoecho
hepat
parenchyma
promin
portal
vasculatur
addit
find
includ
evid
pancreat
inflamm
thicken
gallbladd
wall
dilat
intrahepat
extrahepat
biliari
system
import
note
chang
alway
present
cytolog
histolog
confirm
bacteri
cultur
need
confirm
diagnosi
gener
gallbladd
wall
thicken
occur
result
cholecyst
cholang
hepat
howev
gallbladd
wall
also
appear
thicken
periton
effus
hypoproteinemia
present
gall
bladder
wall
mass
identifi
sonograph
focal
thicken
gallbladd
wall
sonographi
also
use
assess
gallbladd
motil
dog
note
graviti
depend
gallbladd
sludg
found
dog
without
hepatobiliari
diseas
find
consid
incident
abdomin
ultrasound
commonli
use
imag
modal
detect
biliari
obstruct
dog
cat
find
consist
biliari
obstruct
includ
common
bile
duct
distent
intraand
extrahepat
bile
duct
distent
andor
gallbladd
dilat
retrospect
studi
show
common
bile
duct
dilat
greater
mm
sensit
detect
biliari
obstruct
cat
sonographi
also
aid
identifi
caus
biliari
obstruct
biliari
obstruct
classifi
lumin
extralumin
extralumin
caus
includ
nonneoplast
pancreat
diseas
abdomin
adhes
rare
pancreat
neoplasia
lumin
caus
includ
gallbladd
mucocel
biliari
neoplasia
inflamm
cholecystolithiasi
biliari
tract
obstruct
progress
biliari
ruptur
bile
periton
sonograph
sign
biliari
ruptur
includ
loss
gallbladd
wall
continu
free
periton
fluid
sign
local
periton
gallbladd
mucocel
occur
dog
describ
cat
mucocel
variabl
sonograph
appear
typic
find
includ
stellat
fine
striat
bile
pattern
hypoecho
rim
graviti
depend
gb
lt
specif
disadvantag
ct
mri
includ
limit
avail
cost
need
anesthesia
although
cytolog
evalu
liver
provid
definit
diagnosi
often
histolog
examin
also
requir
varieti
techniqu
collect
cytolog
sampl
hepatobiliari
system
abdomin
effus
present
collect
percutan
fineneedl
aspir
fna
liver
collect
percutan
ultrasound
guidanc
cholecystocentesi
also
perform
percutan
ultrasound
apsc
vessel
lead
distent
hepat
vein
ascit
nuclear
scintigraphi
involv
administ
radioact
tracer
substanc
radiopharmaceut
patient
local
specif
organ
tissu
radioact
decay
substanc
detect
gamma
camera
use
form
imag
scintigraphi
use
detect
pss
assess
gallbladd
empti
small
anim
howev
special
equip
licens
use
radioisotop
requir
consequ
avail
imag
modal
current
limit
academ
institut
specialti
referr
hospit
pertechnet
commonli
use
radiopharmaceut
assess
portal
circul
small
anim
patient
two
techniqu
describ
perrect
portal
scintigraphi
transsplen
portal
scintigraphi
analyz
radiat
emit
region
interest
drawn
patient
liver
heart
pss
detect
shunt
fraction
calcul
allow
minim
invas
diagnosi
pss
differenti
pss
portal
vein
hypoplasia
without
portal
hypotens
previous
known
microvascular
dysplasia
comparison
degre
shunt
shunt
attenu
transsplen
portal
scintigraphi
prefer
perrect
portal
scintigraphi
simpler
perform
use
lower
dose
radiopharmaceut
sensit
figur
transsplen
portal
scintigraphi
sensit
specif
diagnosi
congenit
pss
significantli
like
perrect
portal
scintigraphi
detect
shunt
number
termin
dog
nuclear
scintigraphi
use
quantifi
liver
function
assess
biliari
tract
patenc
dog
retrospect
studi
hepatobiliari
scintigraphi
found
sensit
specif
detect
extrahepat
biliari
obstruct
dog
cat
comput
tomographi
ct
figur
magnet
reson
imag
mri
use
detect
hepat
parenchym
neoplasia
human
compar
abdomin
ultrasound
techniqu
improv
accuraci
diagnosi
hepat
neoplasia
human
howev
limit
data
veterinari
literatur
evalu
diagnost
perform
one
studi
diagnost
accuraci
ct
detect
hepat
mass
found
significantli
differ
abdomin
ultrasound
dog
anoth
studi
mri
found
sensit
specif
differenti
benign
malign
liver
lesion
dog
ct
angiographi
use
increasingli
dog
diagnosi
congenit
pss
hepat
vascular
diseas
offer
advantag
less
invas
oper
angiographi
allow
improv
assess
portal
vasculatur
allow
creation
threedimension
reconstruct
vasculatur
detail
afford
ct
angiographi
particularli
use
plan
attenu
congenit
pss
diagnost
util
ct
angiographi
detect
character
pss
dog
shown
compar
favor
techniqu
includ
surgic
explor
transsplen
ct
portographi
describ
dog
without
pss
techniqu
offer
intens
enhanc
splenic
portal
vein
ct
angiographi
mri
angiographi
diagnos
pss
dog
sensit
find
may
aid
make
diagnosi
liver
diseas
substitut
histopatholog
analysi
cytolog
specimen
allow
assess
hepat
architectur
furthermor
tini
proport
liver
sampl
cytolog
sampl
examin
limit
reflect
result
retrospect
studi
found
overal
agreement
histopatholog
cytolog
diagnosi
liver
diseas
dog
cat
cytolog
evalu
bile
also
use
diagnosi
biliari
disord
particularli
cat
world
small
anim
veterinari
associ
wsava
standard
clinic
histolog
diagnosi
canin
felin
liver
diseas
suggest
cytolog
evalu
bile
form
part
minimum
diagnost
requir
cat
extrahepat
cholestasi
dog
guidanc
techniqu
minim
invas
risk
complic
rel
low
caution
exercis
patient
bleed
disord
liver
diseas
caus
abdomin
effus
sever
mechan
case
hepat
insuffici
sever
hypoalbuminemia
gdl
occur
lead
format
pure
transud
result
reduc
plasma
colloid
oncot
pressur
increas
capillari
hydrostat
pressur
portal
hypertens
may
lead
format
pure
modifi
transud
hepat
neoplasia
also
lead
format
modifi
transud
biliari
tract
ruptur
lead
bile
periton
abdomin
effus
exud
bilirubin
concentr
greater
twice
plasma
suggest
bile
periton
cytolog
evalu
hepat
fna
aid
make
diagnosi
liver
diseas
suppur
mix
inflammatori
lymphocyt
rare
eosinophil
pattern
inflamm
appreci
cytolog
pattern
inflamm
suggest
group
possibl
diagnos
find
dark
green
black
bile
cast
suggest
cholestasi
infecti
diseas
histoplasmosi
definit
diagnos
base
cytolog
find
infecti
agent
figur
hepatocellular
vacuol
classifi
caus
lipid
lipid
vacuol
hepatocyt
character
colorless
cytoplasm
vacuol
sever
lipid
vacuol
suggest
hepat
lipidosi
cat
figur
howev
felin
hepat
lipidosi
often
occur
secondari
anoth
diseas
process
group
cat
cytolog
find
suggest
hepat
lipidosi
report
underli
infiltr
liver
diseas
nonlipid
vacuol
character
gener
hepatocyt
swell
laci
vacuol
figur
vacuolar
hepatopathi
occur
secondari
wide
varieti
extrahepat
diseas
process
dog
metastat
tumor
round
cell
tumor
lymphoma
figur
affect
liver
often
diagnos
cytolog
addit
cytolog
evalu
aid
distinguish
liver
nodul
extramedullari
hematopoiesi
caus
neoplasia
howev
possibl
distinguish
hepat
nodular
hyperplasia
hepat
adenoma
welldifferenti
carcinoma
cytolog
case
hepatocellular
carcinoma
diagnos
cytolog
criteria
malign
present
cat
suspect
cholang
find
neutrophil
bacteria
bile
cytolog
support
diagnosi
felin
neutrophil
cholang
cytolog
essenti
diagnosi
diseas
cat
neutrophil
cholang
may
typic
hepat
histopatholog
chang
difficult
distinguish
cat
lymphocyt
cholang
bile
also
submit
aerob
anaerob
bacteriolog
cultur
histopatholog
evalu
requir
make
definit
diagnosi
liver
diseas
histopatholog
evalu
liver
allow
morpholog
sometim
etiolog
diagnosi
made
see
chapter
addit
routin
stain
hematoxylin
eosin
varieti
stain
techniqu
employ
demonstr
hepat
patholog
optim
valu
histopatholog
evalu
liver
particular
attent
paid
specimen
collect
specimen
handl
commun
clinician
pathologist
although
liver
biopsi
consid
rel
safe
patient
assess
bleed
disord
procedur
assess
includ
platelet
count
coagul
time
buccal
mucos
bleed
time
liver
biopsi
collect
number
way
method
advantag
disadvantag
controversi
veterinari
literatur
techniqu
optim
laparotomi
allow
collect
rel
larg
wedg
biopsi
direct
visual
techniqu
requir
special
equip
train
excess
bleed
readili
identifi
howev
laparotomi
requir
gener
anesthesia
invas
biopsi
techniqu
percutan
needl
biopsi
techniqu
describ
techniqu
may
possibl
heavi
sedat
leastinvas
method
collect
liver
biopsi
ultrasound
guidanc
often
use
allow
biopsi
focal
lesion
also
possibl
biopsi
tissu
deeper
within
hepat
parenchyma
possibl
techniqu
howev
specimen
collect
rel
small
may
inadequ
accur
assess
patient
prospect
studi
show
agreement
histomorpholog
diagnos
made
upon
examin
needl
biopsi
made
wedg
biopsi
collect
laparotomi
necropsi
dog
cat
excess
hemorrhag
biopsi
may
identifi
immedi
laparoscopi
allow
collect
biopsi
use
forcep
laparoscop
guidanc
techniqu
requir
gener
anesthesia
less
invas
laparotomi
biopsi
collect
larger
needl
biopsi
excess
bleed
visual
howev
laparoscopi
requir
special
equip
train
use
biopsi
forcep
may
result
crush
artifact
tissu
collect
may
superfici
identifi
lesion
lie
deeper
within
hepat
parenchyma
regardless
techniqu
use
tini
proport
organ
sampl
liver
diseas
affect
hepat
parenchyma
heterogen
manner
sampl
error
possibl
reduc
effect
sampl
error
sever
biopsi
differ
area
liver
collect
focal
lesion
specif
biopsi
clinician
provid
pathologist
pertin
inform
patient
histori
physic
examin
find
result
laboratori
test
find
diagnost
imag
turn
histomorpholog
diagnosi
pathologist
make
interpret
clinician
along
clinic
data
histopatholog
diagnosi
fit
clinic
pictur
pathologist
consult
necessari
second
opinion
request
variat
assess
hepat
patholog
pathologist
highlight
studi
found
agreement
examin
needl
biopsi
wedg
biopsi
examin
hope
adopt
wsava
standard
clinic
histolog
diagnosi
canin
felin
liver
diseas
sinc
aforement
studi
reduc
interobserv
variat
quantif
hepat
metal
concentr
requir
submiss
tissu
flame
atom
absorpt
spectroscopi
although
zinc
role
antioxid
hepat
copper
iron
retent
lead
oxid
liver
injuri
copper
frequent
cours
evalu
patient
asymptomat
abnorm
biochem
test
repeat
evalu
sometim
warrant
gener
guidelin
obtain
liver
biopsi
asymptomat
patient
moder
sever
elev
serum
hepat
enzym
activ
persist
least
month
mild
moder
elev
serum
hepat
enzym
activ
persist
least
month
clinic
sign
hepat
diseas
develop
biopsi
unreason
delay
concurr
elev
serum
bile
acid
biopsi
also
delay
indic
hepat
biopsi
ultrasound
imag
abnorm
focal
hepat
mass
diffus
echotextur
chang
biopsi
may
warrant
depend
result
laboratori
test
one
studi
abdomin
ultrasound
find
alon
reliabl
obtain
diagnosi
infiltr
hepat
diseas
diffus
chang
echogen
either
hypoecho
hyperecho
uniform
mottl
anoth
studi
sonograph
detect
hepat
mass
greater
equal
cm
ascit
abnorm
hepat
lymph
node
abnorm
spleen
predict
liver
neoplasia
base
cytolog
convers
sonograph
detect
hepat
nodul
less
cm
predict
vacuolar
hepatopathi
cytolog
thu
sever
sonograph
find
alon
combin
may
predict
liver
ultrasoundguid
fineneedl
aspir
cytolog
result
light
fact
ultrasoundguid
fineneedl
aspir
cytolog
liver
limit
result
ultrasound
cytolog
adjunct
find
anoth
indic
hepat
biopsi
need
assess
respons
therapi
case
chronic
hepat
dog
often
difficult
determin
ongo
inflamm
resolut
progress
fibrosi
longterm
therapi
particularli
true
patient
receiv
glucocorticoid
therapi
medic
caus
variabl
increas
serum
alp
transaminas
activ
independ
underli
diseas
repeat
serial
hepat
biopsi
analysi
often
help
guid
therapeut
decis
case
among
seriou
complic
liver
biopsi
hemorrhag
infect
injuri
adjac
viscera
consequ
clinician
must
take
account
clinic
question
appropri
invas
biopsi
method
method
manag
postbiopsi
complic
postbiopsi
hemorrhag
often
first
concern
although
unclear
best
predictor
hemorrhag
patient
undergo
hepat
sampl
one
studi
human
patient
bleed
evalu
laparoscop
correl
vitro
coagul
test
liver
bleed
time
studi
man
use
laparoscopi
ultrasonographi
assess
hepat
bleed
time
follow
needl
biopsi
shown
similar
poor
correl
coagulopathi
hepat
bleed
time
similar
studi
report
veterinari
medicin
also
studi
human
veterinari
medicin
evalu
risk
factor
bleed
complic
oppos
hepat
bleed
time
bigg
et
al
correl
coagul
profil
find
bleed
complic
ultrasoundguid
biopsi
dog
cat
appar
correl
coagul
paramet
major
complic
follow
liver
biopsi
studi
show
clot
time
assess
protein
induc
vitamin
k
antagon
sensit
detect
coagulopathi
patient
hepat
diseas
measur
metal
quantif
essenti
diagnosi
hepat
copper
retent
measur
usual
perform
freezedri
piec
liver
specimen
metal
measur
store
salin
kept
metalfre
contain
recent
shown
measur
concentr
copper
iron
zinc
ascertain
deparaffinizedarchiv
liver
tissu
hepatobiliari
diseas
challeng
diagnos
although
diagnost
test
employ
biochem
molecular
biolog
serolog
function
well
imag
techniqu
capabl
establish
etiolog
chronic
acut
liver
diseas
instanc
gold
standard
definit
diagnosi
assess
stage
sever
liver
diseas
histolog
evalu
liver
sampl
recent
advanc
imag
technolog
use
multipl
imag
modal
newer
biopsi
method
result
improv
abil
safe
procur
hepat
tissu
evalu
sever
mean
obtain
hepat
sampl
includ
fineneedl
aspir
ultrasoundguid
biopsi
laparoscopi
laparotomi
techniqu
advantag
disadvantag
care
consid
choos
appropri
sampl
method
mani
biochem
test
avail
evalu
anabol
catabol
function
liver
hepat
circul
includ
measur
concentr
bile
acid
ammonia
bilirubin
abil
excret
organ
dye
test
hepat
function
includ
measur
serum
albumin
glucos
urea
nitrogen
clot
factor
analysi
hepat
function
markedli
abnorm
despit
mainten
hepatocellular
membran
therefor
normal
serum
activ
hepat
enzym
exampl
includ
psss
termin
cirrhosi
metastat
hepat
neoplasia
likewis
liver
continu
normal
anabol
catabol
function
despit
sever
hepatocyt
leakag
intracellular
enzym
mark
reserv
capac
occur
exampl
certain
case
hepatocellular
necrosi
blunt
abdomin
trauma
primari
hepat
neoplasia
thu
limit
serum
hepat
enzym
activ
must
taken
consider
hepatocellular
leakag
enzym
activ
includ
alt
ast
enzym
activ
increas
biliari
tract
obstruct
includ
serum
alp
ggt
laboratori
test
identifi
specif
problem
help
determin
specif
therapeut
manag
predict
outcom
differ
diseas
produc
similar
alter
hepat
function
laboratori
test
biochem
test
identifi
presenc
hepat
diseas
diagnosi
must
pursu
instanc
diagnost
imag
reveal
specif
abnorm
eg
psss
extrahepat
bile
duct
obstruct
result
imag
give
specif
etiolog
next
step
often
pursu
morpholog
diagnosi
obtain
analysi
biopsi
specimen
often
judgment
call
pursu
hepat
biopsi
case
sever
clinic
sign
andor
sever
biochem
abnorm
biopsi
usual
warrant
earli
fineneedl
aspir
sever
advantag
littl
sedat
usual
requir
size
needl
small
littl
risk
hemorrhag
therefor
multipl
site
easili
sampl
procedur
rapid
usual
perform
outpati
basi
also
less
cost
client
primari
disadvantag
fineneedl
aspir
question
accuraci
sampl
size
often
limit
number
avail
cell
obtain
accur
diagnosi
hemodilut
make
difficult
assess
whether
inflammatori
cell
present
liver
peripher
blood
sever
import
element
use
interpret
patholog
inform
includ
lobular
architectur
presenc
locat
inflamm
within
lobul
presenc
sever
fibrosi
metal
accumul
vascular
abnorm
lobul
heterogen
criteria
accur
determin
use
cytolog
sampl
obtain
use
fna
sever
studi
compar
fineneedl
aspir
cytolog
biopsi
histopatholog
one
studi
total
case
good
correl
case
partial
correl
case
correl
case
poor
correl
found
varieti
histolog
chang
includ
vacuolar
chang
lipidosi
cholestasi
inflamm
neoplasia
similar
studi
case
complet
agreement
fineneedl
aspir
histopatholog
seen
case
dog
agreement
inflamm
agreement
neoplasia
mainli
carcinoma
agreement
vacuolar
hepatopathi
cat
overal
agreement
case
agreement
inflamm
agreement
neoplasia
lymphoma
agreement
vacuolar
hepatopathi
although
vacuolar
hepatopathi
sensit
diagnosi
also
common
misdiagnosi
use
cytolog
anoth
studi
best
correl
hepat
cytolog
biopsi
seen
lipidosi
lymphoma
carcinoma
wherea
worst
perform
seen
inflammatori
fibrot
disord
anoth
studi
found
high
sensit
specif
fineneedl
aspir
detect
inflammatori
hepat
diseas
dog
howev
inform
provid
sever
inflamm
histopatholog
featur
addit
noninflammatori
hepat
diseas
cytolog
inaccur
case
proteinsinducedbyvitaminkantagon
test
twice
sensit
dog
three
time
sensit
cat
detect
coagulopathi
compar
prothrombin
time
pt
aptt
howev
pilot
studi
perform
hepat
bleed
time
assess
via
laparoscopi
correl
protein
induc
vitamin
k
antagon
time
thu
appear
indic
coagul
peripher
blood
gener
unreli
guid
risk
bleed
liver
biopsi
henc
limit
valu
determin
contraind
procedur
lack
correl
may
explain
high
concentr
clot
factor
hepat
parenchyma
mechan
compress
needl
tract
elast
tissu
within
liver
case
signific
hemorrhag
technic
error
damag
larg
vessel
caus
rather
persist
ooz
needl
biopsi
site
control
studi
veterinari
patient
necessari
make
final
conclus
regard
postbiopsi
hemorrhag
patient
coagulopathi
one
studi
normal
dog
biopsi
taken
left
later
hepat
lobe
use
biopsi
punch
biopsi
needl
ligatur
method
laparoscop
biopsi
forcep
ultrason
activ
scalpel
result
minim
hemorrhag
ml
howev
investig
assess
risk
hemorrhag
dog
cat
hepat
diseas
risk
discuss
later
sampl
method
except
fineneedl
aspir
patient
prebiopsi
pack
cell
volum
hour
postbiopsi
pack
cell
volum
close
monitor
potenti
hemorrhag
fineneedl
aspir
involv
obtain
small
amount
hepat
tissu
cytolog
analysi
typic
perform
conjunct
guid
ultrasound
ultrasound
imag
help
determin
diffus
abnorm
eg
increas
decreas
echogen
diffus
mottl
focal
abnorm
eg
discret
nodul
cyst
mass
focal
area
heterogen
mottl
appropri
site
sampl
chosen
often
multipl
site
chosen
repres
differ
lobe
case
focal
lesion
sampl
one
area
abnorm
tissu
sampl
seemingli
normal
tissu
site
also
chosen
base
access
exampl
solitari
nodul
dorsocrani
aspect
liver
larg
deepchest
dog
would
imposs
reach
needl
lesion
adjac
gallbladd
caudal
vena
cava
would
involv
consider
risk
clinician
would
need
decid
whether
rel
risk
sampl
lesion
appropri
decis
whether
method
sampl
would
appropri
laparoscopi
laparotomi
figur
depict
typic
setup
fineneedl
aspir
usual
needl
use
patient
procedur
perform
without
sedat
local
anesthet
determin
anim
move
much
initi
ultrasound
examin
sed
may
necessari
anesthet
extrem
case
needl
insert
without
syring
use
ultrasound
guidanc
needl
rapidli
agit
sometim
refer
mimick
action
sew
machin
simultan
twist
multipl
time
second
obtain
sampl
method
reli
capillari
action
rather
suction
get
tissu
needl
result
less
hemodilut
remov
needl
liver
syring
attach
cell
expel
onto
glass
slide
cytolog
examin
often
three
five
separ
attempt
made
increas
sampl
size
divers
examin
perform
prior
biopsi
allow
plan
procedur
base
echo
pattern
lesion
size
proxim
organ
proxim
blood
vessel
determin
cystic
solid
tissu
optim
approach
needl
path
care
must
taken
prior
take
sampl
ensur
vessel
organ
within
path
needl
diffus
lesion
transduc
typic
place
caudal
left
xiphoid
aim
left
medial
later
lobe
patient
small
liver
may
difficult
adequ
visual
needl
without
gastric
ga
interfer
place
anim
right
later
obliqu
posit
reduc
interfer
anim
gener
anesthesia
assist
compress
rebreath
bag
hold
anim
deep
inspir
serv
move
diaphragm
liver
caudal
improv
visual
area
surgic
prepar
ultrasound
transduc
cover
steril
wrap
steril
lubric
use
enhanc
skin
contact
small
stab
incis
made
skin
desir
needl
insert
site
one
hand
maneuv
transduc
hand
advanc
needl
liver
direct
ultrasound
visual
imag
optim
maxim
chanc
recogn
needl
within
liver
allow
distinct
needl
echogen
structur
needl
gentli
move
minim
movement
attempt
move
liver
within
abdomin
caviti
rather
needl
within
liver
occasion
needl
seen
indirect
evid
organ
penetr
must
use
movement
liver
visual
movement
liver
border
needl
direct
trajectori
avoid
structur
fire
needl
fire
immedi
remov
case
four
five
sampl
obtain
submit
aerobicanaerob
cultur
histopatholog
evalu
metal
copper
zinc
iron
quantif
one
studi
liver
tissu
high
metal
concentr
significantli
lower
copper
iron
needlecor
versu
wedg
biopsi
specimen
consequ
valu
needlecor
biopsi
specimen
measur
metal
concentr
question
care
examin
postbiopsi
hemorrhag
perform
extern
digit
pressur
may
use
help
control
hemorrhag
smaller
patient
usual
abdomin
compress
wrap
ineffect
control
hemorrhag
ultrasoundguid
biopsi
mani
advantag
fineneedl
aspir
includ
need
minim
sedat
patient
abil
sampl
multipl
site
low
moder
cost
client
addit
tissu
obtain
histopatholog
one
disadvantag
ultrasoundguid
biopsi
risk
bleed
especi
multipl
site
sampl
largergaug
needl
use
one
studi
percutan
transabdomin
hepat
needl
biopsi
sampl
obtain
advers
consequ
note
howev
studi
perform
normal
dog
still
carri
high
risk
addit
disadvantag
ultrasoundguid
biopsi
includ
need
sedat
anesthesia
patient
difficulti
imag
small
liver
difficulti
obtain
liver
tissu
patient
fibrosi
importantli
obtain
sampl
question
represent
underli
hepat
patholog
diagnost
accuraci
needl
biopsi
question
mani
clinician
observ
result
needl
biopsi
analysi
often
adequ
reflect
clinic
laboratori
featur
patient
question
accuraci
part
result
potenti
sampl
error
method
still
result
rel
small
sampl
size
possibl
although
fineneedl
aspir
easi
perform
involv
littl
risk
littl
sedat
inform
littl
valu
inaccur
often
accur
institut
bia
regard
accuraci
may
relat
experi
expertis
cytologist
given
clear
limit
fineneedl
aspir
best
use
adjunct
diagnost
modal
conjunct
techniqu
clinic
find
replac
histopatholog
clinician
must
awar
inher
inaccuraci
undertak
fineneedl
aspir
reli
cytolog
find
ultrasoundguid
hepat
biopsi
use
cuttingtyp
needl
sampl
tool
autom
needl
prefer
either
complet
autom
semiautom
springload
needl
similar
style
manual
trucut
needl
complet
autom
needl
thrust
inner
obtur
contain
biopsi
tray
specimen
notch
follow
outer
cut
sheath
liver
fraction
second
needl
oper
one
hand
hand
oper
ultrasound
transduc
allow
precis
placement
biopsi
instrument
minim
displac
liver
shorter
intraparenchym
phase
reliabl
yield
tissu
allow
smaller
diamet
needl
use
lighter
degre
sedat
case
use
rapid
cut
action
hepat
tissu
tend
less
fragment
semiautom
needl
requir
manual
placement
intern
obtur
liver
follow
automat
thrust
outer
cut
sheath
springload
mechan
needl
addit
advantag
control
final
needl
posit
tip
needl
precis
local
outer
cut
sheath
deploy
gener
use
needl
ultrasoundguid
hepat
biopsi
figur
depict
typic
setup
ultrasoundguid
biopsi
dog
liver
biopsi
use
local
anesthesia
minim
sedat
cat
requir
gener
anesthesia
safe
obtain
tissu
must
emphas
degre
sedat
must
tailor
individu
patient
care
ultrasound
periton
space
stab
incis
use
number
scalpel
blade
ensur
obstruct
neg
pressur
use
infus
aspir
salin
abdomen
insuffl
carbon
dioxid
ga
maintain
pressur
approxim
mm
hg
scope
port
cannula
place
cm
right
later
veress
needl
veress
needl
remov
replac
instrument
port
hepat
sampl
achiev
use
spoon
oval
cup
biopsi
forcep
multipl
sampl
obtain
direct
visual
sampl
submit
aerobicanaerob
cultur
histopatholog
evalu
metal
copper
zinc
iron
quantif
follow
procur
biopsi
specimen
site
inspect
hemorrhag
abdomen
decompress
lidocain
bupivacain
infus
periton
caviti
either
port
instrument
scope
port
remov
port
site
incis
close
use
either
cruciat
simpl
interrupt
pattern
bodi
wall
subcutan
tissu
skin
techniqu
enabl
gross
evalu
entir
liver
extrahepat
biliari
system
surround
structur
obtain
multipl
larg
specimen
liver
abil
obtain
multipl
sampl
decreas
risk
sampl
artifact
case
region
divers
within
liver
addit
directli
visual
hepat
parenchyma
clinician
correl
histopatholog
find
clinic
data
gross
appear
liver
render
accur
diagnosi
method
also
enabl
visual
smaller
mass
irregular
may
evid
ultrasonograph
imag
mass
also
individu
sampl
laparoscopi
also
give
clinician
excel
view
liver
regardless
hepat
size
conform
patient
make
easi
method
sampl
liver
patient
difficult
imag
ultrasound
gener
minim
bleed
procedur
even
patient
vitro
coagulopathi
use
spoon
ovalcup
biopsi
forcep
typic
result
mark
decreas
amount
hemorrhag
compar
needl
biopsi
hemorrhag
directli
visual
adequ
clot
format
hemorrhag
persist
direct
pressur
use
blunt
probe
minut
use
site
continu
bleed
electrocauteri
appli
biopsi
site
topic
hemostat
agent
gelfoam
place
directli
biopsi
site
use
laparoscop
forcep
disadvantag
laparoscopi
includ
need
expens
equip
need
extens
train
need
gener
anesthesia
case
higher
cost
client
laparoscopi
give
clinician
advantag
laparotomi
larg
sampl
size
abil
best
direct
sampl
abil
take
multipl
sampl
thu
result
highest
diagnost
accuraci
though
rel
minim
invas
procedur
complic
rate
especi
hemorrhag
far
less
ultrasoundguid
biopsi
practic
reason
method
choic
obtain
hepat
biopsi
specimen
case
wedg
biopsi
via
laparotomi
anoth
potenti
method
obtain
hepat
biopsi
random
liver
biopsi
need
section
liver
protrud
guillotin
sutur
use
preform
encircl
ligatur
monofila
absorb
sutur
materi
place
around
protrud
section
liver
fragment
fibrou
tissu
may
enabl
sampl
abnorm
locat
lobe
left
medial
later
lobe
gener
sampl
eas
imag
one
studi
percutan
hepat
sampl
use
core
biopsi
result
diagnost
qualiti
sampl
howev
compar
larg
wedg
biopsi
assess
accuraci
method
anoth
studi
diagnost
accuraci
trucuttyp
needl
biopsi
compar
gold
standard
surgic
wedg
biopsi
liver
patient
overal
discord
two
method
dog
cat
greater
discrep
occur
chronic
hepat
cirrhosi
cholang
cholangiohepat
portosystem
vascular
anomali
microvascular
dysplasia
fibrosi
miscellan
disord
disord
commonli
seen
among
dog
cat
hepatobiliari
diseas
greatest
accuraci
neoplasia
concord
figur
exampl
mass
amen
ultrasoundguid
needl
biopsi
use
versu
needl
may
reduc
discord
rais
number
portal
triad
sampl
approxim
mean
four
seven
though
larger
needl
carri
risk
increas
hemorrhag
summari
ultrasoundguid
hepat
biopsi
rel
easi
perform
involv
risk
patient
primarili
bleed
like
fineneedl
aspir
ultrasoundguid
biopsi
question
accuraci
accuraci
may
increas
use
largergaug
needl
carri
greater
risk
postbiopsi
hemorrhag
patient
suspect
inflammatori
diseas
vascular
abnorm
signific
fibrosi
risk
hemorrhag
laparoscopi
laparotomi
consid
chapter
provid
detail
descript
laparoscop
liver
biopsi
briefli
laparoscopi
perform
gener
anesthesia
patient
dorsal
recumb
tilt
degre
left
veress
needl
place
level
umbilicu
acut
hepat
necrosi
common
morpholog
hepat
lesion
dog
cat
present
acut
liver
diseas
caus
infecti
toxic
metabol
ischem
disord
box
howev
acut
liver
diseas
also
associ
patholog
process
sever
hepat
lipidosi
cat
granulomat
hepat
fungal
infect
intrahepat
cholestasi
bacteri
cholang
leptospirosi
malign
infiltr
lymphoma
malign
histiocytosi
canin
adenoviru
canin
felin
herpesviru
neonat
clostridium
piliform
toxoplasma
gondii
specif
exampl
infecti
agent
caus
acut
hepat
necrosi
variabl
inflamm
often
part
multisystem
disord
although
leptospirosi
wellrecogn
infecti
caus
acut
liver
diseas
dog
hepat
necrosi
uncommon
histolog
featur
hepat
lesion
typic
character
cholestasi
liver
cell
dissoci
nonspecif
reactiv
hepat
despit
larg
number
potenti
caus
acut
hepat
necrosi
specif
etiolog
often
determin
recent
case
seri
dog
primari
hepat
acut
chronic
hepat
present
referr
clinic
dog
diagnos
morpholog
featur
acut
hepat
caus
could
determin
major
case
although
increas
hepat
copper
detect
five
dog
acut
hepat
suggest
copper
accumul
could
signific
contribut
factor
despit
numer
potenti
caus
hepatocyt
death
two
gener
mechan
recogn
apoptosi
necrosi
two
mechan
tradit
consid
distinct
event
howev
appear
apoptosi
necrosi
altern
outcom
initi
caus
signal
pathway
apoptosi
adenosin
triphosphatedepend
caspasedepend
program
cell
death
caus
shrinkag
cell
apoptot
bodi
acidophil
bodi
orderli
resorpt
cellular
content
minim
leakag
cellular
compon
minim
secondari
inflamm
necrosi
occur
deplet
adenosin
triphosph
result
cellular
swell
loss
integr
cell
membran
cell
lysi
releas
cell
content
secondari
inflamm
diffus
hepat
necrosi
consist
histolog
lesion
detect
dog
cat
acut
liver
failur
acut
liver
failur
alf
rare
clinic
syndrom
usual
fatal
occur
sudden
sever
insult
liver
compromis
least
function
hepat
mass
liver
cell
death
exce
hepat
regen
capac
result
clinic
sign
liver
failur
clinic
laboratori
featur
alf
specif
incit
caus
reflect
disrupt
one
major
hepat
function
hepatocellular
injuri
occur
assum
patient
surviv
morpholog
hepat
respons
injuri
may
includ
parenchym
regener
fibrosi
ductular
prolifer
nearli
complet
hepat
regener
possibl
hepatocyt
injuri
limit
reticulin
network
remain
intact
sever
parenchym
destruct
extens
loss
hepatocyt
periport
ductular
prolifer
hepat
fibrosi
postnecrot
scar
regen
hepat
nodul
like
dog
acut
hepat
may
also
progress
chronic
hepat
clinic
present
dog
cat
acut
hepat
necrosi
vari
underli
caus
extent
sever
hepat
lesion
spectrum
hepat
involv
may
ligatur
tighten
crush
hepat
parenchyma
complet
sever
throw
knot
sampl
excis
mm
distal
ligatur
use
metzenbaum
scissor
scalpel
blade
specif
area
liver
need
sampl
obtain
use
transfix
method
biopsi
punch
transfix
method
entail
place
ligatur
liver
lobe
approxim
mm
edg
ligatur
tighten
crush
hepat
parenchyma
along
one
border
desir
biopsi
specimen
addit
throw
made
right
angl
first
ligatur
throw
tighten
crush
parenchyma
second
border
specimen
sampl
remov
mm
distal
crush
area
use
scalpel
blade
metzenbaum
scissor
desir
area
lie
near
edg
liver
lobe
biopsi
punch
use
biopsi
punch
insert
hepat
parenchyma
ensur
penetr
opposit
surfac
biopsi
site
close
hilu
extra
caution
must
use
half
thick
liver
penetr
biopsi
sampl
remov
liver
use
scissor
hemorrhag
control
fill
defect
topic
hemostat
agent
gel
foam
appli
digit
pressur
minut
sutur
hepat
capsul
fine
absorb
monofila
sutur
cruciat
pattern
akin
laparoscopi
method
similar
advantag
disadvantag
list
previous
although
invas
allow
easier
biopsi
abdomin
organ
intestin
mesenter
lymph
node
abil
perform
therapeut
maneuv
hepat
mass
remov
biliari
divers
etiolog
hepatocyt
death
necrosi
apoptosi
dog
cat
occur
secondari
broad
varieti
insult
includ
infecti
agent
drug
toxin
hypoxia
immunolog
event
metabol
disord
hepat
necrosi
acut
inflamm
often
occur
togeth
relationship
two
process
complex
acut
inflamm
may
primari
event
necrosi
hepatocyt
follow
substanti
inflammatori
respons
hallmark
necrot
cell
death
term
acut
hepat
tradit
use
infecti
agent
caus
hepatocellular
necrosi
even
though
earli
stage
hepat
inflamm
minim
absent
controversi
exist
among
veterinari
pathologist
regard
prefer
terminolog
acut
hepat
versu
acut
hepat
necrosi
necrosi
predomin
caus
noninfecti
insult
toxin
ischemia
purpos
discuss
lesion
acut
hepat
acut
hepat
necrosi
discuss
togeth
recogn
primari
contribut
lesion
may
variabl
depend
caus
host
respons
passag
time
acut
hepat
form
primari
hepat
differenti
nonspecif
reactiv
hepat
respons
liver
varieti
extrahepat
disord
character
focal
inflamm
without
necrosi
nonspecif
reactiv
hepat
discuss
later
section
chapter
synthesi
increas
activ
cholestat
liver
enzym
alkalin
phosphatas
ggt
also
commonli
occur
acut
hepat
necrosi
magnitud
increas
much
less
alt
ast
abnorm
biochem
test
hyperbilirubinemia
increas
sba
hypoglycemia
hyperammonemia
indic
compromis
hepat
function
hyperbilirubinemia
bilirubinuria
support
signific
hepat
injuri
prehepat
hemolyt
caus
discount
primari
biliari
tract
disord
includ
posthepat
mechan
hyperbilirubinemia
also
consid
differenti
diagnosi
consider
hypoglycemia
conjunct
acut
liver
diseas
includ
xylitol
toxic
excess
insulin
releas
sepsi
hypoalbuminemia
usual
suggest
chronic
rather
acut
liver
diseas
long
serum
halflif
albumin
azotemia
detect
dehydr
gi
blood
loss
concurr
renal
damag
eg
leptospirosi
nonsteroid
antiinflammatori
drug
nsaid
consid
interpret
azotemia
facilit
concurr
urinalysi
renal
injuri
support
find
cellular
granular
cast
glucosuria
isosthenuria
proteinuria
complet
blood
cell
count
may
reveal
inflammatori
respons
suggest
underli
infecti
inflammatori
disord
also
use
rule
hemolyt
anemia
caus
jaundic
document
coagulopathi
requir
clinic
diagnosi
alf
laboratori
find
indic
coagulopathi
includ
prolong
pt
activ
partial
thromboplastin
time
aptt
decreas
fibrinogen
increas
fibrin
degrad
product
thrombocytopenia
abdomin
radiograph
often
unremark
dog
cat
acut
hepat
necrosi
liver
may
appear
normal
increas
size
abdomin
ultrasound
liver
may
appear
normal
hypoecho
thorac
abdomin
imag
may
help
evalu
caus
acut
hepat
diseas
biliari
tract
disord
dog
cat
acut
hepat
necrosi
present
nonspecif
sign
acut
liver
diseas
clinician
maintain
broad
perspect
regard
mani
potenti
diseas
process
acut
affect
liver
prior
obtain
liver
biopsi
ancillari
test
cytolog
biopsi
access
lesion
infecti
diseas
titer
molecular
test
diagnost
imag
perform
evalu
system
disord
secondari
hepat
effect
multisystem
infect
thu
provid
diagnosi
caus
acut
liver
diseas
lessinvas
manner
acut
hepat
hepat
necrosi
suspect
confirm
liver
biopsi
thorough
histori
essenti
identifi
exposur
potenti
hepatotoxin
infecti
agent
owner
question
regard
recent
medic
includ
prescript
overthecount
drug
altern
medicin
herbal
dietari
supplement
potenti
exposur
chemic
hepatotoxin
amanita
mushroom
bluegreen
alga
sago
palm
aflatoxin
xylitol
assess
detail
see
drug
toxininduc
liver
injuri
section
pertin
histor
question
includ
current
vaccin
histori
canin
adenoviru
leptospirosi
travel
histori
fungal
infect
tickborn
diseas
exposur
anim
infecti
caus
liver
biopsi
requir
document
presenc
acut
hepat
necrosi
evalu
specif
caus
differenti
acut
chronic
diseas
patient
mild
absent
clinic
sign
liver
enzym
elev
correspond
recent
medic
administr
liver
biopsi
may
postpon
medic
discontinu
clinic
sign
liver
enzym
monitor
includ
subclin
biochem
abnorm
b
clinic
sign
acut
liver
diseas
c
clinic
syndrom
alf
liver
injuri
mild
focal
necrosi
inflamm
clinic
sign
may
absent
mild
relat
underli
caus
anoth
organ
system
set
hepat
involv
may
recogn
biochem
evalu
reveal
increas
liver
enzym
activ
mild
hyperbilirubinemia
suggest
mani
dog
acut
hepat
recogn
clinic
sign
mild
selflimit
dog
recov
spontan
regardless
treatment
clinic
sign
acut
hepat
includ
acut
onset
lethargi
anorexia
vomit
diarrhea
pu
pd
previous
healthi
anim
nonspecif
find
acut
liver
diseas
overlap
system
disord
find
icteru
physic
examin
specif
indic
hepatobiliari
diseas
especi
absenc
anemia
dog
cat
acut
diffus
hepat
necrosi
often
present
alf
addit
sign
acut
liver
diseas
describ
anim
alf
show
sign
depress
behavior
chang
dementia
ataxia
pace
circl
blind
hypersaliv
seizur
coma
clinic
evid
bleed
tendenc
melena
hematemesi
cutan
mucos
hemorrhag
suggest
sever
hepat
dysfunct
sign
alf
rapidli
progress
hour
day
clinic
syndrom
often
fatal
report
mortal
vari
acut
hepat
diseas
histori
typic
reveal
acut
onset
sign
previous
healthi
anim
howev
liver
failur
recent
recogn
may
necessarili
recent
onset
occult
chronic
liver
diseas
clinic
sign
may
vagu
go
unrecogn
owner
final
phase
hepat
decompens
owner
question
subtl
sign
chronic
ill
would
suggest
underli
liver
diseas
may
chronic
rather
acut
current
ill
may
exacerb
decompens
chronic
liver
diseas
dog
cat
alf
gener
good
nutrit
statu
compar
chronic
hepat
diseas
find
cachexia
emaci
ascit
edema
suggest
protract
ill
characterist
chronic
rather
acut
liver
diseas
import
make
distinct
acut
chronic
liver
diseas
intens
support
care
indic
alf
might
warrant
chronic
endstag
liver
diseas
longterm
prognosi
better
acut
hepat
chronic
hepat
initi
databas
consist
complet
blood
cell
count
serum
chemistri
urinalysi
obtain
dog
cat
acut
liver
diseas
liver
enzym
elev
common
find
dog
cat
acut
hepat
necrosi
mild
hepat
injuri
focal
hepat
necrosi
increas
alt
activ
may
find
otherwis
unremark
biochem
profil
alt
ast
activ
moder
markedli
increas
enzym
leakag
damag
hepatocyt
although
alt
activ
increas
mani
hepat
diseas
largest
magnitud
increas
seen
acut
hepat
necrosi
roughli
correl
number
involv
cell
alt
activ
may
increas
much
time
upper
rang
normal
increas
ast
activ
parallel
gener
lower
time
upper
limit
normal
alt
note
recogn
hepatotoxin
aflatoxin
microcystin
bluegreen
alga
associ
sever
protract
increas
alt
activ
toxinsuppress
transaminas
improv
period
patient
alf
coagulopathi
clinician
must
care
weigh
benefit
histolog
character
versu
risk
excess
bleed
procedur
acut
hepat
character
histolog
mononuclear
mix
inflammatori
pattern
accompani
hepatocellular
apoptosi
necrosi
necrosi
character
pathologist
morpholog
pattern
injuri
focal
multifoc
confluent
bridg
massiv
piecem
pattern
necrosi
may
provid
insight
pathogenesi
lesion
exampl
centrilobular
hepatocyt
abund
cytochrom
enzym
hepatocyt
preferenti
affect
druginduc
hepatotox
cytochrom
metabol
parent
drug
result
toxic
metabolit
quantit
copper
analysi
histochem
stain
copper
recommend
copper
accumul
may
underappreci
caus
acut
hepat
dog
infecti
caus
acut
hepat
may
diagnos
liver
biopsi
addit
test
perform
liver
tissu
cultur
immunohistochemistri
polymeras
chain
reaction
pcr
viru
isol
tabl
unfortun
case
routin
liver
biopsi
unlik
reveal
specif
caus
acut
hepat
find
inflamm
necrosisapoptosi
accompani
nodular
regener
fibrosi
suggest
chronic
rather
acut
hepat
longterm
prognosi
better
acut
hepat
chronic
hepat
probabl
caus
acut
hepat
hepat
necrosi
determin
specif
treatment
direct
primari
etiolog
eg
discontinu
potenti
hepatotox
medic
treat
leptospirosi
doxycyclin
chelat
hepat
copper
penicillamin
case
specif
therapi
unavail
treatment
direct
gener
support
symptomat
treatment
liver
diseas
glucocorticoid
therapi
typic
indic
treatment
acut
hepat
empir
treatment
antioxid
sadenosylmethionin
mg
kg
po
milk
thistl
silipho
mgkg
po
vitamin
e
iukg
may
warrant
oxid
stress
believ
play
role
drug
carprofen
potenti
sulfonamid
diazepam
methimazol
lomustin
other
toxin
aflatoxin
organ
solvent
heavi
metal
toxic
induc
hepat
injuri
milk
thistl
addit
cytoprotect
properti
could
benefici
necroinflammatori
hepatopathi
hepatotox
antioxid
cytoprotect
agent
discuss
detail
chapter
respect
liver
biochemistri
monitor
assess
patient
respons
therapi
repeat
liver
biopsi
perform
week
initi
diagnosi
recommend
confirm
acut
hepat
improv
resolv
document
progress
toward
chronic
hepat
suggest
dog
mild
idiopath
acut
hepat
alf
recov
sever
day
regardless
treatment
patient
alf
aggress
support
treatment
requir
goal
therapi
treat
underli
caus
possibl
allow
adequ
time
hepat
regener
repair
prevent
control
complic
liver
failur
hypoglycemia
coagulopathi
anemia
gi
ulcer
septicemia
intraven
nacetylcystein
nac
glutathion
sourc
antioxid
antidot
choic
treatment
acetaminophen
toxic
nac
also
appear
addit
potenti
benefit
improv
system
hemodynam
tissu
oxygen
deliveri
consid
use
dog
cat
alf
optim
dose
regimen
nac
use
purpos
determin
treatment
complic
liver
failur
discuss
complic
liver
diseas
section
prognosi
recoveri
dog
acut
hepat
good
dog
recov
unev
howev
potenti
dog
acut
hepat
develop
chronic
diseas
anim
present
sign
advanc
liver
failur
eg
coagulopathi
hypoglycemia
prognosi
guard
anim
surviv
hepat
lesion
periport
ductular
prolifer
hepat
fibrosi
postnecrot
scar
regen
hepat
nodul
like
hepat
drug
reaction
suspect
reexposur
patient
suspect
drug
avoid
etiolog
hepat
abscess
bacteri
infect
liver
occur
uncommonli
dog
cat
abscess
may
form
solitari
multipl
macroscop
mass
microabscess
newborn
anim
gramposit
gramneg
bacteria
caus
hepat
abscess
presum
relat
postpartum
umbil
infect
adult
anim
gramneg
enter
bacteria
especi
escherichia
coli
anaerob
especi
clostridia
spp
commonli
identifi
multiag
infect
frequent
organ
yersinia
spp
actinomyc
spp
nocardia
asteroid
also
caus
hepat
abscess
part
system
infect
pathogenesi
hepat
abscess
dog
cat
unclear
hepat
abscess
usual
associ
extrahepat
infect
region
hepat
parenchym
damag
small
number
bacteria
includ
clostridium
spp
cultur
liver
tissu
healthi
dog
hypoxia
hepat
tissu
caus
hepat
neoplasia
liver
lobe
torsion
trauma
may
predispos
abscess
format
small
number
exist
anaerob
eg
clostridium
spp
prolifer
condit
potenti
sourc
bacteria
includ
hematogen
spread
via
umbil
vein
hepat
arteri
transloc
intestin
bacteria
portal
blood
ascens
via
bile
duct
penetr
abdomin
caudal
thorac
wound
direct
extens
local
suppur
diseas
concurr
diseas
potenti
predispos
factor
dog
includ
system
infect
pneumonia
pyelonephr
prostat
pyometra
endocard
gallbladd
ruptur
pancreat
diabet
mellitu
liver
lobe
torsion
coexist
hepat
diseas
hepat
neoplasia
infect
necrosi
longterm
phenobarbit
administr
longterm
corticosteroid
administr
previou
surgic
biopsi
concurr
diseas
cat
includ
cholecyst
pyothorax
hepat
neoplasia
solitari
abscess
common
dog
wherea
cat
like
septic
multipl
hepat
abscess
associ
felin
leukemia
viru
felin
immunodefici
viru
infect
made
solitari
liver
abscess
like
involv
right
liver
lobe
cat
left
liver
lobe
dog
clinic
examin
adult
dog
cat
diagnos
hepat
abscess
usual
older
year
age
clinic
sign
nonspecif
attribut
sepsi
inflamm
hepat
dysfunct
common
sign
anorexia
lethargi
vomit
diarrhea
clinic
sign
hepat
involv
may
overshadow
sign
associ
diseas
process
eg
neoplasia
pyelonephr
pancreat
dog
hepat
abscess
may
histori
failur
respond
antibiot
improv
relaps
antibiot
discontinu
physic
examin
find
often
vagu
includ
depress
dehydr
fever
abdomin
pain
hepatomegali
abdomin
mass
abdomin
effus
hypothermia
common
find
fever
cat
hepat
abscess
clinic
find
vagu
nonspecif
hepat
abscess
often
go
undetect
abdomin
ultrasound
perform
ruptur
discov
laparotomi
ruptur
hepat
abscess
lead
rapidli
periton
septic
shock
death
clinicopatholog
abnorm
consist
inflammatori
hepat
diseas
potenti
find
complet
blood
count
includ
neutrophilia
left
shift
neutropenia
degen
left
shift
ruptur
occur
mild
anemia
thrombocytopenia
increas
alt
alp
activ
common
find
although
alt
may
normal
rang
liver
enzym
elev
lessconsist
find
cat
hepat
abscess
cat
surviv
rate
appear
better
solitari
abscess
detect
granulomat
hepat
character
histolog
focal
multifoc
aggreg
activ
macrophag
epithelioid
appear
usual
accompani
lymphocyt
plasma
cell
inflammatori
respons
distinct
encount
canin
chronic
hepat
system
infecti
diseas
import
caus
granulomat
hepat
lesion
describ
fungal
infect
histoplasmosi
coccidioidomycosi
mani
other
bacteri
infect
mycobacteria
bartonella
nocardia
actinomyc
rhodococcu
protozo
diseas
cytauxzoonosi
leishmaniasi
parasit
diseas
viscer
larval
migran
schistosomiasi
alveolar
echinococcu
hepatozoon
americana
dissemin
protothecosi
see
tabl
cat
felin
infecti
periton
coronaviru
import
caus
multisystem
granulomat
pyogranulomat
inflamm
caus
granulomat
inflamm
includ
local
respons
foreign
materi
crystallin
materi
sutur
plant
materi
drug
reaction
human
granulomat
liver
lesion
associ
administr
diltiazem
sulfonamid
quinidin
allopurinol
phenytoin
howev
drug
therapi
caus
granulomat
hepat
dog
cat
specif
report
granulomat
lesion
liver
describ
small
number
dog
lymphangiectasia
lymphosarcoma
histiocytosi
mani
case
granulomat
hepat
idiopath
hepat
lipogranuloma
fatti
cyst
often
found
dog
congenit
portosystem
shunt
aggreg
pigmentladen
foami
macrophag
confus
granulomat
hepat
clinic
find
granulomat
hepat
highli
variabl
depend
underli
caus
granulomat
hepat
identifi
liver
biopsi
special
stain
fungal
mycobacteri
organ
perform
diagnost
either
identifi
organ
cytolog
cultur
fecal
exam
pcr
detect
antibodi
organ
serolog
vari
wide
underli
agent
see
tabl
caus
found
thorough
diagnost
evalu
consider
given
presumpt
treatment
undiscov
infecti
agent
atyp
mycobacteria
bartonella
spp
system
fungal
infect
corticosteroid
immunosuppress
agent
use
diagnost
test
empir
treatment
unsuccess
steroidinduc
immunosuppress
may
exacerb
underli
infect
eosinophil
hepat
occur
rare
dog
cat
potenti
caus
includ
viscer
larval
migran
toxocara
schistosomiasi
liver
fluke
infect
sarcocysti
cani
possibl
fungal
infect
see
tabl
parasit
caus
eosinophil
often
locat
near
site
parasit
lesion
liver
dog
cat
system
allerg
parasit
heartworm
hypereosinophil
syndrom
may
also
scatter
eosinophil
liver
variant
nonspecif
reactiv
hepat
hepat
druginduc
liver
injuri
also
consid
phenytoin
minocyclin
associ
eosinophil
infiltr
human
druginduc
liver
injuri
potenti
sulfonamid
suggest
caus
druginduc
eosinophil
hepat
dog
although
typic
pattern
acut
hepatocellular
necrosi
cholestat
hepatopathi
eosinophil
infiltr
identifi
effort
direct
diagnos
parasit
caus
fecal
increas
alt
alp
activ
occur
less
cat
potenti
biochem
find
includ
hyperglobulinemia
mild
hyperbilirubinemia
hypoglycemia
sepsi
laboratori
abnorm
may
also
reflect
associ
diseas
process
eg
hyperglycemia
diabet
mellitu
increas
pancreat
lipas
immunoreact
acut
pancreat
abscess
ruptur
cytolog
abdomin
infus
reveal
septic
suppur
inflamm
abdomin
radiograph
may
normal
reveal
hepatomegali
hepat
mass
lesion
decreas
abdomin
detail
effus
associ
secondari
periton
prolifer
gasproduc
organ
radioluc
area
may
seen
liver
ultrasonograph
examin
permit
earlier
detect
hepat
abscess
ultrasonograph
liver
abscess
appear
hypoecho
anecho
structur
irregular
hyperecho
margin
ultrasonograph
pattern
similar
seen
hepat
hematoma
cyst
neoplasia
biliari
cystadenoma
ga
may
seen
within
abscess
abscess
ruptur
occur
concurr
abdomin
effus
may
detect
addit
ultrasonograph
find
may
reflect
associ
disord
pancreat
cholecyst
pyelonephr
ultrasoundguid
fineneedl
aspir
suspect
liver
abscess
safe
perform
obtain
sampl
cytolog
cultur
confirm
diagnosi
ultrasonographi
avail
diagnosi
hepat
abscess
usual
establish
exploratori
laparotomi
necropsi
attempt
made
isol
identifi
organ
associ
abscess
appropri
antibiot
therapi
institut
base
sensit
test
aerob
anaerob
cultur
perform
abscess
content
fineneedl
aspir
abdomin
exud
blood
hepat
tissu
treatment
hepat
abscess
consist
surgic
resect
drainag
focal
lesion
administr
appropri
antibiot
correct
associ
fluid
electrolyt
acidbas
imbal
identif
treatment
underli
diseas
process
treatment
larg
unifoc
hepat
abscess
typic
involv
surgic
resect
affect
tissu
may
necessit
partial
full
lobectomi
perfor
periton
present
surgic
abdomin
drainag
lavag
indic
ultrasoundguid
percutan
drainag
solitari
abscess
may
resolv
abscess
allow
stabil
surgic
resect
perform
success
manag
focal
hepat
abscess
cm
diamet
ultrasoundguid
percutan
drainag
alcohol
describ
five
dog
one
cat
broadspectrum
combin
antibiot
therapi
direct
toward
aerob
anaerob
bacteria
initi
soon
cultur
obtain
result
gram
stain
exud
may
provid
preliminari
inform
type
organ
guid
empir
choic
potenti
effect
antibiot
recommend
broadspectrum
antimicrobi
coverag
hepatobiliari
infect
includ
either
fluoroquinolon
combin
amoxicillinclavulan
fluoroquinolon
combin
penicillin
metronidazol
cultur
result
avail
dose
metronidazol
adjust
anim
hepat
dysfunct
mgkg
po
antibiot
therapi
continu
least
week
respons
treatment
monitor
serial
ultrasound
examin
repeat
blood
work
histor
hepat
abscess
carri
grave
prognosi
overal
report
mortal
rate
approxim
dog
case
seri
see
chapter
breed
dog
increas
risk
chronic
hepat
includ
bedlington
terrier
west
highland
white
terrier
doberman
pinscher
american
english
cocker
spaniel
skye
terrier
dalmatian
labrador
retriev
english
springer
spaniel
unfortun
except
hereditari
copperassoci
liver
diseas
bedlington
terrier
inform
lack
breedrel
disord
femal
dog
appear
increas
risk
studi
other
report
male
femal
dog
equal
affect
within
particular
breed
sex
differ
note
femal
doberman
pinscher
labrador
retriev
english
springer
spaniel
male
cocker
spaniel
dog
diagnos
chronic
hepat
gener
year
age
adult
dog
age
breed
affect
etiolog
pathogenesi
ideal
canin
chronic
hepat
classifi
etiolog
basi
howev
except
copperassoci
liver
diseas
bedlington
terrier
caus
pathogenesi
natur
histori
optim
treatment
prognosi
disord
unknown
tabl
idiopath
chronic
hepat
common
clinic
diagnosi
infecti
caus
viral
infect
common
caus
chronic
hepat
human
current
recogn
import
etiolog
dog
human
virus
potenti
heartworm
test
see
tabl
system
eosinophilia
hypersensit
reaction
specif
caus
determin
empir
treatment
fenbendazol
consid
follow
corticosteroid
therapi
describ
idiopath
chronic
hepat
term
nonspecif
reactiv
hepat
use
describ
slight
moder
widespread
inflammatori
infiltr
liver
occur
secondari
spectrum
extrahepat
diseas
process
lesion
nonspecif
reactiv
hepat
associ
febril
inflammatori
disord
especi
involv
gi
tract
pancrea
may
repres
residu
evid
previou
intrahepat
inflammatori
disord
inflamm
occur
portal
parenchym
area
necrosi
absent
neutrophil
predomin
acut
extrahepat
disord
wherea
mononuclear
inflamm
occur
chronic
extrahepat
disord
residu
hepat
inflamm
liver
may
secondarili
affect
system
disord
chang
liver
blood
flow
portal
blood
deliveri
bacteria
drug
hormon
cytokin
substanc
gi
tract
activ
intrahepat
kupffer
cell
monocytemacrophag
system
involv
hepat
immun
respons
may
challeng
differenti
nonspecif
reactiv
hepat
resolv
acut
hepat
mild
chronic
hepat
without
support
clinic
inform
clinic
sign
dog
cat
nonspecif
reactiv
hepat
usual
refer
extrahepat
disord
liver
enzym
elev
alttwo
time
upper
limit
normal
alpthreeto
fourfold
increas
common
thu
mimick
primari
hepat
diseas
howev
test
reflect
liver
function
includ
serum
bile
acid
usual
normal
import
consid
extrahepat
disord
secondari
affect
liver
prior
focus
primari
hepat
diseas
treatment
direct
underli
extrahepat
disord
chronic
hepat
heterogen
group
inflammatorynecrot
diseas
liver
occur
commonli
dog
rare
cat
cholang
inflammatori
liver
diseas
target
biliari
tract
rather
hepatocyt
common
cat
also
occur
dogsth
term
chronic
hepat
rather
chronic
activ
hepat
chronic
persist
hepat
recommend
etiolog
known
includ
adject
druginduc
chronic
hepat
copperassoci
chronic
hepat
otherwis
consid
idiopath
chronic
hepat
chronic
hepat
dog
defin
base
histopatholog
featur
hepatocellular
necrosi
apoptosi
associ
inflamm
evid
regener
fibrosi
lymphoplasmacyt
inflamm
characterist
neutrophil
compon
may
present
histopatholog
featur
chronic
hepat
similar
regardless
underli
caus
chronic
hepat
potenti
progress
cirrhosi
recommend
made
includ
clinic
compon
definit
chronic
hepat
document
increas
alt
activ
along
histolog
evid
hepat
inflamm
minimum
month
howev
mani
dog
chronic
liver
diseas
clinic
appar
advanc
stage
durat
difficult
evalu
earli
stage
may
recogn
unless
biochemistri
monitor
hepat
injuri
famili
predisposit
develop
chronic
hepat
suggest
demograph
studi
patholog
survey
clinic
hepat
acut
chronic
account
onethird
dog
primari
hepat
hepat
copper
accumul
hepatopathi
describ
cat
appear
rare
sever
hepat
injuri
correl
amount
hepat
copper
subcellular
local
molecul
molecular
associ
also
play
role
serum
copper
level
accur
reflect
hepat
copper
content
quantit
analysi
copper
liver
requir
hepat
copper
concentr
normal
dog
dri
weight
part
per
million
inflammatori
hepat
injuri
consist
occur
copper
concentr
exceed
dri
weight
howev
may
breed
variat
exampl
doberman
pinscher
hepat
inflamm
present
copper
concentr
less
transient
acquir
fanconi
syndrom
describ
dog
excess
hepat
copper
accumul
copper
granul
demonstr
renal
biopsi
dog
potenti
mechan
hepat
copper
accumul
includ
primari
metabol
defect
hepat
copper
metabol
cholestasi
caus
impair
biliari
excret
copper
excess
copper
absorpt
primari
defect
hepat
copper
metabol
occur
bedlington
terrier
genet
mutat
gene
encod
copper
transport
protein
formerli
result
defect
biliari
copper
excret
caus
hepat
either
persist
hepat
infect
transient
infect
trigger
immun
respons
crossreact
viru
liver
antigen
attempt
identifi
infecti
caus
canin
hepat
pcr
screen
liver
tissu
perform
dog
variou
stage
hepat
look
canin
adenoviru
type
hepadnavirida
hepat
viru
hepat
c
viru
hepat
e
viru
helicobact
spp
leptospira
spp
borrelia
spp
base
neg
result
author
conclud
canin
hepat
typic
caus
infecti
agent
howev
dog
experiment
infect
canin
adenoviru
type
partial
immun
develop
chronic
hepat
progress
cirrhosi
viru
could
detect
beyond
first
week
postinfect
although
diseas
progress
period
month
canin
adenoviru
antigen
demonstr
immunohistochem
techniqu
formalinfix
liver
section
five
dog
variou
hepat
inflammatori
lesion
suggest
canin
adenoviru
may
play
role
spontan
chronic
hepat
contrast
pcr
immunohistochemistri
fail
detect
canin
adenoviru
liver
tissu
dog
chronic
liver
diseas
whether
signific
caus
chronic
hepat
natur
condit
unknown
anoth
propos
viral
caus
chronic
hepat
cirrhosi
canin
acidophil
cell
hepat
viru
report
great
britain
transmiss
agent
like
viru
distinct
transmit
experiment
subcutan
inject
serum
liver
extract
affect
dog
result
experiment
induc
acut
chronic
hepat
studi
publish
clarifi
natur
infecti
agent
associ
hepat
canin
leptospirosi
typic
associ
acut
cholestat
hepat
diseas
acut
renal
failur
howev
persist
infect
caus
chronic
hepat
absenc
azotemia
leptospira
serovar
grippotyphosa
incrimin
caus
chronic
hepat
kennel
american
foxhound
base
serolog
evid
demonstr
spirochet
liver
leptospira
serogroup
australi
serovar
australi
bratislava
muenchen
infect
suspect
caus
chronic
hepat
young
beagl
dog
breed
coloni
routin
vaccin
leptospirosi
serogroup
canicola
icterohaemorrhagica
canin
leishmaniasi
associ
histolog
evid
chronic
hepat
clinic
featur
suggest
hepat
involv
hepatomegali
ascit
icteru
absent
histolog
find
reveal
granulomat
hepat
dog
dog
mark
portal
infiltr
lymphocyt
plasma
cell
mild
portal
fibrosi
leishmania
amastigot
routin
identifi
macrophag
liver
affect
tissu
bartonella
clarridgeia
dna
amplifi
liver
biopsi
doberman
pinscher
copperassoci
chronic
hepat
although
signific
find
unclear
copper
accumul
copper
essenti
trace
element
diet
requir
number
physiolog
import
enzym
cell
highli
special
complex
system
maintain
intracellular
copper
concentr
toxic
concentr
free
intracellular
copper
initi
oxid
damag
caus
hepatocellular
necrosi
inflamm
normal
copper
metabol
review
detail
elsewher
copper
accumul
liver
associ
signific
hepat
injuri
result
acut
hepat
chronic
hepat
cirrhosi
figur
one
welldocu
caus
canin
chronic
hepat
one
studi
copperassoci
b
liver
dog
identifi
control
sampl
healthi
liver
none
dog
decreas
serum
level
posit
antitrypsin
stain
consist
find
english
american
cocker
spaniel
chronic
liver
diseas
breed
author
conclud
accumul
antitrypsin
might
play
role
could
determin
caus
result
chronic
liver
diseas
drug
toxin
drug
toxin
exposur
potenti
caus
canin
chronic
hepat
diseas
drug
incrimin
includ
anticonvuls
phenobarbit
primidon
phenytoin
oxibendazolediethylcarbamazin
lomustin
possibl
carprofen
chronic
hepat
cirrhosi
longterm
phenobarbit
therapi
wide
recogn
exposur
aflatoxin
contamin
commerci
dog
food
usual
associ
alf
lowlevel
longterm
exposur
dog
result
chronic
hepat
injuri
biliari
hyperplasia
fibrosi
nodular
regener
breed
coloni
german
shepherd
dog
develop
chronic
hepat
cirrhosi
suspect
never
confirm
result
exposur
porphyrinogen
substanc
base
find
aggreg
crystallin
pigment
orang
birefring
polar
light
earli
recognit
drugor
toxininduc
chronic
hepat
injuri
requir
biochem
monitor
liver
enzym
dog
clinic
asymptomat
earli
stage
autoimmuneimmun
mechan
autoimmun
hepat
document
dog
howev
dog
chronic
hepat
appear
respond
corticosteroid
therapi
thu
may
correspond
autoimmun
hepat
human
autoimmun
hepat
human
progress
chronic
hepat
unknown
caus
believ
occur
environment
agent
virus
medic
trigger
cascad
tcellmedi
event
direct
liver
antigen
genet
predispos
individu
women
commonli
affect
men
hyperglobulinemia
common
find
infecti
caus
difficult
document
exposur
may
occur
mani
year
prior
overt
autoimmun
diseas
certain
drug
may
induc
unmask
autoimmun
hepat
simpli
caus
hepatocellular
injuri
mimic
autoimmun
hepat
autoimmun
compon
doberman
pinscher
hepat
specul
breed
predisposit
high
femal
predomin
find
express
mhc
class
ii
antigen
hepatocyt
affect
dog
correl
degre
inflamm
decreas
treatment
prednisolon
dog
chronic
hepat
may
concurr
disord
associ
immun
aberr
immun
hemolyt
anemia
hypothyroid
atopi
glomerulonephr
whether
coincident
indic
presenc
multipl
immun
disord
seen
autoimmun
hepat
human
unknown
autoimmun
hepat
human
diagnos
caus
acut
chronic
hepat
exclud
serum
autoantibodi
antinuclear
antismooth
muscl
antibodi
liver
kidney
microsom
type
antibodi
liver
cytosol
type
detect
number
studi
evalu
role
liverassoci
antibodi
cellmedi
respons
dog
chronic
hepat
none
answer
question
whether
immun
respons
primari
caus
hepat
secondari
phenomenon
twentyfour
dog
chronic
hepat
evalu
circul
autoantibodi
cell
nuclei
smooth
muscl
liver
membran
mitochondria
indirect
immunofluoresc
antibodi
cell
nuclei
liver
membran
earli
stage
copper
sequest
hepat
lysosom
hepat
damag
minim
howev
progress
accumul
copper
hepat
injuri
becom
signific
averag
copper
concentr
bedlington
terrier
chronic
hepat
approxim
dri
weight
valu
dri
weight
report
inherit
copperassoci
liver
diseas
also
describ
west
highland
white
terrier
skye
terrier
doberman
pinscher
dalmatian
labrador
retriev
possibl
except
dalmatian
hepat
copper
level
much
lower
bedlington
terrier
pathogenesi
copper
accumul
relationship
chronic
liver
diseas
breed
poorli
understood
seem
like
breed
hereditari
disord
copper
handl
unlik
describ
bedlington
terrier
hepat
copper
accumul
liver
may
also
consequ
rather
caus
chronic
hepat
copper
normal
excret
bile
chronic
cholestasi
impair
bile
flow
result
secondari
copper
accumul
secondari
copper
accumul
predominantli
periport
usual
less
dri
weight
effect
cholestasi
hepat
copper
content
evalu
three
group
dog
bedlington
terrier
copper
toxic
dog
extrahepat
biliari
obstruct
prototyp
exampl
cholestat
disord
chronic
hepat
breed
known
risk
copperassoci
liver
diseas
hepat
copper
content
evalu
semiquantit
method
base
copper
stain
liver
tissu
rubean
acid
use
scale
copper
copper
stain
reveal
absent
mild
increas
score
dog
biliari
obstruct
chronic
hepat
compar
bedlington
terrier
score
conclud
copper
score
higher
suggest
primari
copper
storag
diseas
unfortun
quantit
copper
analysi
evalu
marker
oxid
injuri
alter
defens
mechan
similar
three
group
consist
concept
copper
inflamm
cholestasi
contribut
oxid
injuri
high
dietari
copper
intak
appear
unlik
explan
hepat
copper
accumul
liver
diseas
dog
howev
copper
content
commerci
dog
food
rang
mgkg
dri
matter
rel
high
compar
recommend
minimum
daili
copper
requir
dog
specul
recent
increas
patholog
elev
hepat
copper
concentr
specif
evalu
labrador
retriev
may
coincid
pet
food
industri
recommend
replac
cupriccupr
oxid
feed
formul
low
bioavail
mani
dog
copperassoci
chronic
hepat
also
increas
hepat
iron
concentr
hepat
iron
accumul
usual
correl
degre
inflamm
whether
iron
oxid
interact
copper
contribut
lesion
seen
copperassoci
hepat
remain
determin
antitrypsin
defici
inherit
antitrypsin
defici
wellrecogn
caus
chronic
hepat
cirrhosi
human
may
play
role
pathogenesi
chronic
hepat
dog
antitrypsin
circul
proteas
inhibitor
synthes
secret
liver
antitrypsin
defici
affect
human
result
defect
format
impair
hepat
secret
antitrypsin
result
hepat
accumul
antitrypsin
hepat
injuri
serum
level
antitrypsin
typic
low
studi
dog
chronic
liver
diseas
detect
immunohistochem
stain
earli
stage
chronic
hepat
ultrasonographi
liver
may
normal
reveal
nonspecif
chang
echogen
chronic
hepat
advanc
cirrhosi
potenti
ultrasonograph
find
includ
microhepatia
irregular
hepat
margin
focal
lesion
repres
regen
nodul
increas
parenchym
echogen
associ
increas
fibrou
tissu
ascit
splenomegali
acquir
psss
may
also
detect
liver
biopsi
essenti
diagnosi
chronic
hepat
wedg
biopsi
prefer
needl
biopsi
provid
tissu
like
repres
patholog
process
es
liver
cirrhosi
present
laparotomi
laparoscopi
often
provid
better
appreci
gross
nodular
liver
ascertain
blind
percutan
needl
biopsi
figur
chronic
hepat
character
histolog
moder
sever
inflamm
usual
combin
lymphocyt
plasma
cell
associ
piecem
necrosi
piecem
necrosi
also
refer
interfac
hepat
necrosi
involv
layer
hepatocyt
adjac
portal
tract
limit
plate
term
bridg
necrosi
use
necrosi
inflamm
dissect
across
hepat
lobul
portal
area
central
vein
adjac
hepat
lobul
suggest
sever
form
chronic
hepat
histopatholog
evalu
liver
consid
etiolog
pathologist
also
comment
activ
amount
inflamm
extent
apoptosi
necrosi
stage
diseas
extent
pattern
fibrosi
architectur
distort
suggest
cirrhosi
biopsi
dog
chronic
hepat
routin
evalu
copper
accumul
hematoxylin
eosin
stain
excess
copper
appear
golden
brown
refractil
granul
histochem
stain
rhodanin
rubean
acid
use
semiquantit
evalu
copper
liver
see
figur
stain
consist
detect
copper
amount
exceed
dri
weight
valu
obtain
quantit
copper
analysi
strong
correl
number
size
granul
seen
histochem
stain
within
rang
liver
tissu
zonal
distribut
copper
detect
also
found
dog
type
hepat
diseas
suggest
nonspecif
secondari
respons
pattern
circul
autoantibodi
found
dog
differ
significantli
found
human
chronic
liver
diseas
anoth
studi
serum
antilivermembraneprotein
antibodyposit
dog
higher
alt
activ
total
bilirubin
concentr
sever
hepat
lesion
antilivermembraneprotein
antibodyneg
dog
determin
whether
autoantibodi
primari
secondari
lymphocyt
common
hepat
lymphoid
cell
dog
chronic
hepat
associ
hepat
necrosi
also
account
hepat
lymphocyt
normal
dog
histor
physic
examin
find
dog
chronic
hepat
indic
chronic
hepat
diseas
similar
regardless
underli
caus
sign
often
initi
vagu
nonspecif
anorexia
lethargi
vomit
diarrhea
weight
loss
pu
pd
increas
sever
hepat
dysfunct
sign
overt
liver
failur
develop
ascit
jaundic
presenc
ascit
suggest
chronic
hepat
progress
cirrhosi
ascit
neg
prognost
indic
melena
associ
gastroduoden
ulcer
coagulopathi
also
like
advanc
liver
diseas
larg
function
reserv
capac
liver
onset
sign
may
appear
recent
initi
suggest
acut
rather
chronic
hepat
disord
clinicopatholog
featur
support
chronic
includ
poor
bodi
condit
ascit
microhepatia
hypoalbuminemia
histolog
evid
fibrosi
earli
subclin
stage
dog
asymptomat
identifi
biochem
screen
liver
enzym
elev
increas
serum
alt
activ
reflect
ongo
hepat
injuri
report
dog
chronic
hepat
serum
alt
activ
may
exceed
time
upper
normal
limit
period
normal
alt
activ
may
reflect
cyclic
diseas
activ
vari
sever
necrosi
serum
alp
activ
also
commonli
increas
magnitud
increas
gener
lower
seen
alt
activ
chronic
hepat
advanc
cirrhosi
liver
enzym
activ
may
normal
indic
decreas
viabl
parenchym
mass
abnorm
biochem
test
hyperbilirubinemia
hypoalbuminemia
decreas
blood
urea
nitrogen
bun
hypoglycemia
increas
sba
indic
hepat
dysfunct
advanc
stage
diseas
hyperglobulinemia
seen
dog
cirrhosi
remain
determin
whether
correspond
increas
autoantibodi
occur
human
autoimmun
hepat
whether
reflect
nonspecif
system
antibodi
product
respons
antigen
portal
blood
bypass
liver
acquir
psss
mild
nonregen
anemia
may
reflect
chronic
diseas
regen
anemia
occur
blood
loss
secondari
coagulopathi
bleed
gi
ulcer
copperassoci
hemolyt
anemia
document
bedlington
terrier
abnorm
hemostat
paramet
prolong
aptt
pt
indic
sever
hepat
dysfunct
dic
prolong
pt
thrombocytopenia
may
neg
prognost
indic
analysi
ascit
fluid
reveal
transud
modifi
transud
abdomin
radiograph
unremark
except
advanc
stage
diseas
accompani
microhepatia
ascit
kg
everi
hour
often
recommend
treatment
canin
chronic
hepat
complic
corticosteroid
therapi
includ
gi
bleed
may
precipit
secondari
infect
iatrogen
cush
diseas
worsen
ascit
dexamethason
mgkg
po
may
prefer
dog
ascit
edema
lack
mineralocorticoid
activ
could
exacerb
sign
prednison
often
use
combin
azathioprin
especi
side
effect
prednison
becom
objection
azathioprin
antimetabolit
antiinflammatori
immunemodul
effect
commonli
use
combin
prednison
human
autoimmun
hepat
dose
azathioprin
dog
mgkgday
po
everi
hour
week
taper
everi
hour
mainten
therapi
prednison
mgkgday
given
altern
day
azathioprin
may
caus
bone
marrow
suppress
acut
hepatotox
complet
blood
count
biochem
profil
monitor
antiinflammatori
agent
immunosuppress
drug
discuss
detail
chapter
respect
glucocorticoid
increas
liver
enzym
activ
especi
serum
alp
activ
respons
therapi
best
evalu
followup
liver
biopsi
perform
month
start
therapi
glucocorticoid
therapi
eventu
discontinu
clinic
biochem
paramet
period
monitor
detect
relaps
dog
hepat
copper
concentr
greater
treat
copper
chelat
penicillamin
dose
mgkg
po
everi
hour
treatment
usual
requir
month
year
produc
signific
decreas
hepat
copper
mean
decreas
copper
approxim
achiev
bedlington
terrier
treat
month
dog
secondari
copper
accumul
appear
respond
rapidli
possibl
hepat
copper
content
lower
breed
doberman
pinscher
subclin
hepat
treat
penicillamin
month
mean
decreas
copper
penicillamin
addit
effect
beyond
copper
chelat
may
benefici
dog
chronic
hepat
includ
inhibit
collagen
deposit
stimul
collagenas
activ
immunosuppress
immunomodul
common
side
effect
penicillamin
therapi
includ
anorexia
nausea
vomit
minim
give
medic
small
amount
food
copper
chelat
trientin
mgkg
po
also
effect
reduc
hepat
copper
concentr
fewer
side
effect
penicillamin
effect
dog
hemolyt
anemia
caus
copper
releas
necrot
hepatocyt
iatrogen
copper
defici
microcytosi
hepat
dysfunct
describ
dog
treat
longterm
copper
chelat
therapi
trientin
copperrestrict
diet
decis
durat
chelat
therapi
base
followup
liver
biopsi
period
monitor
quantit
hepat
copper
content
oral
zinc
salt
use
mainten
therapi
copper
chelat
initi
therapi
dog
hepat
copper
concentr
dri
weight
dri
weight
zinc
supplement
typic
use
conjunct
dietari
copper
restrict
zinc
decreas
intestin
copper
absorpt
induc
intestin
copperbind
protein
metallothionein
within
intestin
epitheli
cell
preferenti
bind
dietari
copper
prevent
absorpt
zinc
acet
given
dose
mg
po
bid
month
mainten
dose
mg
po
bid
minimum
month
zinc
therapi
requir
copper
uptak
intestin
tract
block
accumul
note
copper
accumul
start
centrilobular
area
like
primari
metabol
defect
copper
metabol
copper
granul
also
detect
cytolog
hepat
aspir
impress
smear
stain
rhodanin
rubean
acid
quantit
analysi
copper
atom
absorpt
analysi
fresh
hepat
tissu
definit
method
document
increas
hepat
copper
content
needl
core
biopsi
specimen
may
reliabl
metal
analysi
copper
iron
valu
consist
lower
needl
core
versu
wedg
biopsi
sampl
formalinfix
tissu
avoid
formalin
may
contain
copper
leach
copper
tissu
hepat
copper
reliabl
determin
retrospect
deparaffinizedarchiv
liver
biopsi
specimen
chronic
hepat
confirm
care
consider
known
caus
chronic
hepat
essenti
see
tabl
find
would
support
primari
metabol
defect
copper
metabol
includ
previous
recogn
breed
predisposit
copper
accumul
preced
cholestasi
inflamm
centrilobular
zone
distribut
copper
histochem
score
copper
greater
quantit
copper
measur
exceed
dri
weight
special
stain
liver
request
evalu
infecti
agent
leptospirosi
serum
antibodi
titer
leptospirosi
may
indic
histori
chronic
drug
therapi
sought
especi
longterm
anticonvuls
therapi
drug
list
tabl
recommend
treatment
chronic
hepat
empir
best
lack
control
therapeut
studi
welldefin
popul
dog
disord
probabl
caus
categori
injuri
determin
specif
treatment
direct
primari
etiolog
exampl
discontinu
phenobarbit
treatment
leptospirosi
chelat
hepat
copper
penicillamin
case
specif
therapi
unavail
treatment
chronic
hepat
dog
tradit
center
use
corticosteroid
presum
human
autoimmun
form
hepat
immunolog
mechan
inflammatori
cell
mediat
local
cytokin
contribut
hepat
inflamm
progress
cirrhosi
corticosteroid
antiinflammatori
immunemodul
antifibrot
effect
may
benefici
chronic
hepat
larg
retrospect
studi
suggest
corticosteroid
therapi
initi
immunosuppress
dose
mgkgday
eventu
taper
mgkgday
improv
surviv
dog
chronic
hepat
howev
mani
concurr
drug
given
undoubtedli
heterogen
group
disord
includ
diagnosi
chronic
hepat
corticosteroid
therapi
appear
warrant
dog
histolog
featur
activ
inflamm
persist
increas
serum
liver
enzym
activ
known
caus
chronic
hepat
includ
infecti
caus
exclud
glucocorticoid
therapi
indic
treatment
chronic
hepat
caus
drug
therapi
infecti
agent
primari
hepat
copper
accumul
optim
dose
durat
corticosteroid
therapi
treatment
canin
chronic
hepat
unknown
includ
whether
immunosuppress
dose
requir
whether
lower
antiinflammatori
level
would
suffic
even
human
autoimmun
hepat
immunosuppress
dose
corticosteroid
may
requir
prednison
prednisolon
initi
dose
mgkgday
po
gradual
taper
mg
correl
amount
hepat
copper
hepat
injuri
believ
occur
progress
copper
accumul
exce
storag
capac
lysosom
copper
releas
cytoplasm
damag
mitochondria
initi
lipid
membran
peroxid
eventu
caus
cell
death
affect
dog
asymptomat
earli
stage
show
sign
acut
hepat
necrosi
chronic
hepat
cirrhosi
young
dog
copper
accumul
centrilobular
zone
hepatocyt
sequest
hepat
lysosom
first
stage
copper
concentr
dog
asymptomat
biochem
test
within
normal
limit
liver
biopsi
find
unremark
second
stage
hepat
copper
concentr
copper
granul
also
found
midzon
zone
periport
zone
hepatocyt
although
dog
still
asymptomat
focal
hepat
inflamm
centrilobular
mix
cell
foci
necrot
hepatocyt
lymphoplasmacyt
inflamm
copperladen
macrophag
seen
biopsi
increas
serum
alt
activ
reflect
hepatocellular
injuri
advanc
stage
hepat
copper
concentr
exce
morpholog
chang
reveal
chronic
hepat
may
progress
cirrhosi
clinic
biochem
evid
liver
diseas
becom
appar
clinic
sign
includ
anorexia
lethargi
vomit
weight
loss
progress
cirrhosi
find
jaundic
ascit
may
develop
biochem
find
vari
stage
diseas
increas
serum
alt
activ
sensit
laboratori
indic
although
find
normal
young
dog
stage
lack
hepat
inflamm
serum
biochem
abnorm
typic
chronic
hepat
dysfunct
eventu
develop
case
acut
hepat
necrosi
alf
occur
hepatocellular
necrosi
may
associ
releas
copper
necrot
hepatocyt
result
hemolyt
anemia
episod
hemolysi
plasma
copper
level
increas
find
includ
low
pack
cell
volum
hemoglobinemia
hemoglobinuria
liver
biopsi
quantit
analysi
hepat
copper
concentr
requir
definit
diagnosi
stage
diseas
serum
copper
ceruloplasmin
concentr
help
make
diagnosi
liver
biopsi
perform
bedlington
terrier
consid
breed
order
identifi
remov
affect
dog
breed
program
screen
asymptomat
dog
liver
biopsi
month
month
age
determin
affect
dog
homozyg
heterozyg
carrier
affect
dog
homozyg
heterozyg
typic
increas
hepat
copper
month
age
howev
copper
concentr
dog
carrier
heterozyg
return
normal
year
age
wherea
copper
concentr
homozyg
dog
continu
increas
select
breed
program
netherland
decreas
preval
bedlington
terrier
copperassoci
liver
diseas
dna
test
bedlington
terrier
avail
vetgen
wwwvetgencom
assay
evalu
linkagebas
dna
marker
allel
locat
chromosom
close
gene
copper
toxic
test
identifi
normal
affect
carrier
dog
accuraci
howev
marker
reli
diagnosi
genet
statu
individu
dog
support
pedigre
studi
signific
discrep
report
bedlington
terrier
compar
result
liver
biopsi
dna
marker
may
attribut
differ
subpopul
bedlington
terrier
variat
diseasecaus
mutat
gene
second
mutant
copper
gene
could
play
role
liver
biopsi
quantit
zinc
administr
separ
meal
least
hour
theoret
prescrib
time
copper
chelat
serum
zinc
concentr
monitor
achiev
level
zinc
concentr
greater
may
toxic
hemolyt
anemia
lowcopp
diet
benefici
manag
earli
subclin
copper
accumul
dog
affect
primari
metabol
defect
hepat
copper
metabol
feed
lowcopp
diet
decreas
hepat
copper
content
labrador
retriev
subclin
copperassoci
liver
diseas
addit
treatment
zinc
appear
increas
copperlow
effect
dietari
manag
food
contain
larg
amount
copper
liver
organ
meat
shellfish
egg
beanlegum
chocol
nut
cereal
coppercontain
vitamin
supplement
avoid
oxid
stress
signific
mechan
hepat
damag
associ
copper
accumul
necroinflammatori
hepat
disord
antioxid
therapi
vitamin
e
iukgday
mgkgday
advoc
cytoprotect
agent
silymarin
milk
thistl
ursodeoxychol
acid
may
also
benefici
chapter
discuss
cytoprotect
agent
use
treatment
hepatobiliari
diseas
detail
endstag
cirrhosi
diagnos
treatment
mainli
support
cirrhosi
essenti
irrevers
measur
also
institut
control
complic
chronic
liver
failur
ascit
gastroduoden
ulcer
coagulopathi
discuss
detail
complic
liver
diseas
section
respons
treatment
chronic
hepat
variabl
unexpect
like
heterogen
group
diseas
dog
eventu
taken
medic
remain
remiss
often
therapi
must
continu
indefinit
dog
fail
respond
especi
advanc
diseas
cirrhosi
one
studi
estim
median
surviv
time
dog
idiopath
chronic
hepat
month
rang
month
dog
copperassoci
chronic
hepat
month
rang
month
mean
surviv
time
dog
cirrhosi
week
bedlington
terrier
develop
chronic
hepat
cirrhosi
copper
toxic
consequ
inherit
metabol
defect
result
impair
biliari
copper
excret
disord
transmit
autosom
recess
inherit
gene
respons
metabol
disord
differ
describ
copper
toxic
wilson
diseas
human
gene
involv
gender
predilect
one
time
specul
mani
breed
might
affect
hepat
copper
concentr
normal
bedlington
terrier
rang
mean
dri
weight
bedlington
terrier
copperassoci
liver
diseas
associ
progress
hepat
copper
accumul
copper
level
unless
treatment
institut
lowest
hepat
concentr
copper
found
youngest
dog
concentr
increas
age
peak
around
year
copper
content
usual
declin
thereaft
affect
dog
normal
declin
may
result
replac
coppercontain
hepatocyt
fibrou
tissu
regen
nodul
contain
copper
sever
hepat
diseas
recent
effort
focus
identif
affect
doberman
pinscher
prior
advanc
hepat
diseas
finland
survey
randomli
select
clinic
healthi
doberman
pinscher
reveal
dog
increas
alt
activ
hepat
parenchym
portal
mononuclear
inflamm
posit
stain
copper
mean
age
dog
subclin
hepat
year
compar
clinic
affect
dog
year
asymptomat
period
last
averag
month
preval
subclin
doberman
hepat
investig
randomli
select
year
old
doberman
pinscher
netherland
subclin
hepat
identifi
dog
femal
three
male
hepat
copper
concentr
higher
dog
hepat
dri
weight
without
liver
diseas
serial
liver
biopsi
least
period
reveal
hepat
persist
dog
copper
level
greater
dri
weight
copper
level
continu
increas
dog
support
relationship
copper
inflamm
hepat
also
propos
hepat
copper
incident
chronic
hepat
breed
base
find
five
doberman
pinscher
chronic
hepat
normal
copper
level
histolog
chang
similar
regardless
copper
statu
immunemedi
mechan
suggest
base
find
express
mhc
class
ii
antigen
hepatocyt
dog
doberman
hepat
correl
degre
inflamm
aberr
mhc
class
ii
molecul
express
nonlymphoid
cell
could
result
toxin
drug
viral
infect
autoimmun
hepatocyt
mhc
class
ii
express
might
becom
target
antigenpres
cell
cell
dog
treat
lowdos
prednisolon
mgkgday
month
significantli
decreas
express
mhc
class
ii
antigen
chronic
hepat
suspect
doberman
pinscher
especi
femal
clinic
biochem
evid
hepat
diseas
definit
diagnosi
requir
liver
biopsi
caus
chronic
hepat
also
consid
sinc
doberman
pinscher
appear
risk
druginduc
hepat
earli
detect
chronic
hepat
provid
best
opportun
treatment
recommend
doberman
pinscher
older
year
age
screen
alt
activ
persist
increas
alt
activ
suggest
evalu
includ
liver
biopsi
warrant
magnitud
increas
alt
activ
differ
subclin
clinic
affect
dog
hyperbilirubinemia
suggest
advanc
diseas
effect
treatment
doberman
pinscher
chronic
hepat
establish
howev
preliminari
studi
show
diagnos
subclin
stage
treatment
penicillamin
mg
total
dose
po
bid
month
lower
hepat
copper
content
improv
hepat
histopatholog
tradit
antiinflammatori
immunosuppress
drug
prednison
without
azathioprin
institut
efficaci
treatment
remain
determin
gener
respons
poor
dog
present
advanc
stage
liver
failur
use
ursodeoxychol
acid
mgkg
po
bid
deserv
special
consider
chronic
cholestat
disord
yet
object
evalu
treatment
copperassoci
hepat
doberman
pinscher
advanc
diseas
usual
unsuccess
dog
die
within
week
month
prognosi
appear
favor
diseas
detect
earli
stage
optim
therapeut
regimen
remain
determin
copper
morpholog
examin
remain
best
option
diagnosi
individu
dog
databas
certif
bedlington
terrier
maintain
web
site
wwwcaninehealthinfoorg
canin
health
inform
center
sponsor
akccanin
health
foundat
orthoped
foundat
anim
affect
bedlington
terrier
asymptomat
copper
dri
weight
less
dri
weight
dietari
copper
restrict
zinc
supplement
bedlington
terrier
copper
accumul
copper
dri
weight
chronic
hepat
treat
copper
chelat
penicillamin
trientin
earli
diagnosi
treatment
either
zinc
copper
chelat
allow
dog
lead
normal
life
treatment
hemolyt
anemia
may
requir
blood
transfus
trientin
dihydrochlorid
penicillamin
may
effect
chelat
circul
copper
hemolyt
episod
chapter
discuss
copperchel
agent
detail
doberman
pinscher
increas
risk
develop
sever
chronic
hepat
cirrhosi
doberman
hepat
account
death
dutch
popul
doberman
middleag
year
femal
dog
increas
risk
male
also
may
affect
although
hereditari
mechan
suspect
pathogenesi
disord
unclear
copper
accumul
appear
associ
hepat
damag
pathogenesi
differ
bedlington
terrier
disord
immun
mechan
may
also
play
role
mani
doberman
pinscher
diagnos
advanc
stage
hepat
failur
evid
excess
bleed
gingiv
bleed
epistaxi
melena
common
sign
often
predomin
termin
stage
common
physic
examin
find
includ
ascit
jaundic
weight
loss
splenomegali
associ
portal
hypertens
common
laboratori
find
includ
increas
alt
alp
activ
hyperbilirubinemia
hypoalbuminemia
hyperammonemia
coagulopathi
thrombocytopenia
typic
histolog
lesion
includ
portal
inflamm
lymphocyt
plasma
cell
macrophag
piecem
necrosi
bridg
necrosi
bile
duct
prolifer
portal
fibrosi
hepat
copper
concentr
increas
affect
dog
typic
dri
weight
although
valu
high
report
signific
increas
hepat
copper
concentr
breed
remain
controversi
copper
accumul
origin
attribut
secondari
mechan
doberman
pinscher
advanc
diseas
chronic
hepat
cirrhosi
biochem
histolog
evid
cholestasi
howev
evalu
affect
dog
earli
subclin
stage
reveal
copper
accumul
preced
cholestasi
decreas
biliari
excret
radiolabel
copper
document
hepat
distribut
copper
locat
inflamm
vari
stage
diseas
earli
stage
copper
focal
inflamm
centrilobular
disord
progress
copper
accumul
inflamm
pronounc
periport
region
area
bridg
necrosi
although
copper
appear
relat
hepat
inflammatori
reaction
copper
level
typic
less
dri
weight
minimum
amount
copper
believ
caus
hepatocellular
injuri
bedlington
terrier
west
highland
white
terrier
primari
copper
retent
disord
propos
gene
associ
bedlington
copper
toxic
wilson
diseas
human
exclud
milk
thistl
symptomat
therapi
design
lower
hepat
copper
feed
lowcopp
diet
labrador
retriev
hepat
copper
accumul
seven
dog
vari
degre
hepat
effect
decreas
hepat
copper
concentr
sever
inflamm
remain
unchang
addit
treatment
zinc
appear
increas
copperlow
effect
dietari
manag
longterm
surviv
appear
variabl
dog
die
within
month
diagnosi
like
prolong
pt
thrombocytopenia
dalmatian
report
acut
hepat
necrosi
chronic
hepat
cirrhosi
associ
increas
hepat
copper
concentr
cholestasi
promin
biochem
histolog
featur
later
diseas
suggest
hepat
copper
accumul
like
caus
famili
metabol
disord
rather
secondari
alter
hepat
biliari
copper
excret
dog
present
initi
acut
gi
sign
anorexia
vomit
diarrhea
biochem
find
reveal
markedli
increas
alt
activ
lesser
increas
alp
activ
hyperbilirubinemia
hypoalbuminemia
seen
advanc
diseas
glucosuria
absenc
hyperglycemia
proteinuria
identifi
dog
ultrasound
find
usual
unremark
liver
biopsi
reveal
piecem
necrosi
bridg
fibrosi
inflamm
predominantli
lymphocyt
neutrophil
mean
hepat
copper
level
dri
weight
normal
dri
weight
rang
dri
weight
five
nine
dog
copper
exceed
rapid
progress
diseas
characterist
copper
chelat
therapi
may
benefici
diagnos
advanc
liver
diseas
occur
chronic
hepat
cirrhosi
associ
hepat
copper
accumul
dri
weight
genet
relat
skye
terrier
describ
earli
stage
copper
accumul
absent
biopsi
find
indic
hepatocellular
degener
cholestasi
mild
inflamm
chronic
lesion
associ
intracanalicular
cholestasi
chronic
hepat
cirrhosi
skye
terrier
hepat
specul
disord
disturb
bile
secret
subsequ
accumul
copper
american
english
cocker
spaniel
increas
incid
chronic
hepat
cirrhosi
caus
unknown
hepat
copper
accumul
appear
consist
featur
unclear
whether
accumul
antitrypsin
hepatocyt
wellrecogn
caus
cirrhosi
human
import
pathogenesi
male
cocker
spaniel
averag
age
year
increas
risk
despit
chronic
sever
underli
hepat
lesion
affect
dog
short
durat
clinic
ill
usual
less
week
ascit
consist
present
complaint
profound
hypoalbuminemia
mean
gdl
consist
laboratori
find
total
serum
bilirubin
concentr
normal
mildli
increas
support
cholestasi
key
featur
disord
ascit
fluid
analysi
consist
transud
modifi
transud
liver
biopsi
hepat
lesion
consist
chronic
hepat
cirrhosi
treatment
cocker
spaniel
chronic
hepat
consist
gener
support
therapi
complic
liver
failur
corticosteroid
therapi
prior
progress
cirrhosi
may
west
highland
white
terrier
west
highland
white
terrier
increas
risk
develop
chronic
hepat
cirrhosi
male
femal
equal
affect
mode
inherit
famili
copperassoci
disord
establish
decreas
biliari
excret
radiolabel
copper
occur
affect
dog
centrilobular
zone
copper
accumul
occur
first
year
life
rare
exce
dri
weight
contrast
bedlington
terrier
west
highland
white
terrier
continu
accumul
copper
lifetim
fact
copper
content
may
actual
decreas
time
one
report
clinic
normal
west
highland
white
terrier
dog
hepat
copper
level
dri
weight
normal
liver
biopsi
west
highland
white
terrier
chronic
hepat
histolog
lesion
includ
multifoc
hepat
subacut
bridg
necrosi
massiv
necrosi
cirrhosi
relationship
hepat
copper
chronic
hepat
west
highland
white
terrier
unclear
appear
least
two
type
chronic
hepat
dog
copperassoci
hepat
elev
copper
content
multifoc
centrilobular
hepat
copper
concentr
usual
exceed
dri
weight
lesion
chronic
hepat
also
seen
absenc
substanti
copper
accumul
describ
idiopath
chronic
hepat
quantit
copper
analysi
necessari
determin
copper
accumul
signific
dri
weight
contribut
factor
chronic
hepat
cirrhosi
associ
increas
hepat
copper
content
dri
weight
treatment
hepat
copper
accumul
institut
matur
west
highland
white
terrier
chronic
hepat
less
dri
weight
copper
may
requir
chelat
therapi
hepat
copper
accumul
continu
throughout
life
therapeut
option
treatment
idiopath
chronic
hepat
glucocorticoid
consid
dog
labrador
retriev
increas
risk
chronic
hepat
age
present
rang
year
averag
age
year
femal
predisposit
note
two
studi
wherea
anoth
studi
male
femal
equal
affect
affect
dog
increas
hepat
copper
describ
centrilobular
zone
diffus
copper
concentr
exceed
dri
weight
dog
mean
copper
rang
refer
interv
dog
also
elev
iron
level
mean
refer
interv
genet
basi
suspect
base
find
increas
copper
concentr
asymptomat
relat
dog
genet
defect
remain
determin
retrospect
survey
hepat
copper
content
labrador
retriev
two
time
period
reveal
significantli
higher
copper
concentr
recent
period
dog
chronic
hepat
control
dog
differ
age
gender
note
specul
increas
hepat
copper
might
reflect
increas
dietari
copper
bioavail
pet
food
industri
recommend
replac
cupriccupr
oxid
feed
formul
treatment
penicillamin
mgkg
po
appear
effect
decreas
hepat
copper
content
inflamm
howev
dog
appear
respond
immunosuppress
prednison
azathioprin
support
ursodeoxychol
acid
clinic
featur
cirrhosi
dog
includ
ascit
portal
hypertens
hypoalbuminemia
intrahepat
extrahepat
portosystem
shunt
blood
evid
decreas
hepat
function
hypoalbuminemia
increas
sba
coagulopathi
hyperbilirubinemia
find
hepat
ultrasonographi
small
nodular
liver
splenomegali
acquir
psss
suggest
cirrhosi
liver
biopsi
requir
confirm
cirrhosi
essenti
irrevers
treatment
mainli
support
emphas
measur
control
complic
sever
gener
liver
failur
ascit
encephalopathi
gastric
ulcer
coagulopathi
infect
see
complic
liver
diseas
section
clinic
sign
liver
failur
alreadi
present
prognosi
poor
prevent
fibrosi
import
longterm
goal
best
achiev
earli
specif
treatment
direct
probabl
caus
injuri
eg
discontinu
suspect
drug
penicillamin
copperassoci
liver
diseas
antiinflammatori
drug
idiopath
chronic
hepat
surgic
relief
extrahepat
biliari
obstruct
mani
therapeut
agent
use
treatment
liver
diseas
penicillamin
prednison
azathioprin
milk
thistl
ursodeoxychol
acid
zinc
potenti
antifibrot
properti
discuss
detail
chapter
colchicin
microtubul
assembl
inhibitor
increas
collagenas
activ
recommend
treatment
hepat
fibrosi
effect
dog
critic
evalu
recommend
dose
dog
mgkgday
po
report
side
effect
includ
nausea
vomit
diarrhea
bone
marrow
toxic
myoneuropathi
report
human
lobular
dissect
hepat
specif
histolog
form
cirrhosi
seen
neonat
young
adult
dog
suggest
nonspecif
respons
varieti
hepat
insult
age
present
younger
dog
either
acut
chronic
hepat
affect
dog
median
age
month
dog
month
younger
femal
appear
increas
risk
lobular
dissect
hepat
may
occur
isol
dog
group
dog
litter
kennel
standard
poodl
may
increas
risk
clinic
featur
advanc
hepat
failur
portal
hypertens
consist
clinic
find
ascit
liver
enzym
typic
increas
hypoalbuminemia
increas
sba
concentr
common
liver
biopsi
requir
diagnosi
differenti
type
chronic
hepat
cirrhosi
lesion
character
histolog
lobular
hepat
inflammatori
cell
lymphocyt
plasma
cell
macrophag
neutrophil
scatter
throughout
hepat
lobul
rather
concentr
periport
region
band
collagen
reticulin
fiber
dissect
around
singl
small
group
hepatocyt
disrupt
hepat
lobular
architectur
copper
stain
neg
moder
posit
consist
secondari
copper
accumul
specif
treatment
report
gener
measur
manag
chronic
liver
failur
appropri
small
group
dog
lobular
dissect
hepat
mean
surviv
time
approxim
month
significantli
shorter
dog
acut
chronic
hepat
infect
liver
import
caus
hepat
diseas
dog
cat
liver
may
primari
target
infect
eg
infecti
canin
hepat
bacteri
cholang
hepat
abscess
benefici
prognosi
poor
dog
die
within
month
diagnosi
recent
report
describ
seven
american
cocker
spaniel
histolog
featur
resembl
lobular
dissect
hepat
male
femal
equal
affect
contrast
previou
report
hepat
cocker
spaniel
dog
studi
improv
corticosteroid
therapi
english
springer
spaniel
preliminari
report
describ
chronic
hepat
english
springer
spaniel
norway
unit
kingdom
femal
dog
overrepres
copper
appear
play
role
prognosi
appear
poor
dog
die
month
diagnosi
hepat
cirrhosi
endstag
liver
diseas
character
fibrosi
regen
nodul
alter
liver
architectur
intrahepat
microscop
psss
see
figur
hepat
fibrosi
synonym
cirrhosi
cirrhosi
common
dog
less
cat
cirrhosi
result
postnecrot
scar
acut
massiv
necrosi
chronic
hepat
injuri
caus
varieti
insult
infect
eg
leptospirosi
hepatotoxin
eg
copper
phenobarbit
aflatoxin
inflamm
chronic
hepat
hypoxia
common
denomin
hepatocyt
death
lead
repair
fibrosi
nodular
regener
cirrhosi
fulli
develop
histolog
featur
origin
incit
injuri
often
obscur
cirrhot
chang
substanti
hepat
fibrosi
without
cirrhosi
seen
longstand
extrahepat
biliari
obstruct
noninflammatori
fibrosi
congenit
hepat
fibrosi
disord
biliari
system
develop
congenit
portal
vein
hypoplasia
uniqu
form
macronodular
cirrhosi
character
noninflammatori
regen
hyperplast
nodul
diffus
vacuolar
hepatopathi
seen
dog
hepatocutan
syndrom
superfici
necrolyt
dermat
hepat
fibrosi
consid
irrevers
recogn
dynam
process
exist
balanc
synthesi
degrad
better
understand
underli
mechan
may
provid
potenti
therapeut
target
major
fibrogen
cell
liver
activ
hsc
ito
cell
vitamin
astor
cell
normal
present
perisinusoid
space
influenc
fibrogen
stimuli
inflamm
immun
respons
oxid
stress
apoptosi
hypoxia
steatosi
hsc
activ
myofibroblast
produc
collagen
extracellular
matrix
ecm
constitu
cytokin
appear
play
central
role
fibrogenesi
human
dog
perisinusoid
fibrosi
decreas
permeabl
normal
sinusoid
impair
metabol
exchang
hepatocyt
sinusoid
blood
compromis
hepat
function
excess
fibrou
tissu
also
limit
abil
vessel
sinusoid
distend
result
increas
resist
hepat
blood
flow
portal
hypertens
fibrot
septa
becom
vascular
microscop
commun
portal
vein
arteri
arteri
hepat
vein
lead
portosystem
shunt
blood
revers
hepat
fibrosi
improv
liver
function
occur
especi
underli
caus
injuri
treat
remov
exampl
human
medicin
includ
antivir
drug
hepat
b
hepat
c
prednison
autoimmun
hepat
although
fibrosi
potenti
revers
cirrhosi
practic
purpos
accompani
architectur
chang
psss
ocular
complic
occur
approxim
natur
infect
dog
caus
corneal
endotheli
damag
antigenantibodi
complex
ich
suspect
young
unvaccin
dog
evid
alf
ich
must
differenti
diseas
similar
clinic
sign
canin
distemp
parvovir
enter
hepatotox
abnorm
leukogram
common
vari
clinic
stage
infect
viremia
neutropenia
lymphopenia
often
present
neutropenia
also
common
featur
canin
parvoviru
much
preval
diseas
puppi
rebound
lymphocytosi
neutrophilia
occur
recoveri
stage
ich
day
infect
biochem
find
characterist
acut
hepat
necrosi
includ
increas
serum
alt
alp
activ
abnorm
liver
function
test
hyperbilirubinemia
lessconsist
find
hypoglycemia
may
complic
termin
stage
diseas
coagul
paramet
consist
dic
potenti
find
includ
proteinuria
secondari
glomerular
damag
abdomin
fluid
consist
exud
increas
protein
mononuclear
cell
cerebrospin
fluid
clinic
diagnosi
ich
usual
suspect
basi
age
vaccin
histori
clinic
sign
laboratori
find
confirm
liver
biopsi
necropsi
find
addit
diagnost
test
use
less
frequent
includ
serolog
test
viru
isol
direct
immunofluoresc
therapi
alf
caus
ich
primarili
support
care
control
complic
frequent
occur
dic
hypoglycemia
prognosi
dog
ich
depend
sever
hepat
necrosi
incid
seriou
complic
dic
hepat
regener
recoveri
possibl
unless
widespread
coagul
necrosi
destroy
entir
lobul
ich
effect
prevent
vaccin
canin
herpesviru
caus
acut
afebril
rapidli
fatal
diseas
neonat
puppi
week
age
hepat
necrosi
one
manifest
widespread
multiorgan
necrosi
hemorrhag
occur
system
viral
infect
clinic
sign
includ
acut
onset
depress
diarrhea
failur
suckl
cri
abdomin
pain
previous
healthi
puppi
find
includ
petechi
hemorrhag
vesicl
mucou
membran
jaundic
rare
seizur
loss
conscious
may
present
termin
stage
pup
die
within
hour
onset
clinic
sign
typic
gross
patholog
find
includ
focal
area
necrosi
hemorrhag
liver
kidney
lung
seros
surfac
intestin
microscop
area
character
foci
necrosi
occasion
intranuclear
inclus
neonat
infect
oronas
exposur
viru
utero
secret
infect
bitch
litterm
neonat
particularli
suscept
possibl
low
bodi
temperatur
immatur
mechan
temperatur
regul
diagnosi
canin
herpesviru
primarili
base
histori
physic
examin
patholog
find
laboratori
find
inconsist
includ
neutrophilia
neutropenia
increas
serum
alt
activ
treatment
affect
puppi
gener
unsuccess
acut
fulmin
natur
diseas
mainten
bodi
may
one
sever
organ
system
involv
multisystem
diseas
process
felin
infecti
periton
coronaviru
toxoplasmosi
histoplasmosi
see
tabl
infecti
agent
associ
widespread
invas
organ
larg
mononuclear
phagocyt
compon
includ
liver
spleen
lymph
node
bone
marrow
although
clinic
signific
liver
diseas
uncommon
liver
biopsi
diagnost
use
identif
organ
infect
anim
etiolog
infecti
canin
hepat
ich
caus
long
recogn
caus
acut
hepat
necrosi
dog
viru
genet
antigen
distinct
caus
infecti
canin
respiratori
diseas
incid
clinic
diseas
caus
low
effect
vaccin
procedur
neutral
antibodi
also
found
matur
unvaccin
dog
suggest
natur
exposur
viru
widespread
special
tropism
vascular
endotheli
cell
hepatocyt
dog
suffici
immun
neutral
antibodi
develop
clinic
sign
diseas
suscept
dog
titer
develop
widespread
centrilobular
panlobular
hepat
necrosi
often
fatal
distinct
intranuclear
inclus
present
hepatocyt
endothelium
tissu
experiment
dog
intermedi
titer
develop
chronic
hepat
progress
cirrhosi
whether
signific
caus
chronic
hepat
natur
condit
unknown
antigen
demonstr
formalinfix
liver
section
five
dog
variou
natur
occur
hepat
inflammatori
lesion
suggest
may
play
role
spontan
chronic
hepat
attempt
identifi
dog
chronic
hepat
neg
clinic
examin
ich
seen
commonli
unvaccin
dog
younger
year
age
clinic
sign
vari
stage
diseas
dog
peracut
ill
clinic
evid
hepat
diseas
simpli
becom
depress
moribund
die
within
hour
dog
extend
clinic
cours
day
sign
associ
acut
hepat
necrosi
includ
vomit
diarrhea
abdomin
pain
hemorrhag
diathesi
may
occur
virem
phase
manifest
epistaxi
petechi
ecchymot
hemorrhag
skin
excess
bleed
venipunctur
failur
liver
clear
activ
clot
factor
impair
hepat
synthesi
clot
factor
probabl
also
contribut
develop
dic
sign
central
nervou
system
cn
dysfunct
includ
depress
disorient
seizur
coma
attribut
nonsuppur
enceph
common
physic
examin
find
includ
fever
enlarg
tonsil
pharyng
laryng
cervic
lymphadenopathi
subcutan
edema
head
neck
trunk
hepatomegali
abdomin
pain
abdomin
effus
occur
jaundic
rare
develop
dog
surviv
acut
fulmin
stage
ich
uncompl
clinic
cours
last
approxim
day
recoveri
begin
unilater
less
frequent
bilater
corneal
edema
anterior
uveiti
hepat
blue
eye
complic
may
becom
evid
recoveri
period
diagnosi
fip
support
cytolog
histolog
evid
pyogranulomat
inflamm
current
recommend
gold
standard
fip
diagnosi
immunohistochemistri
perform
effus
lesion
contain
infect
macrophag
prognosi
recoveri
poor
etiolog
canin
leptospirosi
caus
leptospira
interrogan
sensu
lato
least
serovar
appear
clinic
signific
dog
serovar
canicola
icterohemorrhagica
includ
vaccin
year
incid
clinic
diseas
serovar
decreas
accordingli
epidemiolog
shift
serovar
caus
clinic
diseas
sinc
occur
increas
report
diseas
associ
serovar
grippotyphosa
pomona
bratislava
suggest
serovar
icterohemorrhagica
pomona
like
associ
hepat
damag
howev
report
unabl
correl
serogroup
specif
clinic
featur
chronic
hepat
associ
serovar
grippotyphosa
serogroup
australi
report
clinic
leptospirosi
cat
rare
although
antibodi
sever
serovar
demonstr
pathophysiolog
acut
renal
failur
common
clinic
diseas
syndrom
dog
leptospirosi
liver
also
target
organ
alf
may
occur
concurr
dog
acut
renal
failur
independ
renal
involv
acut
hepat
involv
liver
enlarg
friabl
yellowbrown
tissu
often
markedli
jaundic
microscop
chang
liver
includ
intrahepat
cholestasi
liver
cell
dissoci
nonspecif
reactiv
hepat
hepat
necrosi
uncommon
histolog
featur
liver
may
show
strike
chang
presum
hepat
dysfunct
caus
toxin
produc
mainli
subcellular
damag
organ
identifi
tissu
warthinstarri
stain
common
clinic
sign
includ
anorexia
depress
vomit
hepatocellular
involv
suggest
jaundic
find
may
includ
arthralgia
myalgia
pu
pd
fever
dehydr
widespread
petechi
ecchymot
hemorrhag
mucou
membran
sclera
skin
caus
thrombocytopenia
dic
termin
stage
includ
sign
cardiovascular
collaps
shock
coma
death
diagnosi
leptospirosi
consid
dog
acut
cholestat
liver
diseas
especi
accompani
acut
renal
failur
hematolog
find
vari
stage
sever
diseas
leukocytosi
left
shift
frequent
earli
stage
leptospiremia
leukopenia
like
thrombocytopenia
also
seen
coagul
paramet
normal
unless
complic
dic
routin
serum
chemistri
urinalysi
find
reflect
involv
liver
kidney
serum
liver
enzym
activ
usual
increas
hepat
involv
magnitud
increas
serum
alp
activ
usual
greater
serum
alt
activ
owe
intrahepat
cholestasi
find
includ
hyperbilirubinemia
bilirubinuria
abnorm
liver
function
test
increas
bun
creatinin
may
result
renal
failur
preren
uremia
urinalysi
often
compat
acut
nephriti
find
proteinuria
increas
temperatur
may
help
intraperiton
infus
ml
hyperimmun
serum
obtain
bitch
previous
infect
litter
may
reduc
mortal
rate
vaccin
herpesviru
infect
routin
perform
low
incid
diseas
canin
acidophil
cell
hepat
encompass
spectrum
hepat
lesion
rang
acut
chronic
hepat
cirrhosi
liver
failur
report
great
britain
caus
transmiss
agent
suspect
viru
distinct
although
specif
viru
never
identifi
diseas
experiment
transmiss
serum
liver
extract
affect
dog
experiment
induc
diseas
acut
hepat
progress
chronic
hepat
absenc
clinic
sign
episod
increas
serum
alt
activ
fever
spike
correspond
histolog
evid
acut
hepat
liver
enlarg
friabl
acut
stage
becom
progress
smaller
nodular
chronic
notabl
histolog
featur
regardless
stage
diseas
acidophil
cell
acidophil
cell
die
hepatocyt
angular
shape
reduc
volum
hyperchromat
nucleu
strongli
acidophil
cytoplasm
caus
small
acidophil
coalesc
granul
endstag
hepat
diseas
accompani
typic
find
cirrhosi
dog
spontan
diseas
present
sign
chronic
hepat
failur
durat
clinic
sign
exceed
year
base
experiment
studi
specul
earli
mild
stage
may
go
unrecogn
advanc
hepat
diseas
failur
present
biochem
find
consist
hepat
inflamm
necrosi
evidenc
increas
serum
alt
activ
advanc
diseas
sever
hepat
dysfunct
note
diagnosi
requir
liver
biopsi
recommend
specif
therapi
acidophil
cell
hepat
await
inform
caus
agent
support
measur
institut
need
felin
infecti
periton
fip
highli
fatal
coronavir
infect
domest
wild
cat
liver
one
mani
organ
kidney
spleen
pancrea
mesenter
lymph
node
cn
uveal
tract
omentum
seros
surfac
affect
widespread
immun
complex
vascul
granulomat
pyogranulomat
inflamm
see
tabl
clinic
find
cat
hepat
involv
nonspecif
includ
lethargi
depress
anorexia
dehydr
weight
loss
fever
jaundic
common
find
extrahepat
find
includ
nodular
renomegali
abdomin
mass
lymph
node
ascit
dyspnea
pleural
effus
ophthalmoscop
examin
may
detect
chorioretin
anterior
uveiti
must
differenti
similar
ocular
chang
seen
system
disord
involv
liver
lymphosarcoma
toxoplasmosi
system
mycos
serum
hepat
enzym
alp
alt
activ
usual
normal
mildli
increas
mild
moder
increas
serum
bilirubin
concentr
common
find
indic
hepat
dysfunct
includ
bilirubinuria
increas
sba
concentr
hyperglobulinemia
neutrophilia
mild
moder
nonregen
anemia
laboratori
featur
fip
abdomin
pleural
effus
present
usual
pyogranulomat
exud
greater
gdl
protein
serolog
detect
high
coronavir
antibodi
titer
may
support
diagnosi
fip
definit
lack
specif
serum
bile
acid
concentr
markedli
increas
extrahepat
bacteri
infectioninduc
hepat
damag
consid
evid
cholestat
hepatopathi
found
concurr
extens
bacteri
infect
organ
system
eg
pyometra
periton
extrahepat
disord
like
associ
endotoxemia
eg
parvovir
enter
associ
clinic
find
would
compat
endotoxem
crisi
includ
shock
fever
hypothermia
hypoglycemia
neutrophilia
neutropenia
left
shift
toxic
chang
neutrophil
hyperbilirubinemia
disproportion
increas
comparison
serum
alp
activ
import
recogn
jaundic
occur
secondari
extrahepat
infect
diagnost
standpoint
clinician
misl
consid
caus
primari
hepat
biliari
diseas
jaundic
patient
evid
inflammatori
process
key
differenti
diagnos
includ
acut
pancreat
extrahepat
bacteri
infect
primari
hepatobiliari
disord
leptospirosi
dog
cholangiohepat
cholecyst
ruptur
gallbladd
mucocel
hepat
abscess
specif
therapi
hepat
diseas
usual
requir
hepat
damag
revers
control
sepsi
morbid
relat
underli
diseas
process
overt
hepat
failur
etiolog
hepatotox
caus
varieti
drug
prescript
overthecount
herbal
dietari
supplement
biolog
toxin
chemic
see
box
liver
uniqu
suscept
xenobiot
substanc
directli
expos
follow
absorpt
gi
tract
liver
also
vulner
toxic
injuri
play
central
role
metabol
mani
substanc
hepat
metabol
render
lipophil
substanc
hydrophil
promot
excret
via
urin
bile
process
control
phase
phase
ii
reaction
phase
reaction
catalyz
cytochrom
enzym
system
activ
detoxifi
oxid
reduc
hydrolyz
drug
toxin
phase
reaction
may
lead
gener
unstabl
chemic
reactiv
intermedi
toxic
phase
ii
reaction
conjug
drug
metabolit
produc
product
nontox
biotransform
liver
either
reduc
enhanc
toxic
parent
compound
exampl
carbon
tetrachlorid
ingest
liver
convert
nontox
parent
compound
toxic
metabolit
subsequ
caus
sever
hepatocellular
damag
genet
polymorph
phase
ii
enzym
potenti
influenc
drug
metabol
individu
anim
increas
awar
recognit
druginduc
liver
injuri
signific
caus
liver
diseas
dog
cat
see
box
inform
gain
isol
case
report
retrospect
clinic
studi
experiment
studi
unfortun
mani
drug
reaction
character
clinic
patholog
featur
lack
small
number
affect
anim
describ
liver
biopsi
typic
obtain
drug
withdraw
result
clinic
biochem
improv
possibl
druginduc
liver
injuri
underrecogn
dog
cat
human
druginduc
hepat
injuri
account
case
alf
unit
state
frequent
reason
cite
withdraw
approv
drug
market
leukocyt
erythrocyt
granular
cast
increas
serum
creatin
kinas
activ
may
indic
leptospiralinduc
muscl
damag
leptospirosi
easili
diagnos
clinic
set
demonstr
fourfold
rise
serum
antibodi
titer
microscop
agglutin
test
pair
sampl
taken
initi
present
week
later
rise
titer
indic
recent
activ
infect
differenti
titer
previou
exposur
previou
vaccin
optimum
treatment
regimen
leptospirosi
unknown
tradit
intraven
ampicillin
mgkg
everi
hour
dose
reduct
dog
renal
failur
penicillin
g
unitskg
iv
use
initi
treatment
leptospirosi
doxycyclin
mgkg
po
week
recommend
followup
therapi
elimin
organ
renal
tubul
howev
doxycyclin
mgkg
oral
intraven
everi
hour
week
appear
effect
clear
phase
leptospir
infect
may
effect
treatment
strategi
manag
fluid
electrolyt
acidbas
imbal
import
support
therapi
prognosi
gener
depend
degre
renal
dysfunct
poor
oliguria
develop
c
piliform
formerli
known
bacillu
piliformi
sporeform
gramneg
bacteria
rare
caus
multifoc
hepat
necrosi
necrot
ileiti
dog
cat
infect
mainli
opportunist
stress
immunocompromis
anim
predispos
disord
eg
canin
distemp
felin
panleukopenia
felin
leukemia
famili
hyperlipoproteinemia
kitten
clinic
sign
includ
acut
onset
anorexia
lethargi
depress
abdomin
discomfort
jaundic
may
observ
especi
cat
sign
rapidli
progress
moribund
state
death
occur
within
hour
mark
increas
alt
activ
may
detect
histopatholog
reveal
multifoc
periport
hepat
necrosi
necrot
ileiti
coliti
bacilli
best
seen
special
stain
techniqu
warthinstarri
giemsa
methylen
bluestain
impress
smear
fresh
tissu
organ
appear
larg
slender
intracellular
filament
organ
within
hepatocyt
surround
area
necrosi
intestin
epitheli
cell
routin
cultur
techniqu
ineffect
isol
organ
diseas
rapidli
fatal
success
therapi
report
extrahepat
bacteri
infect
associ
sepsi
endotoxemia
import
caus
acut
function
cholestat
hepatopathi
howev
morbid
gener
relat
underli
infect
overt
hepat
failur
studi
human
experiment
dog
suggest
endotoxemia
subsequ
releas
cytokin
induc
function
chang
interrupt
transport
excret
conjug
bilirubin
microscop
hepat
lesion
often
mild
nonspecif
intrahepat
cholestasi
character
bile
canalicular
plug
bile
pigment
accumul
hepatocyt
consist
find
mild
periport
lymphocyt
infiltr
seen
scatter
foci
macrophag
neutrophil
occasion
individu
necrot
hepatocyt
total
serum
bilirubin
concentr
high
mgdl
seen
disproportion
high
compar
mild
moder
increas
serum
alp
activ
increas
serum
alt
activ
less
consist
find
hepat
injuri
caus
drug
herbal
dietari
supplement
biolog
toxin
chemic
occur
via
number
mechan
influenc
histolog
pattern
diseas
although
hepat
necrosi
common
histolog
respons
drugand
toxininduc
liver
injuri
also
potenti
mimic
full
spectrum
acquir
hepat
disord
includ
acut
chronic
hepat
granulomat
hepat
cholestat
hepatopathi
vacuolar
hepatopathi
lipid
glycogen
accumul
hepat
fibrosi
cirrhosi
venoocclus
diseas
hepat
necrosi
occur
coval
bind
drug
toxin
intracellular
protein
disrupt
cellular
function
format
drugenzym
adduct
stimul
immunolog
respons
antibodyor
tcellmedi
cytotox
hepat
inflamm
typic
lymphoplasmacyt
may
granulomat
eosinophil
suggest
underli
immunoallerg
mechan
intrahepat
cholestasi
occur
drug
toxin
interfer
hepat
transport
protein
canalicular
membran
interrupt
bile
flow
hepat
lipid
accumul
result
direct
damag
mitochondria
disrupt
fatti
acid
oxid
energi
product
predomin
hepat
lesion
seen
stanozolol
hepatotox
cat
tetracyclin
dog
cat
hepat
vacuol
caus
glycogen
accumul
occur
dog
treat
corticosteroid
typic
caus
signific
clinic
evid
hepat
dysfunct
damag
sinusoid
epithelium
result
peliosi
hepat
venoocclus
diseas
mechan
druginduc
liver
injuri
also
injuri
herbal
dietari
supplement
character
either
intrins
predict
idiosyncrat
unpredict
reaction
intrins
hepatotox
reaction
doserel
occur
shortli
consist
threshold
toxic
reach
intrins
hepatotoxin
predict
damag
liver
expos
popul
experiment
reproduc
studi
hepat
injuri
caus
direct
toxic
effect
parent
compound
reliabl
gener
toxic
metabolit
vital
cell
target
acetaminophen
intrins
hepatotoxin
dog
cat
discuss
detail
later
section
intrins
hepatotoxin
lower
dose
rather
stop
drug
tri
mani
case
drug
chemic
eg
carbon
tetrachlorid
phosphoru
chloroform
longer
use
therapeut
purpos
intrins
hepatotox
recogn
accident
exposur
could
still
occur
contrast
idiosyncrat
hepatotox
reaction
occur
therapeut
dose
small
number
individu
expos
popul
reaction
unpredict
infrequ
individu
treat
drug
reaction
even
high
dose
howev
toxic
may
pronounc
higher
dose
suscept
individu
exampl
drug
caus
idiosyncrat
druginduc
liver
injuri
dog
cat
doserel
effect
phenobarbit
itraconazol
amiodaron
lomustin
ccnu
idiosyncrat
reaction
character
variabl
latenc
period
day
may
longer
drug
phenobarbit
ccnu
amiodaron
initi
drug
ingest
recognit
hepat
injuri
infrequ
occurr
approxim
potenti
hepatotox
may
recogn
preclin
screen
new
drug
usual
reproduc
experiment
set
individu
differ
suscept
idiosyncrat
druginduc
liver
injuri
may
reflect
genet
differ
either
altern
metabol
pathway
drug
convert
differ
potenti
hepatotox
metabolit
b
abil
individu
detoxifi
toxic
intermedi
c
underli
center
veterinari
medicin
food
drug
administr
washington
dc
maintain
registri
http
wwwfdagov
animalveterinarydefaulthtm
report
advers
drug
reaction
anim
servic
use
accumul
data
alert
veterinarian
suspect
drug
effect
includ
hepatotox
howev
report
advers
drug
reaction
voluntari
inform
obtain
may
incomplet
subject
trend
identifi
furthermor
mild
hepat
injuri
may
associ
clinic
sign
case
detect
unless
biochem
test
perform
anim
receiv
drug
evalu
incid
druginduc
liver
injuri
dog
cat
cloud
fact
pathognomon
clinic
laboratori
biopsi
find
distinguish
druginduc
liver
injuri
caus
liver
diseas
specif
drug
report
caus
druginduc
liver
injuri
list
box
herbal
dietari
supplement
herb
botan
nutraceut
vitamin
miner
potenti
caus
hepatotox
similar
druginduc
injuri
human
herbal
dietari
supplement
report
account
patient
druginduc
liver
injuri
incid
hepatotox
may
underrecogn
third
human
take
herbal
dietari
supplement
report
use
product
health
care
provid
causal
difficult
prove
herbal
dietari
supplement
often
dispens
without
medic
supervis
fda
oversight
product
qualiti
minim
multipl
activ
ingredi
contribut
product
variabl
product
contamin
hepatotox
substanc
toxic
herb
heavi
metal
may
occur
drug
interact
herbal
dietari
supplement
prescript
medic
may
also
occur
medicin
plant
effect
hepat
enzym
system
rate
dietari
supplement
use
dog
cat
appear
lower
report
human
howev
product
often
market
natur
pet
owner
may
assum
safe
underreport
use
veterinarian
report
herbal
dietari
supplement
hepat
injuri
anim
rare
pennyroy
oil
volatil
oil
deriv
plant
labiata
famili
pennyroy
squaw
mint
mosquito
plant
associ
fatal
acut
hepat
necrosi
dog
topic
applic
use
flea
repel
clinic
sign
occur
within
hour
applic
includ
vomit
diarrhea
hemorrhag
seizur
death
report
includ
find
increas
liver
enzym
activ
dog
consum
st
john
wort
increas
alt
activ
hypoglycemia
accident
ingest
high
dose
acid
two
dog
pauciti
report
hepat
reaction
necessarili
mean
herbal
dietari
supplement
safe
clinician
maintain
high
level
suspicion
regard
potenti
toxic
box
list
herbal
dietari
supplement
incrimin
caus
hepat
injuri
human
potenti
relev
dog
cat
detail
inform
hepat
injuri
herbal
dietari
supplement
addit
sourc
consult
hepat
injuri
may
also
occur
exposur
wide
varieti
industri
chemic
organ
solvent
pesticid
heavi
metal
biolog
toxin
inform
chemic
hepatotoxin
deriv
experiment
studi
dog
extrapol
inform
speci
clinic
case
report
avail
veterinari
literatur
isol
report
case
seri
clinic
liver
diseas
dog
associ
exposur
biolog
toxin
aflatoxin
amanita
mushroom
bluegreen
alga
cycad
sago
palm
publish
select
hepatotoxin
list
box
increas
liver
enzym
activ
common
find
hepatotox
increas
alt
activ
three
time
upper
limit
normal
high
time
upper
limit
suggest
hepatocellular
injuri
often
necrosi
concern
isol
increas
alp
activ
reflect
cholestasi
although
mix
pattern
commonli
occur
progress
increas
alt
activ
accompani
evid
hepat
dysfunct
hyperbilirubinemia
increas
serum
bile
acid
coagulopathi
hypoglycemia
hyperammonemia
hypoalbuminemia
like
repres
seriou
hepat
injuri
druginduc
liver
injuri
suspect
diagnost
approach
determin
clinic
present
clinic
sign
absent
mild
minimum
databas
consist
complet
histori
physic
examin
complet
blood
cell
count
serum
chemistri
urinalysi
perform
abnorm
detect
increas
liver
enzym
activ
increas
correspond
recent
administr
drug
especi
list
box
drug
discontinu
serum
biochemistri
repeat
day
mani
instanc
clinic
biochem
abnorm
resolv
suspect
hepatotox
drug
discontinu
liver
biopsi
perform
evalu
liver
includ
sba
concentr
abdomin
radiograph
ultrasonographi
liver
biopsi
may
warrant
biochem
abnorm
persist
initi
clinic
biochem
find
suggest
hepat
dysfunct
suspect
drugor
toxininduc
liver
diseas
liver
biopsi
help
character
histolog
chang
consist
previous
describ
lesion
caus
particular
drug
toxin
b
determin
sever
focal
diffus
necrosi
revers
cirrhosi
present
lesion
prognost
purpos
c
rule
known
caus
liver
diseas
histolog
chang
secondari
drugand
toxininduc
hepat
injuri
nonspecif
similar
seen
nondrugrel
caus
acut
chronic
liver
diseas
common
pathophysiolog
respons
necrosi
without
inflamm
hepat
necrosi
may
centrilobular
zone
panlobular
figur
centrilobular
hepatocyt
abund
enzym
preferenti
affect
druginduc
hepatotox
metabol
parent
drug
result
toxic
metabolit
drug
toxin
also
caus
varieti
hepat
lesion
cholestasi
lipidosi
mild
inflamm
chronic
respons
injuri
reflect
find
biliari
immunolog
allerg
reaction
individu
toler
abil
adapt
hepatocellular
injuri
mechan
unknown
resolut
injuri
despit
continu
medic
administr
oral
medic
substanti
hepat
metabol
like
associ
advers
hepat
event
human
presum
hepat
gener
reactiv
toxic
metabolit
unpredict
idiosyncrat
reaction
low
incid
occurr
causeandeffect
relationship
difficult
establish
idiosyncrat
reaction
occur
drug
must
discontinu
could
result
death
patient
idiosyncrat
mechan
suspect
drug
caus
hepat
injuri
dog
cat
suscept
hepatotox
human
influenc
number
factor
age
sex
nutrit
statu
concurr
drug
import
factor
may
effect
genet
polymorph
hepat
drug
metabol
human
preexist
liver
diseas
appear
enhanc
suscept
druginduc
liver
injuri
impact
patient
abil
recov
may
drugmetabol
enzym
system
remark
preserv
hepat
diseas
similar
inform
risk
factor
hepatotox
dog
cat
determin
howev
mani
toxic
metabolit
normal
detoxifi
glutathion
metabolit
may
becom
toxic
hepat
glutathion
store
deplet
eg
anim
preexist
chronic
necroinflammatori
cholestat
liver
diseas
breed
predisposit
suggest
doberman
pinscher
sulfonamid
amiodaron
diethylcarbamazineoxibendazol
labrador
retriev
carprofen
may
reflect
genet
predisposit
clinic
examin
spectrum
drugand
toxininduc
liver
injuri
thu
associ
clinic
present
vari
subclin
hepat
injuri
increas
serum
liver
enzym
activ
sever
liver
damag
manifest
alf
chronic
endstag
liver
diseas
acut
rather
chronic
liver
injuri
like
drug
toxin
list
box
clinic
featur
often
includ
acut
onset
lethargi
anorexia
vomit
diarrhea
pu
pd
jaundic
previous
healthi
anim
correspond
hepatotoxin
exposur
alf
sign
acut
liver
diseas
plu
coagulopathi
like
drug
toxin
caus
diffus
hepat
necrosi
drugand
toxininduc
injuri
import
diagnost
consider
dog
cat
present
acut
hepat
hepat
necrosi
drug
toxin
also
potenti
caus
chronic
hepat
diseas
initi
hepat
injuri
mild
goe
unrecogn
exposur
drug
toxin
continu
exampl
phenobarbit
ccnu
chronic
aflatoxicosi
caus
chronic
liver
injuri
dog
diagnosi
pathognomon
clinic
laboratori
biopsi
find
distinguish
drugor
toxininduc
liver
injuri
caus
liver
diseas
diagnosi
druginduc
liver
injuri
often
reli
clinician
maintain
high
level
suspicion
obtain
accur
thorough
medic
histori
includ
prescript
overthecount
drug
herbal
dietari
supplement
everi
anim
unexplain
increas
liver
enzym
activ
clinic
liver
diseas
definit
diagnosi
hepat
injuri
caus
biolog
toxin
chemic
rare
possibl
clinic
set
unless
owner
specif
observ
ingest
substanc
known
hepatotoxin
prevent
treatment
druginduc
hepat
diseas
consist
discontinu
suspect
drug
drug
discontinu
clinic
biochem
improv
usual
occur
within
week
even
chronic
drug
administr
howev
except
occur
exampl
dog
amiodaron
toxic
liver
enzym
elev
transient
progress
despit
discontinu
drug
biochem
abnorm
may
resolv
week
except
nac
acetaminophen
silymarin
amanita
mushroom
toxic
specif
antidot
avail
treatment
drugand
toxininduc
liver
injuri
primarili
support
symptomat
howev
nonspecif
hepatoprotect
therapi
antioxid
vitamin
e
glutathion
replac
nac
milk
thistl
silymarin
may
help
discuss
detail
chapter
use
nac
may
benefici
glutathion
deplet
may
predispos
hepatotox
eg
methimazol
impair
metabol
toxic
metabolit
nontox
form
nac
suggest
benefici
treatment
alf
associ
toxic
diazepam
methimazol
carprofen
trimethoprimsulfa
addit
treat
amanita
mushroom
hepatotox
silymarin
may
benefici
treatment
carbon
tetrachlorid
acetaminophen
toxic
corticosteroid
typic
indic
treatment
drugand
toxininduc
hepatotox
import
consid
druginduc
caus
liver
injuri
rapid
recognit
prompt
discontinu
hepatotox
drug
lead
improv
complet
resolut
hepat
diseas
depend
specif
drug
stage
lesion
drugor
toxininduc
hepat
injuri
caus
sever
widespread
hepat
necrosi
rapid
deterior
death
day
often
occur
lesssever
hepat
injuri
complet
recoveri
possibl
acetaminophen
acetaminophen
well
known
intrins
hepatotoxin
dog
cat
although
acetaminophen
occasion
use
analges
dog
therapeut
dose
mgkg
tid
toxic
occur
accident
ingest
improperli
store
medic
dog
owner
administr
without
veterinari
supervis
dog
cat
toxic
metabolit
acetaminophen
caus
oxid
injuri
erythrocyt
hepatocyt
result
methemoglobinemia
anemia
hepat
necrosi
therapeut
dose
acetaminophen
detoxifi
combin
hepat
glucuronid
sulfat
renal
excret
acetaminophen
overdosag
pathway
becom
satur
greater
proport
acetaminophen
metabol
system
lead
product
toxic
metabolit
nacetylpbenzoquinoneimin
napqi
glutathion
detoxifi
napqi
thu
protect
hepat
cellular
constitu
direct
toxic
effect
howev
glutathion
level
deplet
larg
amount
napqi
centrilobular
necrosi
occur
toxic
occur
dosedepend
manner
substanti
speci
differ
metabol
acetaminophen
toxic
manifest
cat
uniqu
sensit
acetaminophen
defici
glucuronyl
transferas
limit
sulfat
capabl
clinic
sign
cat
may
develop
administr
littl
mg
tablet
sign
methemoglobinemia
usual
domin
clinic
pictur
cyanosi
dyspnea
facial
edema
depress
hypothermia
hyperplasia
fibrosi
cirrhosi
although
individu
drug
drug
class
may
follow
pattern
often
consist
reaction
given
drug
exampl
hepat
injuri
dog
secondari
potenti
sulfonamid
may
caus
hepat
necrosi
primari
cholestasi
mark
inflamm
mani
potenti
hepatotox
drug
list
box
histolog
featur
fulli
character
emphas
druginduc
disord
diagnosi
presumpt
prove
especi
difficult
pinpoint
caus
agent
patient
receiv
combin
drug
clinic
diagnosi
druginduc
hepat
injuri
easier
establish
hepatotox
drug
previous
describ
associ
clinic
patholog
featur
character
see
discuss
specif
drug
diagnosi
may
less
convinc
suspect
drug
previous
incrimin
caus
liver
damag
howev
drug
reaction
still
consid
sinc
idiosyncrat
reaction
could
occur
drug
clinician
also
maintain
level
suspicion
regard
potenti
hepatotox
newli
market
drug
yet
use
wide
popul
idiosyncrat
reaction
often
first
detect
suspect
hepatotox
drug
discontinu
complet
diagnost
evalu
pursu
caus
liver
diseas
specif
treatment
might
avail
diagnosi
druginduc
injuri
support
follow
evid
liver
injuri
occur
within
first
month
drug
therapi
especi
predrug
liver
enzym
activ
within
normal
limit
b
clinic
biochem
improv
drug
discontinu
c
exclus
caus
liver
diseas
reccurr
hepat
damag
challeng
dose
drug
inadvert
reexposur
emphas
rechalleng
suspect
hepatotox
drug
recommend
diagnost
consider
potenti
danger
especi
drug
caus
acut
hepat
necrosi
rechalleng
consid
associ
drug
hepat
injuri
highli
question
altern
drug
avail
signific
medic
condit
hypersensit
immunolog
reaction
hepat
reaction
rapid
sever
repeat
exposur
hepat
injuri
biolog
toxin
chemic
suspect
exposur
potenti
hepatotoxin
document
clinic
diagnosi
toxic
hepat
injuri
often
made
episod
acut
hepat
injuri
occur
hepat
biopsi
indic
diffus
hepat
degener
necrosi
caus
liver
diseas
identifi
select
case
tissu
blood
food
aflatoxin
sampl
submit
toxicolog
lab
confirm
suspect
toxin
toxininduc
injuri
also
consid
absenc
known
exposur
toxin
potenti
hepatotoxin
present
contamin
dog
food
garbag
aflatoxin
pond
water
bluegreen
alga
mani
unobserv
sourc
ingest
potenti
hepatotoxin
eg
toxic
mushroom
sago
palm
occur
within
preced
hour
gener
procedur
gi
decontamin
recommend
includ
induct
emesi
gastric
lavag
within
first
hour
follow
administr
activ
charcoal
gkg
induct
vomit
contraind
patient
comatos
debilit
way
gag
reflex
diminish
could
predispos
aspir
pneumonia
whenev
possibl
sourc
toxin
exposur
identifi
exposur
given
alternateday
therapi
care
monitor
liver
paramet
everi
week
hepatotox
appear
least
partli
dose
relat
dog
receiv
higher
daili
dose
itraconazol
mgkg
like
affect
icteru
evid
hepat
dysfunct
suggest
seriou
potenti
fatal
hepatopathi
requir
discontinu
medic
symptomat
support
care
recommend
liver
enzym
monitor
monthli
basi
anim
receiv
ketoconazol
itraconazol
azathioprin
purin
analogu
commonli
use
treatment
immunemedi
disord
dog
commonli
list
potenti
hepatotoxin
howev
clinic
detail
regard
hepatotox
reaction
avail
clinic
studi
dog
atop
dermat
treat
azathioprin
mgkg
daili
week
singl
agent
increas
alt
alp
activ
note
first
week
dog
three
dog
clinic
sign
suggest
liver
diseas
resolv
unev
azathioprin
discontinu
experiment
studi
dog
given
azathioprin
dose
mgkg
po
daili
day
dog
increas
liver
enzym
activ
alt
alp
within
day
initi
therapi
valu
peak
within
first
week
declin
normal
despit
continu
medic
administr
hyperbilirubinemia
absent
liver
biopsi
dog
reveal
centrilobular
degener
necrosi
intrahepat
cholestasi
inflamm
find
rais
possibl
azathioprin
may
intrins
dose
relat
hepatotoxin
dog
possibl
adapt
toler
liver
injuri
note
dose
use
studi
exceed
current
clinic
recommend
mgkg
daili
everi
day
mainten
therapi
hepatotox
consid
class
characterist
nsaid
despit
fact
mani
differ
chemic
class
nsaid
consist
mechan
liver
injuri
except
aspirin
intrins
doserel
hepatotoxin
mechan
nsaid
believ
idiosyncrat
either
immun
consequ
toxic
metabolit
toxic
appear
relat
prostaglandin
inhibit
like
renal
gi
side
effect
preexist
hepat
diseas
shown
risk
factor
nsaidinduc
liver
injuri
nsaid
potenti
caus
idiosyncrat
hepatotox
dog
hepat
reaction
appear
rare
carprofen
specif
report
caus
druginduc
liver
injuri
dog
labrador
retriev
overrepres
seri
clear
whether
true
breed
predisposit
clinic
sign
anorexia
lethargi
vomit
pupd
occur
within
first
week
therapi
icteru
common
find
physic
examin
biochem
evalu
reveal
mark
increas
liver
enzym
alt
activ
usual
exceed
alp
activ
hyperbilirubinemia
hepat
biopsi
find
reveal
multifoc
diffus
hepat
necrosi
mild
moder
lymphocyticplasmacyt
inflamm
secondari
cholestasi
variabl
biliari
hyperplasia
bridg
fibrosi
concurr
renal
toxic
glucosuria
without
hyperglycemia
proteinuria
granular
cast
also
note
dog
dog
recov
discontinu
carprofen
appropri
support
care
although
dog
die
alf
gener
hepatoprotect
therapi
silybin
recommend
although
benefit
unproven
nac
suggest
ancillari
treatment
carprofen
caus
alf
vomit
although
increas
serum
alt
activ
may
detect
centrilobular
hepat
necrosi
appear
uncommon
clinic
sign
dog
like
dose
exceed
mgkg
indic
methemoglobinemia
andor
centrilobular
necrosi
laboratori
featur
includ
methemoglobinemia
anemia
increas
serum
alt
activ
hyperbilirubinemia
intraven
nac
treatment
choic
acetaminophen
toxic
dog
cat
nac
increas
synthesi
avail
glutathion
conjug
napqi
decreas
toxic
maximum
effect
nac
given
within
hour
acetaminophen
exposur
howev
may
still
benefit
given
hour
exposur
nac
solut
dilut
salin
given
intraven
nonpyrogen
filter
initi
dose
mgkg
period
mainten
dose
mgkg
given
iv
oral
everi
hour
seven
treatment
also
serv
glutathion
sourc
shown
protect
effect
acetaminopheninduc
oxid
stress
erythrocyt
cat
dog
experiment
studi
cat
silymarin
mgkg
po
effect
nac
treatment
acetaminophen
toxic
given
hour
exposur
vitamin
c
mgkg
iv
may
help
treatment
acetaminophen
toxic
antioxid
effect
cimetidin
mgkg
iv
also
recommend
adjunct
therapi
earli
stage
first
hour
inhibit
hepat
enzym
decreas
napqi
format
antiarrhythm
drug
amiodaron
associ
revers
hepatotox
dog
doberman
pinscher
may
increas
risk
toxic
appear
least
partial
dose
relat
dose
mgday
identifi
doberman
pinscher
treat
amiodaron
one
clinic
seri
clinic
sign
anorexia
lethargi
vomit
diarrhea
biochem
abnorm
increas
alt
alp
activ
hyperbilirubinemia
develop
day
month
initi
therapi
liver
biopsi
one
dog
reveal
multifoc
hepatocellular
necrosi
mild
lipidosi
lymphoplasmacyt
inflamm
clinic
improv
usual
occur
within
day
stop
drug
liver
enzym
elev
may
return
normal
month
transient
progress
enzym
abnorm
despit
discontinu
drug
also
note
may
reflect
long
halflif
amiodaron
caus
delay
system
elimin
biochem
chang
preced
clinic
sign
monitor
liver
enzym
least
monthli
recommend
azol
antifung
drug
ketoconazol
itraconazol
rare
fluconazol
associ
increas
liver
enzym
activ
icteru
dog
cat
hepatotox
like
ketoconazol
itraconazol
cat
sensit
hepatotox
effect
dog
consider
individu
variat
occur
histolog
find
poorli
character
includ
bile
duct
prolifer
infiltr
mononuclear
cell
transient
mild
subclin
elev
liver
enzym
alt
alp
activ
common
necessarili
requir
chang
therapi
clinic
signific
hepat
reaction
suggest
alt
activ
exce
two
three
time
upper
limit
normal
especi
accompani
clinic
sign
anorexia
vomit
drug
therapi
stop
week
appetit
liver
enzym
return
normal
rapid
recoveri
usual
occur
treatment
restart
lower
dose
previou
dose
decreas
appetit
weight
loss
pupd
vomit
ascit
pleural
effus
ascit
due
combin
hypoalbuminemia
portal
hypertens
common
biochem
abnorm
includ
increas
liver
enzym
activ
alt
ast
alp
ggt
hypoalbuminemia
lessconsist
find
includ
hyperbilirubinemia
hypercholesterolemia
increas
serum
bile
acid
concentr
glucosuria
without
hyperglycemia
renal
failur
note
dog
possibl
attribut
ccnu
renal
toxic
liver
biopsi
find
nonspecif
hemosiderinladen
kupffer
cell
hepatocellular
vacuol
mild
moder
periport
inflamm
fibrosi
suggest
chronic
major
affect
dog
die
progress
chronic
liver
diseas
recent
studi
routin
monitor
alt
activ
prior
subsequ
dose
ccnu
suggest
subclin
elev
alt
activ
greater
five
time
upper
limit
normal
common
thirtytwo
dog
increas
alt
activ
develop
commonli
one
three
dose
ccnu
increas
alt
activ
associ
cumul
dose
lower
incid
clinic
hepatotox
studi
versu
kristal
studi
attribut
prompt
cessat
ccnu
treatment
dog
signific
increas
alt
activ
howev
note
chronic
administr
ccnu
could
associ
chronic
irrevers
hepatopathi
absenc
signific
alt
elev
mechan
hepatotox
suspect
result
gener
toxic
intermedi
metabolit
eg
isocyan
diazonium
hydroxid
deplet
glutathion
may
play
role
preliminari
result
clinic
studi
use
denamarin
sylibin
nutramax
lab
lancast
sc
prevent
ccnu
hepatotox
suggest
dog
receiv
denamarin
lesssever
liver
enzym
elev
methimazol
antithyroid
drug
associ
hepat
injuri
cat
hyperthyroid
clinic
find
includ
anorexia
vomit
lethargi
jaundic
markedli
increas
serum
liver
enzym
activ
hyperbilirubinemia
usual
occur
within
first
month
therapi
histolog
lesion
fulli
character
although
biopsi
find
one
cat
reveal
hepat
degener
necrosi
clinic
sign
resolv
within
week
discontinu
therapi
biochem
resolut
may
take
day
reduc
hepat
glutathion
concentr
document
speci
hyperthyroid
may
predispos
hepat
injuri
treatment
may
benefici
phenobarbit
associ
chronic
hepat
diseas
cirrhosi
dog
dog
treat
phenobarbit
year
liver
diseas
appar
mechan
hepat
injuri
known
higher
dose
higher
blood
level
long
durat
appear
import
risk
factor
clinic
sign
dog
reflect
chronic
liver
diseas
includ
sedat
ataxia
anorexia
weight
loss
weak
ascit
jaundic
coagulopathi
encephalopathi
phenobarbitalinduc
hepat
injuri
suspect
dog
histori
chronic
phenobarbit
therapi
clinic
biochem
evid
hepat
dysfunct
routin
biochem
screen
everi
month
dog
longterm
phenobarbit
therapi
recommend
earli
detect
hepat
injuri
howev
mild
liver
enzym
elev
especi
alp
commonli
seen
dog
treat
phenobarbit
clinic
histolog
evid
signific
liver
earli
recognit
hepatotox
includ
period
monitor
liver
enzym
first
month
discontinu
drug
therapi
provid
best
opportun
full
recoveri
whether
dog
previou
carprofen
hepatotox
safe
switch
anoth
nsaid
without
experienc
hepat
reaction
unknown
oral
diazepam
incrimin
caus
acut
idiosyncrat
fatal
hepat
necrosi
cat
intraven
diazepam
oral
oxazepam
clonazepam
zolazepam
also
implic
onset
sign
occur
within
day
initi
therapi
clinic
sign
biochem
evalu
consist
acut
hepat
necrosi
liver
failur
cat
die
within
day
initi
administr
drug
treatment
cat
oral
diazepam
unavoid
liver
enzym
check
within
day
start
therapi
liver
enzym
increas
drug
discontinu
symptomat
therapi
start
ancillari
treatment
alf
nac
may
benefici
glucocorticoid
therapi
dog
commonli
associ
increas
serum
alp
activ
develop
revers
vacuolar
steroid
hepatopathi
result
hepat
glycogen
accumul
hepat
effect
seen
virtual
glucocorticoid
prepar
includ
topic
ophthalm
otic
prepar
influenc
drug
prepar
eg
repositol
versu
shortact
dose
durat
therapi
individu
dog
suscept
contrast
cat
quit
resist
hepat
effect
glucocorticoid
rare
develop
hepat
chang
increas
serum
alp
activ
occur
within
day
initi
glucocorticoid
therapi
dog
often
strike
time
normal
glucocorticoid
associ
induct
specif
corticosteroidinduc
isoenzym
alp
may
account
total
alp
activ
contrast
serum
alt
activ
often
normal
mildli
increas
dog
glucocorticoid
caus
signific
hepat
dysfunct
clinic
relev
hepat
diseas
biochem
test
reflect
hepat
function
serum
bilirubin
albumin
glucos
blood
ammonia
concentr
coagul
test
typic
normal
serum
bile
acid
concentr
normal
mildli
increas
mmoll
hepat
glycogen
accumul
caus
hepatomegali
detect
abdomin
radiograph
diffus
multifoc
increas
hepat
echogen
detect
ultrasonographi
hepat
effect
glucocorticoid
revers
drug
withdraw
length
time
requir
complet
resolut
unpredict
vari
week
month
lomustin
ccnu
oral
nitrosourea
alkyl
agent
use
chemotherapi
lymphoma
mast
cell
tumor
histiocyt
sarcoma
brain
tumor
dog
idiosyncrat
doserel
hepatotox
describ
dog
given
oral
dose
ccnu
mgm
dose
interv
week
median
time
detect
hepat
diseas
last
dose
ccnu
week
rang
week
delay
onset
note
invers
relationship
size
dose
length
time
abnorm
serum
alt
detect
cumul
dose
effect
suspect
clinic
find
hepatotox
includ
glutathion
precursor
nac
vitamin
c
treatment
dog
hepatopathi
less
like
recov
dog
nonhepat
manifest
sulfonamid
hypersensit
tetracyclin
predispos
hepat
lipid
accumul
inhibit
protein
synthesi
interfer
hepat
secret
triglyceriderich
lipoprotein
howev
appear
hepat
effect
clinic
signific
dog
cat
although
clinic
signific
idiosyncrat
hepat
injuri
report
increas
liver
enzym
activ
common
find
dog
treat
doxycyclin
increas
alt
activ
increas
alp
activ
clinic
signific
remain
determin
aflatoxicosi
aflatoxin
metabolit
produc
primarili
strain
saprophyt
fungu
aspergillu
caus
toxic
hepat
dog
mani
speci
exposur
dog
may
occur
inadvert
use
aflatoxincontamin
corn
peanut
meal
commerci
product
dog
food
ingest
homemad
pet
food
moldi
garbag
improperli
store
dog
food
dog
rel
suscept
aflatoxin
liver
target
organ
clinic
case
aflatoxicosi
cat
report
aflatoxin
commonli
implic
hepatotox
toxic
effect
seen
level
exceed
food
aflatoxin
readili
absorb
gi
tract
undergo
hepat
metabol
cytochrom
enzym
toxic
intermedi
aflatoxin
bind
essenti
molecul
within
cell
lead
hepatocyt
necrosi
decreas
protein
synthesi
detoxif
aflatoxin
occur
conjug
glutathion
depend
amount
consum
dog
may
present
acut
subacut
chronic
liver
diseas
highdos
exposur
associ
acut
hepat
failur
jaundic
dic
death
repeat
exposur
low
dose
lead
chronic
liver
diseas
cirrhosi
outbreak
aflatoxicosi
occur
least
dog
result
eat
commerci
avail
dog
food
manufactur
aflatoxincontamin
corn
sever
clinic
sign
vari
significantli
among
dog
dog
die
suddenli
without
preexist
sign
ill
dog
present
sign
anorexia
lethargi
vomit
jaundic
diarrhea
includ
melena
hematochezia
abdomin
effus
evid
bleed
disord
common
biochem
featur
includ
increas
liver
enzym
activ
especi
alt
hyperbilirubinemia
electrolyt
disturb
hypoalbuminemia
hypocholesterolemia
prolong
clot
time
reduc
plasma
antithrombin
iii
protein
c
activ
hypocholesterolemia
suggest
sensit
biomark
aflatoxin
ingest
dog
minim
clinic
sign
possibl
reflect
earli
effect
aflatoxin
biosynthesi
certain
protein
cholesterol
dog
acut
subacut
aflatoxicosi
liver
enlarg
pale
yellow
histolog
featur
diffus
hepat
vacuol
lipid
accumul
scatter
individu
hepatocyt
necrosi
biliari
hyperplasia
modest
inflamm
collaps
zone
hepatocyt
around
central
vein
associ
perivenular
inflamm
may
explain
clinic
featur
portal
hypertens
chronic
lowlevel
exposur
find
includ
small
liver
regen
nodul
acquir
pss
histolog
evid
mark
biliari
hyperplasia
periport
fibrosi
diseas
potenti
indic
clinic
signific
liver
injuri
includ
increas
alt
alp
activ
exceed
five
time
upper
limit
normal
alt
activ
exce
alp
activ
elev
ast
activ
enzym
elev
accompani
evid
hepat
dysfunct
hyperbilirubinemia
hypoalbuminemia
hypocholesterolemia
increas
sba
hepat
cirrhosi
associ
chronic
phenobarbit
therapi
character
grossli
small
nodular
liver
histolog
bridg
portal
fibrosi
nodular
regener
biliari
hyperplasia
mild
inflamm
see
figur
lesion
mean
pathognomon
phenobarbitalinduc
hepat
damag
howev
absenc
known
caus
hepat
damag
circumstanti
evid
would
support
drug
therapi
like
caus
chronic
phenobarbit
therapi
also
associ
superfici
necrolyt
dermat
hepatocutan
syndrom
dog
liver
biopsi
chang
typic
seen
hepatocutan
syndrom
mark
vacuolar
chang
parenchym
collaps
distinct
characterist
chronic
hepat
cirrhosi
describ
phenobarbit
decreas
discontinu
possibl
dog
biochem
histolog
evid
hepat
diseas
dog
phenobarbitalassoci
toxicosi
clinic
biochem
histolog
improv
occur
drug
discontinu
use
reduc
dosag
prior
sever
endstag
liver
diseas
improv
clinic
sign
note
within
day
week
decreas
serum
phenobarbit
level
primidon
also
associ
chronic
liver
diseas
dog
like
consequ
metabol
primidon
phenobarbit
phenytoin
caus
acut
chronic
hepat
dog
well
jaundic
death
risk
hepatotox
increas
combin
therapi
phenobarbit
primidon
phenytoin
sulfonamid
potenti
sulfonamid
trimethoprimsulfadiazin
trimethoprimsulfamethoxazol
ormetoprimsulfadimethoxin
associ
acut
idiosyncrat
druginduc
liver
injuri
dog
trimethoprimsulfadiazin
implic
hepat
drug
reaction
dog
report
center
veterinari
medicin
doberman
pinscher
suggest
risk
develop
polyarthropathi
sulfonamid
hypersensit
necessarili
idiosyncrat
hepat
reaction
onset
clinic
sign
occur
within
day
mean
day
start
drug
previou
exposur
sulfonamid
requir
dose
potenti
sulfonamid
gener
higher
dog
develop
idiosyncrat
hepat
reaction
compar
system
manifest
sulfonamid
hypersensit
thrombocytopenia
fever
polyarthropathi
biochem
find
includ
increas
liver
enzym
activ
alt
alp
hyperbilirubinemia
liver
biopsi
usual
reveal
mark
hepat
necrosi
howev
cholestasi
mark
lymphocyticplasmacyt
inflamm
also
describ
pathogenesi
idiosyncrat
hepat
reaction
unclear
dog
gener
may
increas
risk
sulfonamid
reaction
lack
gene
express
nacetyl
enzym
major
metabol
pathway
detoxif
sulfonamid
human
howev
explain
individu
risk
among
dog
hepatotox
may
result
oxid
sulfonamid
reactiv
metabolit
hydroxylamin
nitroso
metabolit
may
associ
hapten
format
tcell
prolifer
direct
cytotox
impair
detoxif
reactiv
metabolit
via
defici
glutathion
cystein
ascorb
may
play
role
theoret
support
use
hepatocyt
uptak
amanitin
shown
protect
experiment
phalloid
liver
damag
beagl
given
dose
mgkg
iv
twice
hour
exposur
howev
intraven
form
silymarin
current
avail
clinic
use
unit
state
experiment
studi
suggest
penicillin
g
may
also
reduc
hepat
uptak
amanitin
even
sever
hour
ingest
iv
nac
may
benefici
describ
treatment
acetaminophen
toxic
overal
mortal
rate
amanita
mushroom
toxic
high
ingest
toxinproduc
bluegreen
alga
microcysti
aeruginosa
rare
caus
hepatotox
alf
dog
alga
prolifer
shallow
stagnant
water
especi
hot
dri
weather
dead
die
alga
form
thick
bluegreen
scum
water
surfac
releas
toxic
principl
microcystin
toxic
caus
ingest
algaecontamin
water
sign
occur
rapidli
within
hour
ingest
includ
vomit
diarrhea
lethargi
follow
progress
tachypnea
dyspnea
icteru
coma
biochem
featur
reflect
hepatocellular
injuri
increas
alt
ast
activ
typic
exceed
increas
alp
activ
hyperbilirubinemia
howev
profound
protract
increas
alt
activ
may
detect
microcystin
interfer
transaminas
biosynthesi
hepat
lesion
consist
massiv
hepat
necrosi
centrilobular
midzon
hepatocyt
treatment
symptomat
support
oxid
injuri
may
play
role
suggest
glutathion
supplement
nac
may
benefit
prognosi
guard
cycad
sago
palm
nativ
tropic
subtrop
region
use
housepl
residenti
landscap
concentr
cycasin
primari
toxin
cycad
highest
seed
root
present
part
plant
ingest
one
two
seed
fatal
dog
follow
ingest
cycasin
metabol
gi
bacteria
activ
compound
methylazoxymethanol
caus
gi
hepat
toxic
dog
dog
ingest
cycad
develop
gi
sign
includ
vomit
diarrhea
abdomin
pain
neurolog
sign
weak
ataxia
depress
propriocept
deficit
seizur
coma
also
common
clear
result
neurotoxin
onset
clinic
sign
rang
minut
day
may
last
hour
day
hepat
injuri
suggest
find
progress
depress
icteru
excess
bleed
accompani
increas
liver
enzym
activ
hyperbilirubinemia
hypoglycemia
hypoabuminemia
centrilobular
hepat
necrosi
found
liver
biopsi
specif
treatment
avail
mortal
report
vari
xylitol
xylitol
sugar
alcohol
use
sugar
substitut
associ
hypoglycemia
hepat
necrosi
dog
xylitol
safe
human
commonli
use
sugarfre
gum
oral
care
product
avail
granul
powder
bake
xylitol
first
introduc
unit
state
sinc
time
report
toxic
aspca
anim
poison
control
center
increas
two
dog
dog
ingest
gkg
dog
associ
rapid
sever
increas
blood
insulin
result
sign
hypoglycemia
within
minut
ingest
amount
exceed
gkg
alf
may
occur
within
aflatoxicosi
associ
consumpt
commerci
manufactur
pet
food
product
suspect
geograph
tempor
cluster
case
household
kennel
region
histori
may
reveal
recent
chang
diet
feed
new
bag
note
dog
may
consum
contamin
food
week
month
sign
develop
definit
diagnosi
aflatoxicosi
base
chemic
detect
increas
level
aflatoxin
food
aflatoxicosi
suspect
owner
advis
retain
kg
food
airtight
zipper
plastic
bag
four
can
food
laboratori
test
also
recommend
save
packag
inform
includ
product
date
code
help
identifi
contamin
lot
food
sampl
food
longer
avail
serum
liver
sampl
submit
test
aflatoxin
aflatoxin
metabolit
although
use
may
limit
rapid
metabol
excret
aflatoxin
detect
aflatoxin
urin
use
dog
still
consum
contamin
diet
level
fall
detect
level
within
hour
specif
antidot
aflatoxicosi
treatment
consist
symptomat
support
manag
liver
failur
nonspecif
hepatoprotect
therapi
antioxid
vitamin
e
glutathion
replac
nac
milk
thistl
silymarin
lcarnitin
recommend
prognosi
guard
clinic
sign
aflatoxicosi
present
report
mortal
rate
seri
dog
consum
aflatoxincontamin
dog
food
dog
surviv
acut
liver
injuri
potenti
develop
chronic
liver
diseas
consequ
monitor
liver
function
recommend
recov
dog
treatment
thiol
donor
month
empir
recommend
amanita
mushroom
amanita
phalloid
varieti
amanita
verna
amanita
bisporigera
poison
mushroom
found
throughout
north
america
caus
acut
hepat
necrosi
dog
cat
toxic
attribut
extrem
toxic
cyclopeptid
toxin
call
amanitin
ingest
two
phalloid
mushroom
lethal
adult
dog
clinic
sign
occur
within
hour
ingest
character
initi
gi
sign
vomit
bloodi
diarrhea
abdomin
pain
late
phase
hour
exposur
character
alf
hemorrhag
mark
hypoglycemia
termin
coma
caus
sever
massiv
hepat
necrosi
see
figur
toxininduc
renal
tubular
necrosi
may
also
result
renal
failur
biochem
featur
reflect
sever
hepat
injuri
includ
increas
liver
enzym
activ
alt
exce
alp
refractori
hypoglycemia
hyperbilirubinemia
diagnosi
usual
made
base
posit
identif
suspect
mushroom
evid
ingest
consist
clinic
featur
mushroom
piec
gastric
content
confirm
exposur
difficult
identifi
accur
mushroom
identif
requir
consult
experienc
mycologist
suspect
mushroom
wrap
paper
towel
store
paper
plastic
bag
definit
confirm
establish
detect
amanitin
liver
kidney
tissu
serum
urin
sampl
collect
gi
phase
liquid
chromatographymass
spectrometri
california
anim
health
food
safeti
laboratori
gi
decontamin
procedur
recommend
soon
possibl
exposur
describ
treatment
section
drug
toxininduc
liver
injuri
symptomat
support
treatment
alf
indic
includ
close
monitor
treatment
mark
hypoglycemia
silymarin
believ
reduc
lower
urinari
tract
diseas
ammonium
biurat
urolith
form
time
bladder
rare
renal
pelvi
caus
dysuria
urethr
obstruct
male
seldom
uroabdomen
result
chronic
inflamm
subsequ
devit
bladder
wall
ammonium
biurat
crystalluria
pathognomon
portosystem
shunt
may
occasion
occur
normal
dog
cat
found
certain
breed
dalmatian
inborn
error
metabol
prolong
recoveri
anesthesia
sedat
may
occur
seemingli
normal
dog
cat
cpss
liver
play
crucial
role
detoxif
process
toxin
drug
includ
anesthet
patient
cpss
apsc
insuffici
function
hepat
mass
detoxif
addit
dog
portosystem
shunt
increas
endogen
benzodiazepin
gabaerg
activ
therefor
administr
diazepam
barbitur
anim
may
prolong
exagger
effect
see
pathogenesi
section
recurr
fever
togeth
result
depress
anorexia
clinic
manifest
cpss
dog
portosystem
shunt
exclud
dog
experienc
recurr
fever
rare
manifest
report
dog
pathogenesi
understood
elderli
dog
extrahepat
cpss
may
present
characterist
sign
hypercortisol
eg
pupd
polyphagia
thin
skin
symmetr
alopecia
muscl
wast
pot
belli
primari
complaint
unusu
clinic
manifest
cpss
although
small
bodi
size
observ
cat
cpss
infrequ
occur
dog
mani
dog
extrahepat
cpss
show
nonspecif
clinic
sign
throughout
live
shunt
detect
coincident
find
time
necropsi
understood
certain
dog
becom
clinic
ill
other
type
portal
vein
anomali
cpss
never
caus
icteru
ascit
spontan
hemorrhag
portal
vein
disord
much
less
common
cat
dog
cat
younger
month
age
first
sign
appear
cat
cpss
often
smaller
statur
unkempt
hair
coat
episod
saliv
andor
central
neurolog
sign
exampl
compuls
pace
seizur
manifest
typic
present
complain
portal
hypertens
clinic
sign
develop
age
aris
presenc
increas
hydrostat
portal
venou
pressur
portosystem
hour
alf
necessarili
preced
earli
sign
hypoglycemia
mechan
hepatotox
unknown
specul
caus
cellular
deplet
adenosin
triphosph
result
hepatocellular
necrosi
product
reactiv
oxygen
speci
caus
oxid
injuri
addit
sign
hypoglycemia
dog
alf
may
vomit
icteru
evid
excess
bleed
biochem
find
includ
markedli
increas
alt
ast
activ
mild
moder
increas
alp
activ
hyperbilirubinemia
hypoglycemia
hyperphosphatemia
prolong
pt
aptt
thrombocytopenia
ingest
occur
within
last
hour
induct
emesi
recommend
unless
show
sign
hypoglycemia
activ
charcoal
may
limit
valu
adsorb
xylitol
still
recommend
larg
amount
ingest
treatment
recommend
includ
hospit
observ
monitor
dextros
supplement
control
hypoglycemia
symptomat
support
care
complic
liver
failur
hepatoprotect
therapi
nac
silymarin
may
benefici
prognosi
good
recoveri
dog
uncompl
hypoglycemia
guard
poor
dog
liver
failur
howev
surviv
liver
failur
necessarili
correl
amount
xylitol
ingest
vascular
hepat
diseas
includ
congenit
acquir
disord
portal
vein
congenit
anomali
result
hypoplasia
aplasia
portal
vein
b
macroscop
commun
portal
vein
system
vein
c
portal
vein
arteri
acquir
diseas
result
condit
increas
hydrostat
pressur
portal
vein
ie
portal
hypertens
macroscop
venou
connect
portal
system
venou
system
result
portosystem
shunt
ie
blood
flow
portal
system
vein
via
congenit
portosystem
shunt
cpss
acquir
portosystem
collater
apsc
neurolog
sign
hepatoencephalopathi
revers
central
neurolog
manifest
hepat
insuffici
cpss
caus
chronic
follow
grade
chronic
recogn
grade
behavior
chang
grade
compuls
pace
circl
hypersaliv
head
press
blind
grade
seizur
grade
chronic
character
period
sever
grade
sign
last
usual
sever
hour
day
altern
longer
period
day
week
mild
grade
symptom
period
cortic
blind
accompani
appar
mydriasi
sign
may
trigger
ingest
proteinrich
meal
pd
mean
excess
fluid
intak
dog
mlkg
bodi
h
cat
mlkg
bodi
h
pu
may
difficult
diagnos
pd
pet
owner
readili
measur
urin
volum
repeat
low
specif
graviti
morn
urin
dog
cat
compat
pu
macroscop
connect
exist
major
vessel
system
tributari
singl
multipl
portosystem
venou
connect
allow
portal
venou
blood
flow
directli
system
venou
system
without
first
flow
hepat
sinusoid
toxinrich
blood
deliv
cell
bodi
follow
rout
gut
portal
vein
shunt
system
vein
right
heart
lung
left
heart
arteri
connect
singl
rare
doubl
largebor
vein
without
presenc
portal
hypertens
consid
cpss
singl
multipl
connect
presenc
portal
hypertens
apsc
whenev
macroscop
venou
connect
present
portal
vein
one
tributari
system
vein
blood
flow
portal
vein
system
vein
pressur
portal
vein
higher
mm
hg
system
vein
mm
hg
normal
portal
venou
pressur
approxim
mm
hg
cm
h
increas
pressur
portal
venou
system
result
portal
hypertens
anatom
portal
hypertens
classifi
prehepat
ie
portal
vein
b
intrahepat
c
posthepat
ie
hepat
vein
thorac
caudal
vena
cava
heart
posthepat
postsinusoid
portal
hypertens
cardiac
diseas
result
rightsid
congest
heart
failur
caus
posthepat
portal
hypertens
diseas
includ
congenit
acquir
sever
insuffici
tricuspid
valv
eg
dysplasia
myxomat
degener
annulu
dilat
caus
dilat
arrhythmogen
cardiomyopathi
pulmonari
hypertens
variou
etiolog
b
pericardi
diseas
pericardi
tamponad
caus
idiopath
neoplast
effus
constrict
pericard
c
variou
congenit
anomali
cor
triatriatum
dexter
atrial
septum
defect
tricuspid
pulmon
stenosi
intracardiac
tumor
affect
right
heart
e
caval
syndrom
caus
dirofilaria
immiti
heart
worm
kink
compress
thorac
caudal
vena
cava
diaphragmat
hernia
mass
occur
rare
compress
stenosi
thrombosi
hepat
vein
socal
buddchiari
syndrom
occur
dog
cat
posthepat
portal
hypertens
portal
caval
pressur
increas
equal
therefor
apsc
develop
blood
ammonia
concentr
remain
within
refer
rang
high
postsinusoid
hydrostat
pressur
caus
larg
amount
proteinrich
hepat
lymph
filter
hepat
capsul
abdomin
caviti
caus
accumul
modifi
transud
modifi
transud
high
protein
content
fenestr
endotheli
cell
hepat
sinusoid
keep
plasma
protein
capillari
lumen
mark
gener
hepatomegali
dilat
jugular
hepat
vein
well
caudal
vena
cava
hallmark
postsinusoid
portal
hypertens
intrahepat
portal
hypertens
chronic
acquir
parenchym
liver
diseas
lead
hepatocyt
necrosi
subsequ
collagen
deposit
result
disorgan
hepat
architectur
contract
connect
tissu
result
obstruct
intraparenchym
vessel
underli
diseas
process
includ
viral
bacteri
protozo
immunemedi
copperassoci
chronic
hepat
toxic
druginduc
idiosyncrat
liver
damag
lobular
dissect
hepat
chronic
bile
duct
shunt
via
apsc
underli
diseas
led
portal
hypertens
clinic
sign
portosystem
shunt
similar
regardless
whether
congenit
acquir
origin
see
clinic
manifest
section
accumul
larg
amount
pure
transud
modifi
transud
clear
strawcolor
slightli
turbid
bloodting
fluid
abdomin
caviti
commonli
detect
physic
examin
abdominocentesi
absenc
free
abdomin
fluid
exclud
portal
hypertens
depend
etiolog
anatom
locat
underli
diseas
led
develop
portal
hypertens
variou
sign
may
seen
jaundic
period
vomit
anorexia
jaundic
hemorrhag
diathesi
absent
congenit
vascular
disord
congenit
arterioport
fistula
caus
transud
ascit
puppi
month
age
primari
hypoplasia
portal
vein
phpv
also
describ
noncirrhot
portal
hypertens
may
result
ascit
vagu
gi
sign
may
entir
subclin
phpv
sever
enough
caus
portal
hypertens
clinic
sign
may
obviou
mild
form
phpv
also
known
hepat
microvascular
dysplasia
may
detect
serendipit
plasma
bile
acid
concentr
measur
unrel
reason
portal
hypertens
rare
typic
associ
ascit
cat
portosystem
shunt
cpss
apsc
tend
caus
similar
sign
exampl
period
saliv
seizur
manifest
chronic
common
acquir
diseas
caus
intrahepat
portal
hypertens
biliari
cirrhosi
caus
chronic
bile
duct
obstruct
jaundic
achol
fece
typic
find
extrahepat
cholestasi
liver
receiv
blood
suppli
portal
vein
approxim
hepat
arteri
approxim
divers
portal
venou
blood
flow
compensatori
increas
hepat
arteri
flow
occur
arteri
vasodil
mediat
adenosin
energydeplet
hepatocyt
portal
vein
transport
blood
spleen
gi
tract
liver
smallest
portal
venou
hepat
arteri
branch
termin
capillari
system
liver
socal
hepat
sinusoid
larg
amount
plasma
filter
fenestr
wall
sinusoid
space
diss
filter
plasma
taken
lymphat
vessel
system
venou
system
remain
sinusoid
blood
collect
hepat
vein
enter
caudal
vena
cava
normal
hepatofug
portal
flow
prevent
splanchnic
venou
blood
enter
liver
caus
develop
altern
pathway
often
time
accumul
pure
transud
abdomen
interestingli
phpv
alway
accompani
congenit
arterioport
fistula
dog
cat
cpss
arterioport
fistula
concomitantli
present
apsc
ascit
develop
arterioport
fistula
extrahepat
cat
acquir
portosystem
collater
healthi
mammal
multipl
nonfunct
venou
connect
may
exist
portal
system
vein
virtual
commun
becom
function
lumen
becom
suffici
widen
gradual
dilat
take
place
sustain
increas
portal
pressur
take
place
without
simultan
increas
caval
pressur
result
apsc
multipl
usual
thin
tortuou
vein
speciesspecif
anatom
locat
howev
largebor
vein
may
also
develop
latter
case
misinterpret
simultan
cpss
apsc
presenc
exist
cpss
apsc
would
develop
even
hepat
cirrhosi
develop
alreadi
exist
portosystem
connect
abl
drain
portal
blood
without
allow
develop
portal
hypertens
splenoren
collater
consist
present
almost
everi
dog
apsc
apsc
drain
portal
venou
blood
via
splenic
vein
acquir
connect
left
gonad
vein
left
gonad
vein
enter
left
renal
vein
later
empti
caudal
vena
cava
splenoren
apsc
thought
prevent
spleen
undergo
congest
splenomegali
featur
canin
preand
intrahepat
portal
hypertens
disord
shunt
portal
blood
detriment
brain
liver
well
normal
hepat
develop
function
requir
suffici
amount
portal
venou
perfus
hepat
sinusoid
increas
arteri
perfus
unabl
compens
portal
hypoperfus
regardless
whether
insuffici
portal
venou
perfus
caus
cpss
prehepat
portal
hypertens
result
reduc
hepat
mass
function
case
histopatholog
evalu
liver
show
stereotyp
reaction
small
invis
portal
branch
increas
number
arteriol
sometim
bile
ductul
portal
tract
hepatocellular
atrophi
periport
sinusoid
dilat
secondari
portal
vein
hypoplasia
revers
histolog
indistinguish
phpv
primari
secondari
portal
vein
hypoplasia
show
ident
microscop
featur
histopatholog
evalu
liver
biopsi
specimen
unabl
diagnos
simultan
phpv
cpss
glycin
gaba
import
inhibitori
neurotransmitt
wherea
glutam
dopamin
abund
excitatori
neurotransmitt
brain
net
increas
inhibitori
transmiss
occur
result
upregul
gaba
receptor
downregul
dopamin
receptor
activ
gaba
receptor
caus
open
chlorid
channel
lead
hyperpolar
postsynapt
membran
presenc
gaba
benzodiazepin
increas
frequenc
wherea
barbitur
increas
durat
chlorid
channel
open
caus
increas
gabaerg
tone
thought
gut
deriv
gaba
may
also
form
neuron
glutam
endogen
benzodiazepin
proven
obstruct
result
increas
portal
pressur
may
caus
develop
apsc
well
ascit
modifi
transud
may
accumul
abdomin
caviti
diseas
process
predominantli
obstruct
postsinusoid
hepat
venul
howev
diseas
process
affect
predominantli
intrahepat
portal
vein
branch
presinusoid
portal
hypertens
pure
transud
accumul
abdomen
primari
hypoplasia
portal
vein
caus
insuffici
develop
intrahepat
portal
venou
branch
left
portal
vein
branch
whole
portal
venou
system
hypoplasia
sever
enough
caus
intraor
prehepat
portal
hypertens
apsc
develop
condit
also
known
noncirrhot
portal
hypertens
hypoplasia
sever
enough
caus
portal
hypertens
clinic
sign
develop
portosystem
shunt
present
result
rectal
ammonia
toler
test
att
portal
scintigraphi
portographi
normal
see
differenti
diagnosi
section
either
macroscop
microscop
portosystem
commun
present
hyperammonemia
abnorm
att
also
present
never
document
abnorm
could
detect
dog
elev
serum
bile
acid
level
plausibl
explan
hepat
clearanc
bile
acid
hypoperfus
liver
probabl
less
effect
ammonia
diseas
diagnos
histopatholog
examin
liver
biopsi
specimen
condit
also
describ
hepat
microvascular
dysplasia
although
term
noncirrhot
portal
hypertens
hepat
microvascular
dysplasia
use
describ
syndrom
replac
term
phpv
occurr
phpv
cat
rare
poorli
document
common
congenit
caus
portal
hypertens
cat
congenit
hepat
fibrosi
part
polycyst
kidney
liver
diseas
complex
diseas
may
caus
clinic
sign
without
presenc
macroscop
hepat
renal
cyst
prehepat
portal
hypertens
narrow
portal
vein
lumen
may
caus
extravascular
compress
tumor
enlarg
lymph
node
cyst
abscess
hematoma
b
idiopath
circumscrib
stenosi
c
intravascular
obstruct
thrombu
parasit
lead
portal
hypertens
portal
vein
thrombosi
alway
secondari
either
neoplasia
system
disord
caus
hypercoagul
nephrot
syndrom
immunemedi
hemolyt
anemia
hypercortisol
acut
pancreat
periton
sepsi
parasit
portal
vein
also
may
occur
exampl
heterobilharzia
americana
north
america
schistosoma
japonicum
east
asia
depend
degre
portal
vein
occlus
increas
portal
pressur
apsc
ascit
may
develop
hydrostat
pressur
sinusoid
increas
contrast
posthepat
portal
hypertens
result
ascit
fluid
low
protein
content
narrow
lumen
portal
vein
caus
reduc
portal
flow
liver
result
reduct
size
liver
portal
vein
thrombosi
rare
caus
clinic
sign
usual
coincident
find
liver
receiv
littl
portal
venou
blood
insuffici
amount
substrat
ie
ammonia
avail
hepat
urea
product
theoret
result
low
plasma
urea
concentr
also
lower
renal
medullari
urea
concentr
impair
renal
concentr
abil
caus
pu
increas
basal
plasma
concentr
acth
cortisol
well
increas
urinari
cortisoltocreatinin
ratio
invari
present
dog
portosystem
shunt
cortisol
interfer
action
argininevasopressin
renal
tubul
caus
nephrogenictyp
diabet
insipidu
hypersecret
acth
stimul
hormon
shown
aris
predominantli
intermedi
lobe
pituitari
hormon
secret
lobe
regul
tonic
dopaminerg
inhibit
acthhypersecret
explain
product
fals
neurotransmitt
eg
octopamin
whose
effect
onefiftieth
dopamin
dopamin
receptor
central
diabet
insipidu
also
contribut
pu
dog
impair
releas
argininevasopressin
posterior
lobe
pituitari
caus
reduc
magnitud
respons
highli
increas
threshold
increas
plasma
osmol
releas
argininevasopressin
inhibit
gaba
inhibitori
neurotransmitt
system
whose
activ
increas
pseudohyperaldosteron
cortisol
aldosteron
similar
affin
bind
aldosteron
receptor
howev
cortisol
normal
inactiv
dehydrogenas
tissu
aldosteron
action
requir
high
serum
bile
acid
concentr
inhibit
enzym
cortisol
bind
aldosteron
receptor
result
increas
mineralocorticoid
effect
plasma
cortisol
concentr
aldosteron
caus
constant
inappropri
pseudohyperaldosteron
result
sodium
retent
caus
secondari
water
retent
subsequ
pu
pressur
diuresi
hypokalemia
caus
hyperaldosteron
also
contribut
pu
accord
follow
mechan
presenc
channel
renal
collect
duct
cell
membran
necessari
water
reabsorpt
intracellular
signal
pathway
cyclic
adenosin
monophosph
regul
insert
channel
hypokalemia
decreas
sensit
cyclic
adenosin
monophosph
argininevasopressin
result
decreas
insert
channel
cell
membran
lead
nephrogen
diabet
insipidu
pu
congenit
portal
venou
anomali
dog
typic
associ
enlarg
kidney
volum
increas
renal
gluconeogenesi
compens
insuffici
hepat
gluconeogenesi
may
caus
kidney
enlarg
addit
increas
system
circul
growth
factor
concentr
releas
pancrea
may
play
role
increas
volum
normal
growth
factor
act
liver
reach
system
circul
high
concentr
behavior
chang
abnorm
thirst
center
due
may
contribut
pd
howev
difficult
prove
individu
patient
produc
intestin
dog
cpss
sourc
quit
clear
could
aris
diet
intestin
flora
endogen
modif
inact
gut
precursor
form
portosystem
shunt
concentr
aromat
amino
acid
increas
system
circul
wherea
concentr
branchedchain
amino
acid
decreas
high
aromat
amino
acid
concentr
result
impair
hepat
clearanc
increas
product
caus
muscular
breakdown
exacerb
hyperglucagonemia
decreas
concentr
branchedchain
amino
acid
result
increas
util
gluconeogenesi
amino
acid
imbal
may
result
develop
fals
neurotransmitt
eg
octopamin
brain
contribut
develop
fals
neurotransmitt
fraction
dopamin
excitatori
effect
dopamin
receptor
drug
dopaminerg
effect
bromocriptin
may
improv
sign
intestin
toxin
ammonia
bacteria
normal
inactiv
hepatocyt
hepat
macrophag
kupffer
cell
respect
toxinand
bacteriumfre
blood
enter
system
circul
patient
portosystem
shunt
major
portal
venou
blood
bypass
liver
allow
toxinand
bacteriumrich
blood
enter
system
circul
ammonia
neurotoxin
contribut
clinic
sign
toxin
believ
play
role
endogen
benzodiazepin
gaba
tryptophan
glutamin
serotonin
mercaptan
indol
skatol
hyperammonemia
also
lead
impair
glial
function
increas
intracellular
glutamin
concentr
glutamin
made
glial
cell
incorpor
ammonia
glutam
glutamin
synthetas
chronic
increas
glutamin
concentr
caus
swell
glial
cell
result
socal
alzheim
ii
type
degener
astroglia
glial
dysfunct
contribut
develop
hyperammonemia
reserv
capac
astrocyt
glutamin
synthetas
exceed
ammonia
enter
neuron
neuron
ammonia
inhibit
glutaminas
enzym
convert
glutamin
glutam
glutam
excitatori
neurotransmitt
reduc
level
contribut
develop
portosystem
shunt
atroph
liver
alon
insuffici
allow
develop
develop
simultan
present
reserv
capac
liver
ensur
even
advanc
chronic
parenchym
liver
diseas
develop
absenc
portosystem
shunt
alkalosi
hypokalemia
worsen
sign
alkalosi
nh
h
nh
reaction
shift
left
caus
lipophil
ammonia
enter
cell
cn
hypokalemia
potassium
ion
k
move
cell
extracellular
space
exchang
h
later
result
extracellular
alkalosi
intracellular
acidosi
intracellular
acidosi
caus
nh
trap
within
cell
might
explain
blood
concentr
ammonia
close
relat
sever
clinic
sign
individu
case
sever
mechan
contribut
develop
pupd
portosystem
shunt
high
concentr
sodium
urea
renal
medullari
interstitium
essenti
product
concentr
urin
creat
high
osmot
gradient
renal
tubular
lumen
interstitium
necessari
water
reabsorpt
result
reduc
enzym
activ
urea
cycl
clinic
sign
present
treatment
requir
condit
resolv
spontan
age
pup
develop
enhanc
incorpor
ammonia
glutamin
periton
absorpt
ammoniacontain
urin
caus
hyperammonemia
howev
patient
clinic
sign
acut
uremia
predomin
presenc
ureaseproduc
bacteria
eg
staphylococci
necessari
split
urinari
urea
ammonia
fulmin
hepat
failur
ingest
blue
alga
certain
mushroom
eg
phalloid
result
peracut
insuffici
hepat
function
anim
develop
hepat
coma
die
shortli
thereaft
hyperammonemia
dic
icteru
present
affect
patient
arginin
essenti
amino
acid
cat
anorect
cat
hyperammonemia
may
develop
along
hepat
lipidosi
insuffici
amount
hepat
arginin
need
urea
synthesi
urea
cycl
thu
contrast
adult
dog
hyperammonemia
cat
occur
without
portosystem
shunt
methylmalon
acidemia
associ
cobalamin
defici
dog
cat
suspect
transient
hyperammonem
syndrom
german
shepherd
dog
report
extraordinarili
rare
caus
hyperammonemia
blood
sampl
sampl
process
perform
inappropri
hyperammonia
may
erron
diagnos
high
bile
acid
concentr
may
result
portosystem
shunt
also
primari
secondari
hepat
diseas
associ
intraor
extrahepat
cholestasi
therefor
presenc
high
serum
bile
acid
concentr
sensit
specif
indic
portal
venou
disord
simultan
presenc
hyperammonemia
larg
amount
pure
modifi
transud
abdomin
caviti
indic
presenc
sever
preor
intrahepat
portal
hypertens
apsc
biochem
cytolog
analysi
periton
effus
ultrasonographi
central
venou
pressur
measur
may
use
identifi
sourc
ascit
suspect
intrahepat
caus
evalu
histopatholog
examin
liver
tissu
anim
present
central
neurolog
sign
portosystem
shunt
along
metabol
encephalopathi
eg
hypoglycemia
electrolyt
imbal
investig
appropri
blood
test
singl
find
pathognomon
diagnos
vascular
liver
disord
therefor
combin
histori
physic
hyperammonemia
result
higher
filter
load
urinari
concentr
ammonia
high
urinari
concentr
uric
acid
result
decreas
hepat
convers
uric
acid
allantoin
reduc
hepat
mass
function
portal
vein
carri
bacteria
endotoxin
intestin
normal
phagocyt
kupffer
cell
shunt
portal
blood
permit
bacteria
andor
endotoxin
enter
system
circul
caus
bacteremia
andor
endotoxemia
subsequ
fever
system
antibiot
may
result
temporari
resolut
clinic
sign
howev
give
definit
cure
cpss
occur
within
hepat
parenchyma
call
intrahepat
intrahepat
cpss
aris
either
left
right
portal
branch
left
division
intrahepat
cpss
result
failur
postnat
closur
embryolog
ductu
venosu
intrahepat
cpss
aris
right
portal
branch
extrahepat
cpss
thought
development
anomali
poorli
understood
etiolog
dog
anatomi
shunt
vessel
fairli
consist
intrahepat
cpss
may
left
right
central
division
wherea
extrahepat
shunt
drain
portal
venou
blood
via
splenic
right
gastric
vein
caudal
vena
cava
azygo
vein
cours
shunt
vein
cat
much
variabl
inherit
natur
diseas
establish
sever
breed
includ
irish
wolfhound
yorkshir
cairn
terrier
phpv
congenit
anomali
unknown
etiolog
although
arterioport
fistula
may
develop
result
neoplasm
trauma
eg
shot
wound
liver
biopsi
congenit
form
report
dog
cat
congenit
hepat
fibrosi
caus
polycyst
kidney
diseas
pkd
genet
diseas
differenti
diagnosi
high
fast
venou
blood
ammonia
concentr
togeth
high
fast
serum
bile
acid
concentr
specif
sensit
test
diagnos
portosystem
shunt
urea
cycl
enzym
defici
reduc
activ
one
enzym
urea
cycl
may
result
elev
blood
ammonia
concentr
serum
bile
acid
level
remain
within
refer
rang
patient
urea
cycl
enzym
defici
normal
hepat
scintigraphi
liver
histopatholog
result
confirm
absenc
portosystem
shunt
certain
metabolit
eg
citrullin
enzym
activ
eg
argininosuccin
acid
synthetas
measur
urin
liver
biopsi
specimen
respect
establish
definit
diagnosi
condit
rare
dog
one
suspect
felin
case
report
irish
wolfhound
puppi
healthi
irish
wolfhound
commonli
moder
hyperammonemia
age
week
thought
chlorid
nh
cl
solut
administ
dose
mlkg
fifteen
cm
descend
colon
use
soft
feed
tube
venou
blood
ammonia
measur
minut
thereaft
presenc
portosystem
shunt
ammonia
concentr
increas
least
twofold
sampl
time
normal
att
result
exclud
portosystem
shunt
figur
degre
increment
semiquantit
measur
degre
portosystem
shunt
note
rectal
administr
nh
cl
solut
may
caus
transient
irrit
colon
mucosa
first
minut
rectal
att
safe
procedur
sign
rare
occur
att
perform
patient
high
blood
ammonia
level
postprandi
measur
ammonia
thought
decreas
possibl
iatrogen
hyperammonem
howev
increas
blood
ammonia
concentr
feed
take
longer
peak
time
point
poorli
predict
markedli
increas
preprandi
ie
fast
bile
acid
concentr
often
found
portosystem
shunt
result
interrupt
enterohepat
circul
bile
acid
high
fast
plasma
bile
acid
concentr
sensit
nonspecif
indic
portosystem
shunt
specif
increas
simultan
measur
venou
ammonia
plasma
bile
acid
concentr
invari
high
icter
anim
presenc
apsc
justifi
exclud
measur
blood
ammonia
concentr
perform
att
case
normal
fast
bile
acid
concentr
measur
increas
postprandi
plasma
bile
acid
concentr
hour
meal
increas
sensit
specif
bile
acid
test
diagnos
portosystem
shunt
mealinduc
gallbladd
contract
caus
endogen
bile
acid
load
absorb
ileum
substanti
increas
plasma
bile
acid
concentr
portosystem
shunt
present
abnorm
postprandi
increas
bile
acid
occur
also
cholestat
liver
diseas
patient
portosystem
shunt
hypoalbuminemia
hypoproteinemia
hypocholesterolemia
low
plasma
urea
concentr
may
found
result
reduc
hepat
synthesi
hypoglycemia
may
seen
result
reduc
hepat
glyconeogenesi
glycogen
storag
low
creatinin
concentr
reflect
increas
glomerular
filtrat
rate
none
biochem
chang
specif
portosystem
shunt
furthermor
mani
find
may
present
healthi
pup
caus
mild
increas
plasma
alt
alkalin
phosphatas
activ
fulli
understood
microcytosi
without
mild
nonregen
anemia
leukocytosi
may
accompani
portosystem
shunt
rel
iron
defici
thought
caus
microcytosi
bacteremia
may
induc
leukocytosi
although
aptt
often
moder
prolong
dog
cpss
spontan
bleed
tendenc
hemorrhag
occur
hemoabdomen
possibl
postop
complic
surgic
attenu
cpss
acquir
parenchym
hepat
diseas
examin
laboratori
test
diagnost
imag
result
histopatholog
liver
biopsi
specimen
often
requir
establish
specif
diagnosi
intrahepat
cpss
tend
caus
clinic
sign
month
year
age
largebre
dog
bernes
mountain
dog
irish
wolfhound
hovawart
retriev
predispos
australian
cattl
dog
male
dog
like
rightsid
leftsid
intrahepat
cpss
wherea
irish
wolfhound
tend
leftsid
intrahepat
cpss
intrahepat
cpss
smallbre
dog
rare
extrahepat
cpss
usual
occur
small
breed
caus
clinic
sign
age
commonli
affect
breed
maltes
dog
miniatur
schnauzer
dachshund
yorkshir
terrier
jack
russel
terrier
cairn
terrier
clear
sex
predisposit
known
waxingwan
natur
central
neurolog
sign
suggest
chronic
symptom
may
improv
spontan
physic
examin
often
fail
detect
abnorm
occasion
enlarg
left
kidney
palpat
presenc
ascit
detect
physic
examin
exclud
cpss
author
suggest
coppercolor
iri
typic
find
cat
cpss
howev
report
exist
posit
neg
predict
valu
dog
intraor
prehepat
portal
hypertens
may
ascit
jaundic
absent
congenit
portal
hypertens
disord
may
present
acquir
parenchym
liver
diseas
blood
ammonia
concentr
fast
venou
hyperammonemia
specif
sensit
indic
portosystem
shunt
singl
test
increas
blood
ammonia
level
usual
suffici
diagnos
portosystem
shunt
ammonia
form
amino
group
protein
urea
also
collect
tube
blood
sampl
ethylenediaminetetraacet
acid
tube
place
directli
ice
sampl
measur
perform
within
minut
contamin
sampl
airborn
ammonia
may
caus
falseposit
result
sampl
taken
use
close
system
needl
syring
directli
vacutain
hemolysi
may
artifici
increas
ammonia
concentr
erythrocyt
contain
two
three
time
ammonia
plasma
measur
ammonia
perform
clean
locat
air
contamin
ammonia
congest
urin
cigarett
smoke
number
analyz
offer
possibl
ammonia
measur
howev
unreli
measur
arteri
ammonia
concentr
provid
addit
valu
venou
ammonia
concentr
within
refer
rang
slightli
elev
rectal
att
cheapest
quickest
test
exclud
justifi
presenc
portosystem
shunt
patient
suggest
histori
suspici
anim
also
high
fast
plasma
bile
acid
level
ammonium
anomali
highresolut
grayscal
ultrasound
often
suffici
establish
definit
diagnosi
although
certain
secondari
chang
small
liver
larg
kidney
hyperecho
medulla
sediment
stone
urinari
bladder
suggest
presenc
cpss
diagnos
cpss
requir
visual
anomal
vein
origin
termin
urinari
bladder
alway
evalu
presenc
urinari
calculi
ultrasonographi
use
initi
diagnost
workup
also
surgic
treatment
postop
followup
cpss
intraop
grayscal
ultrasonographi
facilit
local
cours
intrahepat
cpss
wherea
intraop
color
spectral
doppler
examin
help
determin
optim
degre
shunt
attenu
scintigraphi
free
tcpertechnet
administ
colon
absorb
portal
vein
appear
liver
first
anim
without
portosystem
shunt
heart
patient
portosystem
shunt
isotop
label
albumin
macroaggreg
may
directli
administ
splenic
vein
ultrasound
guidanc
macroaggreg
trap
first
capillari
bed
normal
liver
fraction
portal
may
lead
spontan
hemorrhag
presenc
dic
plain
radiograph
give
limit
addit
inform
small
liver
possibl
enlarg
kidney
sometim
visibl
urolith
histori
laboratori
result
nt
part
routin
diagnost
workup
vascular
liver
diseas
pure
ammonium
biurat
urolith
radioluc
abdomin
ultrasonographi
first
choic
diagnost
imag
modal
presenc
portosystem
shunt
establish
fast
hyperammonemia
abnorm
rectal
att
see
figur
major
advantag
ultrasonographi
requir
sedat
anesthesia
drawback
oper
depend
use
systemat
examin
protocol
one
accur
differenti
cpss
apsc
intrahepat
extrahepat
cpss
well
readili
diagnos
arterioport
fistula
prehepat
portal
hypertens
disord
although
colorflow
doppler
highli
facilit
evalu
portal
vascular
inject
iodin
contrast
agent
portal
vein
one
tributari
fluoroscopi
use
form
diagnost
imag
avail
diagnos
anomal
vessel
angiographi
allow
identif
extraand
intrahepat
cpss
well
apsc
major
drawback
select
portographi
invas
need
gener
anesthesia
wherea
mesenter
portographi
requir
catheter
mesenter
vein
laparotomi
splenic
portographi
perform
ultrasoundguid
percutan
inject
contrast
materi
parenchym
splenic
vein
visual
portal
vein
segment
hepatofug
flow
shunt
segment
hepatopet
flow
figur
problemat
contrast
reach
part
vessel
blood
bypass
liver
trap
pulmonari
capillari
splenic
venou
inject
isotop
make
exact
calcul
shunt
fraction
possibl
ie
activ
lungsact
liver
lung
howev
procedur
requir
anesthesia
scintigraphi
gold
standard
diagnost
imag
method
justifi
exclud
presenc
portosystem
shunt
howev
differenti
congenit
acquir
portosystem
shunt
intrahepat
extrahepat
cpss
possibl
inform
provid
scintigram
ye
answer
question
patient
portosystem
shunt
answer
reach
much
easili
without
use
radiopharmaceut
document
singl
high
blood
ammonia
concentr
rectal
att
imag
b
arrow
indic
direct
blood
flow
b
intraop
colorflow
doppler
ultrasound
imag
portal
vein
point
congenit
splenocav
shunt
origin
note
diamet
shunt
sh
larger
portal
vein
pvcaudsh
portal
vein
cranial
origin
shunt
pvcrsh
becom
narrow
portal
vein
caudal
shunt
origin
pvcaudsh
hypoperfus
c
blood
alway
flow
toward
lowest
resist
portal
venou
blood
flow
shunt
sh
caudal
vena
cava
cvc
note
blood
gastroduoden
vein
gdv
find
lower
resist
flow
caudal
toward
shunt
toward
liver
creat
hepatofug
flow
ie
flow
away
liver
portal
vein
segment
enter
point
gdv
origin
shunt
pvcrsh
note
portal
vein
becom
even
narrow
cranial
point
gdv
enter
pvcrgdv
diamet
variou
portal
vein
segment
vari
vari
amount
blood
flow
certain
segment
b
note
partial
occlus
shunt
increas
resist
shunt
extent
blood
splenic
vein
splv
find
lower
resist
flow
shunt
vessel
toward
portal
vein
revers
flow
shunt
vessel
prevent
portal
venou
blood
shunt
thu
even
though
shunt
partial
close
nonfunct
also
note
blood
whole
length
portal
vein
forc
flow
toward
liver
ie
hepatopet
flow
direct
establish
normal
perfus
sinusoid
portion
splenic
venou
blood
continu
flow
attenu
shunt
cvc
splenic
blood
contain
toxin
system
vein
hyperammonemia
develop
right
grant
includ
figur
electron
media
pleas
refer
print
public
right
grant
includ
figur
electron
media
pleas
refer
print
public
right
grant
includ
figur
electron
media
pleas
refer
print
public
pine
receptor
increas
effect
gaba
gaba
areceptor
cornerston
therapi
case
cpss
definit
surgic
therapi
case
apsc
highqual
lowprotein
diet
commerci
avail
renal
prescript
diet
ideal
prefer
hepat
diet
protein
content
higher
latter
decreas
colon
transit
time
reduc
product
ammonia
oral
administr
lactulos
recommend
dosag
lactulos
titrat
individu
patient
yield
soft
fece
diarrhea
initi
dosag
mlkg
recommend
diarrhea
result
dosag
reduc
lactulos
also
stimul
growth
colon
bacteria
incorpor
ammonia
bacteri
protein
addit
use
antibiot
eg
neomycin
metronidazol
recommend
diminish
ammoniaproduc
colon
flora
antibiot
administr
usual
necessari
control
clinic
sign
moreov
neomycin
thought
antagon
action
lactulos
may
caus
releas
endotoxin
furthermor
chronic
antibiot
use
may
contribut
develop
antibiot
resist
surgic
closur
apsc
gener
imposs
multipl
natur
also
contraind
apsc
usual
compensatori
mechan
resolv
high
portal
venou
pressur
surgic
narrow
ie
band
caudal
vena
cava
reduc
shunt
increas
caval
pressur
current
recommend
case
cpsss
attenu
complet
closur
shunt
vein
choic
treatment
goal
shunt
occlus
reduc
portal
flow
via
cpss
b
simultan
increas
portal
venou
perfus
liver
shunt
attenu
close
possibl
point
enter
system
circul
attenu
intrahepat
cpss
riski
possibl
major
bleed
excess
dissect
hepat
parenchyma
sever
techniqu
describ
none
perfect
major
problem
shunt
reduct
blood
portal
vein
redirect
newli
perfus
liver
vasculatur
poorli
develop
portal
branch
insuffici
capac
accept
even
normal
amount
portal
venou
blood
case
complet
shunt
occlus
splanchnic
congest
develop
goal
surgeri
suffici
reduc
amount
shunt
blood
without
caus
portal
hypertens
develop
although
complet
shunt
occlus
would
theoret
ideal
partial
shunt
attenu
often
suffici
partial
attenu
often
result
function
closur
see
figur
moreov
b
complet
anatom
occlus
may
follow
mani
case
partial
occlus
extrahepat
cpsss
often
result
better
outcom
chanc
develop
postlig
portal
hypertens
much
smaller
compar
complet
occlus
liver
may
less
normal
size
grow
quickli
follow
success
surgeri
regener
may
take
week
complet
uncompl
case
regener
liver
receiv
progress
portal
blood
flow
usual
result
spontan
complet
closur
cpss
helic
ct
especi
multiscal
version
make
excel
imag
abdomin
vasculatur
includ
cpss
rel
quickli
intraven
inject
iodin
contrast
agent
threedimension
reconstruct
provid
impress
anatom
detail
shunt
vessel
drawback
limit
avail
newgener
scanner
need
patient
anesthesia
although
magnet
reson
angiographi
provid
highqual
imag
abdomin
vessel
becom
popular
limit
avail
high
cost
patent
requir
gener
anesthesia
examin
last
longer
ct
angiographi
characterist
mri
chang
describ
brain
dog
cat
cpss
find
research
clinic
interest
histopatholog
examin
liver
biopsi
specimen
essenti
identifi
underli
diseas
process
intrahepat
portal
hypertens
disord
routin
diagnost
workup
canin
cpss
liver
histopatholog
give
addit
inform
current
presenc
coexist
phpv
diagnos
preoper
dog
cpss
histolog
find
liver
biopsi
ident
follow
condit
cpss
phpv
cpss
phpv
congenit
arterioport
fistula
prehepat
portal
hypertens
disord
eg
portal
vein
thrombosi
howev
take
liver
biopsi
histopatholog
examin
recommend
cat
decid
surgic
closur
cpss
congenit
hepat
fibrosi
part
pkd
present
simultan
especi
persian
persian
crossbre
surgic
shunt
attenu
recommend
congenit
hepat
fibrosi
cpss
simultan
present
cat
patient
grade
may
present
emerg
basi
sourc
ammonia
protein
breakdown
product
caus
clinic
sign
colon
purpos
treatment
reduc
product
amount
ammonia
colon
remov
content
warm
water
enema
b
inhibit
absorpt
ammonia
administ
lactulos
syrup
empti
colon
lactulos
may
given
retent
enema
soft
feed
tube
mlkg
deep
rectal
lactulos
nonabsorb
disaccharid
metabol
colon
bacteria
shortchain
fatti
acid
fatti
acid
acidifi
intralumin
content
caus
form
ammonium
ion
nh
ammonia
nh
polar
nh
pass
enterocyst
membran
instead
trap
colon
lumen
also
essenti
c
correct
acidbas
electrolyt
disord
patient
iv
fluid
therapi
alkalosi
hypokalemia
worsen
sign
seizur
caus
control
intraven
propofol
administr
benzodiazepin
eg
diazepam
barbitur
avoid
worsen
clinic
sign
bind
benzodiazepin
molecul
neuron
benzodiaz
acut
portal
hypertens
variabl
degre
portal
hypertens
necessarili
develop
subsequ
cpss
attenu
portal
hypertens
sever
circulatori
collaps
may
develop
sequestr
blood
splanchnic
vein
slight
abdomin
enlarg
result
ascit
requir
intervent
usual
resolv
spontan
within
week
surgeri
sever
ascit
sign
shock
eg
depress
tachycardia
hypotens
prolong
capillari
refil
time
hemorrhag
diarrhea
necessit
emerg
surgeri
remov
ligatur
constrictor
ring
around
shunt
sign
usual
develop
within
hour
postop
unfortun
prognosi
follow
emerg
surgeri
poor
portal
vein
thrombosi
rare
postop
complic
caus
sudden
onset
shock
usual
within
sever
day
shunt
attenu
exagger
shunt
occlus
sever
portal
hypertens
stasi
portal
venou
blood
believ
caus
thrombosi
surviv
report
chronic
portal
hypertens
growth
liver
develop
portal
branch
insuffici
follow
partial
shunt
closur
chronic
portal
hypertens
may
induc
format
apsc
may
occur
late
week
postop
case
evalu
usual
reveal
partial
patent
shunt
increas
portosystem
shunt
result
newli
form
apsc
develop
apsc
document
surgic
method
apsc
develop
result
underdevelop
portal
branch
exagger
shunt
attenu
dog
apsc
remain
clinic
silent
hepat
mass
substanti
increas
follow
shunt
attentu
patient
reevalu
month
shunt
attenu
measur
fast
blood
ammonia
concentr
perform
abdomin
ultrasonographi
fast
blood
ammonia
concentr
within
refer
rang
rectal
att
perform
fast
hyperammonemia
present
att
abnorm
ultrasonographi
identifi
whether
shunt
occur
via
narrow
cpss
apsc
latter
case
lifelong
conserv
therapi
dietari
modif
lactulos
recommend
normal
att
result
impli
complet
shunt
occlus
pet
gener
favor
prognosi
second
surgeri
reach
shunt
attenu
attempt
patient
persist
clinic
sign
high
fast
blood
ammonia
concentr
abnorm
rectal
att
result
month
first
surgeri
spontan
gradual
shunt
closur
would
occur
beyond
month
surgic
ligat
rare
usual
fatal
complic
shunt
attenu
caus
gener
seizur
day
postop
almost
exclus
cat
smallbre
dog
often
maltes
dog
occurr
unpredict
pathogenesi
unknown
sudden
decreas
endogen
benzodiazepin
ligand
thought
play
role
ie
benzodiazepin
withdraw
syndrom
cerebr
edema
suspect
initi
disord
intraven
mannitol
gkg
iv
minut
may
administ
patient
show
subtl
central
neurolog
sign
first
three
postop
day
seizur
develop
prognosi
usual
poor
patient
euthan
uncontrol
seizur
persist
neurolog
defect
propofol
gradual
shunt
attenu
believ
reduc
risk
portal
hypertens
allow
portal
venou
branch
adapt
gradual
increas
flow
apsc
develop
gradual
shunt
attenu
techniqu
eg
cellophan
band
ameroid
constrictor
ring
cystic
calculi
remov
surgic
procedur
resolut
ammonium
biurat
urolith
dietari
manag
achiev
case
shunt
vessel
identifi
midlin
laparotomi
narrow
complet
occlud
nonabsorb
ligatur
portal
hypertens
determin
direct
measur
estim
base
subject
criteria
includ
sever
intestin
cyanosi
increas
intestin
peristalsi
reduct
arteri
blood
pressur
compensatori
tachycardia
result
stasi
splanchnic
circul
intraop
doppler
ultrasonographi
greatli
facilit
determin
optim
degre
shunt
attenu
extrahepat
cpss
help
prevent
sever
portal
hypertens
cellophan
band
instead
ligatur
threelayerthick
cellophan
band
place
around
shunt
vessel
without
narrow
shunt
diamet
gradual
shunt
occlus
take
place
result
inflamm
induc
cellophan
ameroid
constrictor
ring
metal
ring
fill
thick
layer
casein
place
around
shunt
vessel
swell
casein
occur
absorb
fluid
outer
metal
ring
casein
expand
centripet
caus
gradual
occlus
shunt
month
major
drawback
simpl
techniqu
rate
magnitud
occlus
uncontrol
kink
caus
weight
devic
may
caus
acut
fatal
portal
hypertens
moreov
rel
larg
size
easili
appli
extrahepat
cpss
laparoscopi
laparoscop
shunt
narrow
clip
lessinvas
altern
shunt
ligat
see
chapter
minim
invas
intravascular
techniqu
metal
spiral
thrombogen
fiber
place
shunt
vessel
coil
deliv
via
cathet
insert
jugular
vein
shunt
fluoroscop
guidanc
anesthet
anim
coil
caus
thrombu
format
shunt
result
partial
complet
occlus
prevent
coil
dislodg
shunt
intravascular
stent
often
place
caudal
vena
cava
cover
point
shunt
enter
caudal
vena
cava
coil
especi
attract
method
treat
intrahepat
shunt
liver
dissect
therebi
avoid
opinion
safest
effect
way
attenu
extrahepat
cpss
doppler
ultrasoundguid
partial
attenu
via
surgic
ligatur
intrahepat
cpss
coil
embol
appear
excel
method
ameroid
constrictor
cellophan
band
would
ideal
extrahepat
cpss
portal
vein
cranial
shunt
origin
sever
hypoplast
patient
risk
sever
portal
hypertens
spironolacton
alon
resolv
ascit
furosemid
may
ad
therapi
abdominocentesi
remov
abdomin
effus
recommend
loss
protein
exacerb
starl
forc
permit
fluid
accumul
dietari
medic
manag
reliev
clinic
sign
temporarili
symptomat
young
dog
without
surgic
shunt
attenu
gradual
deterior
liver
function
occur
consequ
conserv
therapi
alon
offer
guard
prognosi
young
dog
older
anim
year
newli
report
sign
cpss
lifelong
conserv
treatment
may
recommend
significantli
higher
complic
rate
surgic
therapi
patient
prognosi
depend
whether
cpss
intraor
extrahepat
b
coexist
phpv
c
extent
shunt
attenu
experi
surgeon
e
age
dog
time
diagnosi
intrahepat
cpss
gener
poorer
prognosi
complet
resolut
clinic
sign
expect
approxim
dog
extrahepat
cpss
hand
experienc
surgeon
paramet
approxim
intrahepat
cpss
extrahepat
cpss
excel
prognosi
expect
blood
flow
hepatopet
ie
toward
liver
portal
vein
segment
cranial
shunt
origin
establish
preoper
doppler
ultrasound
cat
regardless
shunt
type
surgic
method
success
rate
approxim
develop
postop
central
neurolog
sign
prognosi
portal
hypertens
disord
depend
underli
diseas
major
acquir
diseas
underli
disord
chronic
sever
even
stop
diseas
process
caus
regress
apsc
primari
liver
neoplasm
infrequ
dog
cat
estim
preval
necropsi
studi
dog
cat
liver
metastas
frequent
primari
hepat
tumor
dog
tend
origin
spleen
pancrea
gi
tract
primari
hepatobiliari
tumor
common
metastat
diseas
cat
etiolog
liver
cancer
dog
cat
incomplet
understood
potenti
caus
aflatoxin
nitrosamin
food
addit
parasit
radioact
compound
report
liver
cancer
dog
mani
clinic
patholog
histolog
homolog
liver
cancer
human
human
medicin
chronic
diseas
liver
hepat
b
c
infect
well
cirrhosi
often
associ
mgkg
iv
follow
constant
rate
infus
cri
may
use
control
seizur
prophylact
treatment
phenobarbit
reduc
risk
develop
postlig
neurolog
complic
may
use
longterm
seizur
manag
prevent
use
potassium
bromid
shown
reduc
possibl
postop
seizur
everi
patient
central
neurolog
sign
earli
postop
period
hypoglycemia
exclud
measur
venou
glucos
ammonia
concentr
respect
blind
type
central
neurolog
sign
may
develop
cat
shortli
surgeri
pathogenesi
chang
unknown
hemorrhag
liver
biopsi
site
shunt
dissect
case
intrahepat
cpss
lead
hypovolem
shock
death
earli
postop
period
dog
hepat
insuffici
prone
develop
hemorrhag
complic
decreas
concentr
abnorm
synthesi
coagul
factor
postop
portal
hypertens
may
also
contribut
bleed
tendenc
hepat
parenchym
dissect
hemoabdomen
care
differenti
sever
portal
hypertens
septic
periton
caus
shock
variabl
degre
abdomin
distent
coagul
paramet
eg
pt
aptt
routin
monitor
surgeri
abnorm
evid
clinic
bleed
freshfrozen
plasma
transfus
administ
mlkg
iv
toybre
dog
prone
develop
hypoglycemia
shortli
surgeri
blood
glucos
concentr
regularli
monitor
hypoglycemia
treat
glucosecontain
infus
specif
treatment
address
underli
parenchym
liver
diseas
base
histolog
result
liver
biopsi
often
control
dietari
modif
lactulos
current
specif
treatment
exist
portal
venou
hypoplasia
renal
hepat
prescript
diet
lactulos
may
allevi
clinic
sign
case
apsc
diuret
agent
may
use
dog
ascit
liver
lobe
resect
report
anim
congenit
arterioport
fistula
howev
simultan
presenc
phpv
whole
liver
prevent
postop
resolut
portal
hypertens
portosystem
shunt
via
apsc
therefor
pet
owner
educ
partial
hepatectomi
may
result
complet
recoveri
portosystem
shunt
lifelong
dietari
support
andor
lactulos
like
requir
sever
abdomin
effus
treat
diuret
agent
first
choic
spironolacton
mgkg
aldosteron
receptor
antagonist
chronic
hepat
insuffici
associ
hyperaldosteron
b
concurr
hypercortisolemia
associ
cortisol
bind
mineralocorticoid
receptor
c
potassiumspar
diuret
prevent
develop
hypokalemia
alkalosi
would
worsen
sign
show
clinic
sign
liver
cancer
suspect
increas
serum
liver
enzym
activ
common
physic
examin
find
cranial
abdomin
mass
abdomin
bloat
jaundic
jaundic
less
common
find
case
metastat
cancer
manifest
includ
neurolog
sign
result
paraneoplast
syndrom
hypoglycemia
myasthenia
gravi
skin
alter
consist
hepatocutan
syndrom
clear
breed
predisposit
observ
canin
liver
cancer
although
poodl
fox
terrier
miniatur
schnauzer
labrador
retriev
male
dog
overrepres
report
hepatocellular
carcinoma
labrador
retriev
femal
dog
overrepres
report
bile
duct
carcinoma
whether
male
femal
cat
equal
risk
bile
duct
carcinoma
unsettl
male
cat
appear
greater
risk
bile
duct
adenoma
neuroendocrin
tumor
gener
observ
younger
anim
diagnosi
definit
diagnosi
liver
cancer
made
liver
biopsi
asymmetr
enlarg
liver
detect
physic
examin
abdomin
ultrasonographi
survey
radiographi
assum
neoplast
origin
similarli
laboratori
data
distinguish
hepat
neoplasia
liver
patholog
clinic
approach
anim
suspect
liver
cancer
includ
basic
inform
complet
blood
cell
count
serum
biochemistri
coagul
test
urinalysi
thorac
abdomin
radiograph
abdomin
ultrasound
figur
fineneedl
core
biopsi
liver
tnm
tumor
classif
system
use
stage
liver
cancer
repres
tumor
evid
tumor
hepatocellular
tumor
howev
establish
associ
hepat
tumor
viral
infect
dog
cat
moreov
canin
hepat
cirrhosi
appear
predispos
hepatocellular
carcinoma
hcc
possibl
associ
hookworm
whipworm
infect
liver
cancer
report
cat
chronic
cholang
may
increas
predisposit
biliari
carcinoma
sever
liver
mitogen
tumor
suppressor
gene
epiderm
growth
factor
vascular
endotheli
growth
factor
vegf
receptor
associ
liver
cancer
human
may
play
similar
role
dog
human
medicin
small
percentag
hcc
cholangiocarcinoma
origin
hepat
progenitor
stem
cell
dog
diagnos
hcc
cholangiocarcinoma
demonstr
activ
hepat
progenitor
stem
cell
respons
liver
injuri
hepat
progenitor
stem
cell
express
liver
tumor
rel
low
hypothesi
cancer
develop
multistep
process
appli
liver
tumor
dog
cat
well
precancer
lesion
dysplast
nodul
identifi
develop
overt
malign
human
dysplast
nodul
character
cell
atypia
cellular
crowd
trabecular
thick
microacini
histochem
marker
dysplast
nodul
report
dog
cat
studi
need
understand
chronolog
hepat
malign
domest
anim
preliminari
report
histochem
marker
report
dog
hyperplast
hepat
lesion
hepatocellular
biliari
neoplasm
liver
tumor
caus
damag
liver
sever
mechan
inflammatori
effect
obstruct
biliari
system
obstruct
vascular
compart
adjac
organ
spontan
ruptur
hemoabdomen
hepat
tumor
usual
resist
chemotherapi
one
recent
studi
pglycoprotein
highli
express
hcc
cirrhosi
consist
known
resist
hcc
chemotherapi
pglycoprotein
encod
multidrug
resist
gene
normal
express
tissu
excretori
function
includ
jejunum
kidney
liver
adren
gland
primari
liver
neoplasm
usual
classifi
accord
cellular
origin
macroscop
appear
respect
cellular
origin
tumor
may
hepatobiliari
hematopoiet
sarcoma
metastas
tumor
box
relat
macroscop
appear
classifi
lobular
multipl
nodular
diffus
combin
histopatholog
morpholog
classif
consequ
prognosi
treatment
strategi
anim
tabl
clinician
must
alway
address
factor
arriv
correct
manag
decis
dog
malign
tumor
common
benign
lesion
cat
biliari
neoplasm
common
present
particularli
intrahepat
benign
form
anim
liver
neoplasia
present
nonspecif
clinic
sign
anorexia
weight
loss
lessfrequ
clinic
sign
includ
vomit
diarrhea
pd
pu
pale
mucos
membran
acut
weak
anemia
hypovolemia
coincid
tumor
ruptur
affect
anim
diffus
infiltr
multipl
coalesc
nodul
lobe
diffus
disappear
liver
parenchyma
lobular
nodul
larg
mass
singl
liver
lobe
nodular
sever
nodul
throughout
liver
parenchyma
sever
affect
liver
lobe
tumor
involv
one
lobe
tumor
involv
one
lobe
tumor
invad
neighbor
structur
n
repres
region
lymph
node
rln
evid
rln
involv
rln
involv
distant
ln
involv
repres
distant
metastasi
evid
metastasi
distant
metastasi
detect
although
recommend
system
univers
adopt
tabl
illustr
typic
hematolog
biochem
find
dog
cat
affect
liver
neoplasia
leukocytosi
result
inflamm
necrosi
larg
tumor
anemia
tend
moder
nonregen
thought
caus
chronic
ill
inflamm
iron
defici
thrombocytosi
attribut
paraneoplast
syndrom
character
thrombopoietin
product
iron
defici
anemia
serum
liver
enzym
elev
frequent
univers
find
anim
liver
neoplasia
note
howev
degre
serum
enzym
elev
correl
degre
liver
involv
sever
diseas
one
survey
anim
primari
liver
tumor
tend
greater
elev
serum
alt
alp
activ
anim
metastat
diseas
latter
tend
greater
elev
serum
bilirubin
ast
also
suggest
asttoalt
ratio
less
compat
carcinoma
ratio
greater
indic
sarcoma
carcinoid
report
biochem
chang
includ
hypoglycemia
hypoor
hyperalbuminemia
increas
serum
bile
acid
hypoglycemia
paraneoplast
syndrom
associ
hepatocellular
carcinoma
attribut
secret
insulinlik
growth
factor
ii
unlik
dog
cat
usual
present
high
incid
serum
creatinin
bun
elev
coagul
factor
abnorm
commonli
associ
hemangiosarcoma
although
dic
may
evid
endstag
liver
cancer
decompens
patient
coagul
studi
alway
perform
undertak
invas
diagnost
procedur
serum
evalu
dog
increas
report
anim
hepatocellular
carcinoma
biliari
carcinoma
use
biomark
limit
fact
increas
case
hepat
lymphoma
liver
patholog
dramat
elev
may
taken
indic
hepatocellular
carcinoma
abdomin
radiograph
often
reveal
mass
effect
cranial
abdomen
although
find
depend
upon
size
neoplasm
number
size
metastat
tumor
report
find
includ
dorsal
displac
stomach
hepatomegali
loss
abdomin
detail
presenc
free
abdomin
fluid
occasion
biliari
tract
calcif
thorac
radiographi
consid
part
stage
procedur
anim
metastat
diseas
chang
ultrasound
densiti
liver
may
take
varieti
form
box
chang
pathognomon
given
diseas
process
final
diagnosi
establish
basi
clinic
find
laboratori
test
result
cytolog
histopatholog
see
ultrasound
also
use
evalu
abdomin
structur
stage
cancer
diffus
multifoc
liver
neoplasm
tend
present
hepatomegali
depend
degre
infiltr
liver
carcinoma
diffus
affect
multipl
lobe
variabl
ultrasound
characterist
depend
presenc
necrosi
inflamm
hemorrhag
cavit
malign
tumor
common
observ
mix
echogen
pattern
lymphoma
affect
liver
without
detect
ultrasound
chang
caus
diffus
hypoechogen
hyperechogen
mix
echogen
without
hypoecho
nodul
consequ
lymphoma
suspect
even
liver
ultrasound
find
appear
normal
fineneedl
aspir
cytolog
recommend
histiocyt
neoplasm
often
associ
multipl
nodul
hypoecho
mass
although
diffus
liver
hypoechogen
also
describ
mast
cell
infiltr
liver
tend
produc
diffus
hyperechogen
nodular
pattern
benign
nodular
hyperplasia
common
particularli
dog
account
mani
focal
liver
lesion
identifi
ultrasound
explor
estim
nodular
mass
detect
liver
nodular
hyperplasia
benign
liver
adenoma
hepatoma
manifest
focal
mass
variabl
size
normal
hyperecho
characterist
liver
frequent
locat
metastat
spread
fundament
portal
system
drain
abdomin
structur
primari
liver
neoplasm
hepatocellular
carcinoma
present
focal
multifoc
mass
although
less
often
case
metastas
focal
hypoecho
lesion
hyperecho
center
core
refer
target
bullsey
lesion
usual
associ
metastas
although
benign
process
nodular
hyperplasia
gener
similar
pattern
biliari
obstruct
ultrasound
becom
import
tool
evalu
biliari
obstruct
icter
dog
cat
primari
tumor
liver
biliari
tract
duodenum
pancrea
capabl
caus
biliari
obstruct
liver
cytolog
obviou
limit
distinguish
liver
adenoma
regen
nodul
even
hepatocellular
carcinoma
aspir
may
compos
entir
normalappear
hepatocyt
mani
case
may
prove
necessari
resort
ultrasoundguid
biopsi
laparoscopi
exploratori
laparotomi
howev
cytolog
may
prove
use
determin
presenc
lymphoma
mastocytoma
histiocyt
sarcoma
well
contribut
initi
classif
tumor
type
concord
rate
cytolog
histopatholog
find
may
good
diseas
process
report
concord
rate
vari
treatment
provid
prognosi
anim
primari
liver
cancer
depend
cell
origin
degre
malign
clinic
present
clinician
quickli
determin
surgeri
chemotherapi
radiat
therapi
palli
care
treatment
choic
individu
patient
palli
treatment
option
anim
surgic
candid
exampl
tumor
poor
respons
system
chemotherapi
pain
manag
gener
liver
failur
treatment
best
recommend
success
newer
option
chemoembol
metronom
therapi
antiangiogen
drug
tyrosin
kinas
inhibitor
treatment
patient
clearli
establish
macroscop
present
clinic
import
see
figur
diffus
form
metastasi
time
diagnosi
versu
isol
massiv
nodular
clinic
present
note
howev
dog
massiv
hcc
present
without
metastasi
death
case
may
unrel
hcc
histopatholog
subtyp
anaplast
characterist
gener
influenc
prognosi
predict
metastasi
metastat
spread
usual
affect
region
lymph
node
lung
peritoneum
highfield
mri
scan
accuraci
differenti
malign
benign
lesion
sensit
specif
respect
mri
classifi
malign
hepat
lesion
hcc
confirm
case
correctli
predict
histolog
grade
five
hcc
lesion
result
suggest
mri
use
modal
abdomin
imag
veterinari
patient
mri
accur
differenti
benign
malign
focal
hepat
lesion
liver
cytolog
use
initi
evalu
hepatomegali
usual
permit
differenti
primari
tumor
metastat
diseas
focal
infect
see
howev
cytolog
distinguish
benign
focal
inflammatori
diseas
progress
chronic
liver
diseas
establish
extent
distribut
diseas
likewis
definit
diagnosi
regen
nodular
hyperplasia
establish
techniqu
unabl
differenti
benign
inflammatori
reaction
cell
chang
associ
patholog
contraind
ultrasoundguid
cytolog
includ
follow
coagul
abnormalitiesif
one
coagul
test
paramet
alter
advis
administ
vitamin
k
via
subcutan
rout
hour
cytolog
cavitari
massesth
ultrasound
detect
larg
cavitari
lesion
elderli
dog
usual
contraind
cytolog
b
tumor
common
cat
three
morpholog
form
present
describ
lobular
multifoc
diffus
gener
lobular
form
consid
surgic
remov
long
evid
metastasi
prognosi
multifoc
diffus
bile
duct
carcinoma
poor
surgeri
usual
feasibl
anim
die
within
month
surgeri
effect
chemotherapeut
option
describ
malign
dog
cat
also
known
biliari
cystadenoma
biliari
adenoma
cholangiocellular
adenoma
cholangioma
tumor
common
find
age
cat
male
appear
frequent
affect
femal
figur
cat
lesion
isol
lobular
multifoc
biliari
duct
adenoma
usual
caus
clinic
sign
unless
grow
compress
structur
despit
benign
natur
tumor
surgic
remov
usual
recommend
malign
transform
alway
possibl
expans
porta
hepati
may
caus
lifethreaten
consequ
liver
lobectomi
recommend
cat
singl
bile
duct
adenoma
multifoc
tumor
confin
one
two
lobe
cat
surgic
resect
biliari
adenoma
may
provid
cure
tumorfre
surviv
sever
year
carcinoid
tumor
neuroendocrin
carcinoid
tumor
infrequ
dog
cat
dog
carcinoid
aggress
biolog
behavior
usual
amen
surgic
resect
tend
present
diffus
lesion
see
figur
carcinoid
tumor
dog
also
describ
gallbladd
manag
success
cholecystectomi
carcinoid
tumor
cat
intrahepat
extrahepat
involv
bile
duct
occasion
gallbladd
extrahepat
form
carcinoid
tumor
may
caus
biliari
tract
obstruct
icteru
increas
serum
hepat
enzym
activ
biliari
tract
divers
procedur
consid
obstruct
lesion
involv
extrahepat
biliari
tract
unlik
circumst
dog
human
femal
cat
often
affect
tumor
male
femaletomal
ratio
prognosi
carcinoid
liver
tumor
dog
cat
gener
poor
metastat
diseas
present
case
prognost
factor
dog
massiv
hcc
includ
need
surgeri
liver
lobe
involv
serum
alt
ast
activ
ratio
alp
ast
alt
ast
liver
lobectomi
recommend
cat
dog
hepat
tumor
massiv
morpholog
appear
without
metastas
howev
surgic
complic
report
case
mortal
rate
almost
predilect
massiv
hcc
leftsid
liver
lobe
report
advanc
imag
intraop
ultrasonographi
may
provid
use
inform
relationship
rightsid
central
liver
tumor
caudal
vena
cava
prior
liver
lobectomi
even
though
rightsid
liver
tumor
poorer
prognosi
intraop
death
differ
surviv
time
success
surgeri
consider
regen
capac
liver
permit
success
resect
hepat
mass
remain
tissu
function
normal
critic
support
care
provid
median
surviv
time
dog
massiv
hcc
follow
liver
lobectomi
greater
year
without
surgeri
averag
life
expect
day
prognosi
gener
consid
poor
tumor
recurr
dog
massiv
hcc
rare
report
lobectomi
prognosi
dog
nodular
diffus
hcc
poor
surgic
resect
usual
possibl
involv
multipl
liver
lobe
effect
system
chemotherapi
radiat
therapi
protocol
describ
hcc
treatment
hcc
consid
chemoresist
human
although
mitoxantron
report
help
case
like
reason
poor
respons
system
chemotherapi
express
pglycoprotein
hepatocyt
treatment
option
nodular
diffus
hcc
human
includ
liver
transplant
minim
invas
procedur
region
control
ablat
chemoembol
immunotherapi
hormon
therapi
lowdos
metronom
chemotherapi
recent
report
recommend
therapi
sorafenib
multikinas
inhibitor
antiangiogen
agent
chemoembol
procedur
commonli
use
treatment
diffus
hepatocellular
carcinoma
human
median
surviv
time
year
compar
month
system
chemotherapi
veterinari
medicin
chemoembol
report
moder
success
palliat
four
dog
hcc
cat
hepatocellular
carcinoma
less
frequent
less
data
avail
hepatocellular
adenoma
tumor
also
known
hepatoma
common
cat
dog
dog
sometim
difficult
distinguish
adenoma
reactiv
nodular
hyperplasia
biopsi
need
clarifi
diagnosi
prognosi
adenoma
usual
good
advis
remov
focal
mass
lesion
grow
spontan
ruptur
sever
bleed
bile
duct
carcinoma
adenocarcinoma
cholangiocarcinoma
bile
duct
carcinoma
common
liver
malign
cat
second
common
liver
malign
dog
see
figur
tumor
behavior
aggress
speci
metastas
present
time
diagnosi
case
bile
duct
carcinoma
usual
metastas
region
lymph
node
lung
peritoneum
kidney
heart
adren
gland
eye
bone
bile
duct
carcinoma
intrahepat
extrahepat
rare
occur
within
gallbladd
intrahepat
bile
duct
tumor
common
dog
extrahepat
bile
duct
must
alway
consid
possibl
hepat
tumor
diagnos
benign
mesenchym
neoplasm
fibroma
hemangioma
describ
quit
rare
lymphoma
dog
liver
involv
variabl
form
lymphoma
includ
multicentr
alimentari
hepatosplen
form
studi
cat
document
abdomin
lymphoma
current
common
anatom
locat
liver
occasion
organ
involv
mani
protocol
recommend
treatment
lymphoma
dog
cat
includ
vincristin
cyclophosphamid
prednison
variabl
combin
lasparaginas
methotrex
doxorubicin
care
evalu
liver
function
necessari
start
chemotherapi
mani
drug
undergo
hepat
metabol
alter
hepat
clearanc
may
lead
unpredict
potenti
increas
toxic
surgic
resect
liver
lobectomi
recommend
cat
primari
hepat
myelolipoma
prognosi
excel
prolong
surviv
time
report
local
recurr
dog
advanc
diseas
mast
cell
tumor
metastas
liver
primari
viscer
mast
cell
tumor
common
cat
dog
spleen
usual
primari
site
metastasi
liver
bone
marrow
surviv
time
splenectomi
alon
year
overal
prognosi
dissemin
mast
cell
tumor
dog
grave
median
surviv
time
report
one
studi
day
despit
therapi
variou
chemotherapi
agent
canin
mastocytoma
involv
liver
control
cyclophosphamid
vinblastin
prednison
recent
tyrosin
kinas
inhibitor
shown
promis
ccnu
shown
activ
felin
mast
cell
tumor
hepat
nodular
hyperplasia
common
benign
lesion
observ
liver
older
dog
occasion
observ
cat
character
discret
accumul
hyperplast
hepatocyt
aris
either
macroscop
microscop
hepat
nodul
reportedli
occur
dog
older
year
dog
year
wsava
standard
clinic
histolog
diagnosi
canin
felin
liver
diseas
includ
hepat
nodular
hyperplasia
classif
system
hepatocellular
neoplasia
may
differenti
true
neoplasia
etiolog
hepat
nodular
hyperplasia
unknown
suggest
preneoplast
lesion
yet
report
dog
hepatocyt
microscop
chang
suggest
nutrit
metabol
disord
play
role
pathogenesi
lesion
hepat
nodular
hyperplasia
character
microscop
welldifferenti
hyperplast
hepatocyt
increas
mitot
activ
hyperplast
nodul
may
accompani
concurr
focal
intrahepat
cholestasi
mechan
compress
higado
b
time
diagnosi
better
prognosi
observ
extrahepat
carcinoid
life
expect
year
liver
sarcoma
primari
liver
sarcoma
rare
dog
cat
hemangiosarcoma
frequent
primari
hepat
sarcoma
cat
leiomyosarcoma
common
dog
also
report
hepat
fibrosarcoma
rhabdomyosarcoma
osteosarcoma
liposarcoma
histiocyt
sarcoma
anim
speci
usual
aggress
tumor
metastas
case
spleen
lung
spread
diffus
within
liver
chemotherapi
studi
treatment
primari
hepat
sarcoma
although
similar
solid
sarcoma
respons
rate
like
poor
histiocyt
sarcoma
respond
partial
ccnu
mean
durat
remiss
day
surviv
day
continu
lowdos
oral
chemotherapi
may
effect
altern
convent
highdos
chemotherapi
adjuv
therapi
dog
hemangiosarcoma
mass
resect
may
offer
palliat
circumst
tumor
hemorrhag
despit
irrefut
evid
metastasi
cat
primari
extraskelet
hepat
osteosarcoma
treat
surgeri
carboplatin
aliv
month
diagnosi
clinic
evid
diseas
hand
metastas
felin
hepat
lipidosi
hl
metabol
syndrom
found
obes
middleag
cat
undergo
period
acut
anorexia
catabol
morbidli
obes
cat
increas
risk
cat
hl
suffer
underli
disord
contribut
initi
anorect
event
although
underli
pathogenesi
hepat
lipid
accumul
cat
yet
complet
elucid
sever
uniqu
biochem
nutrit
featur
place
oblig
carnivor
risk
fat
mobil
fatti
infiltr
liver
period
anorexia
starvat
box
gener
consensu
reduc
calor
intak
proteincalori
malnutrit
import
predispos
factor
result
rapid
mobil
peripher
fat
culmin
fatti
accumul
liver
intracellular
process
fat
import
function
hepatocyt
fast
starvat
fatti
acid
metabol
becom
derang
oblig
carnivor
result
obes
catabol
chronic
overnutrit
impair
fatti
acid
oxid
vldl
secret
enhanc
hepat
fatti
acid
synthesi
figur
hl
disord
middleag
older
cat
domest
shorthair
cat
commonli
affect
cat
hl
often
present
histori
acut
stress
andor
nearcomplet
anorexia
sever
day
durat
icteru
variabl
featur
hl
serum
bilirubin
concentr
exceed
mgdl
clinic
icteru
observ
pinna
mucou
membran
sclera
hard
palat
cat
gener
cat
hl
obes
time
present
mani
cat
ideal
bodi
weight
prior
episod
hl
physic
featur
hl
includ
hepatomegali
dehydr
vomit
weak
develop
consequ
hl
neurolog
abnorm
ptyalism
stupor
coma
ataxia
seizur
may
observ
minimum
databas
includ
complet
blood
cell
count
serum
chemistri
urinalysi
almost
alway
reveal
sever
liver
enzym
elev
abnorm
nonregen
anemia
stress
leukogram
poikilocytosi
bilirubin
crystalluria
pattern
liver
enzym
elev
typic
cholestat
natur
character
mark
increas
serum
alp
activ
follow
smaller
increas
serum
alt
serum
ast
activ
serum
ggt
activ
often
normal
affect
cat
increas
serum
bile
acid
bilirubin
often
observ
cat
hl
electrolyt
abnorm
hypophosphatemia
surround
hepat
parenchyma
well
alter
microvascular
circul
vacuolar
chang
seen
frequent
suggest
reactiv
metabol
condit
us
hyperadrenocortic
lipidosi
hypothyroid
nodular
hyperplasia
affect
older
dog
mean
age
year
without
gender
breed
predisposit
hepat
nodular
hyperplasia
appear
caus
clinic
sign
ill
laboratori
find
may
includ
mild
mark
increas
serum
alkalin
phosphatas
activ
less
commonli
increas
serum
alt
activ
liver
function
test
usual
normal
hepat
nodular
hyperplasia
hepat
nodular
hyperplasia
usual
discov
incident
find
diagnost
workup
medic
problem
nodular
hyperplasia
clinic
import
may
easili
confus
primari
metastat
hepat
neoplasia
abdomin
ultrasound
surgeri
even
microscop
may
imposs
differenti
hepat
nodular
hyperplasia
hepatocellular
adenoma
larg
sampl
wedg
rather
needl
biopsi
may
requir
confirm
hyperplasia
welldifferenti
hcc
routin
abdomin
radiograph
gener
unremark
ultrasonograph
featur
inconsist
vari
hepatocellular
morpholog
characterist
size
nodul
multipl
nodul
vari
size
distribut
randomli
among
liver
lobe
superfici
deep
within
parenchyma
found
case
hyperplas
nodul
hepatocyt
need
differenti
regen
nodul
hyperplas
nodul
develop
liver
normal
mass
wherea
regen
nodul
aris
result
compensatori
hyperplasia
surviv
hepatocyt
background
hepat
injuri
atrophi
fibrosi
treatment
usual
requir
ruptur
larg
nodul
may
requir
emerg
mass
remov
blood
transfus
rare
hepat
nodular
hyperplasia
signific
morbid
affect
patient
metabol
disord
liver
commonli
encount
companion
anim
practic
section
focus
metabol
liver
diseas
induc
concurr
endocrinopathi
hyperthyroid
hypothyroid
diabet
mellitu
hyperadrenocortic
lipid
disturb
lipoproteinemia
felin
hepat
lipidosi
hyperlipidemia
metabol
infiltr
amyloidosi
hepat
lipidosi
hyperthyroid
hepatopathi
primari
metabol
hepatopathi
cat
dog
steroid
glycogen
vacuolar
hepatopathi
frequent
metabol
liver
disord
diabet
hepatopathi
hyperlipidem
hepatopathi
lipoproteinemia
hypothyroid
occur
less
commonli
essenti
dietari
arginin
low
level
hepat
ornithin
high
dietari
protein
requir
lack
hepat
enzym
adapt
low
protein
insuffici
hepat
glutam
reductas
insuffici
intestin
ornithin
transcarbamylas
divers
orot
acid
metabol
differ
lipoprotein
metabol
hdl
kcalkg
bodi
weight
cat
unless
present
dietari
protein
restrict
ideal
protein
dri
matter
basi
even
protein
restrict
controversi
protein
need
support
hepat
regener
feed
multipl
small
frequent
meal
may
help
maintain
euglycemia
lessen
metabol
impact
liver
protein
content
diet
consid
present
see
chapter
dairi
vegetablebas
protein
higher
sourc
branchedchain
amino
acid
meatderiv
protein
may
lessen
sign
diet
high
fiber
gener
avoid
decreas
nutrient
densiti
diet
cat
hl
occasion
may
experi
refeed
syndrom
condit
result
metabol
electrolyt
disturb
reintroduct
food
insulin
secret
promot
intracellular
uptak
phosphoru
potassium
magnesium
hypophosphatemia
result
muscl
weak
hemolyt
anemia
gradual
reintroduct
food
correct
electrolyt
diminish
risk
refeed
syndrom
glucos
intoler
hyperglycemia
common
cat
hl
address
decreas
carbohydr
content
diet
can
lowcarbohydr
highprotein
formul
without
ad
fiber
ideal
treatment
felin
hl
provid
amino
acid
limit
carbohydr
water
easili
administ
feed
tube
small
amount
food
administ
via
feed
tube
residu
gastric
fluid
content
remov
trickl
feed
perform
place
liquefi
food
empti
fluid
bag
allow
graviti
forc
flow
feed
tube
altern
largebor
hypokalemia
may
frequent
observ
particular
presenc
hypophosphatemia
alert
clinician
possibl
refeed
syndrom
presumpt
diagnosi
felin
hl
made
basi
clinic
histori
physic
examin
clinicopatholog
featur
ultrasound
examin
liver
aspir
ultrasound
examin
liver
often
reveal
hepat
parenchyma
hyperecho
falciform
fat
thorough
ultrasound
evalu
gallbladd
pancrea
intestin
kidney
bladder
abdomin
structur
essenti
rule
primari
disord
acut
pancreat
necrosi
may
basi
anorect
event
precipit
episod
hl
definit
diagnosi
best
achiev
liver
biopsi
howev
anesthesia
biopsi
may
possibl
acut
ill
patient
presenc
coagulopathi
vitamin
k
defici
liver
aspir
reveal
fatti
infiltr
hepatocyt
may
use
presumpt
diagnosi
hl
respons
treatment
day
liver
biopsi
may
necessari
rule
underli
hepatobiliari
condit
cholang
catabol
state
develop
quickli
anorex
cat
prompt
measur
taken
place
enter
feed
tube
tabl
nasoesophag
esophag
gastrostomi
tube
use
purpos
calor
need
approxim
increas
serum
ast
alt
activ
report
approxim
hyperthyroid
cat
liver
enzym
elev
attribut
increas
liver
metabol
activ
compar
blood
flow
longterm
untreat
hyperthyroid
human
be
ultim
lead
cirrhosi
middleag
older
cat
typic
affect
breed
sex
predilect
hyperthyroid
character
hypermetabol
polyphagia
weight
loss
pd
pu
promin
featur
diseas
hyperact
tachycardia
pupillari
dilat
behavior
chang
also
characterist
diseas
associ
activ
sympathet
nervou
system
longstand
hyperthyroid
lead
hypertroph
cardiomyopathi
highoutput
heart
failur
cachexia
long
nail
dermatolog
condit
pant
elev
bodi
temperatur
poor
groom
overgroom
addit
clinic
sign
felin
hyperthyroid
clinicopatholog
featur
hyperthyroid
includ
erythrocytosi
stress
leukogram
neutrophilia
lymphocytosi
caus
increas
circul
catecholamin
concentr
increas
catabol
muscl
tissu
hyperthyroid
cat
may
result
increas
bun
serum
creatinin
cat
decreas
urin
specif
graviti
particularli
exhibit
pu
clinic
sign
increas
metabol
rate
result
liver
hypermetabol
therefor
serum
activ
liver
enzym
alt
ast
increas
hyperthyroid
cat
diagnosi
diagnosi
felin
hyperthyroid
achiev
measur
serum
total
thyroxin
tt
concentr
serum
thyroxin
concentr
elev
hyperthyroid
cat
make
sensit
test
thyroxineinduc
hypermetabol
falseposit
test
result
rare
nonexist
suggest
hyperthyroxinemia
specif
test
felin
hyperthyroid
clinic
hyperthyroid
cat
thyroid
hormon
still
fluctuat
daili
hourli
basi
hormon
concentr
intermitt
decreas
normal
rang
avoid
type
diagnost
error
clinician
repeat
blood
sampl
week
first
test
nonthyroid
diseas
signific
effect
circul
thyroid
hormon
concentr
case
persist
nonthyroid
ill
eg
renal
diseas
syring
attach
syring
pump
may
use
deliv
food
feed
tube
crystalloid
fluid
supplement
fortifi
b
vitamin
includ
thiamin
riboflavin
niacinamid
dpanthenol
pyridoxin
cyanocobalamin
use
nutrit
supplement
enhanc
antioxid
function
vitamin
e
glutathion
precursor
eg
may
also
benefici
amino
acid
supplement
support
hepat
regener
metabol
includ
carnitin
taurin
carnitin
function
transport
fatti
acid
hepat
mitochondria
energi
product
taurin
essenti
nutrient
cat
involv
cn
cardiac
biliari
function
sign
taurin
defici
may
similar
associ
antiemet
therapi
necessari
control
vomit
facilit
feed
appropri
type
quantiti
diet
see
chapter
inject
antiemet
maropit
cerenia
pfizer
anim
health
kalamazoo
mi
select
receptor
antagonist
dosag
mgkg
sc
iv
daili
basi
prefer
oral
maropit
dosag
oral
ondansetron
receptor
antagonist
dosag
mgkg
h
may
use
cat
largerbor
feed
tube
persist
vomit
investig
identifi
feed
tube
occlus
undiagnos
diseas
prognosi
depend
upon
durat
ill
time
frame
resolut
hepat
enzym
elev
hyperbilirubinemia
biochem
chang
cat
surviv
episod
hl
greater
reduct
liver
enzym
bilirubin
concentr
within
day
therapi
wherea
cat
die
usual
within
day
hospit
longterm
prognosi
recoveri
good
major
cat
resolut
hl
long
underli
diseas
process
eg
pancreat
identifi
treat
hyperthyroid
cat
caus
adenomat
hyperplasia
thyroid
gland
result
increas
circul
concentr
thyroxin
triiodothyronin
hyperthyroxinemia
increas
hepat
metabol
without
proportion
increas
hepat
blood
flow
overal
consequ
reduc
oxygen
deliveri
hepatocyt
characterist
lesion
superfici
necrolyt
dermat
hard
crack
foot
pad
elbow
pain
feet
caus
footpad
lesion
common
clinicopatholog
featur
includ
mild
nonregen
anemia
microcytosi
advanc
liver
dysfunct
increas
serum
liver
enzym
alp
alt
activ
hypoproteinemia
hypoalbuminemia
fast
hyperglycemia
serum
bile
acid
usual
increas
serum
glucagon
inconsist
elev
plasma
amino
acid
concentr
often
less
normal
diagnosi
abdomin
ultrasonographi
may
reveal
small
normal
increas
liver
size
howev
usual
characterist
swiss
chees
appear
hepat
parenchyma
result
hepat
degener
nodular
collaps
pancreat
imag
biopsi
indic
glucagonoma
suspect
symptomat
palli
therapi
may
benefici
includ
highprotein
diet
egg
white
approxim
egg
white
day
dog
zinc
mgkg
po
niacinamid
mgdog
po
ursodeoxychol
acid
mgkgday
po
vitamin
e
iukg
daili
po
mgkgday
po
hour
feed
fatti
acid
supplement
patient
respond
parenter
amino
acid
solut
aminosyn
abbott
laboratori
chicago
given
dose
ml
hour
intraven
largebor
central
venou
cathet
respons
observ
follow
initi
amino
acid
infus
therapi
repeat
everi
day
total
four
treatment
prognosi
poor
case
howev
remiss
longer
year
report
intens
amino
acid
hepat
support
therapi
steroid
hepatopathi
develop
follow
exogen
corticosteroid
therapi
endogen
hyperadrenocortic
pituitari
adren
origin
dog
liver
uniqu
suscept
glucocorticoidand
sex
steroidinduc
liver
enzym
elev
glycogen
accumul
vacuolar
degener
pathophysiolog
healthi
dog
glucocorticoid
administr
result
signific
liver
enzym
alp
alt
elev
day
increas
alp
ggt
activ
develop
parallel
enzym
undergo
induct
releas
sinusoid
canalicular
membran
within
day
glucocorticoid
administr
glucocorticoidinduc
alp
isoenzym
increas
significantli
glycogen
accumul
within
hepatocyt
result
vacuolar
degener
typic
syndrom
steroid
hepatopathi
occur
primarili
dog
one
report
case
steroid
hepatopathi
cat
histori
corticosteroid
administr
sign
consist
endogen
steroid
overproduct
cush
syndrom
usual
evid
exampl
pd
pu
pant
potbelli
appear
bilater
symmetr
alopecia
trunk
polyphagia
dog
affect
measur
unbound
thyroxin
free
may
prefer
repeat
tt
measur
free
concentr
sensit
test
diagnosi
hyperthyroid
hyperthyroid
cat
exhibit
elev
serum
free
concentr
specif
free
good
sensit
mani
euthyroid
cat
concurr
ill
high
free
concentr
reason
remain
unclear
result
free
use
screen
test
free
valu
interpret
light
tt
concentr
combin
high
free
low
tt
indic
nonthyroid
ill
howev
high
free
highnorm
tt
suggest
hyperthyroidisim
methimazol
tapazol
antithyroid
drug
often
recommend
mg
avail
transderm
gel
oral
tablet
methimazol
often
use
prepar
patient
surgic
thyroidectomi
radioiodin
therapi
antithyroid
drug
sever
side
effect
anorexia
vomit
common
side
effect
methimazol
wherea
rare
side
effect
includ
selfinduc
excori
face
thrombocytopenia
bleed
diathesi
agranulocytosi
develop
serum
antinuclear
antibodi
cholang
bleed
jaundic
agranulocytosi
necessit
immedi
withdraw
drug
hepat
injuri
relat
antithyroid
therapi
methimazol
well
document
human
report
cat
mild
histolog
chang
common
case
fulmin
hepat
failur
central
lobular
necrosi
describ
prognosi
excel
definit
therapi
hyperthyroid
surgeri
radioact
iodin
hepat
reaction
methimazol
necessit
discontinu
therapi
etiolog
unknown
hypoaminoacidemia
may
play
role
develop
diabet
hepatopathi
fatti
acid
niacin
zinc
defici
also
may
involv
pathogenesi
increas
serum
glucagon
origin
thought
caus
diabet
hepatopathi
found
onethird
report
case
much
stronger
associ
skin
lesion
superfici
necrolyt
dermat
glucagonoma
hyperglucagonemia
poorli
regul
diabet
mellitu
observ
human
dog
pathophysiolog
hepatopathi
thought
occur
secondari
metabol
abnorm
associ
diabet
mellitu
glucagonoma
nutrit
defici
hepat
featur
includ
vacuolar
hepatocyt
degener
hepat
parenchym
collaps
hepat
nodular
disord
seen
frequent
middleag
male
dog
report
one
cat
acut
present
may
includ
clinic
sign
vomit
diarrhea
lethargi
weight
loss
pd
pu
icteru
lame
dermatopathi
footpad
case
clinic
sign
mild
nonexist
physic
examin
may
reveal
poor
bodi
condit
lethargi
lipoproteinemia
etiolog
genet
abnorm
lipid
metabol
lead
diffus
vacuolar
hepatopathi
biliari
mucocel
increas
circul
cholesterol
triglycerid
caus
vacuolar
hepatopathi
associ
excess
lipid
accumul
andor
hepatocyt
glycogen
synthesi
storag
chronic
hypercholesterolemia
increas
biliari
cholesterol
content
predispos
cystic
hyperplasia
dysmotil
gallbladd
smooth
muscl
biliari
mucocel
famili
hypercholesterolemia
hyperlipidemia
found
certain
breed
dog
includ
miniatur
schnauzer
shetland
sheepdog
briard
west
highland
white
terrier
scottish
terrier
cairn
terrier
beagl
mixedbre
dog
may
also
affect
clinic
sign
usual
associ
necrot
cholecyst
may
includ
icteru
cranial
abdomin
pain
often
dog
asymptomat
biliari
mucocel
identifi
serendipit
ultrasound
evalu
medic
problem
pancreat
clinic
patholog
find
usual
includ
hypercholesterolemia
hypertriglyceridemia
elev
liver
enzym
activ
particularli
alp
necrot
cholecyst
may
accompani
leukocytosi
neutrophilia
hyperbilirubinemia
diagnosi
may
made
characterist
ultrasound
find
nongravit
gallbladd
sludg
increas
gallbladd
wall
thicken
kiwi
shape
mucos
imag
bior
trilaminar
appear
gallbladd
wall
hepat
parenchyma
may
pattern
multifoc
hyperechogen
hypoecho
nodul
best
treatment
biliari
mucocel
surgic
remov
mucocel
andor
cholecystectomi
may
becom
emerg
procedur
clinic
sign
necrot
cholecyst
sever
medic
therapi
follow
surgic
remov
usual
necessari
includ
fatrestrict
diet
lifelong
treatment
ursodeoxychol
acid
mgkg
po
prognosi
good
patient
undergo
success
remov
mucocel
long
lifelong
medic
therapi
continu
dog
cat
amyloid
deposit
usual
secondari
sustain
system
inflammatori
respons
exampl
chronic
infect
chronic
inflamm
immun
disord
malign
amyloidosi
famili
disord
chines
sharpei
dog
abyssinian
orient
siames
cat
hepat
amyloidosi
also
report
secondari
vitamin
toxic
cat
pathophysiolog
deposit
amyloid
fibril
within
hepat
sinusoid
result
progress
organ
dysfunct
light
deposit
found
space
diss
heavier
deposit
often
found
atyp
hyperadrenocortic
caus
sex
steroid
overproduct
dermatolog
chang
alopecia
poor
hair
coat
reproduct
manifest
perian
adenoma
castrat
male
femal
dog
often
sign
suggest
sex
steroid
imbal
atyp
hyperadrenocortic
sex
steroid
excess
may
present
clinic
sign
except
increas
serum
liver
enzym
activ
diagnosi
steroid
hepatopathi
base
histori
exogen
steroid
administr
endocrin
function
test
without
liver
biopsi
classic
liver
enzym
elev
consist
moder
mark
increas
alp
ggt
mild
moder
increas
alt
ast
bile
acid
may
also
increas
lowdos
dexamethason
suppress
ldd
test
consid
screen
test
choic
endogen
canin
hyperadrenocortic
ldd
test
high
sensit
dog
pdh
exhibit
suppress
cortisol
concentr
hour
addit
dog
pdh
exhibit
suppress
hour
follow
escap
suppress
hour
pattern
consid
diagnost
pdh
make
test
unnecessari
major
disadvantag
ldd
test
lack
specif
dog
nonadren
ill
corticotropin
acth
stimul
test
use
diagnos
varieti
adrenopath
condit
includ
endogen
iatrogen
hyperadrenocortic
well
spontan
hypoadrenocortic
screen
test
diagnosi
natur
occur
hyperadrenocortic
acth
respons
test
diagnost
sensit
approxim
higher
specif
ldd
test
studi
kaplan
peterson
dog
nonadren
diseas
exhibit
exagger
respons
acth
stimul
prefer
acth
respons
test
ldd
test
acth
respons
test
accur
diagnosi
iatrogen
hyperadrenocortic
histori
incomplet
sex
steroid
imbal
addit
pdh
adrenaldepend
hyperadrenocortic
urin
cortisoltocreatinin
ratio
uccr
highli
sensit
separ
normal
dog
hyperadrenocortic
howev
test
highli
specif
hyperadrenocortic
dog
moder
sever
nonadren
ill
also
exhibit
elev
ratio
elev
uccr
alway
confirm
ldd
test
uccr
test
urin
collect
day
baselin
uccr
anim
given
three
dose
dexamethason
mgkg
po
h
final
uccr
collect
hour
first
dose
dexamethason
failur
uccr
suppress
normal
rang
diagnost
hyperadrenocortic
treatment
exogen
hyperadrenocortic
consist
discontinu
exogen
steroid
slowli
wean
patient
prevent
develop
addisonian
crisi
treatment
endogen
hyperadrenocortic
achiev
chemotherapi
trilostan
surgeri
hypophysectomi
adrenalectomi
treatment
sex
steroid
imbal
achiev
mitotan
trilostan
prognosi
steroid
hepatopathi
good
excel
diagnos
earli
corticosteroid
injuri
abat
discontinu
steroid
therapi
treatment
underli
disord
threefold
increas
frequenc
hypothyroid
pathogenesi
stone
format
hypothyroid
believ
involv
hypercholesterolemia
gallbladd
dysmotil
bilirubin
retent
common
clinic
symptom
hypothyroid
lethargi
weight
gain
depress
hypothermia
bradycardia
gi
sign
reflux
esophag
gastric
atoni
constip
diarrhea
hepatopathi
mucocel
format
rare
clinic
sign
hypothyroid
dog
symmetr
truncal
tailhead
alopecia
classic
find
hypothyroid
anim
hyperkeratosi
hyperpigment
secondari
pyoderma
demodicosi
also
observ
clinicopatholog
find
normocyt
normochrom
anemia
hypertriglyceridemia
hypercholesterolemia
seen
major
hypothyroid
anim
alter
lipid
metabol
bind
protein
increas
hdl
decreas
fecal
excret
cholesterol
decreas
convers
lipid
bile
acid
total
serum
concentr
endogen
thyroidstimul
hormon
tsh
may
use
confirm
diagnosi
hypothyroid
combin
test
shown
highest
specif
sensit
lowest
overal
cost
tt
low
normal
normal
rang
tsh
high
anim
suffer
primari
hypothyroid
tt
tsh
low
free
dialysi
determin
distinguish
euthyroid
sick
syndrom
normal
free
true
secondari
hypothyroid
low
canin
thyroid
stimul
hormon
ctsh
result
pituitari
tsh
defici
treatment
synthet
thyroid
hormon
supplement
treatment
choic
hypothyroid
levothyroxin
sodium
therapi
start
dosag
mgkg
given
oral
twice
daili
thyroid
function
monitor
everi
week
first
month
treatment
twice
yearli
thereaft
stabl
wellcontrol
anim
total
treatment
may
given
daili
excel
clinic
result
long
adequ
peak
hormon
concentr
achiev
thyroid
hormon
replac
therapi
hypothyroid
dog
prognosi
excel
inflammatori
diseas
involv
intrahepat
bile
duct
commonli
encount
veterinari
practic
cholang
recogn
commonli
cat
dog
speci
affect
wsava
liver
standard
group
suggest
cholang
consid
follow
four
group
neutrophil
cholang
nc
lymphocyt
cholang
lc
chronic
cholang
associ
liver
fluke
infest
destruct
cholang
sinusoid
lumen
amyloid
fibril
readili
detect
routin
hematoxylin
eosin
diffquik
stain
amyloidosi
confirm
examin
congo
redstain
aspir
biopsi
polar
light
extracellular
materi
show
characterist
green
birefring
concurr
amyloid
deposit
kidney
liver
spleen
adren
gland
occur
clinic
manifest
liver
failur
common
chronic
progress
liver
failur
clinic
sign
anorexia
weight
loss
lethargi
typic
clinic
cours
mani
case
anim
may
instead
present
acut
collaps
follow
hepat
ruptur
intraabdomin
hemorrhag
pallor
mucou
membran
hypothermia
hepatomegali
frequent
recogn
physic
examin
find
typic
laboratori
find
includ
regen
anemia
leukocytosi
thrombocytopenia
mark
elev
serum
alt
ast
mark
prolong
aptt
pt
time
radiographi
use
detect
free
periton
fluid
hepatomegali
irregular
hepat
border
ultrasonographi
reveal
diffus
heterogen
echogen
highli
echogen
sparkl
area
hypoecho
foci
definit
diagnosi
requir
tissu
biopsi
congo
red
stain
specif
treatment
disord
colchicin
recommend
may
block
format
amyloid
earli
stage
diseas
unproven
benefit
associ
signific
side
effect
dimethyl
sulfoxid
recommend
may
promot
resorpt
amyloid
specif
therapi
diseas
treatment
instead
larg
symptomat
support
progress
amyloidosi
lesion
prognosi
longterm
surviv
poor
famili
hyperlipoproteinemia
report
cat
character
fast
hyperchylomicronemia
elev
circul
concentr
vldl
hypertriglyceridemia
serum
cholesterol
minim
elev
underli
biochem
lesion
reduct
activ
lipoprotein
lipas
disord
transmit
autosom
recess
gene
xanthoma
accumul
soft
tissu
includ
liver
clinic
sign
often
relat
involv
peripher
nerv
dietari
fat
restrict
improv
clinic
sign
affect
anim
etiolog
decreas
circul
thyroid
hormon
concentr
affect
hepat
metabol
cholesterol
turnov
liver
liver
function
test
mildli
disturb
almost
patient
hypothyroid
despit
normal
histolog
find
pathophysiolog
decreas
hepat
metabol
hypothyroid
reflect
reduc
oxygen
consumpt
patient
common
bile
duct
stone
gallbladd
stone
respect
sevenfold
infect
bile
commonli
identifi
cat
ehbdo
clinic
examin
previou
literatur
highlight
differ
clinic
present
cat
differ
form
cholang
howev
recogn
differ
variou
form
suggest
statist
signific
differ
cite
previous
hold
littl
clinic
relev
given
larg
degre
overlap
within
data
rang
nc
occur
cat
age
breed
sex
clinic
sign
nonspecif
includ
anorexia
lethargi
vomit
weight
loss
durat
clinic
sign
rang
day
month
may
shorter
cat
anc
cnc
consist
find
physic
examin
find
commonli
includ
dehydr
icteru
fever
present
case
report
suggest
fever
commonli
associ
anc
cnc
other
recogn
differ
hepatomegali
seen
fewer
half
case
abdomin
pain
note
occasion
diagnosi
definit
diagnosi
made
examin
liver
biopsi
specimen
ancillari
diagnost
provid
support
inform
hematolog
find
variabl
may
includ
poikilocytosi
neutrophilia
left
shift
although
abnorm
present
fewer
onethird
case
biochem
analysi
commonli
reveal
increas
activ
alt
ast
alp
ggt
rang
sever
mild
sever
howev
increas
liver
enzym
activ
may
absent
case
serum
total
bilirubin
increas
case
serum
cholesterol
may
becom
increas
case
ehbdo
imag
find
nonspecif
cholang
may
provid
use
inform
regard
concurr
diseas
abdomin
radiograph
rare
help
ultrasonograph
appear
liver
cat
nc
vari
greatli
common
abnorm
diffus
chang
echogen
rang
hypoto
hyperecho
dilat
intraand
extrahepat
bile
duct
gallbladd
distent
increas
gallbladd
sediment
thicken
gallbladd
bile
duct
wall
may
seen
gallbladd
distent
bile
duct
dilat
may
indic
ehbdo
chang
may
occur
cat
cholang
lack
obstruct
ultrasonographi
also
provid
inform
regard
presenc
concurr
diseas
pancreat
inflammatori
bowel
diseas
wedg
liver
biopsi
laparotomi
optim
method
obtain
definit
diagnosi
biopsi
techniqu
may
consid
includ
laparoscop
ultrasoundguid
trucut
needl
approach
trucut
needl
biopsi
diagnos
correl
wedg
biopsi
fewer
case
diagnost
accuraci
laparoscop
liver
biopsi
compar
wedg
biopsi
evalu
laparotomi
laparoscopi
provid
addit
benefit
evalu
sampl
extrahepat
structur
laparotomi
perform
cat
suspect
ehbdo
optim
sampl
strategi
unknown
biopsi
obtain
multipl
liver
lobe
recogn
wide
rang
sever
differ
lobe
cat
patient
stabl
enough
liver
biopsi
hypotens
coagulopathi
fineneedl
aspir
cytolog
offer
lessinvas
diagnost
approach
usual
perform
quickli
light
sedat
howev
liver
cytolog
correl
biopsi
result
case
cytolog
sensit
identifi
presenc
hl
howev
common
misdiagnosi
use
cytolog
cytolog
cholang
common
hepatobiliari
disord
cat
second
hl
although
vari
terminolog
creat
confus
regard
syndrom
clear
felin
cholang
includ
spectrum
diseas
process
includ
form
display
neutrophil
inflamm
lack
neutrophil
inflamm
histolog
nc
character
presenc
neutrophil
lumen
andor
epithelium
bile
duct
diseas
recogn
occur
acut
chronic
form
acut
neutrophil
cholang
anc
edema
neutrophil
inflamm
seen
portal
area
occasion
extens
inflamm
hepat
parenchyma
chronic
neutrophil
cholang
cnc
mix
inflammatori
infiltr
consist
neutrophil
lymphocyt
plasma
cell
vari
degre
bile
duct
hyperplasia
fibrosi
present
depend
chronic
diseas
etiolog
although
true
etiolog
remain
unknown
nc
larg
suspect
caus
ascend
bacteri
infect
intestin
rate
bacteri
isol
use
tradit
method
vari
greatli
less
affect
cat
recent
fluoresc
insitu
hybrid
fish
rdna
probe
recogn
bacteria
gener
use
identifi
local
bacteria
cat
cholang
combin
tradit
cultur
fish
bacteria
isol
three
three
cat
anc
eight
cnc
local
bacteria
identifi
use
fish
support
transloc
enter
bacteria
caus
infect
although
appear
bacteria
play
import
role
etiolog
nc
mani
case
import
note
identifi
affect
cat
author
theoriz
nc
cnc
particular
may
immunemedi
etiolog
persist
inflamm
follow
initi
bacteri
infect
unknown
initi
factor
pathophysiolog
nc
cat
commonli
associ
inflammatori
bowel
diseas
pancreat
pathophysiolog
underli
relationship
diseas
unknown
ration
theori
revolv
around
uniqu
anatomi
felin
biliari
pancreat
duct
system
cat
common
bile
duct
pancreat
duct
merg
prior
enter
duodenum
major
duoden
papilla
cholang
may
develop
secondari
reflux
ascend
bacteria
duodenum
vomit
pancreat
may
result
bacteri
reflux
pancreat
duct
pancreat
duct
obstruct
secondari
cholang
report
case
inflammatori
bowel
diseas
associ
cholang
moder
sever
wherea
pancreat
tend
mild
chronic
interstiti
diseas
nc
also
commonli
associ
extrahepat
bile
duct
obstruct
ehbdo
ehbdo
identifi
cat
anc
cat
cnc
cholang
andor
pancreat
common
caus
ehbdo
cat
one
studi
cat
ehbdo
cholang
repres
cat
neoplast
caus
unknown
whether
cholang
caus
result
ehbdo
histolog
chang
consist
cnc
seen
liver
cat
ehbdo
secondari
pancreat
carcinoma
cholelithiasi
surgic
occlus
common
bile
duct
contrast
cholang
implic
sole
caus
ehbdo
result
prolifer
mucosa
within
common
bile
duct
bacteri
choleret
properti
make
ration
choic
treat
cholang
possibl
immunemedi
mechan
perpetu
nc
particularli
cnc
corticosteroid
may
appropri
case
initi
treatment
alway
involv
antibiot
cat
nc
failur
improv
within
week
antibiot
therapi
clinic
deterior
prior
time
warrant
initi
corticosteroid
therapi
prednisolon
mg
kg
twice
daili
given
initi
gradual
taper
lowest
effect
dose
antibiot
continu
concurr
corticosteroid
minimum
week
durat
corticosteroid
therapi
vari
individu
patient
mani
case
gradual
taper
corticosteroid
month
other
requir
lifelong
therapi
surgic
intervent
requir
cat
ehbdo
howev
optim
surgic
procedur
unknown
biliari
divers
cholecystocholedochostomi
choledochoduodenostomi
cholecystojejunostomi
choledoch
stent
common
procedur
surgeri
cat
ehbdo
associ
signific
periop
morbid
mani
case
profound
hypotens
develop
intraop
minut
result
decreas
vascular
respons
decreas
myocardi
contractil
often
refractori
intervent
fluid
vasopressor
therapi
whichev
surgic
procedur
chosen
clear
anesthesia
time
minim
longterm
medic
manag
necessari
biliari
divers
associ
shortterm
mortal
rate
associ
longterm
complic
small
case
seri
describ
choledoch
stent
cat
pancreat
cholang
five
seven
experienc
longterm
surviv
month
reobstruct
occur
two
seven
chronic
vomit
recurr
cholang
report
prognosi
prognosi
cat
nc
typic
good
surviv
discharg
report
cat
cholang
one
studi
median
surviv
time
month
report
cat
nc
differ
anc
cnc
prognost
factor
identifi
given
high
rate
periop
morbid
mortal
seem
like
cat
ehbdo
wors
prognosi
without
ehbdo
thirti
percent
cat
ehbdo
secondari
inflammatori
diseas
die
within
week
surgeri
howev
surviv
discharg
longterm
surviv
report
wsava
liver
standard
group
describ
lc
common
slowli
progress
chronic
diseas
cat
character
histolog
infiltr
small
lymphocyt
occasion
plasma
cell
eosinophil
restrict
portal
area
associ
vari
degre
fibrosi
bile
duct
hyperplasia
remark
inflamm
center
bile
duct
may
present
hallmark
diseas
also
state
welldifferenti
lymphoma
may
difficult
differenti
lc
base
exist
literatur
regard
lc
cat
descript
wsava
group
includ
sever
clinic
histopatholog
differ
subset
may
may
revolv
around
common
pathogenesi
recognit
differ
subset
within
umbrella
lc
may
therapeut
prognost
ramif
sever
investig
describ
group
cat
lc
inflamm
confin
portal
region
lack
target
bile
ductul
biliari
epithelium
insensit
identifi
cholang
cat
diagnos
fewer
case
cytolog
examin
bile
may
prove
sensit
diagnosi
nc
cat
five
seven
cat
cnc
evalu
institut
bile
cytolog
reveal
neutrophil
inflamm
presenc
bacteria
techniqu
describ
safe
obtain
bile
via
ultrasoundguid
percutan
cholecystocentesi
lightli
sedat
cat
sampl
aerob
anaerob
bacteri
cultur
obtain
cat
suspect
cholang
gallbladd
bile
prefer
liver
tissu
cultur
sourc
group
cat
suspect
hepatobiliari
diseas
bile
cultur
isol
pathogen
compar
liver
cultur
studi
dog
cat
liver
bile
cultur
none
posit
liver
cultur
absenc
posit
bile
cultur
group
cat
cholang
bile
cultur
like
isol
pathogen
vs
less
like
yield
contamin
vs
liver
cultur
small
studi
compar
bile
versu
liver
cultur
cat
variou
hepatobiliari
diseas
bile
cultur
posit
five
four
cnc
liver
cultur
posit
two
two
cat
posit
liver
cultur
organ
isol
bile
import
recogn
mani
cat
nc
hepatobiliari
diseas
mimic
clinic
stabl
enough
toler
diagnost
test
patient
risk
aggress
diagnost
may
outweigh
benefit
obtain
definit
diagnosi
case
diagnosi
may
suspect
base
clinic
respons
support
care
includ
broadspectrum
antibiot
therapi
treatment
optim
treatment
protocol
cat
nc
unknown
recommend
herein
base
sole
anecdot
clinic
experi
antibiot
mainstay
treatment
drug
select
ideal
base
result
bacteri
cultur
suscept
test
case
cultur
perform
result
pend
broadspectrum
coverag
provid
commonli
isol
pathogen
aerob
anaerob
bacteria
enter
origin
includ
e
coli
enterococcu
spp
clostridium
spp
among
other
effect
empir
antibiot
combin
would
includ
penicillin
fluoroquinolon
metronidazol
optim
durat
antibiot
therapi
unknown
recommend
cours
initi
treatment
support
care
treatment
specif
sequela
liver
diseas
includ
indic
nutrit
support
requir
mani
cat
best
accomplish
use
enter
feed
tube
recommend
placement
esophag
feed
tube
cat
cholang
anorex
stabl
enough
gener
anesthesia
unstabl
patient
nasoesophag
feed
tube
offer
lessinvas
method
provid
shortterm
support
sever
medic
nutrit
supplement
includ
ursodeoxychol
acid
udca
milk
thistl
vitamin
e
vitamin
c
carnitin
taurin
phosphatidylcholin
suggest
treat
cat
cholang
compound
theoret
benefit
clinic
benefit
proven
optim
client
complianc
avoid
advers
drug
reaction
prefer
minim
number
medic
given
felin
patient
cat
anc
respond
well
antibiot
therapi
rare
includ
medic
treatment
protocol
howev
cat
anc
quickli
respond
antibiot
mani
cat
cnc
like
use
udca
among
theoret
benefit
udca
immunomodulatori
distinct
lc
welldifferenti
small
cell
lymphoma
challeng
even
experienc
pathologist
preliminari
data
use
immunohistochemistri
pcr
tcell
receptor
clonal
proven
use
differenti
two
condit
surprisingli
cat
lc
lymphoma
monoclon
tcell
receptor
oligoclon
tcell
receptor
polyclon
tcell
receptor
use
light
microscopi
follow
featur
uniqu
lc
present
cat
lymphoma
ductopenia
bile
duct
target
lymphocyt
presenc
lipogranuloma
within
portal
region
repres
residu
marker
cell
death
studi
done
evalu
molecular
techniqu
featur
may
prove
use
differenti
two
condit
interestingli
bile
duct
hyperplasia
fibrosi
present
cat
lc
lymphoma
may
suggest
inflammatori
state
preced
develop
lymphoma
report
anecdot
treatment
therapeut
approach
cat
lc
similar
describ
cat
nc
regard
support
care
symptomat
treatment
sequela
liver
diseas
bacteria
isol
cat
lc
recommend
treatment
broadspectrum
antibiot
await
result
bacteri
cultur
contrast
nc
longterm
treatment
cultur
neg
cat
antibiot
warrant
immunomodul
immun
suppress
major
compon
treatment
base
presum
immunemedi
etiolog
cat
cultur
neg
fail
respond
antibiot
within
day
treat
prednisolon
mgkg
twice
daili
respond
taper
gradual
month
lowest
effect
dose
drug
use
immunomodul
includ
metronidazol
udca
cat
fail
respond
complet
corticosteroid
immunomodul
relaps
treat
may
requir
addit
immunosuppress
drug
although
drug
well
evalu
cat
lc
chlorambucil
methotrex
suggest
author
cat
small
cell
lymphoma
often
respond
combin
therapi
prednisolon
chlorambucil
may
requir
multidrug
weekli
sequenti
chemotherapi
protocol
prognosi
cat
lc
variabl
prognosi
like
result
diagnos
differ
stage
chronic
diseas
process
surviv
greater
year
report
mani
cat
die
appear
succumb
diseas
unrel
liver
case
report
fail
respond
treatment
die
acut
though
uncommon
experi
diseas
like
requir
lifelong
manag
monitor
relaps
ill
possibl
medic
dose
taper
trematod
parasit
famili
dicrocoeliida
opisthorchiida
may
inhabit
gallbladd
bile
duct
cat
rare
dog
multipl
speci
worldwid
distribut
commonli
identifi
speci
includ
dicrocoelid
platynosomum
concinnum
opisthorchid
amphimeru
pseudofelineu
p
concinnum
mainli
found
tropic
subtrop
area
includ
southeastern
unit
state
pseudofelineu
wider
area
distribut
throughout
north
south
america
life
cycl
similar
dicrocoelid
opisthorchid
parasit
egg
ingest
land
snail
subulina
octona
eulota
bradybaena
similari
develop
cercaria
enter
second
refer
lymphocyt
portal
hepat
connect
histopatholog
find
clinic
diseas
cat
unknown
may
repres
common
chang
associ
age
identifi
cat
older
year
age
cat
older
year
age
necropsi
popul
primari
liver
diseas
also
possibl
lesion
repres
respons
inflamm
distant
site
similar
lesion
nonspecif
reactiv
hepat
associ
chronic
extrahepat
diseas
although
clinic
sign
describ
cat
lymphocyt
portal
hepat
common
occurr
concurr
diseas
cat
make
difficult
know
clinic
sign
attribut
lesion
liver
anoth
subset
cat
lc
mark
inflamm
target
bile
ductul
infiltr
biliari
epithelium
lead
progress
ductopenia
case
seem
like
clinic
diseas
attribut
liver
patholog
although
sidebysid
comparison
case
without
bile
duct
target
perform
cat
form
lc
unit
state
similar
clinic
pictur
cat
nc
unit
kingdom
lesion
associ
ascit
icteru
hyperglobulinemia
young
cat
term
progress
lymphocyt
cholang
etiolog
although
etiolog
lc
unknown
theori
suggest
immunemedi
infecti
phenomenon
genet
factor
may
also
play
role
persian
cat
overrepres
unit
kindgom
immunohistochemistri
affect
cat
provid
evid
immunemedi
pathogenesi
although
incit
antigen
unknown
bacteria
identifi
liver
bile
fewer
cat
lc
although
helicobact
pylori
isol
liver
bile
cat
cholang
evid
organ
play
import
role
felin
cholang
compel
time
pathophysiolog
nc
concurr
inflammatori
bowel
diseas
pancreat
appear
common
cat
lc
although
author
report
uncommon
theori
reflux
duoden
bacteria
biliari
pancreat
duct
incit
inflamm
may
hold
true
cat
lc
although
common
immun
mechan
must
consid
clinic
examin
clinic
pictur
cat
lc
vari
wide
signific
overlap
form
hepatobiliari
diseas
cat
includ
nc
although
studi
describ
predomin
older
cat
other
describ
younger
cat
nonspecif
clinic
sign
includ
anorexia
lethargi
vomit
weight
loss
may
chronic
intermitt
physic
examin
find
may
includ
icteru
hepatomegali
ascit
none
consist
find
sign
dull
ptyalism
seizur
may
develop
sever
affect
cat
diagnosi
definit
diagnosi
made
liver
biopsi
discuss
nc
ancillari
diagnost
provid
inform
support
hepatobiliari
diseas
specif
lc
hematolog
result
may
unremark
even
though
mark
lymphocytosi
describ
case
activ
serum
liver
enzym
increas
mani
case
vari
sever
hyperglobulinemia
describ
abdomin
radiograph
ultrasonograph
find
nonspecif
may
aid
recognit
concurr
diseas
amoxicillinclavulan
milbemycin
oxim
amitraz
prior
onset
clinic
sign
propos
toxic
etiolog
base
case
histori
histopatholog
similar
human
idiosyncrat
drug
toxic
toxic
insult
viral
infect
canin
distemp
also
result
destruct
cholang
affect
dog
typic
present
sign
refer
cholestasi
includ
anorexia
icteru
vomit
achol
fece
activ
serum
liver
enzym
total
bilirubin
moder
markedli
increas
abdomin
ultrasound
may
unremark
show
mild
dilat
intrahepat
bile
duct
definit
diagnosi
made
liver
biopsi
optim
treatment
option
unknown
undoubtedli
involv
discontinu
medic
preced
ill
corticosteroid
immun
suppress
antiinflammatori
effect
udca
immunomodulatori
choleret
effect
would
ration
treatment
option
efficaci
document
prognosi
appear
poor
six
eight
report
case
euthan
within
week
remain
two
shortterm
followup
month
nc
describ
cat
rare
report
dog
bacteria
isol
major
case
report
includ
e
coli
klebsiella
spp
proteu
mirabili
streptococcu
spp
clostridium
spp
although
bacteri
speci
would
support
ascend
infect
intestin
literatur
spars
make
conclus
pathophysiolog
diseas
dog
bacteri
infect
could
also
spread
hematogen
via
transloc
portal
circul
clinic
present
diagnost
find
similar
report
cat
nc
affect
dog
present
lethargi
anorexia
vomit
icteru
usual
acut
onset
fever
report
approxim
half
case
neutrophilia
without
left
shift
common
activ
serum
liver
enzym
typic
increas
dog
mild
moder
elev
serum
total
bilirubin
ultrasonographi
nonspecif
liver
vari
normal
hyperecho
heterogen
thicken
hyperechogen
gallbladd
wall
common
definit
diagnosi
made
liver
biopsi
chang
similar
report
cat
nc
dog
degre
mix
inflammatori
infiltr
similar
cnc
infiltr
extend
hepat
parenchyma
major
case
aerob
anaerob
cultur
bile
hepat
tissu
perform
though
bile
sourc
bacteri
isol
case
treatment
involv
antibiot
therapi
guid
cultur
suscept
result
durat
treatment
prolong
antibiot
cours
week
greater
requir
complet
elimin
bile
infect
clinic
improv
preced
bacteri
erad
prognosi
appear
good
case
although
dog
concurr
diseas
may
wors
prognosi
liver
cyst
aris
intrahepat
bile
duct
rare
encount
veterinari
practic
although
cyst
may
acquir
secondari
trauma
neoplasia
inflamm
biliari
obstruct
vast
major
case
describ
literatur
congenit
origin
congenit
cystic
liver
diseas
result
dilat
variou
segment
intrahepat
bile
duct
associ
vari
degre
hepat
fibrosi
cyst
organ
commonli
kidney
littl
known
inherit
pattern
cystic
diseas
dog
cat
variou
morpholog
pattern
cystic
diseas
like
repres
abnorm
bile
duct
intermedi
host
dicrocoelid
tend
use
arthropod
opisthorchid
util
fish
typic
cat
acquir
infect
ingest
second
intermedi
host
case
p
concinnum
sporocyst
leav
snail
intermedi
host
may
eaten
paraten
terrestri
isopod
host
pill
sow
dung
bug
cat
infect
ingest
form
varieti
lizard
amphibian
intermedi
host
cercaria
migrat
cat
intestin
gallbladd
bile
duct
develop
adult
eight
week
infect
egg
pass
fece
complet
life
cycl
clinic
sign
proport
parasit
burden
cat
light
infect
often
asymptomat
clinic
ill
cat
may
present
nonspecif
sign
anorexia
lethargi
vomit
diarrhea
sever
affect
cat
present
sign
ehbdo
icteru
achol
fece
preliminari
diagnost
nonspecif
fluke
infest
eosinophilia
proport
parasit
burden
may
present
serum
liver
enzym
activ
may
mildli
moder
increas
although
normal
mani
case
abdomin
ultrasound
often
reveal
evid
ehbdo
definit
diagnosi
identif
fluke
fluke
egg
fece
difficult
small
number
egg
shed
daili
egg
vari
morpholog
differ
stage
develop
egg
quit
small
fecal
concentrationsediment
use
formalineth
techniqu
reliabl
method
identifi
egg
stool
egg
may
also
identifi
cytolog
prepar
bile
egg
adult
may
seen
liver
biopsi
specimen
inconsist
identifi
histopatholog
chang
seen
liver
character
dilat
larger
intrahepat
bile
duct
associ
papillari
project
mark
periduct
portal
fibrosi
mild
moder
inflamm
may
present
within
duct
neutrophil
macrophag
portal
area
neutrophil
lymphocyt
plasma
cell
eosinophil
may
present
limit
number
rare
chronic
cholang
associ
liver
fluke
result
develop
cholangiocarcinoma
optim
treatment
protocol
establish
praziquantel
mgkg
daili
day
appear
effect
dose
high
mgkg
daili
use
success
dose
also
fatal
cat
sporad
resumpt
egg
shed
follow
praziquantel
report
suggest
complet
elimin
infect
reason
continu
treatment
interv
recommend
symptomat
support
therapi
tailor
individu
patient
cat
ehbdo
requir
surgic
decompress
glucocorticoid
udca
may
benefit
control
inflamm
provid
choleresi
although
infect
cat
may
remain
asymptomat
patient
ehbdo
appear
grave
prognosi
longterm
surviv
report
rare
case
cholang
rare
report
dog
report
cholang
dog
includ
two
distinct
entiti
destruct
cholang
nc
destruct
cholang
character
histopatholog
loss
bile
duct
ductopenia
within
smaller
portal
area
associ
cholestasi
portal
inflamm
consist
primarili
macrophag
neutrophil
occasion
eosinophil
progress
portal
fibrosi
rare
report
lesion
unknown
etiolog
postul
lesion
repres
idiosyncrat
drug
toxic
howev
eight
case
report
literatur
three
prior
drug
histori
two
receiv
potenti
sulfonamid
receiv
adult
polycyst
diseas
commonli
recogn
polycyst
kidney
diseas
persian
cat
also
report
cat
breed
dog
similar
autosom
domin
polycyst
kidney
diseas
human
inherit
persian
cat
autosom
domin
liver
cyst
thought
repres
late
defect
develop
peripher
intrahepat
bile
duct
liver
may
contain
multipl
cyst
rang
less
mm
greater
cm
diamet
cyst
typic
contain
clear
colorless
fluid
discret
fibrot
area
contain
small
irregularli
form
bile
duct
refer
von
meyenburg
complex
may
present
kidney
multipl
cyst
may
form
segment
kidney
may
involv
small
percentag
nephron
popul
contrast
diffus
cyst
seen
congenit
dilat
larg
segment
bile
duct
juvenil
polycyst
diseas
hepat
cyst
present
cat
polycyst
kidney
diseas
hepat
fibrosi
recogn
hepat
cyst
usual
incident
find
anim
clinic
ill
unless
develop
renal
failur
secondari
cyst
kidney
happen
adulthood
biliari
atresia
extrem
rare
congenit
disord
report
one
dog
one
cat
case
common
bile
duct
patent
atresia
dog
occlud
segment
bile
duct
histolog
compris
fibrou
tissu
minim
inflamm
etiolog
unknown
lesion
like
repres
embryolog
nonfus
cranial
hepat
caudal
cystic
anlag
bile
duct
develop
possibl
explan
includ
ischem
toxic
traumat
infecti
insult
occur
preor
postnat
affect
anim
present
month
age
clinic
sign
depress
anorexia
vomit
lame
associ
ricket
inadequ
vitamin
absorpt
affect
anim
show
icteru
hepatomegali
achol
fece
serum
biochemistri
abnorm
consist
ehbdo
definit
diagnosi
made
exploratori
laparotomi
surgic
biliari
divers
viabl
treatment
option
depend
locat
atresia
unsuccess
one
case
report
guard
prognosi
given
anim
undergo
biliari
divers
procedur
see
discuss
neutrophil
cholang
cholestasi
impair
bile
flow
result
accumul
bile
compon
blood
intrahepat
cholestasi
occur
secondari
varieti
primari
secondari
hepatobiliari
diseas
increas
activ
serum
liver
enzym
particularli
alp
ggt
common
intrahepat
cholestasi
specif
condit
clinic
patient
may
appear
jaundic
predomin
clinic
sign
relat
underli
diseas
process
cholestasi
mark
presenc
bile
plug
canaliculi
phagocytos
bile
kupffer
cell
bile
granul
within
hepatocyt
chang
easili
recogn
cytolog
frozen
prepar
less
appar
paraffinembed
specimen
particularli
cat
cholestasi
identifi
ehbdo
rule
easili
accomplish
abdomin
ultrasonographi
anim
intrahepat
cholestasi
lack
dilat
intraand
extrahepat
bile
duct
typic
ehbdo
howev
exploratori
laparotomi
consid
highli
suspici
case
confirm
develop
differ
stage
format
wsava
liver
standard
group
suggest
cystic
disord
classifi
one
follow
group
congenit
dilat
larg
segment
bile
duct
juvenil
polycyst
diseasecongenit
hepat
fibrosi
adult
polycyst
diseas
congenit
dilat
larg
intrahepat
bile
duct
ie
hepat
duct
segment
duct
describ
dog
lesion
similar
caroli
diseas
human
thought
repres
earli
defect
format
intrahepat
bile
duct
diseas
mark
extrem
diffus
grossli
evid
dilat
extrahepat
portion
larg
intrahepat
bile
duct
contain
paleyellow
viscou
fluid
gallbladd
common
bile
duct
normal
separ
embryolog
origin
intrahepat
bile
duct
liver
normal
mildli
increas
size
diffus
cyst
vari
size
throughout
histolog
area
mark
bridg
portal
fibrosi
contain
multipl
dilat
bile
duct
lobular
architectur
liver
normal
although
concurr
ascend
cholang
commonli
occur
human
rare
report
dog
addit
hepat
lesion
affect
dog
fusiform
radial
arrang
renal
cyst
moder
mark
fibrosi
throughout
renal
cortex
medulla
affect
dog
present
earli
life
rang
week
year
clinic
sign
includ
vomit
weight
lossfailur
thrive
decreas
appetit
lethargi
ascit
rare
icteru
neurolog
sign
clinic
sign
typic
chronic
natur
gi
sign
neurolog
sign
ascit
like
result
portal
hypertens
caus
pressur
cyst
portal
vein
hepatomegali
may
note
physic
examin
activ
serum
liver
enzym
typic
normal
mildli
increas
although
mark
increas
activ
alt
alp
report
renal
azotemia
present
patient
ultrasonograph
cystic
dilat
intrahepat
duct
associ
calcif
easili
recogn
even
though
renal
cyst
alway
appar
definit
diagnosi
made
basi
gross
histolog
find
describ
ration
treatment
option
prognosi
unknown
one
dog
literatur
treat
dog
well
lowprotein
diet
month
followup
affect
dog
fairli
stabl
support
care
may
warrant
despit
appear
sever
cystic
diseas
juvenil
polycyst
diseasecongenit
hepat
fibrosi
describ
litter
cairn
terrier
west
highland
white
terrier
cat
form
analog
autosom
recess
polycyst
kidney
diseas
human
inherit
appear
autosom
recess
famili
veterinari
patient
describ
liver
cyst
thought
repres
intermedi
defect
develop
intrahepat
bile
duct
liver
involv
primarili
microscop
includ
fibrot
portal
area
contain
abnorm
structur
dilat
small
bile
duct
result
grossli
enlarg
firm
liver
renal
cyst
present
ident
describ
dog
dilat
larg
segment
bile
duct
affect
anim
usual
present
less
week
age
abdomin
distent
renomegali
hepatomegali
howev
one
cat
similar
lesion
report
affect
anim
ill
die
time
present
liver
enzym
activ
increas
anim
evalu
abdomin
ultrasound
may
identifi
cyst
definit
diagnosi
made
base
histolog
find
describ
treatment
attempt
prognosi
appear
grave
hepat
progenitor
cell
may
identifi
intrahepat
extrahepat
locat
appear
aggress
cours
cholangiocellular
carcinoma
major
present
multipl
lobe
greater
metastas
time
diagnosi
major
pathogenet
mechan
canin
felin
extrahepat
biliari
tract
diseas
obstruct
inflamm
exud
major
caus
extrahepat
biliari
tract
obstruct
ehbo
pancreat
gallbladd
mucocel
dog
cholelithiasi
parasit
infect
cat
tumor
ehbo
common
dog
cat
biliari
tract
inflamm
eg
cholecyst
cholang
primarili
caus
bacteri
infect
nonsept
parasit
especi
cat
gallston
may
associ
biliari
tract
diseas
eg
infect
obstruct
major
appear
clinic
silent
stone
gallbladd
term
cholelith
stone
biliari
tract
term
choledocholith
biliari
tract
exud
leakag
caus
traumat
primarili
bile
duct
spontan
ruptur
primarili
gallbladd
latter
caus
necrot
cholecyst
caus
sepsi
eg
infecti
cholecyst
pressur
necrosi
eg
mucocel
infarct
biliari
tract
tumor
rare
uncertain
caus
common
bile
duct
pass
lesser
omentum
pancreat
parenchyma
enter
mesenter
wall
duodenum
dog
empti
near
open
minor
pancreat
duct
major
duoden
papilla
wherea
cat
join
major
pancreat
duct
empti
duodenum
inflamm
edema
pancreat
may
suffici
caus
compress
obstruct
bile
duct
probabl
common
caus
canin
ehbo
howev
consist
relationship
clinic
sever
pancreat
likelihood
ehbo
possibl
pancreat
affect
differ
region
pancrea
pancreat
rare
caus
ehbo
cat
chapter
discuss
breed
increas
risk
pancreat
caus
gallbladd
mucocel
occur
primarili
dog
case
gallbladd
fill
inspiss
semisolid
mucu
may
extend
bile
duct
caus
obstruct
mucocel
exceed
storag
capac
gallbladd
therebi
caus
pressur
necrosi
wall
gallbladd
also
spontan
ruptur
often
fundu
caus
bile
periton
caus
gallbladd
mucocel
unknown
might
includ
dysfunctionhyperplasia
mucussecret
cell
gallbladd
mucosa
mucocel
may
becom
secondarili
infect
gallston
often
clinic
silent
observ
incident
time
abdomin
imag
associ
cholecyt
rare
caus
ehbo
must
small
enough
enter
cystic
bile
duct
larg
enough
lodg
intrahepat
cholestasi
associ
extrahepat
bacteri
infect
dog
syndrom
well
character
human
may
occur
speci
cat
repres
import
differenti
diagnosi
hyperbilirubinemia
anim
without
primari
liver
diseas
increas
total
bilirubin
report
physiolog
behind
mechan
incomplet
understood
thought
result
reduct
bile
saltdepend
independ
bile
flow
caus
bacteri
toxin
andor
inflammatori
mediat
tumor
biliari
origin
dog
cat
includ
cholangiocellular
adenoma
cholangiocellular
carcinoma
carcinoid
uncommon
repres
less
canin
felin
neoplasm
tumor
epitheli
origin
cholangiocellular
adenoma
carcinoma
common
compris
hepat
neoplasm
dog
hepat
neoplasm
cat
tumor
show
characterist
hepatocellular
cholangiocellular
carcinoma
report
rare
dog
biliari
epitheli
tumor
malign
cat
malign
cholangiocellular
adenoma
commonli
contain
cystic
compon
especi
cat
refer
biliari
hepatobiliari
cystadenoma
speci
cholangiocellular
tumor
aris
predominantli
intrahepat
bile
duct
speci
extrahepat
locat
common
cat
dog
alway
associ
malign
speci
cholangiocellular
carcinoma
like
present
multipl
diffus
tumor
adenoma
carcinoma
highli
metastat
rate
local
lymph
node
peritoneum
lung
common
site
metastasi
etiolog
biliari
neoplasia
unknown
affect
dog
cat
typic
middleag
older
although
anim
malign
may
present
younger
age
benign
diseas
clinic
sign
usual
vagu
anorexia
lethargi
somewhat
chronic
malign
tumor
like
caus
clinic
sign
mani
benign
tumor
incident
find
associ
ill
hepatomegali
presenc
cranial
abdomin
mass
may
identifi
physic
examin
increas
activ
serum
liver
enzym
commonli
associ
malign
often
absent
benign
tumor
even
though
abdomin
radiograph
often
identifi
presenc
hepatomegali
hepat
mass
ultrasonographi
prefer
imag
method
identif
biliari
neoplasm
modal
allow
determin
cystic
natur
tumor
evalu
metastat
potenti
fineneedl
aspir
cytolog
limit
util
diagnosi
biliari
epitheli
tumor
carcinoma
correctli
identifi
via
liver
mass
aspir
case
one
studi
howev
cytolog
recommend
like
exhibit
high
specif
especi
metastat
lesion
surgic
excis
biopsi
optim
diagnost
therapeut
techniqu
tumor
confin
one
two
liver
lobe
surgic
excis
appear
cur
cat
benign
tumor
malign
tumor
carri
poor
prognosi
dog
cat
mani
case
surviv
discharg
surviv
greater
month
report
case
adjunct
chemotherapeut
protocol
report
carcinoid
also
refer
neuroendocrin
tumor
far
less
preval
dog
cat
tumor
biliari
epitheli
origin
tumor
thought
develop
neuroendocrin
cell
epithelium
bile
duct
gallbladd
anorexia
vomit
promin
symptom
fever
uncommon
icteru
inconsist
leukocytosi
often
insignific
even
mark
bacteri
infect
biliari
tract
gallston
gener
asymptomat
associ
cholecyst
ehbo
biliou
abdomen
clinic
mild
condit
associ
lifethreaten
sign
septic
biliou
abdomen
caus
extrem
sever
periton
system
inflammatori
respons
syndrom
eg
anorexia
vomit
abdomin
pain
poor
perfus
fever
death
patient
may
initi
hyperdynam
state
eg
red
mucu
membran
bound
puls
fever
hypothermia
initi
undiagnos
late
hypodynam
state
eg
pale
mucu
membran
weak
puls
hypothermia
intraperiton
bile
seem
make
septic
periton
sever
contrast
anim
steril
biliou
abdomen
eg
consequ
automobil
trauma
essenti
normal
except
ascit
icteru
plain
radiographi
occasion
diagnost
biliari
tract
diseas
gallston
radiopaqu
figur
find
air
gallbladd
wall
gallbladd
ie
emphysemat
cholecyst
figur
diagnost
infect
gasproduc
bacterium
porcelain
gallbladd
ie
radiopaqu
gallbladd
intramur
miner
gallbladd
associ
carcinoma
ultrasound
gener
accept
import
sensit
method
diagnos
extrahepat
biliari
tract
diseas
mani
patient
suspici
biliari
tract
diseas
fortuit
diagnos
ultrasound
radiograph
request
variou
reason
difficult
case
eg
partial
ehbo
versu
complet
ehbo
nuclear
scintigraphi
techniqu
use
howev
seem
rare
requir
diagnosi
ehbo
gener
reli
upon
use
ultrasound
dilat
bile
duct
normal
canin
bile
duct
mm
normal
felin
bile
duct
mm
primarili
caus
ehbo
gener
seen
day
postobstruct
one
unsur
whether
duct
dilat
repeat
examin
day
help
enlarg
gallbladd
diagnost
ehbo
anorexia
starvat
caus
may
thing
howev
fail
find
dilat
gallbladd
parasit
occasion
caus
obstruct
platynosomum
fastosum
ie
p
concinnum
fluke
inhabit
gallbladd
andor
bile
duct
cat
infect
eat
lizard
toad
natur
infect
found
primarili
florida
hawaii
caribbean
may
asymptomat
may
caus
obstruct
fibrosi
rare
caus
cholecyst
tumor
may
caus
obstruct
may
one
common
caus
cat
cholecyst
commonli
caus
bacteri
infect
ostens
bacteri
migrat
bile
duct
variou
gramposit
gramneg
aerob
anaerob
bacteria
eg
clostridium
staphylococcu
spp
enterococcu
spp
streptococcu
spp
klebsiella
spp
e
coli
helicobact
spp
report
infect
caus
gasproduc
bacteria
produc
emphysemat
cholecyst
share
biliari
pancreat
ductal
system
cat
hepatobiliari
diseas
wellestablish
risk
factor
pancreat
cat
asept
inflamm
gallbladd
necrot
cholecyst
report
infarct
one
caus
exud
leakag
bile
abdomen
result
mechan
forc
eg
automobil
trauma
caus
shear
effect
result
transact
common
bile
duct
one
bile
duct
mechan
ruptur
also
report
follow
gunshot
trauma
necrosi
gallbladd
rais
risk
ruptur
gallbladd
occasion
bile
duct
canin
felin
gallston
typic
compos
cholesterol
bilirubin
may
mix
oppos
human
gallston
usual
caus
cholesterol
felin
gallston
typic
calcium
carbon
mix
stone
biliari
tract
diseas
caus
sever
clinic
sign
eg
anorexia
depress
vomit
icteru
abdomin
pain
may
rel
asymptomat
symptomat
patient
serum
biochem
abnorm
eg
increas
serum
alt
alp
serum
bilirubin
hypercholesterolemia
common
patient
ehbo
hyperbilirubinemia
littl
besid
caus
icteru
therefor
patient
extrem
high
serum
bilirubin
concentr
rel
asymptomat
renal
failur
attribut
excess
high
serum
bilirubin
concentr
unclear
bilirubin
caus
common
shetland
sheepdog
appear
increas
risk
biliari
tract
diseas
cocker
spaniel
might
also
see
chapter
besid
icteru
clinic
sign
patient
ehbo
primarili
result
caus
obstruct
obstruct
canin
pancreat
particular
may
caus
sever
clinic
sign
eg
anorexia
vomit
abdomin
painse
complic
liver
diseas
section
howev
patient
pancreatitisinduc
ehbo
sever
pancreat
caus
ehbo
insidi
eg
mucocel
tumor
stone
often
unsuspect
patient
becom
icter
biliari
tract
inflamm
septic
cholecyst
welldocu
dog
cat
shetland
sheepdog
appear
greater
risk
inflammatori
biliari
tract
diseas
breed
clinic
sign
vari
anim
clinic
ill
cholecyst
often
diagnos
ultrasoundguid
percutan
aspir
gallbladd
bile
cytolog
cultur
rel
sensit
specif
procedur
diagnos
biliari
tract
infect
find
dilat
bile
duct
coincid
normals
gallbladd
suggest
cholecyst
prior
ehbo
rare
congenit
problem
caroli
diseas
import
note
patient
bacteri
cholecyst
may
ultrasonograph
gross
abnorm
ultrasound
may
suggest
rel
insensit
cholecyst
consequ
probabl
best
routin
aspir
bile
cytolog
cultur
patient
hepatobiliari
diseas
gallston
rel
easi
diagnos
found
radiograph
almost
found
ultrasonographi
figur
ehbo
underli
caus
alway
primari
concern
ehbo
primari
consider
decid
upon
therapi
pancreat
exampl
primarili
medic
diseas
see
chapter
surgeri
rare
appropri
manag
pancreat
even
caus
ehbo
deem
necessari
ehbo
caus
pancreat
reliev
percutan
aspir
placement
biliari
tract
stent
absolut
necessari
cholecystoduodenostomi
may
perform
surgeri
avoid
possibl
procedur
seldom
necessari
almost
patient
ehbo
caus
pancreat
experi
resolut
obstruct
medic
therapi
gallston
remov
caus
obstruct
cholecyst
usual
better
perform
cholecystectomi
oppos
cholecystotomi
former
lower
morbid
mortal
rate
peopl
presum
dog
cat
well
biliari
tract
tumor
seldom
cure
surgic
patient
ehbo
caus
someth
treat
medic
eg
tumor
pancreat
strictur
traumat
torn
bile
duct
biliari
bypass
procedur
perform
cholecystoduodenostomi
reliev
obstruct
although
surgeri
requir
special
surgic
skill
surgeri
predispos
patient
recurr
ascend
cholecyst
complic
perform
patient
patient
clearli
dilat
bile
duct
suggest
biliari
tract
inflamm
prior
ehbo
dog
ehbo
suspect
acut
pancreat
proven
otherwis
chapter
detail
diagnosi
pancreat
acut
pancreat
elimin
patient
ehbo
one
look
gallston
tumor
first
imag
exploratori
surgeri
laparoscopi
imag
fail
provid
diagnosi
mucocel
readili
diagnos
ultrasound
although
debat
constitut
mucocel
classic
mucocel
describ
produc
kiwi
fruit
appear
without
gravitydepend
bile
movement
sludg
gallbladd
common
find
gravitydepend
movement
clinic
signific
gallbladd
clinic
normal
dog
may
appear
abnorm
ultrasound
examin
figur
patient
signific
biliari
tract
diseas
may
appear
essenti
normal
whether
patient
ultrasonograph
abnorm
gallbladd
becom
symptomat
reliabl
predict
gallbladd
fill
hyperecho
materi
arrow
graviti
depend
dog
asymptomat
biliari
tract
diseas
still
good
health
without
therapi
gallbladd
month
imag
taken
stone
found
fortuit
abdomin
ultrasound
evid
caus
clinic
sign
gb
risk
dehisc
gener
one
either
remov
gallbladd
aspir
gallbladd
bile
gentli
express
gallbladd
leav
undisturb
leakag
associ
septic
periton
true
emerg
requir
immedi
aggress
medic
surgic
therapi
gallston
may
monitor
patient
asymptomat
tumor
rare
resect
gener
inoper
found
rare
exampl
exist
patient
biliari
tumor
cure
surgic
biliari
fluke
treat
praziquantel
mgkg
sq
day
chapter
discuss
pancreat
greater
detail
biliari
mucocel
ruptur
often
good
prognosi
howev
one
report
found
mortal
rate
patient
without
ruptur
versu
mortal
patient
bile
periton
report
author
recommend
preemptiv
approach
ie
versu
wait
patent
symptomat
anoth
group
found
differ
mortal
ruptur
nonruptur
mucocel
ie
gallston
gener
innocu
even
caus
sign
good
prognosi
long
ruptur
occur
bacteri
cholecyst
good
prognosi
long
gallbladd
intact
risk
ruptur
septic
biliou
periton
guard
poor
prognosi
depend
upon
sever
periton
gallston
usual
asymptomat
occasion
caus
problem
usual
easili
remov
resolv
biliari
tumor
usual
poor
prognost
find
late
diagnosi
fluke
treat
without
earli
recognit
extens
tissu
injuri
may
may
resolv
therapi
liver
serv
mani
import
function
includ
metabol
carbohydr
protein
lipid
nucleic
acid
xenobiot
porphyrin
vitamin
miner
glutathion
endogen
hormon
coagul
factor
synthesi
biliari
secret
immun
surveil
see
chapter
surpris
therefor
anim
liver
diseas
experi
broad
rang
complic
reflect
perturb
one
function
hepat
portal
venou
system
account
total
hepat
circul
serv
transport
nutrient
gi
tract
hepat
sinusoid
capillari
hepatocyt
coalesc
central
vein
hepat
vein
caudal
vena
cava
health
multipl
branch
main
portal
vein
venul
capillari
reduc
overal
resist
blood
flow
circuit
parallel
reduc
resist
therefor
pressur
requir
perfus
capillari
maintain
low
level
less
mm
hg
diseas
process
obstruct
flow
intrahepat
branch
portal
vein
sinusoid
elev
pressur
result
signific
portal
hypertens
hepatocyt
swell
imped
portal
flow
acut
pathophysiolog
state
fibrosi
imped
flow
absolut
requir
gener
speak
ehbo
caus
pancreat
resolv
quickli
desir
necessarili
good
indic
procedur
patienc
medic
therapi
gener
resolv
problem
fact
pancreat
complic
surgeri
region
mani
anim
hepat
diseas
concurr
treat
antioxid
hepatoprotect
although
drug
hurt
patient
biliari
tract
diseas
fact
may
benefici
diseas
extend
hepat
parenchyma
cholangitischolangiohepat
care
must
taken
administ
udca
udca
choleret
agent
stimul
bile
flow
could
disadvantag
patient
complet
ehbo
mucocel
usual
need
remov
surgic
medic
manag
may
attempt
eg
fatrestrict
diet
plu
udca
substanti
increas
mortal
rate
patient
experi
gallbladd
ruptur
figur
consequ
surgeri
probabl
safest
cours
patient
risk
immedi
ruptur
long
ultrasonographi
suggest
impend
ruptur
one
make
sure
patient
optim
anesthet
risk
bacteri
cholecyst
uncompl
ehbo
stone
gener
first
treat
antibiot
usual
week
howev
patient
bacteri
cholecyst
cure
antibiot
therapi
ostens
infect
local
gallbladd
mucosa
patient
consist
relaps
discontinu
antibiot
therefor
cure
may
achiev
antibiot
plu
cholecystectomi
perform
surgeri
great
care
taken
avoid
caus
strictur
obstruct
common
bile
duct
postcholecystectomi
bile
duct
obstruct
may
prove
fatal
also
import
avoid
traumat
pancrea
avoid
sever
pancreat
biliari
tract
leakag
treat
base
upon
underli
caus
gallbladd
ruptur
cholecystectomi
usual
appropri
bile
duct
ruptur
difficult
success
anastomos
two
end
instanc
one
gener
must
perform
cholecystoduodenostomi
ligat
end
torn
bile
duct
import
avoid
biopsi
gallbladd
clinic
sign
associ
dog
cat
includ
depress
behavior
chang
circlingheadpress
ataxia
appar
blind
abnorm
swallow
saliv
stupor
seizur
coma
tabl
saliv
much
common
cat
dog
brain
dysfunct
histor
consid
neurotransmitt
dysfunct
current
evid
suggest
lowgrad
cerebr
edema
caus
astrocyt
swell
predomin
patholog
chang
consensu
ammonia
key
toxin
blood
ammonia
concentr
alway
correl
sever
clinic
sign
larg
number
factor
interact
effect
ammonia
precipit
astrocyt
play
central
role
express
glutamin
synthetas
detoxifi
ammonia
reach
cn
intraastrocyt
accumul
osmot
activ
glutamin
result
astrocyt
swell
thu
lowgrad
cerebr
edema
larg
revers
precipit
factor
treat
edema
becom
sever
result
irrevers
cn
chang
sever
acut
precipit
factor
includ
inflammatori
cytokin
benzodiazepinetyp
sed
disturb
amino
acid
metabol
dopaminerg
neurotransmiss
sourc
ammonia
primarili
absorpt
gut
although
sourc
also
exist
result
interorgan
metabol
gutderiv
ammonia
tradit
assum
byproduct
intestin
bacteri
metabol
colon
remain
import
sourc
condit
melena
howev
recent
studi
speci
suggest
small
intestin
enterocyt
metabol
glutamin
main
energi
sourc
import
sourc
postprandi
ammonia
absorpt
portal
vein
also
like
case
dog
normal
diet
unusu
undigest
protein
reach
colon
although
sourc
gutderiv
ammonia
never
investig
dog
normal
dog
ammonia
transport
liver
via
main
portal
vein
metabol
chronic
pathophysiolog
state
sustain
portal
hypertens
associ
mani
complic
liver
diseas
portal
hypertens
import
potenti
lifethreaten
complic
liver
diseas
dog
rare
poorli
document
cat
portal
hypertens
develop
often
dog
chronic
liver
diseas
cirrhosi
occasion
recogn
congenit
lesion
young
anim
arterioven
fistula
hypoplast
disord
intrahepat
portal
vein
branch
result
condit
refer
noncirrhot
portal
hypertens
prehepat
portal
hypertens
develop
secondari
portal
vein
thrombosi
congenit
hypoplasia
extrahepat
portal
vein
less
common
sustain
portal
hypertens
may
progress
splanchnic
congest
gi
ulcer
ascit
encephalopathi
portal
venou
hypertens
produc
vascular
stasi
venou
congest
increas
risk
gi
ulcer
particularli
conjunct
risk
factor
anorexia
steroid
nonsteroid
antiinflammatori
drug
usag
portal
hypertensionrel
ulcer
dog
typic
duoden
although
bleed
esophag
varic
similar
report
human
occasion
observ
glucocorticoid
use
great
caution
dog
portal
hypertens
reduc
system
blood
pressur
anoth
consequ
portal
hypertens
splanchnic
venou
congest
chang
system
blood
pressur
activ
reninangiotensinaldosteron
system
describ
chapter
renal
sodium
retent
thu
increas
total
circul
fluid
volum
increas
circul
fluid
volum
overfil
hypothesi
believ
trigger
event
develop
ascit
anim
portal
hypertens
aldosteron
antagonist
initi
treatment
choic
ascit
caus
portal
hypertens
detail
see
chapter
ascit
neg
prognost
indic
dog
chronic
hepat
although
individu
anim
chronic
hepat
ascit
manag
maintain
mani
month
sustain
portal
hypertens
multipl
acquir
psss
develop
serv
conduit
portal
blood
flow
directli
system
circul
shunt
serv
dissip
increas
portal
pressur
thu
reduc
risk
advers
complic
venou
congest
gi
hemorrhag
ulcer
howev
rais
risk
yet
anoth
complic
liver
diseasehepatoencephalopathi
syndrom
potenti
revers
brain
dysfunct
result
impair
liver
function
result
either
sever
hepatocyt
dysfunct
commonli
presenc
portosystem
collater
circul
either
congenit
acquir
variabl
combin
shunt
portal
blood
hepatocyt
dysfunct
contribut
clinic
sign
acut
chronic
present
acut
often
result
acut
fulmin
liver
failur
see
consequ
hepatocyt
biliari
tract
injuri
section
carri
poor
prognosi
chronic
usual
result
congenit
acquir
psss
platelet
count
ddimer
fibrinogen
protein
c
dog
affect
liver
diseas
coagul
abnorm
also
common
cat
liver
diseas
one
studi
found
abnorm
cat
liver
diseas
multipl
mechan
coagulopathi
possibl
liver
diseas
patient
alf
case
xylitol
toxic
dog
hl
cat
cirrhosi
dog
loss
normal
hepatocyt
function
result
sever
coagul
factor
defici
vitamin
k
defici
also
implic
coagulopathi
particularli
cat
cholestasi
imped
bile
salt
secret
emulsif
micellar
fat
fatsolubl
vitamin
fatsolubl
vitamin
absorpt
concurr
inflammatori
bowel
diseas
pancreat
exacerb
condit
mani
cat
cholang
final
platelet
abnorm
cytopenia
cytopathi
may
contribut
coagulopathi
dog
liver
diseas
liver
uniqu
abil
regul
growth
mass
hepatocyt
loss
caus
viral
bacteri
chemic
injuri
partial
hepatectomi
trigger
hepatocyt
replic
liver
injuri
stimul
hepatocyt
turnov
may
also
stimul
biliari
prolifer
activ
prolifer
hsc
chang
usual
occur
togeth
orchestr
woundheal
respons
case
hepatocyt
loss
normal
quiescent
hepatocyt
replic
restor
liver
function
capac
mass
main
cell
regener
liver
mass
howev
sever
injuri
hepatocyt
turnov
inhibit
senesc
progenitor
cell
reserv
may
also
replic
regener
liver
mass
although
hepatocyt
capabl
replic
slow
turnov
normal
liver
neg
consequ
longterm
increas
stimul
turnov
chronic
liver
diseas
shown
cycl
hepatocyt
suffer
irrevers
eros
telomer
lead
senesc
function
capac
rel
rather
absolut
paramet
set
point
growth
regul
ratio
liver
mass
bodi
mass
rather
liver
mass
per
se
optim
ratio
indic
liver
reach
state
perform
amount
metabol
work
need
meet
function
requir
bodi
gene
express
regener
liver
multistep
process
least
two
critic
step
transit
quiescent
hepatocyt
cell
cycl
prime
progress
beyond
restrict
point
g
phase
cell
cycl
hepatocyt
must
first
prime
fulli
respond
growth
factor
mani
differ
gene
particip
earli
respons
hepatectomi
tnf
appear
major
cytokin
involv
prime
hepatocyt
prolif
effect
tnf
hepatocyt
influenc
reactiv
oxygen
speci
nitric
oxid
glutathion
content
least
four
transcript
factor
nuclear
factor
kappa
b
play
major
role
initi
earli
liver
regener
progress
cell
cycl
beyond
initi
phase
requir
growth
factor
primarili
hepatocyt
growth
factor
subsequ
express
cellcycl
gene
particularli
cyclin
establish
stage
replic
becom
growth
factorindepend
autonom
point
hepatocyt
irrevers
commit
replic
cellcycl
replic
machineri
take
regen
capac
residu
hepatocyt
may
restor
liver
mass
function
much
hepatectomi
progenitor
cell
activ
sever
liver
injuri
appear
resid
nich
particular
regulatori
environ
recent
immunohistochem
urea
hepatocyt
krebshenseleit
cycl
portosystem
shunt
sever
hepatocyt
dysfunct
ammonia
accumul
brain
tissu
taken
astrocyt
result
edema
describ
previous
dog
also
show
disturb
cn
aromat
amino
acid
metabol
aromat
amino
acid
tyrosin
tryptophan
phenylalanin
accumul
cn
portasystem
shunt
brain
tyrosin
metabol
phenylethanolamin
octopamin
act
fals
neurotransmitt
howev
dietari
supplement
branchedchain
amino
acid
eg
leucin
isoleucin
valin
convincingli
improv
either
dog
human
howev
dietari
protein
sourc
appear
better
other
dog
dog
soya
protein
diet
show
lower
plasma
ammonia
concentr
fed
meat
protein
dog
also
tradit
fed
proteinrestrict
diet
howev
protein
restrict
longer
advoc
human
may
digest
type
protein
rather
reduc
amount
import
dog
studi
need
investig
sever
metabol
alter
exacerb
clinic
sign
associ
includ
acidbas
disord
electrolyt
abnorm
particularli
hypokalemia
hypoglycemia
hypoxemia
arginin
defici
cat
import
trigger
human
rodent
inflamm
recent
studi
confirm
inflammatori
cytokin
synergist
ammonia
precipit
control
inflamm
organ
import
part
manag
patient
anecdot
evid
also
true
dog
liver
signific
structur
function
reserv
capac
support
ongo
metabol
need
mild
moder
form
liver
injuri
moreov
liver
abil
regener
liver
volum
cell
mass
recoveri
phase
form
liver
injuri
sign
liver
failur
develop
earlier
acut
form
liver
injuri
chronic
progress
liver
diseas
zone
hepatocyt
hepat
acinu
differ
function
zone
periport
hepatocyt
exampl
high
capac
cycl
ammonia
urea
cycl
therebi
reduc
toxic
ammonia
zone
hepatocyt
nearer
hepat
vein
lesser
capac
ammonia
instead
convert
glutamin
health
zonat
permit
flexibl
hepat
function
metabol
acidosi
exampl
liver
rapidli
divert
ammonia
toward
glutamin
product
necessari
h
ion
excret
kidney
sever
acut
liver
injuri
becom
import
tradeoff
acut
select
destruct
periport
zone
hepatocyt
readili
result
sign
encephalopathi
reduc
abil
zone
hepatocyt
detoxifi
ammonia
chronic
liver
diseas
hepatocyt
undergo
piecem
necrosi
differ
rate
differ
zone
remain
hepatocyt
assum
function
clinic
sign
defici
seen
later
chronic
diseas
process
coagulopathi
complic
acut
chronic
liver
diseas
dog
cat
recent
studi
report
one
coagul
abnorm
prolong
coagul
time
chang
caus
chronic
hepat
usual
unknown
increas
evid
fibrosi
even
form
cirrhosi
human
rodent
model
revers
underli
caus
remov
challeng
remov
caus
also
defin
point
cirrhosi
move
revers
irrevers
state
increas
fibrou
septal
thick
smaller
nodul
size
reduc
cellular
togeth
increas
collagen
crossbridg
associ
irrevers
cirrhot
state
rodent
human
unknown
whether
liver
fibrosi
cirrhosi
dog
revers
clinic
case
chronic
hepat
dog
rare
sequenti
liver
biopsi
long
period
time
assess
progress
diseas
noninvas
marker
fibrosi
remain
valid
serum
hyaluron
acid
increas
dog
cirrhosi
use
marker
follow
progress
clinic
case
assess
identifi
reliabl
noninvas
marker
fibrosi
sequenti
studi
human
dog
remain
challeng
studi
suggest
canin
human
liver
progenitor
cell
function
similar
character
molecular
event
regul
hepatocyt
replic
liver
regener
improv
outcom
anim
affect
sever
liver
diseas
normal
ecm
liver
provid
cell
posit
inform
mechan
scaffold
adhes
migrat
ecm
consist
collagen
glycoprotein
proteoglycan
glycosaminoglycan
molecul
bound
specif
ecm
certain
growth
factor
cytokin
matrix
metalloproteinas
process
enzym
tissu
transglutaminas
procollagen
propeptidas
normal
liver
contain
small
amount
fibrou
tissu
percentag
total
mass
acut
chronic
liver
injuri
caus
dynam
woundheal
respons
product
remov
fibrosi
hsc
major
sourc
collagen
compris
fibrosi
cirrhosi
well
tissu
inhibitor
metalloproteinas
timp
inhibit
collagen
degrad
balanc
collagen
product
hsc
degrad
matrix
metalloproteinas
determin
sever
revers
fibrot
respons
follow
acut
chronic
liver
damag
hsc
stimul
multipli
undergo
complet
phenotyp
transform
quiescent
vitamin
astor
cell
contractil
myofibroblast
synthes
larg
amount
ecm
import
stimuli
hsc
transform
multipl
liver
injuri
includ
oxid
stress
chemokin
includ
plateletderiv
growth
factor
vegf
adipokin
part
innat
immun
system
includ
tolllik
receptor
ligand
role
adipokin
stimul
fibrosi
increasingli
recogn
human
nonalcohol
fatti
liver
diseas
lead
fibrosi
cirrhosi
produc
hsc
well
fat
cell
increas
leptin
reduc
adiponectin
drive
fibrosi
import
dog
unknown
also
unknown
whether
vacuolar
fatti
liver
diseas
progress
fibrosi
dog
import
question
answer
futur
given
widespread
occurr
obes
dog
contractil
function
activ
hsc
contribut
significantli
develop
portal
hypertens
increas
angiogen
chemokin
vegf
plateletderiv
growth
factor
contribut
fibrogenesi
hsc
also
develop
portal
hypertens
two
patholog
process
inextric
link
activ
hsc
greatli
increas
product
timp
particularli
prevent
action
matrix
metalloproteinas
ecm
degre
fibrosi
revers
depend
balanc
perpetu
hsc
prolifer
secret
resolut
hsc
either
apoptosi
senesc
hsc
inde
revers
inact
state
mani
factor
contribut
hsc
apoptosi
senesc
revers
includ
reduct
timp
nuclear
factor
kappa
b
increas
fa
howev
spite
understand
molecular
mechan
fibrosi
truli
effect
treatment
hepat
fibrosi
either
human
dog
yet
found
import
rememb
normal
fibrot
respons
scar
import
wall
pathogen
tissu
injuri
inhibit
respons
without
remov
incit
caus
eg
viral
caus
could
lead
spread
patholog
futur
treatment
strategi
fibrosi
therefor
incorpor
treatment
underli
caus
diseas
clearli
problem
dog
